<SEC-DOCUMENT>0001104659-13-039795.txt : 20130510
<SEC-HEADER>0001104659-13-039795.hdr.sgml : 20130510
<ACCEPTANCE-DATETIME>20130509212800
ACCESSION NUMBER:		0001104659-13-039795
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20130509
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130510
DATE AS OF CHANGE:		20130509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THERAVANCE INC
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		13830860

	BUSINESS ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6508086000

	MAIL ADDRESS:	
		STREET 1:		901 GATEWAY BLVD
		CITY:			S. SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a13-11872_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, DC 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Current Report Pursuant</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">to Section&nbsp;13 or 15(d)&nbsp;of the</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event Reported): <b>May&nbsp;9, 2013</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">THERAVANCE,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact Name of Registrant as Specified in its Charter)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or Other Jurisdiction of<br>   Incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-30319</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">94-3265960</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification Number)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">901 Gateway Boulevard</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;"><br>  </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">South San Francisco</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">, California 94080 <br>  </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">(650) 808-6000</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Addresses, including zip code, and telephone numbers, including area code, of principal executive offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt .25in;padding:0in;text-indent:-.25in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kdefran\13-11872-1\task6040796\11872-1-ba.htm',USER='kdefran',CD='May  9 20:09 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 7.01 Regulation FD Disclosure.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">The information in this Current Report (including Exhibits 99.1, 99.2 and 99.3) is being furnished and shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Securities Exchange Act of 1934&#148;), or otherwise subject to the liabilities of that Section. The information in this Current Report (including Exhibits 99.1, 99.2 and 99.3) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On May&nbsp;9, 2013 at the 32nd Annual Scientific Meeting of the American Pain Society, New Orleans, Louisiana, posters presenting information from Theravance,&nbsp;Inc.&#146;s Study 76 and Study 84 of the Phase 2b program with TD-1211 in patients with opioid-induced constipation were made available for viewing. TD-1211 is an investigational once-daily, orally administered, peripherally selective, multivalent inhibitor of the mu opioid receptor designed with a goal of alleviating gastrointestinal side effects of opioid therapy without affecting analgesia. Copies of the posters are furnished as Exhibits&nbsp;99.1, 99.2 and 99.3 to this report and are incorporated herein by reference.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&nbsp;&nbsp;Exhibits.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="95%" style="border-collapse:collapse;margin-left:.35in;width:95.34%;">
<tr>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="84%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:84.98%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TD-1211   Demonstrates Tolerability and Clinical Activity Following Multiple Treatment   Administration Strategies in Patients with Opioid-Induced Constipation</font></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TD-1211   Demonstrates a Durable Increase in Bowel Movement Frequency and Return Toward   Normal Bowel Function in a 5-Week Phase 2b Opioid-Induced Constipation Study</font></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.86%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.98%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No   Evidence of Analgesic Interference or CNS Opioid Withdrawal for TD-1211 in a   Phase 2b Study in Opioid-Induced Constipation</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_023036_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\kdefran\13-11872-1\task6040796\11872-1-ba.htm',USER='kdefran',CD='May  9 20:09 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.58%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THERAVANCE,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   May&nbsp;9, 2013</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Michael W. Aguiar </font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Michael   W. Aguiar</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.26%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Chief   Financial Officer</font></b></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_023127_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\kdefran\13-11872-1\task6040796\11872-1-ba.htm',USER='kdefran',CD='May  9 20:09 2013' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="86%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:86.26%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TD-1211   Demonstrates Tolerability and Clinical Activity Following Multiple Treatment   Administration Strategies in Patients with Opioid-Induced Constipation</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TD-1211   Demonstrates a Durable Increase in Bowel Movement Frequency and Return Toward   Normal Bowel Function in a 5-Week Phase 2b Opioid-Induced Constipation Study</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;99.3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No   Evidence of Analgesic Interference or CNS Opioid Withdrawal for TD-1211 in a   Phase 2b Study in Opioid-Induced Constipation</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_023212_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\kdefran\13-11872-1\task6040796\11872-1-ba.htm',USER='kdefran',CD='May  9 20:09 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a13-11872_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Poster 376</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">APS2013, New Orleans, LA</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;rvickery@theravance.com</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TD-1211 Demonstrates Tolerability and Clinical Activity Following Multiple Treatment</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Administration Strategies in Patients with Opioid-Induced Constipation</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Neil Singla(1), Daniel Canafax(2), Angela Kang(2), Yu-Ping Li(2), Ullrich Schwertschlag(2), Lynn Webster(3), and Ross Vickery(2)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)&nbsp;Lotus Clinical Research,&nbsp;Inc., Pasadena, CA; (2)&nbsp;Theravance,&nbsp;Inc., South San Francisco, CA; (3)&nbsp;Lifetree Clinical Research,&nbsp;Inc., Salt Lake City, UT</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid analgesics such as morphine continue to play a critical role in chronic cancer and non-cancer pain control.(1)&nbsp;Despite their effectiveness, opioids have significant drawbacks, notably the development of analgesic tolerance and physical dependence, sedation, respiratory depression and bowel dysfunction.(2)</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid-induced constipation (OIC) is common, affecting up to 80% of patients receiving opioids for chronic non-cancer pain.(3)</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 is an investigational, peripherally selective, mu-opioid receptor antagonist designed to alleviate gastrointestinal side effects of opioid therapy without affecting analgesia.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 was assessed in a Phase 2, single-blind exploratory study in 95 adult patients with OIC.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The safety and tolerability of various doses, dosing strategies and dose escalations of TD-1211, as well as efficacy results, from this study are reported here.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Methods</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A single-blind, multi-center, six-cohort study was conducted in chronic non-cancer pain patients with OIC, defined as <u>&lt;</u>5 spontaneous bowel movements (SBMs) over a 2-week baseline period and at least one additional symptom of constipation in at least 25% of the bowel movements.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The first four cohorts received an oral dose of TD-1211 5mg once daily for either 4 days (Cohorts 1 and 2) or 2 days (Cohorts 3 and 4), followed by an increase in daily dose to either 10mg or 15mg for two weeks. Cohort 5 received 2mg once daily and cohort 6 received 2.5mg q6h for two weeks without dose escalation (<b>Figure 1</b>).</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">For at least 14 days prior to Day 1, patients were on a stable chronic opioid regimen, with a total daily dose of <u>&gt;</u>30mg morphine equivalent units (MEU).</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Patients were required to stop laxatives and bowel regimens, except protocol-permitted rescue bisacodyl use, throughout the study.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Electronic diaries collected frequency, timing, and symptoms of bowel movements; use of laxatives and opioids; and daily pain scores.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The primary study objective was to evaluate the safety and tolerability of TD-1211 5mg once daily as an initiation dose, for 4 or 2 days, escalated to 10mg or 15mg once daily as maintenance therapy for 2 weeks.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Additional study objectives were to examine the tolerability and effects of a TD-1211 2mg qd dose and a TD-1211 2.5mg q6h dose administered for two weeks; and to assess the efficacy of TD-1211 10mg and 15mg doses.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Results</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Patient baseline characteristics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">95 patients were enrolled, 16 patients per cohort, except Cohort 6 which enrolled 15 patients.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">12 (12.6%) patients terminated study early; 6 due to adverse events (AEs); 2 each for physician decision and withdrawal by subject; and 1 each for other and protocol deviation.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Demographics</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean age was 48.0 years (range = 22.0 to 65.0) and was similar across cohorts.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">55.8% of patients were female and 78.9% were white.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OIC</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean baseline daily oral opioid dose ranged across cohorts from 93 to 170 MEU, with the lowest and highest doses being 30 and 745 MEU, respectively.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">During the baseline period, 55% of patients used bisacodyl, and bisacodyl was not used more than 3 days by any patient.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean baseline SBMs/week was 0.9 to 1.7; mean baseline complete spontaneous bowel movements (CSBMs)/week was 0.1 to 0.6.</font></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 1: Study Schematic</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="439" height="264" src="g118721mmi001.jpg"></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 1: Adverse Events Reported in </font></b><u><font size="2" style="font-size:10.0pt;">&gt;</font></u><b><font size="2" style="font-size:10.0pt;font-weight:bold;"> 5% of Patients</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="75%" colspan="13" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Safety</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;1</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;2</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;3</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;4</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;5</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;6</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">All<br>   TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Population</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=15)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=95)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any AEs, n (%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7 (43.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11 (68.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9 (56.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8 (50.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (40.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44 (46.3)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gastrointestinal Disorders</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (31.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7 (43.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (37.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (25.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (40.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31 (32.6)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal Distension</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.7)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (5.3)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal Pain</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (26.7)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14 (14.7)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Diarrhea</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (6.3)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Flatulence</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (20.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8 (8.4)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nausea</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.7)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9 (9.5)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nervous System Disorders</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (25.0)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.7)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9 (9.5)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Headache</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (6.3)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 2: GI-Related Adverse Events; 4-Day and 2-Day Initiation Periods</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="27%" valign="bottom" style="padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="70%" colspan="11" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:70.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="bottom" style="padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Combined</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Combined</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="bottom" style="padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;2</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">1&nbsp;&amp;&nbsp;2</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;3</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cohort&nbsp;4</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">3&nbsp;&amp;&nbsp;4</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Safety&nbsp;Population</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">1&nbsp;(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=32)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=16)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=32)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="34%" colspan="5" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:34.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">4-Day&nbsp;Initiation&nbsp;Period</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="34%" colspan="5" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:34.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2-Day&nbsp;Initiation&nbsp;Period</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any GI-related AEs of interest, n&nbsp;(%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (9.4)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (18.8)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal Pain</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (3.1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (18.8)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (18.8)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Diarrhea</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.1)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nausea</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (12.5)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (9.4)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-autospace:none;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vomiting</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (6.3)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (3.1)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 2: Spontaneous Bowel Movements</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="440" height="277" src="g118721mmi002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intent to Treat Population (ITT) - observed cases TMP = treatment maintenance period.</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 3: Complete Spontaneous Bowel Movements</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="433" height="286" src="g118721mmi003.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intent to Treat Population (ITT) - observed cases. TMP = treatment maintenance period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Primary study objective</font></b></p>
<p style="margin:0in 0in .0001pt .05in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 was generally well tolerated at all dose levels tested (<b>Table 1</b>) .</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Initiating treatment with TD-1211 5mg for 4 days resulted in fewer GI-related AEs (<b>Table 2</b>).</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Escalating TD-1211 to 10mg versus 15mg did not produce unexpected AEs or events of greater severity <b>(Table 1</b>)<b>.</b></font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Secondary tolerability and safety objectives</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The majority of treatment-related GI AEs were associated with initiation of treatment, resolved within a few days, and were mild or moderate in severity.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No treatment-emergent serious adverse events (SAEs) were reported.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were no reports of central opioid withdrawal.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No clinically significant laboratory, ECG, or vital sign abnormalities were observed.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Efficacy</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Study 0076 was not powered to show statistical differences between the various doses of TD-1211.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 10mg and 15mg mean change from baseline at Week 2 in SBM frequency ranged from 3.3 to 5.4.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 10mg and 15mg mean change from baseline at Week 2 in CSBM frequency ranged from 2.8 to 4.4.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 2mg demonstrated minimal activity with a mean increase from baseline at Week 2 of 1.8 SBMs and 0.7 CSBMs</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 2.5mg q6h was clinically active with a mean increase from baseline at Week 2 of 4.3 SBMs and 4.5 CSBMs.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TD-1211 Conclusions</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 was generally well-tolerated at dose levels up to 15mg. Majority of GI AEs resolved within a few days, and all GI AEs resolved without sequelae.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">There were no treatment-emergent SAEs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Initiation of dosing at 5mg before escalating to 10mg or 15mg resulted in fewer GI-related AEs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No evidence of centrally-mediated opioid withdrawal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 10mg and 15mg administered orally once a day demonstrated a clinically meaningful response at Week 2.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">These results support further development of a 5mg treatment initiation dose followed by maintenance therapy at up to 15mg qd.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">References</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (2000). Seminars in Oncology, 27, 45-63.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (1990). J. Pain Symptom Manage., 5, 362-367.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Holzer, P. (2012). Current Pharmaceutical Design, 18, 6010-6020.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105537\13-11872-1\task6036964\11872-1-mm.htm',USER='105537',CD='May  9 06:28 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>a13-11872_1ex99d2.htm
<DESCRIPTION>EX-99.2
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.2</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Poster 411</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">APS 2013, New Orleans, LA</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">rvickery@theravance.com</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TD-1211 Demonstrates a Durable Increase in Bowel Movement Frequency and Return</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Toward Normal Bowel Function in a 5-Week Phase 2b Opioid-Induced Constipation Study</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ross Vickery(1), Yu-Ping Li(1), Ullrich Schwertschlag(1), Neil Singla(2), Lynn Webster(3), and Daniel Canafax(1)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1) Theravance,&nbsp;Inc., South San Francisco, CA; (2)&nbsp;Lotus Clinical Research,&nbsp;Inc., Pasadena, CA; (3)&nbsp;CRI Lifetree,&nbsp;Inc., Salt&nbsp;Lake&nbsp;City,&nbsp;UT</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid analgesics such as morphine continue to play a critical role in chronic cancer and non-cancer pain control.(1)&nbsp;Despite their effectiveness, opioids have significant drawbacks, notably the development of analgesic tolerance and physical dependence, sedation, respiratory depression and bowel dysfunction.(2)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid-induced constipation (OIC) is common, affecting up to 80% of patients receiving opioids for chronic non-cancer pain.(3)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 is an investigational, peripherally selective, mu-opioid receptor antagonist designed to alleviate gastrointestinal side effects of opioid therapy without affecting analgesia.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Safety and efficacy results, including the primary and key secondary endpoints, from a 5-week, Phase 2b study in chronic non-cancer pain OIC patients have been previously reported (see also <b>APS 2013 Poster #421</b>).(4)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As mu-opioid receptor antagonists can quickly reverse the effects of opioid agonists on gastrointestinal opioid receptors, demonstration of a sustained response on bowel movement frequency is necessary for a therapy intended for patients taking opioids chronically.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Therefore, additional pre-specified week-by-week efficacy analyses are reported here.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Methods</font></b></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A 5-week, double-blind, randomized, multi-center, placebo-controlled, parallel-group study was conducted in chronic non-cancer pain patients with OIC, defined as <b><u style="font-weight:bold;">&lt;</u></b>5 spontaneous bowel movements (SBMs) over a 2-week baseline period and at least one additional symptom of constipation in at least 25% of the bowel movements.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">For the first 4 days of dosing, patients randomized to TD-1211 received 5mg daily and on Day 5, remained at 5mg or were dose-escalated to 10mg or 15mg daily for the remainder of the treatment period. Patients randomized to placebo received placebo for all 5 weeks.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">For at least 14 days prior to Day 1, patients were on a stable chronic opioid regimen, with a total daily dose of <u>&gt;</u>30mg morphine equivalent units (MEU).</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Patients were required to stop laxatives and bowel regimens, except protocol-permitted rescue bisacodyl use, throughout the study.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Electronic diaries collected frequency, timing, and symptoms of bowel movements; use of laxatives and opioids; daily pain scores; and satisfaction / quality of life metrics.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Week 1 was excluded from the primary analysis in order to confirm the durability of response and predictability of longer term efficacy studies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Results</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Patient baseline demographics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">As shown in <b>Table 1</b>, baseline characteristics were similar for all treatment groups.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Subjects were on a representative spectrum of opioids.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Daily opioid doses ranged from 30-1740 oral MEU.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Back pain was the most commonly reported reason for chronic opioid use.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 1: Patient Baseline Demographics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="55%" colspan="7" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:55.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Placebo</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">5&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">10&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">15&nbsp;mg</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Modified&nbsp;Intent&nbsp;to&nbsp;Treat&nbsp;Population</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=54)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=55)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=53)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=53)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mean Age </font></b><font size="2" style="font-size:10.0pt;">(years)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47.6</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48.3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49.2</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48.9</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Female Gender</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BMI Mean </font></b><font size="2" style="font-size:10.0pt;">(kg/m</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">2</font><font size="2" style="font-size:10.0pt;">)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28.3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27.8</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27.8</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28.1</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Duration of OIC Mean </font></b><font size="2" style="font-size:10.0pt;">(years)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.5</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.7</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.3</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Durability of Response</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">An increase in complete spontaneous bowel movements (CSBMs) was observed in Week 1 vs. baseline for each treatment group (<b>Figure 1</b>). The increased CSBMs per week was sustained for each week during Weeks 2-5, ranging from between 2.5 to 3.3 for 10mg TD-1211 patients, 2.5 to 2.9 for 15mg TD-1211 patients, and 0.9 to 1.2 for placebo patients.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Similarly, an increase in SBMs was observed in Week 1 vs. baseline for each treatment group (<b>Figure 2</b>). The increased SBMs per week was sustained for each week during Weeks 2-5, ranging from between 4.1 to 4.9 for 10mg TD-1211 patients, 4.6 to 5.2 for 15mg TD-1211 patients, and 2.6 to 3.3 for placebo patients.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">In an exploratory analysis, the mean number of days per week with at least 1 SBM ranged weekly between 3.3 to 3.8 for 10mg TD-1211 patients, 3.6 to 3.9 for 15mg TD-1211 patients, and 2.4 to 2.8 for placebo patients. (<b>Figure 3</b>)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">During Weeks 2-5 of treatment, 51-53% of 15mg TD-1211 patients reported <u>&gt;</u>5 SBMs per week compared to 14-29% of placebo patients, indicating a return toward normal bowel function for treated patients. (<b>Figure 4</b>)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tolerability and Safety</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 was generally well tolerated, with overall treatment emergent adverse events (TEAEs) similar between TD-1211 and placebo and gastrointestinal (GI) TEAEs predominant.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The majority of treatment-related GI AEs were associated with initiation of treatment, resolved within a few days, and were mild or moderate.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 1: Mean Number of Complete and Spontaneous Bowel Movements (CSBMs) at Each Week</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="417" height="271" src="g118721moi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 2: Mean Number of Spontaneous Bowel Movements (SBMs) at Each Week</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="461" height="275" src="g118721moi002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 3: Mean Number of Days per Week with at Least 1 SBM</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="416" height="272" src="g118721moi003.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 4: Percent of Patients Reporting <u>&gt;</u>5 SBMs per Week on Treatment</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="417" height="272" src="g118721moi004.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .05in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 2: GI-Related Adverse Events Occurring After the Dose Initiation Period ( <u>&gt;</u> Day 5)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="36%" valign="bottom" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="47%" colspan="7" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:47.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TD-1211&nbsp;Randomization&nbsp;Group</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="36%" valign="bottom" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Placebo</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">5&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">10&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">15&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-top:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">All</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="36%" valign="bottom" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=54)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=56)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=53)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=52)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=161)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any GI-related TEAE of interest</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.6%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7 (12.5%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10 (18.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20 (12.4%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal pain</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.4%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (7.5%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8 (5.0%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mild</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.7%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (1.9%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Moderate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.4%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3.1%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severe</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal cramping</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.7%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (2.5%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mild</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1.2%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Moderate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1.2%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severe</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Diarrhea</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4 (7.1%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (9.4%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11 (6.8%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mild</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.7%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3.1%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Moderate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (5.4%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (3.1%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severe</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (0.6%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nausea</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.6%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (11.3)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9 (5.6%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mild</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 (9.4%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6 (3.7%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Moderate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.6%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3 (1.9%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severe</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vomiting</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (3.6%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2 (1.2%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mild</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" style="padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Moderate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.9%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (0.6%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="36%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:36.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severe</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (1.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1 (0.6%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tolerability and Safety (con&#146;t)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">At target doses (i.e., after the first 4 days of treatment initiation at 5mg for patients randomized to TD-1211), &lt;13% of all patients reported any GI-related TEAE (<b>Table 2</b>). Two severe AEs (diarrhea and vomiting) were noted.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No treatment-related serious adverse events (SAEs) were reported.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No clinically significant laboratory, ECG, or vital sign abnormalities were observed.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TD-1211 Conclusions</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">10mg and 15mg demonstrated a clinically meaningful, sustained response in CSBM and SBM frequency over the duration of the treatment period in OIC patients.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">CSBM and SBM frequency measures indicated a return toward normal bowel function for the 2 highest doses.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Generally well-tolerated with no treatment-related SAEs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Majority of treatment-related GI AEs were associated with initiation of treatment, resolved within a few days, and were mild or moderate.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">References</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (2000). Seminars in Oncology, 27, 45-63.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (1990). J. Pain Symptom Manage., 5, 362-367.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Holzer, P. (2012). Current Pharmaceutical Design, 18, 6010-6020.</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Vickery, R., et al. PainWeek 2012, Las Vegas, NV, September&nbsp;5-8. Poster #121.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106457\13-11872-1\task6040234\11872-1-mo.htm',USER='106457',CD='May 10 02:22 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>a13-11872_1ex99d3.htm
<DESCRIPTION>EX-99.3
<TEXT>


<html>
<head>


  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.3</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Poster 421</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">APS2013, New Orleans, LA</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">rvickery@theravance.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">No Evidence of Analgesic Interference or CNS Opioid Withdrawal for TD-1211 in a</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Phase 2b Study in Opioid-Induced Constipation</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ross Vickery(1), Lynn Webster(2), Yu-Ping Li(1), Ullrich Schwertschlag(1), Neil Singla(3), and Daniel Canafax(1)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)&nbsp;Theravance,&nbsp;Inc., South San Francisco, CA; (2)&nbsp;Lifetree Clinical Research,&nbsp;Inc., Salt Lake City, UT; (3)&nbsp;Lotus Clinical Research,&nbsp;Inc., Pasadena, CA</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid analgesics such as morphine continue to play a critical role in chronic cancer and non-cancer pain control.(1)&nbsp;Despite their effectiveness, opioids have significant drawbacks, notably the development of analgesic tolerance and physical dependence, sedation, respiratory depression and bowel dysfunction.(2)</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Opioid-induced constipation (OIC) is common, affecting up to 80% of patients receiving opioids for chronic non-cancer pain.(3)</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 is an investigational, peripherally selective, mu-opioid receptor antagonist designed to alleviate gastrointestinal side effects of opioid therapy without affecting analgesia.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Safety and efficacy results, including the primary and key secondary endpoints, from a 5-week, Phase 2b study in chronic non-cancer pain OIC patients have been previously reported.(4)</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Additional assessments on daily pain score, opioid dose, and central opioid withdrawal are reported here to demonstrate that TD-1211 is peripherally selective and does not impact centrally-mediated analgesia.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Methods</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">A 5-week, double-blind, randomized, multi-center, placebo-controlled, parallel-group study was conducted in chronic non-cancer pain patients with OIC, defined as <b><u style="font-weight:bold;">&lt;</u></b>5 spontaneous bowel movements (SBMs) over a 2-week baseline period and at least one additional symptom of constipation in at least 25% of the bowel movements.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">For the first 4 days of dosing, patients randomized to TD-1211 received 5mg daily and on Day 5, remained at 5mg or were dose-escalated to 10mg or 15mg daily for the remainder of the treatment period. Patients randomized to placebo received placebo for all 5 weeks.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">For at least 14 days prior to Day 1, patients were on a stable chronic opioid regimen, with a total daily dose of <u>&gt;</u>30mg morphine equivalent units (MEU).</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Patients were required to stop laxatives and bowel regimens, except protocol-permitted rescue bisacodyl use, throughout the study.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Electronic diaries collected frequency, timing, and symptoms of bowel movements; use of laxatives and opioids; daily pain scores; and satisfaction / quality of life metrics.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Clinician Opiate Withdrawal Scale (COWS) was used to assess symptoms of opioid withdraw at baseline and on Day 1 and Day 35.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The primary efficacy endpoint was the change from baseline in weekly average complete spontaneous bowel movements (CSBMs) over weeks 2-5 of treatment.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Week 1 was excluded from the primary analysis in order to confirm durability of response and predictability of longer term efficacy studies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Results</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Patient baseline characteristics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Symbol" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">217 patients were randomized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Opioid Use</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Symbol" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Majority of patients were on opioids for &gt;3 years.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean and median baseline daily oral opioid dose were 145 and 89 MEU, respectively, with a range of 30-1740 MEU.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Subjects were on a representative spectrum of opioids.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Back pain was the most commonly reported reason for chronic opioid use.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OIC</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Symbol" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean duration of OIC was 6 years.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean baseline SBMs/week was 1.1-1.2.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Mean satisfaction with ability to manage OIC was 3.0 (on 1-6 scale); 45% of patients were notably dissatisfied (score <b><u style="font-weight:bold;">&lt;</u></b>2).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">20% of patients reported sometimes taking less pain medication (typically a few days each month) because of OIC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Primary efficacy endpoint</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">All doses of TD-1211 achieved statistical significance for the change from baseline in weekly average CSBMs over weeks 2-5 of treatment. (<b>Figure 1</b>).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Measures demonstrating no evidence of analgesic interference</font></b></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="1" face="Symbol" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The mean average daily pain score (0 - 10 VAS with 10 as worst imaginable pain) was 5.9 - 6.1 across treatment groups at baseline, and the change from baseline at Week 5 ranged from -0.7 to 0.1 across the 4 treatment groups (<b>Figure 2</b>).</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The mean change from baseline in daily opioid dose at Week 5 was -6, -8.9, and -4.3 MEU for the 5, 10, and 15mg TD-1211 treatment groups, respectively, compared with +4.8 MEU for placebo (<b>Figure 3</b>).</font></p>
<p style="margin:0in 0in .0001pt .2in;page-break-before:always;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">On the COWS, with a maximum possible score of 48, the maximum post-treatment score reported was 6 for patients receiving TD-1211 (2 patients) and placebo (3 patients), indicating no evidence of CNS withdrawal. (One patient in the 15mg TD-1211 group had a score of 7 at baseline.) (<b>Figure 4</b>)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 1: Primary Efficacy Endpoint: Change from Baseline in Weekly Average CSBMs over Weeks 2-5</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="367" height="214" src="g118721mqi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy Analysis (EA) Population, diff = Least Squares (LS) Mean Differences from placebo</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 2: Average Daily Pain Scores Per Week</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="370" height="206" src="g118721mqi002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy Analysis (EA) Population. Weeks 6+7 = follow-up period. Asterisk =mean. Black line = median. Blue box = upper and lower quartiles. Whiskers = minimum and maximum score range.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 3: Mean Change from Baseline in Daily Opioid Use on Study Visit Days</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="350" height="213" src="g118721mqi003.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy Analysis (EA) Population. x = mean. Black line = median. Box = upper and lower quartiles. Whiskers = Q1 - 1.5*IQR, Q3 + 1.5*IQR, where IQR = Q3-Q1. Circles = outliers beyond the whisker range.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Figure 4: Clinician Opiate Withdrawal Scale</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="346" height="212" src="g118721mqi004.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Efficacy Analysis (EA) Population. x = mean. Black line = median. Cylinder = upper and lower quartiles. Whiskers = Q1 - 1.5*IQR, Q3 + 1.5*IQR, where IQR = Q3-Q1. Circles = outliers beyond the whisker range.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table 1: GI-Related Adverse Events Occurring in at Least 2 Patients in Any Group</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="56%" colspan="9" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:56.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Placebo</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">5&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">10&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">15&nbsp;mg</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">All&nbsp;TD-1211</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Safety&nbsp;Population</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=54)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=56)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=53)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=52)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(N=161)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="40%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No.&nbsp;of Patients and   Percentage with GI AEs</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(20.4%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(23.2%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28.3%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(26.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(26.1%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal Pain</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11.1%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12.5%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11.3%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(15.4%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13.0%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Abdominal Pain Upper</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3.6%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5.7%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4.3%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Diarrhea</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7.1%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11.3%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7.7%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(8.7%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Flatulence</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5.6%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3.8%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2.5%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nausea</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3.7%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7.1%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(15.1%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5.8%)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9.3%)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vomiting</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(7.1%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1.9%)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.08%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3.1%)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Tolerability and Safety</font></b></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="1" face="Symbol" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">TD-1211 was generally well tolerated, with overall treatment emergent adverse events (TEAEs) similar between TD-1211 and placebo and gastrointestinal (GI) TEAEs predominant. <b>(Table 1)</b>.</font></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The majority of treatment-related GI AEs were associated with initiation of treatment, resolved within a few days, and were mild or moderate.</font></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No treatment-related serious adverse events (SAEs) were reported.</font></p>
<p style="margin:0in 0in .0001pt .15in;text-indent:-.15in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No clinically significant laboratory, ECG, or vital sign abnormalities were observed.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TD-1211 Conclusions</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">10mg and 15mg demonstrated sustained, clinically meaningful response over the 5-week treatment period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Met primary endpoint of change from baseline in CSBMs / week in moderate to severely constipated OIC population.</font></p>
<p style="margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No evidence of interference with analgesia, as noted by stable average daily pain scores and daily opioid doses over the treatment period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">No evidence of centrally-mediated opioid withdrawal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Generally well-tolerated with no treatment-related SAEs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade color="black" align="left"></div>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">References</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (2000). Seminars in Oncology, 27, 45-63.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Walsh, T.D. (1990). J. Pain Symptom Manage., 5, 362-367.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Holzer, P. (2012). Current Pharmaceutical Design, 18, 6010-6020.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Vickery, R., et al. PainWeek 2012, Las Vegas, NV, September&nbsp;5-8. Poster #121.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:9.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\kyangb\13-11872-1\task6040384\11872-1-mq.htm',USER='Kyangb',CD='May  9 16:49 2013' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g118721mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$(`;<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBL[7SJ2Z!?'2`#?B!OLX./OXXZ\9H`T:*\TEFUC[=:BUEUPZ;Y
M]KN:43^9YGS><#QG9C9G^'/3O72>$Y;V2/&K&_\`[4RYNED#"!3N(4)GY<8Q
MC;^-`'3T444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110!Q,_C"YT_6;J">6*X#2B.!%D001@NJ[I'`+1D9Y##GM4US
MXZEM87E.EK.!J!L4%O<;MS`9)^Z`..@)ZUU?V>#Y_P!S'^\^_P#*/F^OK2^1
M#M*^4FTG<1M&"?6@#A'^*21E'DTGRH6FDCWS72H2%91D`CK\W3VIMK\3"K10
M2V<<[R(S*ZWB98YEP`-HX_=]?<5W;6ELY):WB8DY.4!YJ.;3;*XA:&6UB9'4
MH1L`X/N.E`%3PYJ\VN:0E]/:):L[,!&LPDX!P#D`8SZ5-KNJ#1-#O=4:%IA:
MPM)Y:]6P.E2V&G6NF6WV>TC\N/)8Y8L23W)))-)JMT;'2;N[$`N/(A:0Q%@-
MX`R1D^U`&)<^*FT6SMI=6\JXDN4\P+9#[B`;F)W-R`.XY/850G^()N42/2M-
ME,S7*0YN-H7:6=2P`;GF-@.1V-1Z3XA\(W6GPQ7>FVEEND,L,'E"17*J&W(5
M7!/./J"!FI$O_`PGDG_LZSC38EP)6LF5I-^[#!2F2,;CD9[]*`)[;QXDNGI=
M'2[MU_T<.Z^6HS,!MP"^>IP?2B+XBZ>]ND[V%Y$C31QG=L^4.`5;[W3YA[TZ
MPE\+ZCK$NAV6DVDL`A6=I4A'EED.P`<<E<\$9QTK7C\+Z!"<QZ+8H>.ENO;I
MVH`YZ#XB*,M=Z;/%NCWPQ)L8R#>XSNW8&%C)P0.G&<BM?0_%]EK^HRV=M;W$
M91&=9)%`60*0#C!S_$.OK5UO#NB/O#:39MY@`;,"\X.X=O4D_C4MMHVEV=Y)
M>VNGVT-S)D/+'$%9L]<D4`7:***`"BBB@`HHHH`****`"BBB@#E_$VNW.DZI
M;(EVD<!3+1H4,A8M@95N=GNN<=2,5CVOQ-5H]ALXIG6V64-]K0-(QC5^1CCJ
M1D=QTKO&AB=P[Q(SKP&*@D5!<Z587=N\$UK&4<8.T;3CV(Y%`'$6GQ$O5U9;
M>[L`YNW@$=O%*K&W#*2V6`^8]#CCN*D\0^*=0TWQ3<V<.IHD$:1$1E(SL+A\
MY'WSC:IXX'?BNSM-+L;&V2WM[9%C0Y`(W'.<Y)/).3UJ8V\#2&0PQER,%BHS
M^=`'GUK\2I;2QM7O(H;J254\QA<*F/W<;'`V]3O.![=:U_#_`(FN_$>JZK!'
M-':PQP(T"_*[Q'<ZDL/7Y0<'.*ZDVEL>MO%Z_<%/6&)&9EC12W4A0,T`<1HO
MBK41;V;S74.JF^DN5&&2,QB$MT"@[LJ!QZD=C0GQ+$L%C*NE%?MC,%#SC('\
M+`8R03P>F#QS7;);P1[=D,:[>F%`Q0MO`N-L,8QTPHH`\_\`^%H26]K$9["U
MDE-O',Y6]"C#1&0X!7T!'UXJ2?XII$CS?V05A69XP\MRJ%@JDD@8Z\=/<<UW
M1M+8];>(]ON"AK2V;[UO$<G/*"@#C;[Q7J+^$-2U6.>"SEMM0,$)4JVY!(%P
M=^`"02?R-1/X\U'1TGL]3TU9[JSMUFEF\Y8T;<V%'`(R5(Y&1N&/>NY:WA9"
MC0H5)R5*C&:'@A<Y>)&.,9*@\4`<8WCR:SUF?3[NR621+D1D13A@H(C&$^4%
MFR^<'L&YXJ]X0\2W'B*]U-I#&L,7DM!$K!FC#*20Q`'.1R.QXKI?)BW;O*3=
MG=G:,Y]:5(HXR2D:J6ZE1C-`#Z***`"BBB@`HHHH`****`"BBB@#D[;QN//O
MA?6L<,5G<M;-Y,CRR,^2%PNP9S@G@G&.:0>/[0:B89+?_1=[K'<1N7,F%C*[
M5"\[O-`Z]:USX7T<V<UHUL[0SSFX<-/(3YAZL#G(/TQ5=O!7AYY6D.GX8\_+
M-(`IPHRH#84X5>GH*`(D\=Z'+/##')<,T_\`J\6[8;@'KCT/Z'TJ6Y\9Z):W
M#0-<M(57?OAC+H1M9N&'!X1ORJPGA;1(YK>9-/C#VP01$$_+LW;>_P#M-]<\
MU#JOA'2=4+S&`0W1B,<<T9(V9#`':"%.-QZCO0!<T?6K+7+5KBR:3:C;762,
MHRG`(R#SR"#]#6A6?HNC6NA:>EI:@G`!DD8DM(P`&XDD]@/I6A0`4444`%%%
M0I<I)=2VP#;XE5F)'&&SC^1HL!-1437$"B0M-&!&<.2P^7Z^E+'<0RMMCFC<
MXSA6!]J`)**:'4LRA@67J`>13J`"J]]9Q:A8SV<Y<13H4?8Q4X/!Y'2K%1P3
MQW,7FQ-N3)7.,<@D']0:`,F;PGI,_P!E,D<IDM+=K:*3S3O$9&,$_P!>M13^
M"]%N%0213GR[>.W0B=@51`0`.?1F!/<$UM&ZMP@D,\00MM#;QC/I]:6.:*;/
ME2H^,9VL#C-`&9IWA?2M)U!KZRBDBD9&0()6**&(8@*3@<C-:]-5U?.U@V#@
MX.<'TIU`!114<<\<LDL:-EH6"N,="0#_`"(H`DHHHH`***CBGCF:54;)B?8_
M'0X!_D10!)1110`445'-/';JK2MM#.J#C/).!^IH`DHHHH`****`"BBB@`HH
MHH`***BEN8(98XY951Y<[`QQNP,G]*`"XN(;2W>>>01QQC+,>U1IJ%K);Q3K
M*/+E8*A((R2<8QVY]:BF6'6--#6MT`K$/%/'AMK`Y!]#R.E8^H^$_M;M=W&J
MLLOE!9)'A0J<$$DCIMXX!X')H`Z1F502S``=233)+B&*6*)W`>8D1C'WB!D_
MI7(KX5TN=FEDU2.XWL8/WD2,#)MP.#U;G/J1@=!6W'=V.HZA!:V>J0F;3Y"9
M8$`).`5(/IC/:@#8HILDB11M)(P1%&2Q.`*7J,B@!:*B^T1"Y%MN_>E"X7'\
M.<9_6I:`"BBB@`HHJ*WN(KJ!9X6W1OT.,9H`EHHHH`**JWUTUJD+*H;S)TC.
M>P8XS5JG;2XKA16=KD4LNG%(8+F9RZX%O*(V'/WLEAP/3//O61J>CZE+KHE@
M-R]M-M,A^U,@C^4HP"AAZANG;CFD,ZBBN)GE\<3+);R:5&(?,<(\5RH;"E2A
MSD'!Y_#.:ZZP:X:P@:Z4K.8QYBMC(;'/0D?E0!8HHHH`****`"L^V_Y#M]_U
MQA_]GK0K/MO^0[??]<8?_9ZJ.S_KJ2]T59-$:ZEU59X+2.*]C$:-&"6.,X+@
MC!()]_TK+3PQK=O:`6>HVEO<_:A(9$B('EGEUXQ_&20#QTS7745)1QEEX<\4
MP)+]HUBVDFDBV^<AD5BP8E2>YX..O>NR7.T;L9QSBEHH`*S]$&=+`_Z:S?\`
MHQJT*S]$_P"08/\`KM+_`.C&JE\+_KN3]I&>WA^:?2KFW>&R@G>Z%Q%Y2EHP
M1C!((X)`(./7-9Y\+Z_;P01:?JUO:[+>2*0K&PW'I$>".B@`]QCBNPHJ2CE=
M+T+Q%:,IN=2MG/GQRR&,NHDP,/D=R>O/?KFNJHHH`*H6'_(0U/\`Z[I_Z*2K
M]4+#_D(:G_UW3_T4E5'9DO=%^BBBI*"J&F_\?.I?]?7_`+32K]4--_X^=2_Z
M^O\`VFE4MF2]T7Z***DH*H:O_P`>\'_7W!_Z,6K]<IXL\3P:;J-CI8A:>:66
M.5@C`%0'!`Y[G%.+2DKC4)3NHHZNBL/_`(2&]_Z%S4OR3_XJC_A(;W_H7-2_
M)/\`XJHYD:>QG_31N45A_P#"0WO_`$+FI?DG_P`51_PD-[_T+FI?DG_Q5',@
M]C/^FC<HK#_X2&]_Z%S4OR3_`.*H_P"$AO?^A<U+\D_^*HYD'L9_TT;E%8?_
M``D-[_T+FI?DG_Q5'_"0WO\`T+FI?DG_`,51S(/8S_IHW*HZC8/?F%1.(XU+
M>8NS)<%2.#D8ZY[U1_X2&]_Z%S4OR3_XJC_A(;W_`*%S4OR3_P"*HYD'L9_T
MT07_`(5EOK>V0WZ+)"SO(Y@)#EL=`'&T<=.:JZ=X;U&VNM5:>5)1-#'%`S#`
M;:![G`..<UH_\)#>_P#0N:E^2?\`Q5'_``D-[_T+FI?DG_Q5',@]C/\`IH6;
MP\U[<QW5U>2J\5T+B-(B4"C`^1L-ANG7WZ57O?"]U?BZ2?5%\N5W>();;3'N
M(ZMNR>!CC'K4_P#PD-[_`-"YJ7Y)_P#%4?\`"0WO_0N:E^2?_%4<R#V,_P"F
MBM#X<FCE%TK[9(I&(B;YEE!7:<\_+N)+=R,XK?M(#;6<,!<N8HU0L>^!C-9/
M_"0WO_0N:E^2?_%5')XFNXR`?#.K-G^ZB'_V:CF0_83?_#HOM_R,:?\`7FW_
M`*&M:-<B?$MS_;*S?\(YJV1;,OE^4N[[P.>O2K?_``E=U_T*^L?]^E_^*JI2
M6@HT*FNGXHZ.BN<_X2NZ_P"A7UC_`+]+_P#%4?\`"5W7_0KZQ_WZ7_XJIYD5
M]7J=OQ1T=9V@_P#($MOH?YFLX>*KK//AC60/^N*__%55TCQ)-!I<$0\/:O(%
M!^=(%*GD]/FJE)<K^7ZDNA4YEI^*\CK**Y__`(2F;_H6M:_[\+_\51_PE,W_
M`$+6M?\`?A?_`(JIYD5["IV_%&AK'^JM?^ON'_T(5H5P/B'Q?>Q7UB!I-[%"
M958V]Q"%>1E.?D(8_3&*ZZ#6K25$WEX)&;:8I$(96V[L'WQ5<R:1$J%2#NUN
M8D\>N6NHZI?V0NI@9%C@MYR63&!EE&_&">,\$<GGI3;:X\1Q76V*TGQ+)AFN
M?G5!N;&/F&!C!SST`QSQNKKFFM$D@N04<(5.T\ASA>W<TY]:T^-79[@`('+?
M*>`APW;M2NA<D^QDV]]XHDM)Y'LX$>)N`\9#.O4E0&.3VP2*?HFK:K?:K+;7
M4*+'!&/-_=[#&YQ@??/49./3'/-:@U:Q,B1B<;G<(HVGEBNX#IZ<TS^V]-$?
MF?:`%*JV=AZ,=J]O6BZ#DEV-"BJ+:Q8*Q4W`!42$_*>B?>[=JRKKQC:Z?JAM
MKV)DM7*K%=(=PW$9PR]1^M#DD5&C4D[)'1T4BL&4,IR",BBF9"UGVW_(=OO^
MN,/_`+/6A6?;?\AV^_ZXP_\`L]5'9_UU)>Z-"BBBI*"BBB@`K/T3_D&#_KM+
M_P"C&K0K#T?4=EIY7V2Y.+F=-X3Y3AF;.?0]![U7V7_7<23<M#<HK-76=T:/
M_9]Z-_E\&+D;_7GMW]*4ZP!&[FPO/E1WP(LD[6Q@<]3U'M471I[.78T:*HG4
MU$@3[)='+E,B+@87=GZ=OK2#5E*!_L=WR(^/).?G./T[^E%T')+L7ZH6'_(0
MU/\`Z[I_Z*2L[7?$%Q8::]S:V[(T(:1OM,95&53@KGLQ[>M4-$\6I="ZNSI.
MHCSY%;;'`7`_=J.OX9^A%-26J_K<IT*CBI):7_0O77B&;2K"[O+M8[E8[L11
M^2=BA6(`R2>2,\U'I_C.WU'4;:SBMOFG21RPF5MH7MQU/3CMFK7_``D\?_0)
MU7_P%-5SK-DUZ+TZ)JIG5-@?[,W3Z9Q4\R#V-3L1GQ%J!MKN0VIB6/3C=Q3,
M@,9;&0/O9[@8P.0:H:/XHGC?RQ$NIR7L^5GMR(T+>2I(P2>A&WKUK8B\0V\$
M?EQ:-JB+DG`M#CGGUJG!KL$AU&*72M3>.><[E6W.0#&@P<'@\?K5J2LR71G=
M:%RW\2&ZO!`D'E%&BWHYY*29VD>G(Z5O5@'7[8F(G1M4_=?<_P!$/R\8]?2I
M/^$GC_Z!.J_^`I_QJ.9%>QJ=C;K@_&>BV$GB+1`T))U"](N&W'+#:H`![#Z5
MLW7BY%MI?(T[44F"G:TEFVT'W]JYN+6[CQ??Z)=BQ>#^SKP&X?&8VW$*-I]<
M]J%).21O3I5:<95-E9_D[?B>BH@C14&<*`!DYIU%%4<84444`%%%%`!1110`
M4444`%%5=0NS96AE5`[DA$5FV@L3@9/89[UFW7B:*Q`BN8";E2HD2'+J,MMP
M&QR<'.,`XH`W**P9?&.EQLJHMU,S_<$5NS;P%+$CV&#^(K2N;N>*:U$=N'CF
M;:Y9]K(".H7'/OR*`+E%%%`&<W_(QI_UYM_Z&M:-9S?\C&G_`%YM_P"AK6C5
M2Z$KJ%%%%24%9V@_\@2V^A_F:T:SM!_Y`EM]#_,U2^%_UW)^TC1HHHJ2C*UF
MUMS+:71AC,XN8D$I4;@N\<9]*U,#T%4-8_U5K_U]P_\`H0K0JG\*%?43:/04
M;1Z"@\#@9]JQ+G7+RUTXW4MC$K+<^2X,YVX/"L&V\Y)`Z#G/I4C-O`]!1M'H
M*YR+QMIR0++?O';^9!YZ!'+Y7`R.@YW9'X5HZ-K=OK23-!@B)L;E.05(RISC
MN"#B@#2P/051&BZ>-4;4VMP]VP`$CG=L`_N@]/PJ_118:DULPHHHH$%9]M_R
M';[_`*XP_P#L]:%9]M_R';[_`*XP_P#L]5'9_P!=27NC0HHHJ2@HHHH`*S]$
M_P"08/\`KK+_`.C&K0K/T3_D&#_KM+_Z,:J7PO\`KN3]I&A1114E!1110!!=
M6=M>HJ74"3(CAU5UR`PZ&J]@,7^I`<`3I@?]LDJ_5"P_Y"&I_P#7=/\`T4E5
M'9B;>B+]%%%2,*H:=_Q\ZE_U]?\`M-*OU0TW_CYU+_KZ_P#::52V9+W1?HHH
MJ2B.>"*Y@>"9`\<@VLIZ$50U"WAM;"U@MXDBB2Z@"HBX`'F+VK3JAJ__`![P
M?]?<'_HQ:J'Q(4F^5HOT445(PHHHH`****`"BBB@`JG>WC6LUHH\O;/+Y9#M
M@_=)&/RJY4<D$,S(TL2.8SN0LH.T^H]*`,&X\06\6D1?VU:H_P!I=XGBBP\?
M!Z98C(QWJG'J'AG4ENK>+1XI?LEFCE7ACV[#RB=21S[8X-=-+86<T:1RVD$B
M1_<5XP0OT':JT.@Z;!/<RQVZ@W*;'4?="XQ@#L*`,*673+.>&WDT6SDDEO/L
MS-;VY944J%^8@'!P<8.,BF7&OV\6I74^HV5E-#I<SQP>3\UQ'M16W`'@9SCC
M'.*ZJ&SMX%VQPH,L&8[1EF_O$]S[TW^S[(22R?8X-\PQ(WE+E_J<<T`9?_"4
MVLGE1QPRQRSOY<(GVJK.5+*,Y[J,^O-;%M.MU:Q7"`A94#C/H1FH/[+M#"T3
M1[PSE\L<E21C@]L#@8Z"K2JJ*%4`*HP`.PH`H-_R,:?]>;?^AK6C6<W_`",:
M?]>;?^AK6C52Z$KJ%%%%24%9V@_\@2V^A_F:T:SM!_Y`MM]#_,U2^%_UW)^T
MC1HHHJ2C/UC_`%5K_P!?</\`Z$*T*R?$=W;V.GPW=U*L4$5U$SR-T4;QR:TH
M)XKF%9H)4EB<95T8$$>Q%6_A1*W9D>(-6O-.N=-M[.&&4WL[1N)"<JH4L2`.
MO`-94>N:5'&8;2RM(=.)WS1.H#,<GD*,@YPI_GBNL>&*21)'B1WC.49E!*GV
M/:H?[-L-RM]AM\J20?*7@GKV]Z@HYI=7\,W4\%M)H>7>.2.-6MHV^4\NH`)R
M#AN!G.#UJ6WU_P`/:5</%9Z8]LS$*_EP)&>A(R"0>@Z$9KI([.UBV>7;1)Y8
MPFU`-H]!Z=34%SI%C=W,-Q-;HTD,GF*<#EL$`GUQGO0!<!R,BEHJ%[NVCN8[
M62XC2>4$I&S`,P'7`[T`34444`%9]M_R';[_`*XP_P#L]:%9]M_R';[_`*XP
M_P#L]5'9_P!=27NC0HHHJ2@HHHH`*S]$_P"08/\`KM+_`.C&K0K/T3_D&#_K
MM+_Z,:J7PO\`KN3]I&A1114E!1110`5GV3*E]JC,0JK,I)/0#RDJ[++'#$TL
MLBQQH,LS'``]2:H6.)KK4RC*RO*NUOO`YB3\Q51V9+W1<M;J"]MH[FUE66&0
M91U.0P]14CNL:,[L%51DDG``K`U'PLU]:V4*7JQFUW9)A+!BQ!X`88''`YXJ
MGIOAG4+:XU-YY8Y#-'''$Y&`VW';)P#C!!J2CH;G5].M+9KFXO(HX48*SEN`
M3T'UYJ'1YXKEK^>"19(I+G*NIR"/+2JH\/20VTXLKV2"6>X2XS/NG"$8.T`L
M.,CUK%LO".-1U.X\]YGEN55L?(%;"NTF,XZL1C'0XS5+9DO='9B5#*8@XWJ`
MQ7/(!Z']#3ZQ]*T:33;K_6AX45Q'\N"`S`A>O(4+U/7-;%24%<)\4M2OXM'3
M3]/@D+2LDDLPR%10ZA1N]2Q'X9KNJY3QS=VU[X*EFM9XYXC<VX#QN&'^N3N*
MNG\2$]ANC>&-*U/2H+N:WO[>5UQ)$]W*"C@X8=?4&KW_``A.C?\`3Y_X&2__
M`!5=!12YGW"QS_\`PA.C?]/G_@9+_P#%4?\`"$Z-_P!/G_@9+_\`%5T%%',^
MX6.:/@/1R<^=J`_[?9/\:/\`A`]'_P">VH_^!LG^-=+11S2[A9'-?\('H_\`
MSVU'_P`#9/\`&E7P+I*'*W&I*?47TG^-=%)(D4;22.J(HRS,<`#U)J..\MIH
M$GCN(GBD(".K@JQ/3![T<TNX61A_\(3IO_/WJ?\`X'R_XT?\(3IO_/WJ?_@?
M+_C715%+<P0211RS1QO,VV-68`N>N!ZFCF?<+(PO^$)TW_G[U/\`\#Y?\:/^
M$)TW_G[U/_P/E_QKHJ*.9]PLCG?^$)TW_G[U/_P/E_QH_P"$)TW_`)^]3_\`
M`^7_`!KHJ*.9]PLCG?\`A"=-_P"?O4__``/E_P`:/^$)TW_G[U/_`,#Y?\:Z
M*BCF?<+(Y$^#]/\`[<2'[5J6TVS-G[=)G[P[YJY_PA.F_P#/WJ?_`('R_P"-
M:+?\C&G_`%YM_P"AK6C52D]-1);G._\`"$Z;_P`_>I_^!\O^-'_"$Z;_`,_>
MI_\`@?+_`(UT5%3S/N.R.=_X0K3?^?O4_P#P/E_QJCI/@W3[G2(7:[U-"RG[
ME](,<GIS785G:#_R!+;Z'^9JE)\KU_K45M3'_P"$`T__`*"VM_\`@QDH_P"$
M`T__`*"VM_\`@QDKJ:*7/+N.R."\0^`X4TP+9ZEJ;SRS1QH+F_D:/)8#)%:/
MAKP''X<T^2WBU>^:29,.5?:BG(.57L>V:W-8_P!5:_\`7W#_`.A"M"J<Y<J0
MDM3/;2W,A?\`M*\&6=MH<8&Y<8Z=!U'O2)I3HJC^TKQMOE\EQSL'.>/XN_K6
MC16=RC+;1I&B9/[5OP3&R;A(,C+;MW3J.@]JE;3'9BPU&[&79\!Q@97&.G0=
M1[U?HHN!E#1IQM_XF]Z<&(_>'.SKV_B[U@^)?"&H:U)9VT5T&CC#E[R=LR1$
MMD%`,'<.@.<8KLZ*:DT[BL5M/M&L;&&V>YFNFC7!FF(+O[FBK-%2,*S[;_D.
MWW_7&'_V>M"L^V_Y#M]_UQA_]GJH[/\`KJ2]T:%%%%24%%%%`!6!9:=<7=@S
M0ZI<V@9W4+$%PI$S$D9!Y(X/M6_6?HG_`"#!_P!=I?\`T8U6OA9+^(8^E73%
MR-9O%W>;@`)\N\?+CC^#M^N:0:3=AXF_MJ\(22-RN$PX5=I4_+T8_,??IBM2
MBINRC(.C7AMVB_MV^#&()YF$R"'W;ON]2/E^GO3WTF[>4N-:O$&93L`3'SC"
M_P`/\'4?KFM2BB[`Q+_2;TV,VR^NKQAL;[,_EA9@JX,9)7`5SR?TKEO"W@O6
M+2&[MY/$=W8,DP)@L]C(N55L9=3T!`XP.*]$JA8?\A#4_P#KNG_HI*N,G9DM
M:HQ_^$4U7_H<]8_[YA_^(H_X135?^ASUC_OF'_XBNGHJ>=CL<Q_PBFJ_]#GK
M'_?,/_Q%5++PQJ<D]Z!XOU92EQM)"P_,=B')^3WQ^%=E5#3?^/G4O^OK_P!I
MI5*3LQ-:HQ_^$4U7_H<]8_[YA_\`B*/^$4U7_H<]8_[YA_\`B*Z>BIYV.QS'
M_"*:K_T.>L?]\P__`!%<M9>`-1MY);K5M2F6"ZO(=UG&R_O/WBX9RH`SW^45
MZA5#5_\`CW@_Z^X/_1BU<)N]A26A?HHHK(H****`"F-)&CHC.JLYPH)P6[\>
MM/JCJ-I-=26IB\H".0EV<'<%*D?+COS0`Z\A35-.>.WGC.XY1QAUW*>X[C(P
M16+?^&]1O6$IU"!',>'18W6/=NR<`../?KD=:27P_JR:9'!97L5O,)VD?RV>
M-,8P``OT!.>^:@L=*\0+?W\=Y=22Q&R$,1,K["Y'49/X9P#UY.>`!DGABXO6
M#S:\LJA@'"O(%=O+*@'$G8L#CV&<GFMJ6**\N+.TBO;;S+)@\L:L6D&!@8&[
MC_@0/7UYJK)H%S>O'*9_L21W4=Q'%"!R`%R'R#\W!`(]:KW'AK4)K[49HI[2
MW%S*98IHE99E)C5,%AT'RYX[XH`ZAF"@LQ``ZDTM<Q!H^J*$=[N>98'`EBGD
M9A<`)AL#=C#,<C/3TK?L(9+>P@AF??)'&JLWJ0*`+%%%%`!1110!G-_R,:?]
M>;?^AK6C6<W_`",:?]>;?^AK6C52Z$KJ%%%%24%9V@_\@2V^A_F:T:SM!_Y`
MEM]#_,U2^%_UW)^TA-=@FN+`)!!/+)YBD>1,(V3G[V21G'IWK*U71=0FUU;B
MU1GMYRGG$W3J$&UD;`#=<%3T[>M,>'7K;4[^\M!<R++<I&D4S;E2/&2Z`OC!
M.!T!`R<'I389/$<6([6TG7=(H+7;"0`<YYWY``YSZX&.21)1B^(U\<W&GP6R
MV<**;L`,MPH88D4QG/!P0/7.,YKO[(SFRA-TK+.4'F!L9#=^G'Y5RMW/XI?3
MUDNH;9)%O(=B;.2-P/&&P3U')'3-:.@:CJU[?W,5ZJB.#Y'`C"E'P#C(8Y/)
M[>G-4]D);LZ"BBBI&%%%%`!1110`4444`%9]M_R';[_KC#_[/6A6?;?\AV^_
MZXP_^SU4=G_74E[HT****DH****`"L_1/^08/^NTO_HQJT*S]$_Y!@_Z[2_^
MC&JE\+_KN3]I&A1114E!1110`50L/^0AJ?\`UW3_`-%)5^L9KB2VEU-XMH=K
MJ)%+]%RD8R?SJH[,E[HL75]<6^JI$/(-M]G>1QG][N'3N`%QW]?2L-OB%IRV
MC3FW;(**$%Q"<EC@<AL#J/SIUUK4BZ4UP-9M(\7PMS=?9\C;W4@GMSSGM58Z
MM'?!+2?15N'B$<ADBD:$/G@';C."2O!R/F]JDH[,'(!QBN:&OM9:MJ=I;Z5>
M:@Z7`9S;!"$S&F`<L.>#5S3M7FU)MJ1K"724*I!/E.C;>>F0<@_@>:Y_PMH4
M]EXOU.9;]I'@=%N2R\3[XPQ/MAC^52Y-:+J=%&G"2E*?1;&S_P`)/>_]"MJ_
M_?,?_P`71_PD][_T*VK_`/?,?_Q==#119]Q>TI_R?B_\SGO^$GO?^A6U?_OF
M/_XNJFI>([N6&('PUJJ8N(FRRQ\X<''WNIZ5UE4-7_X]X/\`K[@_]&+513YE
MJ3*I3M\"^]_YF;_PD][_`-"MJ_\`WS'_`/%T?\)/>_\`0K:O_P!\Q_\`Q==#
M14V?<KVE/^3\7_F<]_PD][_T*VK_`/?,?_Q='_"3WO\`T*VK_P#?$?\`\770
MT46?</:4_P"3\7_F<[_PE5W_`-"MK/\`W[3_`.*H_P"$JN_^A6UG_OVG_P`5
M71446?</:4_Y/Q9SO_"57?\`T*VL_P#?M/\`XJGQ^)[AL[_#>KQXZ9A4Y_)J
MWZ*+/N+VE/\`D_%F'_PDDO\`T`-6_P"_`_QH_P"$DE_Z`&K?]^!_C6Y119]Q
M<\/Y?Q,/_A))?^@!JW_?@?XT?\))+_T`-6_[\#_&MRBBS[ASP_E_$P_^$DE_
MZ`&K?]^!_C1_PDDO_0`U;_OP/\:W**+/N'/#^7\3#_X227_H`:M_WX'^-'_"
M22_]`#5O^_`_QK<HHL^X<\/Y?Q.6/B"3^W$E_L35,BV9=GDC=]X<]>E7?^$D
ME_Z`&K?]^!_C5MO^1C3_`*\V_P#0UK1JI)Z:B4X:^[^+,/\`X227_H`:M_WX
M'^-'_"22_P#0`U;_`+\#_&MRBIL^X^>'\OXG%7_C>]L-<MX#I-TT%P,"W>+;
M,#ZK@G(^N.E:V@:FYT:V']GW@Y9<F,=LG/7H>GUK9%G;+=M=B",7#*%,NT;B
M!VSZ54T'_D"6WT/\S513Y7KU_P`QU*E.3BHQMH.74W9@O]GW8R(SDQC`W]NO
M\/?TIHU9S$7_`+,O>%9MOEC/RG&.O4]1[5HT4M2+Q[&'JU^S>3']BN1LOHUW
M%!AL8;(YZ'I]:N)JCNJ'^SKQ=PC.&C'&X]^>W?THUC_56O\`U]P_^A"M"J:?
M*B4XW>AG-JKK$\G]FWIVASM$8R=IQ@<]^H]JD&H,9=GV&Z'S[=VP8^[NSUZ=
MOK5VBIU*O'L9PU9S$DG]FWHW!#M,8R-QQSSVZFE;5'5';^SKP[5=L",9;:<8
M'/4]JT**-0YH]BB=282*GV"[.Y]F[8,#Y=V3ST[?6L'4?%MWIFKP1O8M+;W,
M:%;<+BX4G.<+D[L8YZ8KK*@6RM5O'O%MXQ<.H5I=HW$#H,TFGT9=.<(OWHW)
M8W\R-7VLNX9PPP1]:*=15&(5GVW_`"';[_KC#_[/6A6?;?\`(=OO^N,/_L]5
M'9_UU)>Z-"BBBI*"BBB@`K(T:_M%LA"UQ&)!<2H5W<[B[$#ZXYK7K,T6&(Z<
M&,:%O/E.=HSGS&YJOLO^NXM.;4G_`+6T[;N^VPXVA\[Q]TG`/XGBG?VG8@D&
M[BR-^?FZ;?O?EWJ7[-!C'D1XP!]P=.M+]GA_YXISG^$=^OYU&II[A`-3L2^P
M7<1;<J8W#JPR!^(YH&JZ>4WB\A*[0^=X^Z3@'\^*G^SPYSY,><@YVCJ.!2?9
MX,8\F/&,8VCIUHU#W2AJ.O6UE:/-#B[>-F#11.-WR_?QGKM')%9%AXI\.WC7
M[S7\`AN)%(2;@D>6@Y!]P?RK=U'2;?4K-[5R\*N?F:$A6(/49]^]4]%TJPL)
MK^UMK2*.*.90JA<X_=I37-K8N]'E5T[W)$\4Z"_W=6M>/60"FR:_X>E*-)J=
MFQC;<N91P?6M$V-H3DVL)/\`US%-.GV3##6<!'H8E_PJ?>%>EV?W_P#`,?4O
M%NB:9LNUFBN1(0DKP2*S(O8D9R1SVJ'PM=17^MZ_>VT@EMYIH?+E7[K`1CI]
M*O:GX6TO58XXI8%BB5MSI"JIYGL2!G'TJ71+6"R^W6UM$D,,=SA408`_=I0H
MR;N^AHZE*-/EBG=Z?C?]#4HHHJCF"J&K_P#'O!_U]P?^C%J_5#5_^/>#_K[@
M_P#1BU4/B1,MF7Z***DH****`"BBLW4KV2VO;6&.=(_.27AT)&57(/'8?KF@
M!VM7$UK8>9%))$N\"26.+S&C7NP7!SV'0]>E8.H>)M1LB%CM)IEA*$R&!P9E
M*D\@(=N>,8[CG%3W?BB;1[&P^UP"YFGB+.X;RP2"!D`*>#G/TIUGXK;4Q?K!
M:B`VS1(LCN3NWD#.,#@9[$^G'-`$#>*M5>Y$<.D!8\L6DE\W"@%1C`3[WS9]
M..IK9O+K48]:L8(+0O9R;O.F#+\IP<9!Y_+UJC#K-^]]9P11-=0/=2PSW*HJ
MA=N[`()R,8'.#FLR+Q7?6J7L[-_:8AGE0VZ0F(Q!9"J?-@YW*,T`=I17.S^)
M+F-Q"]E]GE;S0K%BZDQC<1]T=1T)(KH(W\R-7P5W`'![4`.HHHH`****`,YO
M^1C3_KS;_P!#6M&LYO\`D8T_Z\V_]#6M&JET)74****DH*SM!_Y`EM]#_,UH
MUG:#_P`@2V^A_F:I?"_Z[D_:1)J=W<65LLMO`DQW@,C2;203SMXY/H*R;SQ)
M=VVM-IHM;8L21&S3-DY4%"0%.`3N'_`:JR:VLLMT-;LK2ZLX;SR;8QHKY89.
M3N;&0.W!ST!HM_$UE+=)]LM;:ZNRH>,VJJQ4`<<L<YR3C'3/.!DU)1#JOCG1
M9H;3R+@,WVE'(/'RK(`W3\3_`(5V$<@EB61<X<`C/O7#WFH^&KRP@GCT2,11
MWJHS&UC*J=X+`L.!G(/)&<^M=)I&OV6ISO:6D3Q^4@(SLVXP",;2<<$?Y%4]
MD);FO1114C"BBB@`HHHH`****`"L^V_Y#M]_UQA_]GK0K/MO^0[??]<8?_9Z
MJ.S_`*ZDO=&A1114E!1110`5GZ)_R#!_UVE_]&-6A6?HG_(,'_7:7_T8U4OA
M?]=R?M(T****DH****`"J%A_R$-3_P"NZ?\`HI*OUBFZDMK^]6$1[Y;E1NE.
M%4"%22?P%5'9DO=#KK5I[*[U%Y6@DMK6W6544[64\Y#,3@9[<=*RX_'MK*]M
M&MJ#)<7"0!1<H<;L\Y'T/'^-2W'B"Z33[&X6]TE#/YA=G8E)=O380W?\<9J-
MO$&GZA+'++I5Q(]K,4#*ZX5]H/3<,]^H_A/&:DHZNL*#6])L-0U*WO=3M+:4
M7(;9-,J'!C3!Y/M5S3=3_M%&>-4*-&LL+!LY5AWQWR#TK@/#WAJ_G\>ZI=:F
MUG?212HMY'+$&0JZ;ALR."IP/I6D$FG<E[H[O_A*/#W_`$'=-_\``N/_`!H_
MX2CP]_T'=-_\"X_\:D_X1[1/^@-8?^`R?X4?\(]HG_0&L/\`P&3_``J?='J1
M_P#"4>'O^@[IO_@7'_C5+5?$F@R00A-;T]B+F%B!=(<`."3UK1_X1[1/^@-8
M?^`R?X52U70=&2"$II%BI-S"#BV0<%QD=*J/+S(4KV+/_"4>'O\`H.Z;_P"!
M<?\`C1_PE'A[_H.Z;_X%Q_XU)_PCVB?]`:P_\!D_PH_X1[1/^@-8?^`R?X5/
MNCU(_P#A*/#W_0=TW_P+C_QH_P"$H\/?]!W3?_`N/_&I/^$>T3_H#6'_`(#)
M_A1_PCNA_P#0&L/_``&3_"CW0U&?\)/X?_Z#NG?^!:?XT?\`"3^'_P#H.Z=_
MX%I_C1_PC.@_]`6P_P#`9/\`"C_A&=!_Z`MA_P"`R?X4>Z&H?\)/X?\`^@[I
MW_@6G^-5DU?PG'Y^W5-*'VDDS?Z3'\Y/7/-6?^$9T'_H"V'_`(#)_A1_PC.@
M_P#0%L/_``&3_"CW0U$'B?P\!@:YIW_@6G^-3)KVCR('35K)E/0BX0C^=1?\
M(SH/_0%L/_`9/\*7_A&M!_Z`UA_X#I_A1[H:B)?Z#';BW2]L!$#G9YZ8SG/K
MZ\U-_;6D_P#04L_^_P"O^-1?\(UH7_0&L?\`P'3_``H_X1K0O^@-8_\`@.G^
M%'NAJ2_VUI/_`$%+/_O^O^-']M:3_P!!2S_[_K_C47_"-:%_T!K'_P`!T_PH
M_P"$:T+_`*`UC_X#I_A1[H:DO]M:3_T%+/\`[_K_`(T?VUI/_04L_P#O^O\`
MC47_``C6A?\`0&L?_`=/\*/^$:T+_H#6/_@.G^%'NAJ56UC2_P#A(4?^TK3;
M]D89\]<9WCWJ_P#VUI/_`$%+/_O^O^-9A\/:+_;Z1_V19;/LK';]G7&=XYZ5
M>_X1K0O^@-8_^`Z?X54K:"74E_MK2?\`H*6?_?\`7_&C^VM)_P"@I9_]_P!?
M\:B_X1K0O^@-8_\`@.G^%'_"-:%_T!K'_P`!T_PJ?='J4KCQMH=IJ\>GW%XD
M?FKF.XWJ8F/==P/!^N*LZ!>VAT:V474))X`\P=220/RYK/N?A_H-YJZ7UQ:H
M8HE`CM$C5(@W=C@98_7CBKN@:;8C1K5A9P`CY@?+'!&0#]0.*M\O+I_6XM>8
MN^;I0C^_9[&(EZK@DG`;ZD]_6D4Z3$VY#9HRECD;`00,-^0ZTK:/IKH$:PMR
MH55"^6,`*=P'X'F@Z/IK;LV,!W;\Y0<[_O?GWK/0HIZL]B8+:!6MR&O(08P5
MP>01Q]!G\*GLUTBR:::VFMT-P1(["4<]%&.>!Q@#I4&JZ=91BUD2UB5_MD!W
M!1G(.T?H2/I5L:+IBH$%A`%"A`-@QM#;@/SYJG;E1*W9.;ZT4D&ZA!&[(,@_
MA^]^7?TH%[:L0!<PDD@`"0<DC('XBHFTC3G8LUE`6._)*#G?]_\`/'-"Z5IZ
M,&6SA#*RL"$'!484_@.*G0HD%_9GI=P'Y=W^L'3.,_3/%/\`M,&<>?'D9_C'
M;K^55O[%TO;M^P6^"@CQY8^Z&W8^F>?K3SI6GEBQLX<DN2=@Y+C#?GWHT`F^
MU6Y.//CSD#[XZGI^=9</BK2I-8DTJ6?[/=*?W8F^59QZHW1AVJZ-(TX,&%E`
M&#(V=@ZJ,*?P'`K'3P/I+:S_`&G>)]K:+BUA=0(K9<YPJCKSDY/K37+U%J=)
M1114C"L^V_Y#M]_UQA_]GK0K/MO^0[??]<8?_9ZJ.S_KJ2]T:%%%%24%%%%`
M!6?HA']F#_KM+_Z,:M"L+1M(LGL_/:(F1KF>0G>WWF9E)Z^E4OA?]=R7\2-S
M(]:,CUK.7P_IBQI&+<[8_+VCS&X\O[G?M^O>AO#^FO$\;0$K(CQL/,;E7;<P
MZ^M+0HT<CUHR/6J!T33VE64PG>LAD!WM]XKM)Z^E-&@::(Q'Y!V@1@#S&_Y9
MG*=^Q_/O1H!+JFKV6C6HNK^;R8"X0R;20I/KCH/>JMBEKJ-Q?2`I/$;B.2-U
M;()\I,$$56UKPM'J%@UM9.MJ\JO%)*X9\1N<N`,XR3W/2LO1O`&A6K7EH%NF
M6"50&^TNN<QJ2<*0.I-7%1Y62]T==]DMBJ+]GBVQG*#8,+]/2D-I`TRR^6`R
MDGC@$GN1T)^M8G_"#:%_SSNO_`R7_P"*H_X0;0O^>=U_X&2__%5-H]QZE^]U
M#2M`9'NY%MENY-HD8';N`X!/11Z9P*R_#K*_C+Q.ZL&5GMB"#D']U5/6?AQ8
M:C!';6EQ-:Q,^9V::21F7T4,V!]2*U_"^D6>B6]Y86,96**YV@LVYC^[3J?Q
MJER\KL)[HW****S*"J&K_P#'O!_U]P?^C%J_5#5_^/>#_K[@_P#1BU4/B1,M
MF7Z**KR7MM%>16<DRK/,"8T/\0'6I*"[OK>Q16G=AO;:H5&=B?H`32"_M3-%
M")EWR@E!SSC'&>QY'!YJ._TX7LD$R7$EO/;DF.6,`D`\,,$$8(KGKSPQIL5X
M`^K3PO-,&V".-B2QP,G:3G.<-G/OP*`.H^UVV5'VB++G"C>.3[4RUO[:]DN$
MMY-YMI#%+\I`5AU&2.?PKF(M'T#1"+R:^#B&Y1,_9D.V5<G`VID<'M]>IKI;
M%(6#W<,_GBY(<.,8QC@#'_ZZ`+=%1B:)IFA#CS%`8KW`/0U)0`4444`%%%%`
M!1110`4444`9S?\`(QI_UYM_Z&M6[NZALK9[B<L(T&3M0L?R`)-5&_Y&-/\`
MKS;_`-#6JNJ:Q:/=3Z*UU/93>3YC7.Q=B)Z[FXQVZ=:J70E=2S<:_IEM<QV\
MD[>9(B.H6)V!5CA3D#&,\58_M&T^Q?;#+B+9OY4AL8S]W&<X[8S6'?P:5J<L
M4,]]+;-:H%\SY45_F&TY(P?F`(QZU2F\*:'>ZC<WL.OSJ[R><R17,;(@"D'@
M@X'S9SVX&<<5)1V$4J31K)&P9&&015'0?^0);?0_S-1Z)_9UA:1:9;:E%=-&
M&*CS$+D9)Z+C\\5)H/\`R!+;Z'^9JE\+_KN3]I&C1114E&?K'^JM?^ON'_T(
M5H5GZQ_JK7_K[A_]"%:%4_A1*W84445)04444`%%%%`!1110`5GVW_(=OO\`
MKC#_`.SUH5GVW_(=OO\`KC#_`.SU4=G_`%U)>Z-"BBBI*"BBB@`K/T3_`)!@
M_P"NTO\`Z,:M"L?1X;HV(9;O:GVF1MOE@_+O;*Y]SSFG>T=OZU!).6YL453^
MS7V/^0ASL`SY*_>SDG\1QBE-O>$\7V.7_P"6([_=_+]:SYGV_+_,TY%_,OQ_
MR+=%5!;W@?)OLC<IQY0Z`<C\3S[4GV:^V@?VASLP3Y*\MG.[\N,4<S[?E_F+
ME7\R_'_(MDA1DD#ZU1L/^0AJ?_7=/_1257U6SNY+"5"YN]S-MA$:CK]WG/&T
M\YK-T;3M:C:\B.JB-TE4,#$)/^6:]S[8'X4E4DFURO;]47[&+BI<ZW\^WW_@
M=3163]@UO_H-+_X"K1]@UO\`Z#2_^`JTO:2_D?X?YC]E'^=?C_D:U4--_P"/
MG4O^OK_VFE0?8-;_`.@TO_@*M4[&RU@W%_LUA5(N<,?LRG<?+3G\L?E51J2L
M_=?X?YDNE&Z]]?C_`)'145D_8-;_`.@TO_@*M'V#6_\`H-+_`.`JU/M)?R/\
M/\RO91_G7X_Y&M5#5_\`CW@_Z^X/_1BU!]@UO_H-+_X"K5+4[+5UAA\S6%8&
MYA`Q;*,'>,&JA4ES+W7^'^9,Z4>5^^OQ_P`CHZIW%G--J%M<"Y"PP[BT/E`[
MR1@'=U&,G\S5;[!K'_0;_P#)1/\`&C[!K'_0;_\`)1/\:GVDOY7^'^8_90_G
M7X_Y'.7O@*X6PGAM+Y',P"E3`B<9!SGGTZ$5T']CSA@D4Z0QXA)*IG!CXV@'
MHI'Y4_[!K'_0;_\`)1/\:/L&L?\`0;_\E$_QH]I+^5_A_F'LH_SK\?\`(@7P
MW]CM'@TR^DM2]T+C=(#-C@#;\QZ<53;P;"L[R^9]H,IC#&10"FW.6X'.<L,>
MC>U:?V#6/^@W_P"2B?XT?8-8_P"@W_Y*)_C1[27\K_#_`##V4?YU^/\`D&EZ
M0^G3!?-#Q1JXC.`&^9LX..P[=^M:M97V#6/^@W_Y*)_C1]@UC_H-_P#DHG^-
M'M)?RO\`#_,/91_G7X_Y&K165]@UC_H-_P#DHG^-'V#6/^@W_P"2B?XT>TE_
M*_P_S#V4?YU^/^1JT5E?8-8_Z#?_`)*)_C1]@UC_`*#?_DHG^-'M)?RO\/\`
M,/91_G7X_P"1JT5E?8-8_P"@W_Y*)_C1]@UC_H-_^2B?XT>TE_*_P_S#V4?Y
MU^/^1JT5E?8-8_Z#?_DHG^-'V#6/^@W_`.2B?XT>TE_*_P`/\P]E'^=?C_D2
M9#>(HR""/L;<C_?6F7N@VU]+<R333;KA4'!7]UMZ%>/SSD5@Z5I>JP:_)_I/
MV8/`[*#&IR-P_AZ#GFNG$%Z)`3>`KN!*^4.FW&/SYJE4E**;BT*=*,)-*:?W
MF6?!VGL?FN;LJ.%0R#"CT''3M4UMX4TFVEG<0&43$'9+AE3&<;1CCT_`5<%M
M?XP=0'W5&?)'4'D_B./:G?9[SG_3NH?'[D<9^[^7ZT<S[?E_F+D7\R_'_(S-
M.\,)8:K]J^T22QQK^Z5R-VX@@EB`,\=/J?;%W0?^0);?0_S-3"WO-^3?97>#
MM\H=,8(_$\YJAHD%TVC6Y2\V`H`!Y0."&.3^(XJU)\KT_K4AQ7,M5^/EY&U1
M5,VU[SB_QG?C]R.,_=_+]:<(+O=DWN1N!QY0Z`8(_$\U/,^WY%<J_F7X_P"1
M#K'^JM?^ON'_`-"%:%8FJ6]XMO:A[[>?M$*Y\D#YMX^;\N,5H-;WA!VWV"=^
M#Y0XS]W\OUJG)\JT_(2BN9^\OQ_R+=%5!;W@<$WV1N4X\H=`.1^)Y]J0VU]Y
M84:AAMH&[R5ZYR3CZ<5',^WY?YCY5_,OQ_R+E%5#;WA+8OL`E\#R1QG[OY?K
M2_9[S<I^W<!E)'E#D`<C\3S[4^9]OR#E7\R_'_(M4@8$D`@D=?:J@MK[9@ZA
MEMN-WDKUSG/Y<5DSZ7J4NN&>UE-L`V7GP/W@XPNWOCU-1*I*-K1-(4HR;O-+
M[SHJ*09`&3D^M%:F`M9]M_R';[_KC#_[/6A6?;?\AV^_ZXP_^SU4=G_74E[H
MT****DH****`"L_1/^08/^NTO_HQJT*S]$_Y!@_Z[2_^C&JE\+_KN3]I&A11
M14E!1110`50L/^0AJ?\`UW3_`-%)5^J%A_R$-3_Z[I_Z*2JCLR7NB_1114E!
M5#3?^/G4O^OK_P!II5^J&F_\?.I?]?7_`+32J6S)>Z+]%%%24%4-7_X]X/\`
MK[@_]&+5^J&K_P#'O!_U]P?^C%JH?$B9;,OT5$UU;K<K:M/&)W4LL18;F`ZD
M#KBB"Y@N0YMYHY0CE&*,&VL.H..XJ2AMW>VUC$);J98D+!06/4GM3_M$.^-/
M,7=*"4&?O`>GYU5U#3Y+N6WN+>Y^SSV[':Q3>I###`KD=NA[5S]_X;1-0$C:
M\EM)<3!HTD0;F(]/F'S<XR!TP,<4`=;445U!/++%%*KO"=L@4YVGT/O7,Q>%
M++3KZ"[O-1B9HYEDB65-H5MW\.6XSD?B<]\5H6-MIOAPZA<S:A;Q137&^0NP
M0(QY^8D\L<]>,C%`&Y14<$\-S"D\$J2Q.,JZ,"K#U!%.WIYACW#>!G;GG'K0
M`ZBBB@`HHHH`****`"BBB@#.;_D8T_Z\V_\`0UJW=74%E;/<W,JQ0H,L['@5
M4;_D8T_Z\V_]#6HM0U&WGGET>"]^SWQ3<&:W9U08SG/"],]ZJ70E=2>XUS2[
M6X2WGOH4ED"LJ%N2&.%/XD58%[;&Q^W"9?LWE^9YO;;C.?IBL*]TZTU2>&"'
M4C;W%I&$<I%C=A@1U[!ATYZU4NO!DEQJ-Q=P^([B-))1*(=BLJ`(5QZ]QSZ#
M%24=:CK(BNA!5AD$=Q5#0?\`D"6WT/\`,TNBV8TS3HK$W2W+Q[CO"A2V23R,
MGUZTF@_\@2V^A_F:I?"_Z[D_:1HT445)1GZQ_JK7_K[A_P#0A6A6?K'^JM?^
MON'_`-"%:%4_A1*W84445)04444`%%%%`!1110`5GVW_`"';[_KC#_[/6A6?
M;?\`(=OO^N,/_L]5'9_UU)>Z-"BBBI*"BBB@`K/T3_D&#_KM+_Z,:M"L32)[
MY;,*EDK1_:Y%#^:!\A=\MCV/&*I?"_Z[DOXD;=%9PN]5VY_LQ,^6#CSQ][=@
MKT[#G/X4YKK4A]W3E;F3_EL.@'R=OXOTJ1W+]%4%O+\R;3IA"[T&[SEZ$98_
M@>/>F_;=1V`_V2<F,,1YZ\-NQM_+G/X4!<T:H6'_`"$-3_Z[I_Z*2L[7]3O[
M;2+B4QMI_EL^VX#J_P!W[GRXYWGC'45DZ!K_`(ADMY[B;PY+/-+(ID\N5(]O
MR*!\KG(R,'\:J.S,Y5$I)';45SIU[7NWA&Z_&[B_QI/[?\0?]"C<?^!D7^-2
M/VD?/[F='5#3?^/G4O\`KZ_]II5!=8UYE!_X1AUSV-Y'D55L=4UM9[XIX=9R
MUQEA]K0;3L3CWXP?QJELP<U=?Y,ZBBL+^U]>_P"A9;_P,CH_M?7O^A9;_P`#
M(ZD?.OZ3-VJ&K_\`'O!_U]P?^C%JC_:^O?\`0LM_X&1U4U+5-;>"$2>'FC`N
M(B#]K0Y(<8'XGBJA\2%*:M_P&;-S9W,VI07,<ENL42G*O$2Y;H"&R.,$\8[U
M1O?#\T^EO:6MS':N]QYV8T957U`"L#SU//7/%-.K^(\\>&N/>\2A=5\1LV/^
M$;5?<WB_X5(^=?TF4+'P]K-MKJ/->M);QVKQB0,P`=B2"`7)R,]Q^(J*/PC?
MW`:66X2"=%:$%][ATW9'23(4]<$[@<<]JU_[1\1?]`"+_P`#5_PH_M'Q%_T`
M(O\`P-7_``H'SK^DP?2=0\E(A+`\OV9(C<.A(#*P)^7=G!'OU%,;PY/#!?K9
MWY:2\N$F!NP953;CC`(/./6G_P!H^(O^@!%_X&K_`(4?VCXB_P"@!%_X&K_A
M0'.OZ3*4OAF]24SB[,C2(%9(08E1R^[>!OQ@<\8)(]:T--TB>PORS3>;$I=D
M<YW8;'R')).,9S[CBF?VCXB_Z`$7_@:O^%(VH^)=OR:!#GWO1_A0'.OZ3-VB
MN?\`[1\5?]`"U_\``T?X4X7_`(H(S_8EF/8WG_V-`N=?TF;U%87V[Q1_T!;/
M_P`#/_L:/MWBC_H"V?\`X&?_`&-`<Z_I&[16%]N\4?\`0%L__`S_`.QH^W>*
M/^@+9_\`@9_]C0'.OZ1NT5A?;O%'_0%L_P#P,_\`L:B>]\8;CLT;3MO;=>-G
M_P!!H#G7G]QHM_R,:?\`7FW_`*&M5]1\.0ZE/=S33?-<1I&I,*-Y84YQR/F!
M/53D5RVB:CXFF\:7"-;QRQKN64/*2D0R-VQB`3@XXP:Z_;KOE</9>9L'\+8W
M;N?PV_K52Z$PGS)NQFR>#8I0%DU&=XUP%1HT(`&..G/3KU'45):>#-,MI+AB
M&D2;HA`4(/08`)&,`@YS@9K0QK.Y_GM,;I-O#=,?N\_CG-`&L[UR]IMW)NP&
MSMQ\^/?/3VJ32YF:5X5.G:R+MID>.)?W;"-%=F((.["C`'L><\]!6GH/_($M
MOH?YFFJNN>3\SV7F>7V5L;]W\MOZU2T4:Q_9$'EO:;/WN-P;..=GZ]:I?"_Z
M[DW]Y'045GHNK_+YDEIUCW85NF/G_7I32FM^4<366_R^"4;&_=]>FW]:DJX[
M6/\`56O_`%]P_P#H0K0K"UA=3V6W[RVV_;DQ\K9VY&SOUSU]JNA-8RN9;/&Z
M//R-T_C[]?3]:I_"B4]6:%%9Q36?+XFL]^P\[&QOW<=^FW]:<4U?S.);39O?
MJC9V[?E[]=W7VJ2KE^BJ`35LKF6TQ^[S\C?\#[_E3-FM[/\`766[8W\#8W[O
ME[]-O7WH"YI4519=5\P[9;79O;&4;.W;\O?KNZ^U<O/;^)CXK+Z:QC_=Q_:I
M)`PMG;'S84\D],;<>]!,I6Z';44BYVC=C..<=**"Q:KQVOEWT]UOSYR(NW'3
M;N_^*JQ6+XBDF3[)Y4VHQ`NVXV,/F$\<;OE.!G'I3N!M45S-IJ_B![H6\UE!
M'^\6/=(K*S?*"6'8@$$'&>HJ?5KG4ENT6$7<38D"+!%YL<B[3@L=N%;.,`GM
MWS2`WZ*H:(]R^C6S7?F^>4^<S+AS]1@?R%7Z`"J]E:_8[80[]^'=LXQ]YBW]
M:Y--1U^T_M">W@O[V5)I0L%U`5CV!SY>PA03D?7U-;UE?:G<6TTAMK>1TEV*
M%D*JPSR<X/0'IZ@BG?2P6-:BN>LKK67O]/403-8D2B:6<;)"03MW*5&!P,'(
MSFNAI`%%%%`#657&&4,.O(J&"V\BXN9M^[[0X?&/NX4+_P"RUCZ[)>)J<`M)
M=15O*)1+>'?$SYX#DK@=^I%)IVK:U=74,=Q9P0(\CA@RNKA5/#8/J._3-.X6
M.AHJCI4LLD$WF^>2D\BJ9T*L1NXQP,CT/I5N7(A?!8':<;1D_A2`?5>VMOL\
MER^_=Y\OF8QC;\JKC_QW]:Y6PU+7K>.V$,-Y=1RO&LTFHP,C1$@[R,*/E'R]
M1CJ,UIM=ZI<:9:3L#%</<I\EJI960'Y@3@@`\G/`QCO3N!OT444@"J]Y:_:X
MXTW[=DJ29QG.U@<?I6#J%UJ-OK5P]F=1E,84K";?-N5VY;#;1DYQT8G/:K&F
MZEJ]YO6[AAML6X<F-&+HQ&,;3W!!.".1BFG;4-S>HJGI"W":7;K=R22S!<-)
M(,,_N1@8)].U7*0!1110`4444`%%%%`!1110`4444`%%%%`!117)75]K-I?7
M\UDE_=/&[[8)[<^1MV_+L(4$G=QP3QGTH`Z4VN=16\W](3%LQZD'.?PJQ6%#
M?:G<VE\;B)8A%"2IM@6DW%<X`Y^8<C&.N*DTRXU:;5I1=VY2R-M&T+$\EN<[
MEV@AO49XQ3;N%C9HHKF=2N-3C\3.+9M0:-8(FBB2'-N[9?S`S;>/E"_Q#FD!
MTU5K"T^PV4=MOW^6"-V,9YS67HNJ:M?2(E]:0VY,9>1%W;DPQ`R#R,X!''3-
M5M.N=:DU'3$F6X^R_9V,IDB*L[Y8?.<8&`%P.,[L]J=]+!8Z:BBL_76F31+I
MK=KA9@GR&V3?)G/88.?RI`6Y[>.Y""4$A'61<''(.14M<G'J^LV@6-()IK8K
M(ZW-_"R/QT#8``S@@9`/*^M7M0N-3\NV>(3I)):S%U@BW*K[05SD=?3GGWH`
MWJ*HZ*UR^CVK7?FF<I\YE7:Y^HP/Y"KU`!1110`4444`%%%%`!1110`THA=7
M*J67.&(Y&>M.HHH`****`"FQQI$FR-%11DX48'K110`ZBBB@`HHHH`*;L3S/
M,VC?C&['./3-%%`#J***`$(#`JP!!X(/>A55%"JH50,``8`%%%`"T444`%-5
M$5F954,W+$#D_6BB@!U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`U41,[%5=QR<#&3ZTZBB@`HHHH`:(T5VD5%#OC<P')QTS3J**`"BBB@!LD:2
?H4D174]589!IU%%`!1110`4444`%%%%`!1110!__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g118721mmi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mmi002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$5`;@#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#URXU.PM)A
M!<WUM#*5WA))55BN<9P3TS3/[:TK_H)V?_?]?\:S)[2VN?'`%Q;Q3`:;QYB!
MO^6GO6I_9.F_]`ZU_P"_*_X4`)_;6E?]!.S_`._Z_P"-']M:5_T$[/\`[_K_
M`(TO]DZ;_P!`ZU_[\K_A1_9.F_\`0.M?^_*_X4`)_;6E?]!.S_[_`*_XT?VU
MI7_03L_^_P"O^-4KH:3;7AM1HHGD6-9&\FU5@`Q8#_T$U'OT[_H6Y?\`P"6@
M#1_MK2O^@G9_]_U_QH_MK2O^@G9_]_U_QK.WZ=_T+<O_`(!+1OT[_H6Y?_`)
M:`-'^VM*_P"@G9_]_P!?\:/[:TK_`*"=G_W_`%_QK.WZ=_T+<O\`X!+1OT[_
M`*%N7_P"6@#1_MK2O^@G9_\`?]?\:/[:TK_H)V?_`'_7_&L[?IW_`$+<O_@$
MM&_3O^A;E_\``):`-'^VM*_Z"=G_`-_U_P`:/[:TK_H)V?\`W_7_`!K(^VZ-
M]L^Q_P!@2>?Y?F^7]B7.W.,_G4V_3O\`H6Y?_`):`-'^VM*_Z"=G_P!_U_QH
M_MK2O^@G9_\`?]?\:SM^G?\`0MR_^`2T;]._Z%N7_P``EH`T?[:TK_H)V?\`
MW_7_`!H_MK2O^@G9_P#?]?\`&L[?IW_0MR_^`2T;]._Z%N7_`,`EH`T?[:TK
M_H)V?_?]?\:/[:TK_H)V?_?]?\:SM^G?]"W+_P"`2T;]._Z%N7_P"6@#1_MK
M2O\`H)V?_?\`7_&C^VM*_P"@G9_]_P!?\:R);W1H;B&WDT"19;C=Y2FR7+8&
M3^E3;]._Z%N7_P``EH`T?[:TK_H)V?\`W_7_`!H_MK2O^@G9_P#?]?\`&L[?
MIW_0MR_^`2T;]._Z%N7_`,`EH`T?[:TK_H)V?_?]?\:/[:TK_H)V?_?]?\:S
MM^G?]"W+_P"`2T;]._Z%N7_P"6@#1_MK2O\`H)V?_?\`7_&C^VM*_P"@G9_]
M_P!?\:SM^G?]"W+_`.`2T;]._P"A;E_\`EH`T?[:TK_H)V?_`'_7_&C^VM*_
MZ"=G_P!_U_QK(N+W1K3R_/T"1/-D$29LE^9CT%3;]._Z%N7_`,`EH`T?[:TK
M_H)V?_?]?\:/[:TK_H)V?_?]?\:SM^G?]"W+_P"`2T;]._Z%N7_P"6@#1_MK
M2O\`H)V?_?\`7_&C^VM*_P"@G9_]_P!?\:SM^G?]"W+_`.`2T;]._P"A;E_\
M`EH`T?[:TK_H)V?_`'_7_&C^VM*_Z"=G_P!_U_QK.WZ=_P!"W+_X!+1OT[_H
M6Y?_``"6@#1_MK2O^@G9_P#?]?\`&C^VM*_Z"=G_`-_U_P`:R;J]T>RMI+FY
M\/R1PQC+N;)<`5+OT[_H6Y?_``"6@#1_MK2O^@G9_P#?]?\`&C^VM*_Z"=G_
M`-_U_P`:SM^G?]"W+_X!+1OT[_H6Y?\`P"6@#1_MK2O^@G9_]_U_QH_MK2O^
M@G9_]_U_QK.WZ=_T+<O_`(!+1OT[_H6Y?_`):`-'^VM*_P"@G9_]_P!?\:/[
M:TK_`*"=G_W_`%_QK.WZ=_T+<O\`X!+1OT[_`*%N7_P"6@#1_MK2O^@G9_\`
M?]?\:/[:TK_H)V?_`'_7_&LQYM+BC:1_#LJJH))-DO`%-@N=)N;>.XA\/2O%
M*@=&%DO((R#0!J_VUI7_`$$[/_O^O^-']M:5_P!!.S_[_K_C6=OT[_H6Y?\`
MP"6C?IW_`$+<O_@$M`&C_;6E?]!.S_[_`*_XT?VUI7_03L_^_P"O^-9V_3O^
MA;E_\`EHWZ=_T+<O_@$M`&C_`&UI7_03L_\`O^O^-']M:5_T$[/_`+_K_C6=
MOT[_`*%N7_P"6C?IW_0MR_\`@$M`&C_;6E?]!.S_`._Z_P"-']M:5_T$[/\`
M[_K_`(UG;]._Z%N7_P``EJY9V>D7MI'<Q:=;!)!D!H%!'U&*`+%OJ>GW<Y@M
MKZVFE"[S''*K,%SC.`>F>]%8L%K;VWQ"(MX(H0=)R1&@7_EK[44`6O\`F>?^
MX9_[5K:K%_YGG_N&?^U:VJ`"BBB@#!NM:T[2O$ERM]=+"9+.`J""<X>;T%2?
M\)AX?_Z"2?\`?#?X582*.3Q%=^9&KXM(,;AG^.:KOV6W_P">$?\`WP*`,A_%
M^@LC!-416((#;&.#Z]*YY?$%M!%;"UO[>-O+2.[+`MYS*5RW*\@CS!G@DL/2
MNX^RV_\`SPC_`.^!7.:SJ=SI]Y,MOIL,RHR`(8LEEV,Q88]UVT`<Y9>)-2M=
M-CMAK4`,4<:1_(">%((.5]2F/93FM+_A(;3[/8K-J_G20ZF\KN2V3"6DVYX'
M\++Q[5L7[W]L+=A96Y<RN/*C3(D`AD*@GM\X0?C1HLLT]RL%S;H^8G9G,8'*
ML`&''`8$\?[%`R?_`(3#P_\`]!)/^^&_PH_X3#P__P!!)/\`OAO\*U?LMO\`
M\\(_^^!1]EM_^>$?_?`H$<B?%&B?\)JMS]O3RO[.*;MK?>\P''3TK9_X3#P_
M_P!!)/\`OAO\*@-O!_PGBKY,>/[+)QM'_/45N?9;?_GA'_WP*`,K_A,/#_\`
MT$D_[X;_``KG9O$-M%"7L]2@6]\R4-<,#^\1BQ3@J>AV=1P`0.M=O]EM_P#G
MA'_WP*P]<O)["XV6EC#)^Z5E#1Y#L9%4]/[H.?QH`YBV\27EL;B.+5X$@,CO
M$OECY=TI;'*GC;GZ$CL*LCQ!;S:'?6^H:F+N>X9/+&2NS,2!B,*`,.'(]\&M
MUIKU]/M[I[*"`2R6Y`1-S;6D3>",<?*6J'3+N\EOX8KNQ1/-GD1U,8PJ!"P(
MX_A("^^Z@9<C\7Z`(U!U%`0!G*L?UQS3O^$P\/\`_023_OAO\*U?LMO_`,\(
M_P#O@4?9;?\`YX1_]\"@1R.I^*-$D\2:),E^ACA,^]MK<9CP.U;/_"8>'_\`
MH))_WPW^%0:M;P#Q3H`$,8!:XR-HY_=UN?9;?_GA'_WP*`,K_A,/#_\`T$D_
M[X;_``K#N/$5@+FYGAU&*2?[0LEO,=PVQ[55H\;?3?CMDYZUV/V6W_YX1_\`
M?`K'\07+Z;$CVME%(?+E?!CSN94)5./4_P`J`.3A\1WL%W<-'K-NJ3_,Q\O_
M`):>4JA@-O\`?&3[`\#-7[#Q+$RW;:IJRW"30*BQ8P`1))G`"X^X4Z]<8-:C
MW.HS:#=78L;>%E@EV%8\MO7<!A3ZD#\Z:;R[75)5:Q01?:HHXAY8PR,VT]NN
M"7S[8H&.TGQ1HUGH]G:W.JQO-#`D;L%<Y(`&<D<U<_X3#P__`-!)/^^&_P`*
MU?LMO_SPC_[X%'V6W_YX1_\`?`H$<CXB\4:)<+IGE7Z-Y>HPNWRMPH)R>E;/
M_"8>'_\`H))_WPW^%0>)[>!5TG$,8SJD`.%'J:W/LMO_`,\(_P#O@4`97_"8
M>'_^@DG_`'PW^%8VH>(=,GO;B6/489-T4?V5G#`02*6).,=#\N?7&#Q77?9;
M?_GA'_WP*H:N1:00-#;Q#S+A(W<Q@A%)Y/\`3\:`.,'B2YCUDW<>JPB.58TF
M&P9*J\I_N_>VLH!X]^E6]+\3RB]274==B=5BE0J$(3<1%L;`49Y$G<?AFMC1
M;V_U2T2>?3+:W7($F4P5RH;@'TW8^HK-AU+4UL89I;`,RZ?')GR@-\VT%@1C
M^)LICMUH&6M!\2Z98Z88+_5XI9OM$S[U1^5:1F7KGL1].E:7_"8>'_\`H))_
MWPW^%:OV6W_YX1_]\"C[+;_\\(_^^!0(Y/Q5XIT2Y\,7\$-^CR/$0J[6YY^E
M:_\`PF'A_P#Z"2?]\-_A47C"W@7PEJ)6&,$0GD*/45M?9;?_`)X1_P#?`H`R
MO^$P\/\`_023_OAO\*R]3\1:+=W<1:_CGM3!)&T7S+AR5VOG'8!AGJ,\5U/V
M6W_YX1_]\"J6L;;+2;BXM[6-I47CY`<<X)_`<_A0!P]UXBO6O8+J#5[83QQ/
M$6*?+\QBZ_+TRKD=QGJ<U=MO%$K:K%+<ZXGV6.XW>6%QF,K*,'"\D$Q>W!^M
M;&G7M_?3W,0TRU"P2E5=D(WIO90?J0F?^!"JJ7=\98D>V'D^=<J\WE`8`E<(
M3QT5`I]\T#'Z1XBT6RDOWEU./;<732H"I+`$#J0HXXX'85I?\)AX?_Z"2?\`
M?#?X5=T]$NM-M;B>SCBEEA1WCV#Y&(!(_`U8^RV__/"/_O@4",*_\7:#)I]R
MBZBA9HF`&QN3@^U0:%XLT*'P_IL4FH(KI:1*PVMP0@SVK;U&VMQIET1!'_J7
M_@']TU7\/6T!\-:63#&2;.')*C^X*`(_^$P\/_\`023_`+X;_"J&J>)]&N'M
M#'J$<D,<I:>$JP$B[6`[<X)!P?3VKI/LMO\`\\(_^^!4=Q#%%;2R1VD<CHA9
M4V#YB!P*`//[[7IMUI]CU6!5LY"8AC=A?+D51DKD\,H.<Y(SQ4Z>)[R2=1/K
MT0C4QL1&FW<0\>\9V9P0)"![@'-;&G:A?WDWD)86L@\O<)6C*[ODB8GTZR,/
M^`&EF>^:6:-$B5X]2A4)Y/WHO*C+*IQ_>+\GT-`R#3_$MC#K-[/=:M#)!*?W
M1V-D#C:!QP`,Y'<\^M:W_"8>'_\`H))_WPW^%6-)"7>GI+-;Q;][KNV`;PKE
M5;\0`?QJ[]EM_P#GA'_WP*!&5_PF'A__`*"2?]\-_A4_AUUET&TD0Y5U+*?4
M$FKWV6W_`.>$?_?`JGH``T2V`X&#_P"A&@"C_P`U#_[A/_M6BC_FH?\`W"?_
M`&K10!+_`,SS_P!PS_VK6U6+_P`SS_W#/_:M;5`!6(+S4?\`A+Y+7:QLA:[U
M^7&7R._XFMNB@#G6TNUUG7+B35-/Q)':PA5,IX&Z7^Z:L?\`"(Z%_P!`\?\`
M?U_\:N1?\AZ[_P"O6#_T*6KU`&+_`,(CH7_0/'_?U_\`&D_X1#0LY_L\9_ZZ
MO_C6W10!B_\`"(Z%_P!`\?\`?U_\:3_A$-!SG^SAG_KJ_P#C6W10!B_\(CH7
M_0/'_?U_\:/^$1T+_H'C_OZ_^-;5%`&)_P`(?H.[=_9R[L8SYCYQ^=+_`,(C
MH7_0/'_?U_\`&MJB@#%_X1'0O^@>/^_K_P"-)_PB&A9S_9XS_P!=7_QK;HH`
MQ?\`A$="_P"@>/\`OZ_^-)_PB&@YS_9PSZ^:_P#C6W10!B_\(CH7_0/'_?U_
M\:/^$1T+_H'C_OZ_^-;5%`&(?!^@D@G3E)'0^8_'ZTO_``B.A?\`0/'_`']?
M_&MJB@#%_P"$1T+_`*!X_P"_K_XTG_"(:$>NGCC_`*:O_C6W10!B_P#"(Z%_
MT#Q_W]?_`!I/^$0T$XSIPXZ?O7_QK;HH`Q?^$1T+_H'C_OZ_^-'_``B.A?\`
M0/'_`']?_&MJB@#$/@_06QNTY3@Y&9'X/YTO_"(Z%_T#Q_W]?_&MJB@#%_X1
M'0O^@>/^_K_XTA\(:"1@Z<#_`-M7_P`:VZ*`,7_A$="_Z!X_[^O_`(TA\(:$
M>NGC_OZ_^-;=%`&+_P`(CH7_`$#Q_P!_7_QH_P"$1T+_`*!X_P"_K_XUM44`
M8A\'Z"PPVG*0>H,CD?SI?^$1T+_H'C_OZ_\`C6U10!B_\(CH7_0/'_?U_P#&
M@^$="(P=/'_?U_\`&MJB@#%_X1'0O^@>/^_K_P"-(?"&A$8.G@@_]-7_`,:V
MZ*`,7_A$="_Z!X_[^O\`XT?\(CH7_0/'_?U_\:VJ*`,0^$="(P=/!'_75_\`
M&@>$-!``&G*`.@$C\?K6W10!B_\`"(Z%_P!`\?\`?U_\:/\`A$="_P"@>/\`
MOZ_^-;5%`&(/"&@@8&G`#_KJ_P#C2_\`"(Z%_P!`\?\`?U_\:VJ*`,0>$-"`
MP-/``_Z:O_C2_P#"(Z%_T#Q_W]?_`!K:HH`Q?^$1T+_H'C_OZ_\`C5O18D@T
MF&&-=J1[E4>@#$"K]4]*_P"0>G^\_P#Z$:`,S_FH?_<)_P#:M%'_`#4/_N$_
M^U:*`)?^9Y_[AG_M6MJL7_F>?^X9_P"U:VJ`"BBB@"C%_P`AZ[_Z]8/_`$*6
MKU48O^0]=_\`7K!_Z%+5Z@`HHHH`R4UJ6XDG2TT]YC`[*_[Q1T=U_/*$X]"/
M6FV^L32BTWI&#-.(V/(&#"7R/^!#;^!K4B@B@5EAC6,,Q=@HQEB<D_4DT_`]
M!0!@/KMT!'''Y$S.)")XQF,XSM`^;`)QT+=QZ\;-E,]S8P3R(8WEB5V0_P`)
M(SBIMH`Q@4M`!1110`4444`9DFKR&^GL[:S::6`X/[P*#\J-_P"U!^1J'^V+
MC9+NA2-ED"Y/(0;V4Y]<!0>/[XK52"*.221(U5Y2#(P'+$``9]>`!^%/P/2@
M#G3X@O$CDEDBA4HVY(6.&E7:"54AC\RG(Z9)QP,YK9TZY:\LDF==K$L",8Y#
M$<<GCC@YY'-6=H]!1TH`6BBB@`HHHH`SKK53!J'V&*V::8QJXPX4'.__`.-G
MGW%5VUBZ1KA9+0(\:$A-V<$*AY/<'<W3^X:U1!$+@W`C7S64(7QR5!)`SZ9)
M_.GX'I0!S2^([]I;E?LJ`02*%PI)F7(R5Y')&6`ZXQC=SC7TB^FU"V>6:'RF
M#*-OU16(^H+%3[J:O8'H**`%HHHH`****`*-_J0LIX(1"TKSYV@,!_$J_P#L
MX/T!JM_:UXEXD,UCY>X#*!PQY#G.>G5%'U<5IR11-(L[1J9(U(1B.5!QG'UP
M/RKG+#7+ZZ16=D!([)4N26Y<8.6P\^([Q1_QYA_FC4,O`._.6Y/13@'W[BM#
M1]5?4S,7@>$(%*ATP2"6'/)Y^7..P(ZYK*O]=OK8?(T?XI716<AFLH)F`W21
MJS8]2,T1DGL$H..Y/1115$!1110`4444`%%%%`!1110`4444`5[V[6RMC.R[
MAO1.H'WF"Y)].:RY]<O%M$N4TUECD!*%G!+?(S`8'0DJ%'U'6MF6&*>/RYHU
MD3(.UAD9!R/U`IV!Z4`85]X@N;62<1V9D5&PI"D[1\O)QV8,<?[OY3VVJ7$U
MS:IMC999IXY-HY4(SA6^]D`[!V/7J.,ZV!Z48`[4`+5/2O\`D'I_O/\`^A&K
ME4]*_P"0>G^\_P#Z$:`,S_FH?_<)_P#:M%'_`#4/_N$_^U:*`)?^9Y_[AG_M
M6MJL7_F>?^X9_P"U:VJ`"BBHOM$/VC[/YB^=MW;,\X]:`*T7_(>N_P#KU@_]
M"EJ]5&+_`)#UW_UZP?\`H4M7J`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`(YYDMX'FD.$C4LQ]A5./6;2490N1_NU)K'_(&O/^N#_P`C
M7-Z;_J:SG)QV-Z=-25V;LFOV$3!7=E)./NUIUP&I_P"N'^\*[^G"39-6"C:P
M44459D%%%%`#7^XWTKBM'_U*_05VK_<;Z5Q6C_ZE?H*RJ'30V8S6/NFNPTW_
M`)!=I_UP3_T$5Q^L?=-=AIO_`""[3_K@G_H(I4PK;%JBBBMCF"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`JGI7_`"#T_P!Y_P#T(U<JGI7_`"#T_P!Y
M_P#T(T`9G_-0_P#N$_\`M6BC_FH?_<)_]JT4`2_\SS_W#/\`VK4/BM[]+-6@
M>"&V0AY9Y)V3;VQP"2#GM4W_`#//_<,_]JUF^+9DAU&WD,9\R*,,LGD22;`6
MP2-KJ%(_'/'2@#IK0N;*`RD%_+7<0<Y..:IC1U&LR:B)Y!Y@PT8)`/RA>N>F
M!D#U).>:MV1)L+<E2I,2\-G(X'KS4]`&78VL5KK5W'$&"_9H#\SLQ^]+W)-:
M>!5*+_D/7?\`UZP?^A2U>H`3`HP*6B@!,"C`I:*`$P*,"EHH`3%&!2T4`)@4
M8%+10`F!1@5'<7$5K"9IW"1KC)(]3BH%U6R896;(]D;_``I72&HM[(MX%&!5
M-=8T]YDA6X'F.=JJ5(R?RJ[3!IK<3%&!2T4"$P*,"EHH`I:P/^)->?\`7!_Y
M&N<TT?N:Z36/^0->?]<'_D:YO3?]36-0ZJ.S*&IC]\/]X5WV!7`ZG_KA_O"N
M_IT]B:_03%&!2T5J<XF!1@4M%`#7`V-]*XK1Q^Y7Z"NU?[C?2N*T?_4K]!65
M0Z:&S&:P/E-=AIH_XE=I_P!<$_\`017'ZQ]TUV&F_P#(+M/^N"?^@BE3"ML6
M<48%+16QS"8%&!2T4`)@48%+10`F!1@4M%`"8%&*6B@!,"C`I:*`$P*,"EHH
M`3`HP*6B@!,"JFE?\@]/]Y__`$(U<JGI7_(/3_>?_P!"-`&9_P`U#_[A/_M6
MBC_FH?\`W"?_`&K10!+_`,SS_P!PS_VK3?$=M9!8[V^N'CB3Y2H4%6(R5SGL
M#SCID#/04[_F>?\`N&?^U:@\:2>7HJ-ACB=3M'?`).?;`)_"@#;M0@M(1$Q:
M,1KM8]QC@U-5#0XIX=&MDN9C-)MSN/7!)('X`@?A5^@"C%_R'KO_`*]8/_0I
M:O51B_Y#UW_UZP?^A2U>H`****`(Y9HH%#2R)&"<`L<9-,^V6N,_:(\?[PK)
M\5C-E;?]?`_]!:J,2K]F^Z.GI6<I\IO"DI*YTL=Y;2R"..XB=ST57!-35Q6B
M@#Q-#@=G_P#037:U47=$5(\KL%%%%49A1110!E>)?^0'-_O)_P"A"LBS_P"/
M?\*U_$O_`"`YO]Y/_0A619_\>_X5A5.NC\)1C_Y#UG_UW7^==U7"Q_\`(>L_
M^NZ_SKNJNGL9U]T%%%%:&`4444`4]8_Y`UY_UP?^1KF]-_U-=)K'_(&O/^N#
M_P`C7-Z;_J:QJG51V90U/_7#_>%=_7`:G_KA_O"N_IT]B:_0****U.<****`
M&O\`<;Z5Q6C_`.I7Z"NU?[C?2N*T?_4K]!650Z:&S&:Q]TUV&F_\@NT_ZX)_
MZ"*X_6/NFNPTW_D%VG_7!/\`T$4J85MBU1116QS!1110`4444`%%%%`!1110
M`4444`%<_=:U=Q:O/:IL$<9`'R\\J#_6N@KD+[_D8[O_`'E_]`6HF[(VHI-Z
MEZZUB\@CW*R'ZK5[0-0FU*P>:<+N64I\HQQ@?XUAZA_J*TO"'_()D_Z[M_(5
M%-M[FE6*4=$;M4]*_P"0>G^\_P#Z$:N53TK_`)!Z?[S_`/H1K8Y3,_YJ'_W"
M?_:M%'_-0_\`N$_^U:*`)?\`F>?^X9_[5IGBV*:32HV@9EDCFW!@P7'RL.IX
M'6G_`/,\_P#<,_\`:M/U_3[S4HX8H?)\E7#2!D#/Z?(&^4'!/)S]*`-&T5DL
MX%<@L(U!(.<G'K4U16H*VD(;?D1KGS,;NG?'>J$FKNGB*/2UMY"K6LDV_8P#
M,I3`!(QT?UZXH`FB_P"0]=_]>L'_`*%+5ZLNQGDGUJ[>6UEMV^S0C9(5)^]+
MS\I(K3S[&@!:*3/L:,^QH`P_%?\`QYVW_7P/_06JE%_Q[?A5SQ6?]#MN/^6X
M_P#06JG$?]&Z=JPJ;G92^`JZ+_R,T'T?_P!!-=I7%:*?^*F@X[/_`.@FNTS[
M&M(;&-;XA:*3/L:,^QJS$6BDS[&C/L:`,OQ+_P`@.;_>3_T(5D6?_'O^%:WB
M4_\`$CFX_B3_`-"%9%F?]'Z=JPJG71^$I1_\AZS_`.NZ_P`Z[JN%C/\`Q/K/
MC_ENO\Z[G/L:NGL9U]T+129]C1GV-:&`M%)GV-&?8T`5-8_Y`UY_UP?^1KF]
M-_U-='K!_P")-><'_4/_`"-<WII_<]*QJ'51V91U/_7#_>%=_7`:F?WPX_B%
M=]GV-.GL37Z"T4F?8T9]C6ISBT4F?8T9]C0`C_<;Z5Q6C_ZE?H*[5S\C<'I7
M%:.?W*\=A650Z:&S&:Q]TUV&F_\`(+M/^N"?^@BN/U@_*>*[#33_`,2NTX/^
MH3_T$4J85]BU129]C1GV-;',+129]C1GV-`"T4F?8T9]C0`M%)GV-&?8T`+1
M29]C1GV-`"T4F?8T9]C0`M<A??\`(QW?^\O_`*`M==GV-<A?'_BH[OC^)?\`
MT!:B>QO0^)BZA_J*TO"'_()D_P"N[?R%9NH']QTK1\(G_B4R<?\`+=OY"LZ9
MI5^$WJIZ5_R#T_WG_P#0C5O/L:J:5_R#T_WG_P#0C6YR&9_S4/\`[A/_`+5H
MH_YJ'_W"?_:M%`$O_,\_]PS_`-JU#XIN;V*.&*VCF1=V]KB*1%*X#9`W'`..
M<G(Q4W_,\_\`<,_]JU1\<V4,FFB[9F\Q"%"^:44CD_3\?:@#?T]I9+"&29][
MNN[.`#@\@''&0,"K&T;@V!D#`-06`"Z=;`,&`B497.#P.F>:L4`48O\`D/7?
M_7K!_P"A2U>JC%_R'KO_`*]8/_0I:O4`%%%%`&%XK_X\[;_KX'_H+52B_P"/
M;\*N^*_^/.V_Z^!_Z"U4HO\`CV_"L*FYV4OA*NB_\C-!]'_]!-=I7%Z+_P`C
M-!]'_P#037:5I#8QK?$%%%%68A1110!E>)?^0'-_O)_Z$*R+/_CW_"M?Q+_R
M`YO]Y/\`T(5D6?\`Q[_A6%4ZZ/PE&/\`Y#UG_P!=U_G7=5PL?_(>L_\`KNO\
MZ[JKI[&=?=!1116A@%%%%`%/6/\`D#7G_7!_Y&N;TW_4UTFL?\@:\_ZX/_(U
MS>F_ZFL:IU4=F4-3_P!</]X5W]<!J?\`KA_O"N_IT]B:_0****U.<****`&O
M]QOI7%:/_J5^@KM7^XWTKBM'_P!2OT%95#IH;,9K'W378:;_`,@NT_ZX)_Z"
M*X_6/NFNPTW_`)!=I_UP3_T$4J85MBU1116QS!1110`4444`%%%%`!1110`4
M444`%<A??\C'=_[R_P#H"UU]<A??\C'=_P"\O_H"U$]C>A\3#4/]16EX0_Y!
M,G_7=OY"LW4/]16EX0_Y!,G_`%W;^0K.F:5?A-VJ>E?\@]/]Y_\`T(U<JGI7
M_(/3_>?_`-"-;G(9G_-0_P#N$_\`M6BC_FH?_<)_]JT4`2_\SS_W#/\`VK5+
MQ0]^][';6<)F5XP74(7_`(CCY>GYU=_YGG_N&?\`M6H_%]_=:=I,<MF[K(TZ
MH=B%F(PW``![@=J`-R,$1J",$`9%.J"QD:6PMY'.6>)6)]20*GH`HQ?\AZ[_
M`.O6#_T*6KU48O\`D/7?_7K!_P"A2U>H`****`,+Q7_QYVW_`%\#_P!!:J47
M_'M^%7?%?_'G;?\`7P/_`$%JI1?\>WX5A4W.RE\)5T7_`)&:#Z/_`.@FNTKB
M]%_Y&:#Z/_Z":[2M(;&-;X@HHHJS$****`,KQ+_R`YO]Y/\`T(5D6?\`Q[_A
M6OXE_P"0'-_O)_Z$*R+/_CW_``K"J=='X2C'_P`AZS_Z[K_.NZKA8_\`D/6?
M_7=?YUW573V,Z^Z"BBBM#`****`*>L?\@:\_ZX/_`"-<WIO^IKI-8_Y`UY_U
MP?\`D:YO3?\`4UC5.JCLRAJ?^N'^\*[^N`U/_7#_`'A7?TZ>Q-?H%%%%:G.%
M%%%`#7^XWTKBM'_U*_05VK_<;Z5Q6C_ZE?H*RJ'30V8S6/NFNPTW_D%VG_7!
M/_017'ZQ]TUV&F_\@NT_ZX)_Z"*5,*VQ:HHHK8Y@HHHH`*P5\02O=30K`F(Y
M&3))YP<5O5Q<'_(2NO\`KXD_]"-1-M+0VI14KW-:Z\03VRY,$;?B:T],O#J&
MG1710(9`?E';!(_I7+:K_JJZ#PW_`,@"U^C?^A&IA)O<JK"*6AJ4445J<X44
M44`%<A??\C'=_P"\O_H"UU]<A??\C'=_[R_^@+43V-Z'Q,-0_P!16EX0_P"0
M3)_UW;^0K-U#_45I>$/^03)_UW;^0K.F:5?A-VJ>E?\`(/3_`'G_`/0C5RJ>
ME?\`(/3_`'G_`/0C6YR&9_S4/_N$_P#M6BC_`)J'_P!PG_VK10!+_P`SS_W#
M/_:M5?&7VJ73OL\5HSPD;GGRI1.""'!9>,'KG'K5K_F>?^X9_P"U:MW^C6FI
MW$<MV))!$/DC\PA`?[V!P3[T`6+'(L+?=G/E+G)![#TX_*IZ9&GEQ)'N9MJ@
M;F.2?<UGO8ROKXO?(C15MVC697^<EL$Y&.<;1CGU]>`"6+_D/7?_`%ZP?^A2
MU>K*L(9H=9NTFNGN&^S0G>ZJ#C=+Q\H`K4P?6@!:*3!]:,'UH`P_%?\`QYVW
M_7P/_06JE%_Q[?A5SQ6/]#MN?^6X_P#06JG%_P`>W7M6%3<[*7P%71?^1F@^
MC_\`H)KM*XK1?^1FAY[/_P"@FNTP?6M(;&-;XA:*3!]:,'UJS$6BDP?6C!]:
M`,OQ+_R`YO\`>3_T(5D6?_'O^%:WB4?\2.;G^)/_`$(5D6?_`![]>U853KH_
M"4H_^0]9_P#7=?YUW5<+'_R'K/G_`);K_.NYP?6KI[&=?="T4F#ZT8/K6A@+
M128/K1@^M`%36/\`D#7G_7!_Y&N;TW_4UT>L`_V-><_\L'_D:YO3?]3UK&H=
M5'9E'4_]</\`>%=_7`:G_KAS_$*[[!]:=/8FOT%HI,'UHP?6M3G%HI,'UHP?
M6@!'^XWTKBM'_P!2OT%=JX.QN>U<3H_^I7GL*RJ'30V8W6/NFNPTW_D%VG_7
M!/\`T$5Q^L?=/-=AIH/]EVG/_+!/_012IA7V+5%)@^M&#ZUL<PM%)@^M&#ZT
M`+7%P?\`(2NO^OB3_P!"-=G@^M<7!_R$KKG_`);R?^A&LZFQT4.HNJ_ZJN@\
M-_\`(`M?HW_H1KG]5_U76M_PV#_8%KSV;_T(U-(JM\)JT4F#ZT8/K6QRBT4F
M#ZT8/K0`M<A??\C'=_[R_P#H"UUV#ZUR%\/^*CN^?XE_]`6HGL;T/B8NH?ZB
MM+PA_P`@F3_KNW\A6;J'^HZUH^$1_P`2F3G_`);M_(5G3-*OPF]5/2O^0>G^
M\_\`Z$:MX/K532O^0>G^\_\`Z$:W.0S/^:A_]PG_`-JT4?\`-0_^X3_[5HH`
ME_YGG_N&?^U:VJQ?^9Y_[AG_`+5K:H`****`*,7_`"'KO_KU@_\`0I:O51B_
MY#UW_P!>L'_H4M7J`..NG=M=NU9V($F`,^PI+_*194D'V-)<?\A^[_ZZ_P!!
M2ZC_`*FNGL9LA$CR>&[<NQ8B](R3_LFKT7_'M^%9\?\`R+4'_7\?_0#6A%_Q
M[?A7#7^([Z/P(JZ+_P`C-!]'_P#037:5Q>B_\C-!]'_]!-=I50V,JWQ!1115
MF(45BZAKDEGJ1M$@5L*&W$^M-EUV>*/?Y$9_X$:OD8KHG\2_\@.;_>3_`-"%
M9%G_`,>_X4ZZUEM6T.]#0B,PO$.#G.6_^M3;/_CW_"N:LK.S.RA\)1C_`.0]
M9_\`7=?YUW5<+'_R'K/_`*[K_.NZJJ>QG7W04445H8!152[U.UL9$CG<JSC*
M@#-,.KV@7<6?'^Z:?*PN.UC_`)`UY_UP?^1KF]-_U-:]YJUG?:;?PV\A9UMW
M8@C'&*R--_U-8U5;<ZJ'PE#4_P#7#_>%=_7`:G_KA_O"N_HI[$U^@4445J<Y
ME:YJDVF1P-"B,9'*G=GCBJRZS>-%OV1?D:9XM_U5G_UU/\JJ1_\`'M^%;)+E
M(;=RS8>(+J[U5+*2*((ZMDKG/`)_I67H_P#J5^@I-(_Y&6'_`'7_`/032Z/_
M`*E?H*PQ"2M8Z\/LQFL?=-=AIO\`R"[3_K@G_H(KC]8^Z:[#3?\`D%VG_7!/
M_0165,=;8M4445L<P45F^(+B6VT>66"0QN&0!AU&6`K(MKR[DAW-=S9^M6HW
M5Q-V.IKBX/\`D)77_7Q)_P"A&G1:I?C6+6$W<C1O,JLI/4$TV#_D)77_`%\2
M?^A&LJT>5'1AW>X:K_JJZ#PW_P`@"U^C?^A&N?U7_55T'AO_`)`%K]&_]"-9
MTBZWPFI1116QRA1110`5R%]_R,=W_O+_`.@+77UR%]_R,=W_`+R_^@+43V-Z
M'Q,-0_U%:7A#_D$R?]=V_D*S=0_U%:7A#_D$R?\`7=OY"LZ9I5^$W:IZ5_R#
MT_WG_P#0C5RJ>E?\@]/]Y_\`T(UN<AF?\U#_`.X3_P"U:*/^:A_]PG_VK10!
M+_S//_<,_P#:M;58O_,\_P#<,_\`:M;5`!1110!1B_Y#UW_UZP?^A2U>JC%_
MR'KO_KU@_P#0I:O4`<9<?\A^[_ZZ_P!!2ZC_`*FDN/\`D/W?_77^@I=1_P!3
M71V,F5X_^1:@_P"OX_\`H!K0B_X]OPK/C_Y%J#_K^/\`Z`:T(O\`CV_"N*O\
M1Z%'X$5=%_Y&:#Z/_P"@FNTKB]%_Y&:#Z/\`^@FNTJH;&5;X@HHHJS$Y'6O^
M1B;_`*YI1>?\>WX4:U_R,3?]<THO/^/;\*Z.B,WN4+'_`)`NJ?\`72'_`-"K
M1L_^/?\`"LZQ_P"0+JG_`%TA_P#0JT;/_CW_``KCQ'Q'=A_@*,?_`"'K/_KN
MO\Z[JN%C_P"0]9_]=U_G7=44]B*^Z"BBBM#`Y?Q1_P`A2T_ZYG^=1O\`\>WX
M5)XH_P"0I:?]<S_.HW_X]OPK=?"C-[F?IGW]4_Z\I/Z5<TW_`%-4],^_JG_7
ME)_2KFF_ZFN;$;G9A_A*&I_ZX?[PKOZX#4_]</\`>%=_44]@K]`HHHK4YSGO
M%O\`JK/_`*ZG^55(_P#CV_"K?BW_`%5G_P!=3_*JD?\`Q[?A6\?A1G+<IZ1_
MR,L/^Z__`*":71_]2OT%)I'_`",L/^Z__H)I='_U*_05SXCH=>&V8S6/NFNP
MTW_D%VG_`%P3_P!!%<?K'W378:;_`,@NT_ZX)_Z"*RIE5MBU1116QS&3XG_Y
M`4W^^G_H8K'L_P#4?A6QXG_Y`4W^^G_H8K'L_P#4?A6T?A(EN48_^0]9_P#7
M=/YU8@_Y"5U_U\2?^A&J\?\`R'K/_KNG\ZL0?\A*Z_Z^)/\`T(UEB-D=.&ZA
MJO\`JJZ#PW_R`+7Z-_Z$:Y_5?]570>&_^0!:_1O_`$(UA2-*WPFI1116QRE;
M49WMM-N9X\;XXF9<C(R!6'::SJ$\>YI(A](__KUL:S_R!;W_`*X/_(US6F_Z
MG\*U@ERDR9)>>(M3MI`%>$C/>/\`^O27W_(QW?\`O+_Z`M9NJ_ZP?[U:5]_R
M,=W_`+R_^@+6==+E1OAG[S#4/]16EX0_Y!,G_7=OY"LW4/\`45I>$/\`D$R?
M]=V_D*YZ9M5^$W:IZ5_R#T_WG_\`0C5RJ>E?\@]/]Y__`$(UN<AF?\U#_P"X
M3_[5HH_YJ'_W"?\`VK10!+_S//\`W#/_`&K6U6+_`,SS_P!PS_VK6U0`5FG6
M8EU9K!HF&TE?,Z_,$5R,>FUASZ\5I5"+6`71NA$OG%=N_'.*`*%A>07NLW<L
M#,R"VA&2A7G=+V(K4R*I36,[7SW4%X82\21LOEAL[2Q!Y_WC1]DO_P#H)G_O
MPM`'.7,<BZ[=L8I-IDR"$)!X%%^&>+"QR$_[A_PKH_LE_P#]!,_]^%J"UAU:
M7SO.OC'LE94_<+\RCH:U]IY$\ISR03#PY`ODR;A>%B-ASC:>:N1[A;X,<F<?
MW#_A6Y]DO_\`H)G_`+\+4$L.JI=01I?%HWW>8_D+\N!Q^M83CSNYT0J\L;6,
M/1H9E\10R-%($`;+%2!]TUV&15+[)?\`_03/_?A:/LE__P!!,_\`?A::5D1.
M7,[EW(HR*I?9+_\`Z"9_[\+1]DO_`/H)G_OPM,@P=:CD.OLXC<J8UY"DBFW6
MYH,+'(3C^X?\*Z#[)?\`_03/_?A:@AAU9[NXC>^*Q)M\M_(7Y\CG\JTY]M">
M4YNRMYQHVI@PR`M)#M!0Y.&YJ[:AE@PT<@./[AK>^R7_`/T$S_WX6HKF#5(X
M@T5^78R(I'D+]TL`Q_`$G\*QJ+G=S>G4Y%8YN*"8ZW:.(9-HF4D[#@<UVV15
M+[)?_P#03/\`WX6C[)?_`/03/_?A:(QL*<^8NY%&15+[)?\`_03/_?A:/LE_
M_P!!,_\`?A:HS,?Q-&[ZC:LD;LH0Y*J3CFH7)-OC9)G']P_X5O?9+_\`Z"9_
M[\+4'DZK]N\K[<?)\K=YGD+][/3\JT4]+$N)SFF03!M3)AD`:S<#*$9/'%6;
M!7CBPT<@/^X:Z'[)?_\`03/_`'X6HKN#5(K.:2&_,DJ1LR)Y"_,P'`K*HN=F
MU.?(K'+ZA!-+,NR&1OF'\!KNLBJ7V2__`.@F?^_"T?9+_P#Z"9_[\+2C'E"<
M^<NY%&15+[)?_P#03/\`WX6C[)?_`/03/_?A:HS,WQ4CR0VNQ&?$ASM4G'%4
MXR1;X*29Q_</^%;WV2__`.@F?^_"U!+#JJ74$:7Q:-]WF/Y"_+@<?K5J=E8E
MQN<_I$,H\0Q2&&0*%?+%"!]TT:5')%$H>*13@=4-=/\`9+__`*"9_P"_"T?9
M+_\`Z"9_[\+45/?-J<^1-'*ZI%+*/DAD;Z(:Z[3\KIMJK`@B%`01TX%5K2#5
M);.&2:_,<KQJSIY"_*Q'(J7[)?\`_03/_?A:B,>4<ZG,7<BC(JE]DO\`_H)G
M_OPM'V2__P"@F?\`OPM69$'B16DT2545F;<G"C)^\*QK7<L.&CD!_P!P_P"%
M=!]DO_\`H)G_`+\+4%S#JL0B\F^,FZ55?]PORJ>IJU*RL)JYS44,S:Y:.(9-
MHG4D[#@<U8BCD34;DM%(`9W(.P\_,:Z3[)?_`/03/_?A:/LE_P#]!,_]^%J*
MGOFE.7(<WJ2221X2*1OHAK?\/*T>AVR.I5@&R",$?,:+:#5)(BTM^482.H'D
M+]T,0I_$`'\:E^R7_P#T$S_WX6HC#E*G4YE:Q=R*,BJ7V2__`.@F?^_"T?9+
M_P#Z"9_[\+5F0NK@OH]XJ@LQ@<``<G@US5@'2+#1R`_[A_PKI/LE_P#]!,_]
M^%J*[@U2*SFDAOS)*D;,B>0OS,!P*N,K*PFKG*:C#-+(-D,K<]D-:-]')_PD
M%T_E2%2RX(0D'Y5K?^R7_P#T$S_WX6C[)?\`_03/_?A:FH^=6+IRY'<Y^^5W
MAPL<A/\`N&M+PHCQ:7(LB,A,S'##'&!5B"'57FN5DORBQRA8SY"_.NQ3G\RP
M_"IOLE__`-!,_P#?A:SC#E-)U>96L7<BJFE?\@]/]Y__`$(TW[)?_P#03/\`
MWX6I[2W^RVR0[RY7.6(QDDY/\ZLQ,?\`YJ'_`-PG_P!JT4?\U#_[A/\`[5HH
M`E_YGG_N&?\`M6MJL7_F>?\`N&?^U:VJ`"BBB@`HHHH`JZC=O8V$MS'"9G0<
M(#C)]SV'J>PJCX;UAM7L6>1T:2-@"RC&X8'('IG<`>^W/>MBN:OM.GT?4_[3
MT\@02$^>C$D+DY+=/NCYCU[^@&`#I:Q-2UN6QOBQCQ9P`+,[C!9F(P$_O$`Y
M/^-6M)U4:I%O\AHS@$@\[<@'!]#SD?[)![T:SI2ZI:[5;9/&0\+GH&!##/ME
M1[\4`:-%8&FPWNB6UQ/?7*O8QQN_[QR9`1SN);C)RW'084#/)K>!!&0<@T`+
M1110!'/+Y%O)*$:38I;8@RS8'0#UK%\.:[)JLMQ%<>6)(SD!2,#DY4'^+:-N
M3ZMCM6]7/:UI5Q!>#6-,!,ZG,L7)\SC'``/7"Y_W?<Y`.AK(UG5+BQE06\0*
M1*9KAY/E0)SP#_>)'`_.G:5K2ZC(8O+&5S\RG(8`D;O]TXX/<AAVYM:GIL&J
MV4EI<;MCJ1E3R,@C^1-`$\$R7%O'/'G9*@=<C!P1GI4E8&CZ9JUC>F2:Z66%
MS^_#NQ+-@\J#PJ@A0!W!8GG`K:MKB.[M8KF%@T<J!U(.<@C-`$M%%%`"5SVD
M>(I;[6Y[.=%B&TE(R1N3&,!O]H_,2O;:/6NBK&US1GO)(KVT8)=0E3R3AE!Y
MZ=\%@/KZ@$`&S6;K%Y<VR1164>Z>1L[G'[M$&-Q8]AC\:JZ3KSW<B6T\.V8#
M#8/);"DC'^SG#>AQQSQKW%O'=0-#(#M;T/<<B@"+3KZ/4M/AO(@0LHS@_7!_
M45:KF=-T+4],OD^SW0:"+:A65VP8@<*JKT!"Y)/4L`.!70V]Q'<QL\3!@KLA
MY[JQ4_J*`):***`"N='B.4>)OL$R+#`24`8C=P#\Y]`3M`'?.>U=%65KNC#5
MK4>6PCN8P?+8GY>W!]N`?P[@D$`U:I:K=36MD3;1-+<2'9"JC(W'H3Z#U-9=
MAKTR7`L;N']ZK8.#\W5L+@]6(`8#NN3VYWI8TFB:)QE7!5AG'!H`IZ1J(U*U
M=_E,D,AAD*?=+#J5/<<U?KE_^$?U.SOC)IUVH56=HEE9@BACN((`P2SDC/9>
MF3TZ*&XCFDFC5@7@8)(`<X)4-_)A0!-1110`5SVJ^(9;#7;>T\L)`64,S]9,
MD9(]%5<DGU&*Z&J.K:9%JMD8)"58?,C`XP<$?E@D?CQ@X(`+H(8`@Y!Y!%07
MMR+.TDG\MY"HX2-=S,3P`!]:P++5KK2733;Z-69,*&#8&!M&[D="25'JP`[\
M=*IWH&P1N&<'J*`,W1=2EO%FM;H(+NUVB;RSE<L,@9]1R#_]>M2N9NO#=U%J
M'F:==&&-W#@%VPKX"LQQ]["J,`]3R3Z[EI<.Q%M<M']LCA1YEC.5YR,C/.,J
M>HH`M4444`%<_P")->GTB2!(8\*QRSL,[ST"*.Y)ZG^$<UT%5[VSBO[5[:8'
M8V#E3@@@Y!'XB@"6.5)HUDC<.C#(8'(-$TJP0O,^=L:ECM&3@>U<O;7EYX;?
M[#<HDD./W;[B%Q\Q)R1T4`;CS@'/;GIX91-&)`K*"3C</?K]*`,O2-5GN+M[
M.]C$<[(9XT'58]V`']&Y''O[&MBN=U?P_-+=?:+"0IY@'F1^8R!W#$KEEY"Y
M9B?H!P.FI9SS0>19:A-')=NKL&3@.JD#.#T.&7(&1G-`%ZBBB@#`_P":A_\`
M<)_]JT4?\U#_`.X3_P"U:*`)?^9Y_P"X9_[5K:K%_P"9Y_[AG_M6MJ@`HHHH
M`****`"D(#`@@$'@@TM%`'-R:1?Z9K?VO2@KQ3AO,21C@$Y///3/(/JS9SD$
M=)110!0UJPDU'3)+>&4QR`ATYX+*<J#[;@"<<\5G>'[R&S#:5+,0T'R(9"!O
MVDJQQU&2I.2><Y[XKH*QM;T"/56CD5O+??&)<=)(U8DJ?P9OSQWH`V%974,K
M!E89!!R"*6LRSU$3WJ6UHOG6T<;+)-@C8ZD#:<^O/Y5IT`%%%%`'.ZEHUU;Z
MK%J>E?ZQG`EC)P",8]1Q@#C_`&5QP"#O0&4P1F=564J-X0Y`;'./;-244`5[
M^T%_836C2O$LR%&>,@,`>N,^U8&B3?V-='3+R3#,QW/D!3(0&XSR0`P4'I\N
M,<9KIZRM>T5=7LW$;^3=+&RQ2CMG!(_\='TZT`::2)(NZ-U=<D94Y''%.K)@
MN8[.XM]*L$\U87*3C!'DKM+*<^G0?C6M0`4444`8&O:+--*FI:<2+R+'R@XW
M`'/J/4\=PS="<C8M&N6ME-VB)-SN$9R.IQ^F*GHH`;(I>-E5RA8$!EQE?<9K
ME--C'AB_-K/*[12$'>2.$.50$GEC\N3C&"Y/.:ZVJ>IZ;#J=MY4GRNN3'(!D
MHV",^_!/%`%F.6.4$QR*X!P=IS@_Y-/K`LS_`&'96VEVX^TWO[MI8\'D,0'?
M/UR:WZ`"BBB@#'\0:,=2MQ+;L4NH<F,@XST[^O`(/J!G(XJUI+7[6*G48T2;
MC`0GI@=>3SG/<U>HH`*Y)K<^&]9>[DEDE2Y9F#'&0N0SY)XR6?H`,A!SQ76U
M!>6<-];F"==R$AN.H((((^A`H`?%<0SC,4J/P#\IS@'I_(_E4E<W90'PS830
M>;]IOYR\D2;3^]P3@#'0X(&/\*Z-22H)&"1R/2@!:***`,_6=)CU:S,1(613
MN1CTS@\''..2..>3C%1:`NJ1V7E:DB@Q@*C%LNV"0=W;ICGWZ#I6K10`5RNJ
MV+Z7K)UD2R2"5L*O&5<KR<GA0$0`$@_>([YKJJBN+>*ZMY+>=`\4JE'4]P1@
MT`,M;ZVO(DD@E5MZ[@N1G'T_$58KGK.PB\/75U<SW19KN79;[@3Q@$*<>X;Z
MY]36U92S3V4,MQ#Y,KH&>,_PG'(H`GHHHH`JZC81:E9O;2DJ&'#+U4@Y!'X@
M5G>'K;5++S+2[2/[-&6\MPQ)[$8R3\O)Z\\#KU.W10`5S?B'372_CUA9'81!
M59,9P0<)@=`-SEB3G&T''&*Z2D(!&",@T`4M-U.WO[6-TE&]OE*,PW;AUZ=>
MAZ5>KG8='M-!U*34I+@QV:1I'$A!(CSD$?3[O/MZ"MC3[B>YM?-GA\IM[`#U
M4$@''N,&@#*_YJ'_`-PG_P!JT4?\U#_[A/\`[5HH`E_YGG_N&?\`M6MJN6U+
M6].T?QNIO[CR0VF@#Y&;/[P^@/H:M?\`"<>&_P#H(_\`D"3_`.)H`WZ*P/\`
MA./#?_01_P#($G_Q-'_"<>&_^@C_`.0)/_B:`-^BL#_A./#?_01_\@2?_$T?
M\)QX;_Z"/_D"3_XF@#?HK`_X3CPW_P!!'_R!)_\`$T?\)QX;_P"@C_Y`D_\`
MB:`-^BL#_A./#?\`T$?_`"!)_P#$T?\`"<>&_P#H(_\`D"3_`.)H`WZ*P/\`
MA./#?_01_P#($G_Q-'_"<>&_^@C_`.0)/_B:`-U45"Q50NXY.!U/K3JP/^$X
M\-_]!'_R!)_\31_PG'AO_H(_^0)/_B:`-^BL#_A./#?_`$$?_($G_P`31_PG
M'AO_`*"/_D"3_P")H`WZ*P/^$X\-_P#01_\`($G_`,31_P`)QX;_`.@C_P"0
M)/\`XF@#?HK`_P"$X\-_]!'_`,@2?_$T?\)QX;_Z"/\`Y`D_^)H`W0BARX4!
MFX)QR:=6!_PG'AO_`*"/_D"3_P")H_X3CPW_`-!'_P`@2?\`Q-`&_16!_P`)
MQX;_`.@C_P"0)/\`XFC_`(3CPW_T$?\`R!)_\30!OT5@?\)QX;_Z"/\`Y`D_
M^)H_X3CPW_T$?_($G_Q-`&_16!_PG'AO_H(_^0)/_B:/^$X\-_\`01_\@2?_
M`!-`&[L7>'VC<!C=CG%.K`_X3CPW_P!!'_R!)_\`$T?\)QX;_P"@C_Y`D_\`
MB:`-^BL#_A./#?\`T$?_`"!)_P#$T?\`"<>&_P#H(_\`D"3_`.)H`WZ*P/\`
MA./#?_01_P#($G_Q-'_"<>&_^@C_`.0)/_B:`-^BL#_A./#?_01_\@2?_$T?
M\)QX;_Z"/_D"3_XF@#=**S*S*"5Y4D=*=6!_PG'AO_H(_P#D"3_XFC_A./#?
M_01_\@2?_$T`;]%8'_"<>&_^@C_Y`D_^)H_X3CPW_P!!'_R!)_\`$T`;]%8'
M_"<>&_\`H(_^0)/_`(FC_A./#?\`T$?_`"!)_P#$T`;]%8'_``G'AO\`Z"/_
M`)`D_P#B:/\`A./#?_01_P#($G_Q-`&ZR*X`90P!R,C.#3JP/^$X\-_]!'_R
M!)_\31_PG'AO_H(_^0)/_B:`-^BL#_A./#?_`$$?_($G_P`31_PG'AO_`*"/
M_D"3_P")H`WZ*P/^$X\-_P#01_\`($G_`,31_P`)QX;_`.@C_P"0)/\`XF@#
M?HK`_P"$X\-_]!'_`,@2?_$T?\)QX;_Z"/\`Y`D_^)H`W6574JZAE(P01D&G
M5@?\)QX;_P"@C_Y`D_\`B:/^$X\-_P#01_\`($G_`,30`?\`-0_^X3_[5HJC
MINM:?K'Q`9["X\Y5TH@G8RX/FCU`]110!UM%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g118721mmi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mmi003.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$>`;$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#U`PZC=7UY
MY6JO!%'*$2,0(V!Y:'J1GJ33O[/U3_H.2?\`@-'_`(59L_\`CZO_`/KX'_HJ
M.K=`&7_9^J?]!R3_`,!H_P#"C^S]4_Z#DG_@-'_A6I10!E_V?JG_`$')/_`:
M/_"C^S]4_P"@Y)_X#1_X4FGZ=:7%E'-+`KR/DLQ').:L?V18?\^L?Y4`0?V?
MJG_0<D_\!H_\*/[/U3_H.2?^`T?^%-O;*RMS!'':1&2XE\M-R\`[68Y_!363
M>:AIE@]O'/:1>9N<7&U"0`D1=]OT.WUZT`;']GZI_P!!R3_P&C_PH_L_5/\`
MH.2?^`T?^%9LFHZ&LL<,5F99)"NT!,#:SHH;/3&7%7X;*RDU*YM39Q`0I&P(
M'7=N_P#B:`'_`-GZI_T')/\`P&C_`,*/[/U3_H.2?^`T?^%3_P!D6'_/K'^5
M']D6'_/K'^5`$']GZI_T')/_``&C_P`*/[/U3_H.2?\`@-'_`(53\.Z?:W.C
M1RS0K(YDE!9N3@2,!^@%:?\`9%A_SZQ_E0!!_9^J?]!R3_P&C_PH_L_5/^@Y
M)_X#1_X4V^LK&UB0K:1EY)%C7*\`L<<UE7U]IVG@1S6<1GCEVS!$)&!M)Q[X
M=#^/M0!K_P!GZI_T')/_``&C_P`*/[/U3_H.2?\`@-'_`(5ESZIH,>Y8[,RN
M$:0*J=5#%2<]/O`C\*T5L+?^U3;FRA,'D[PP'*G(&#]><?[IH`?_`&?JG_0<
MD_\``:/_``H_L_5/^@Y)_P"`T?\`A4_]D6'_`#ZQ_E1_9%A_SZQ_E0!!_9^J
M?]!R3_P&C_PH_L_5/^@Y)_X#1_X53\/Z?:W&GS/-"LC"^NT!;G"K<2*H_``#
M\*T_[(L/^?6/\J`(/[/U3_H.2?\`@-'_`(4?V?JG_0<D_P#`:/\`PI+ZRL+2
MV\T6D99I$C7CC<[A1GVRPK,O;BQL%2&6SA:Z^T1Q,J(2I#2`8'/7:<T`:G]G
MZI_T')/_``&C_P`*/[/U3_H.2?\`@-'_`(5D2ZSX>6S^TQ6AF#1-*@6/[P4.
M3],>6WY5HM:VB:S#9-9Q".:!Y%.TYW*5R,].C=/:@";^S]4_Z#DG_@-'_A1_
M9^J?]!R3_P`!H_\`"I_[(L/^?6/\J/[(L/\`GUC_`"H`@_L_5/\`H.2?^`T?
M^%']GZI_T')/_`:/_"J>B:?:SB_\V%7\N^E1<\X4$8%:?]D6'_/K'^5`$']G
MZI_T')/_``&C_P`*/[/U3_H.2?\`@-'_`(47UEI]G9O/]D1B,`#'<D`?J:R]
M0GLM-5H9[2`W6]`H5"5(8G'?KA'_`"H`U/[/U3_H.2?^`T?^%']GZI_T')/_
M``&C_P`*RFU;P]Y43I:ES.A:-1&?FPF]OI@8_.K/F:2=5L=/^S0K+=0--L)&
MX``8_K^5`%S^S]4_Z#DG_@-'_A1_9^J?]!R3_P`!H_\`"I_[(L/^?6/\J/[(
ML/\`GUC_`"H`@_L_5/\`H.2?^`T?^%']GZI_T')/_`:/_"J>DZ?:S7VLI)"K
M+#?!(P?X5\B)L#\6)_&M/^R+#_GUC_*@"#^S]4_Z#DG_`(#1_P"%']GZI_T'
M)/\`P&C_`,*+ZRTZRL)[MK1&$,;.0!UP,UEZE-9Z5:W7VBTMS<11F1`B$J1M
M)7//<JP_"@#4_L_5/^@Y)_X#1_X4?V?JG_0<D_\``:/_``K-74=`=E1+4L[N
M8PHC.=XVY'_CZ_G4L:VMPVDR1:?&MO?QEV9DR5RFY1D<`]>OI0!=_L_5/^@Y
M)_X#1_X4?V?JG_0<D_\``:/_``J?^R+#_GUC_*C^R+#_`)]8_P`J`(/[/U3_
M`*#DG_@-'_A1_9^J?]!R3_P&C_PJGINGVLNL:O$\*LD,T8C4]%!B4G'XDFM/
M^R+#_GUC_*@"#^S]4_Z#DG_@-'_A1_9^J?\`0<D_\!H_\*==V.FV=G/=/:(4
MAC:1@%Y(`S_2LG4IK32;&XDN[2W\Y8C)$$4E>@`W<_WV`H`U/[/U3_H.2?\`
M@-'_`(4?V?JG_0<D_P#`:/\`PK-_M'0`%_T4EC+Y&T1G_6;]FW\Z>L^ER+IQ
M%DD8O4$F77(525`&1T)+`"@"_P#V?JG_`$')/_`:/_"C^S]4_P"@Y)_X#1_X
M5/\`V18?\^L?Y4?V18?\^L?Y4`0?V?JG_0<D_P#`:/\`PJ-H]2M-0T\2:J\\
M4T[(\9@1<CRG8<@9ZJ*LV$,=O>7D42A8PR$*.@RM&H_\?NE?]?;?^B9:`+]%
M%%`%2S_X^K__`*^!_P"BHZMU4L_^/J__`.O@?^BHZMT`%%%%`'/V&G:K)9H\
M6NR0QMDK&+:,[1D\9(R:L?V7K/\`T,4O_@)%_A52RU>_AM5BCT::58V90X?A
ML,1GI5C^V]2_Z`,__?S_`.M0`2Z-JLR;)=?=UR#AK.(C(_"J+Z%]I3?)K4,B
MN,Y:QA.05VYZ=U./H:O'6M2(Q_8,_P#W\_\`K5B:=:7EA<I<_P!D79D6'RCM
MDVY&V->H7/2)>_<T`6CI`\QA_;2%U<)@6$.2S8?`XYSA6_#VJ]!I.H.[74.O
MMOE`5W%G%EMN1@G';FLRZ@NKN62231[S+R!Q^\'RD1[.#MSG'.>H-7K'4=3M
M+<Q'0YV+222$^9W=RQ[?[5`%O^R]9_Z&*7_P$B_PH_LO6?\`H8I?_`2+_"F?
MVWJ7_0!G_P"_G_UJ/[;U+_H`S_\`?S_ZU`&=X;TW5GT2-H]>DC7S9?E%M&?^
M6C>HK4_LO6?^ABE_\!(O\*S])O-5TW3DM7T65V5W;<K\?,Y;^[[U=_MO4O\`
MH`S_`/?S_P"M0`2:-JLR&.77W=#C*M9Q$>OI5)]#-P"TFMQ.#UW64)S@X]/4
M5=_MO4O^@#/_`-_/_K5B6=I>6MW%='2+HO%"(1MDQE5!`R0N<XQGGM0!9?1T
M5GC.LQY50"HL(>1)G@<<YP?RJ[!HU\\S7D.NGS6RC2"RBW'!P03CL1^E9M]!
M=7\TDDNCWGSJJ@>8#MVK(N<E>N)6_2KUEJ&IVD<@.ASL9)6D/[SID].GI0!<
M_LO6?^ABE_\``2+_``H_LO6?^ABE_P#`2+_"F?VWJ7_0!G_[^?\`UJ/[;U+_
M`*`,_P#W\_\`K4`9WA[3=6?3IBFO21C[==@@6T9R1<2`GIW//XUJ?V7K/_0Q
M2_\`@)%_A6?I5YJNG6DD#Z+*Y>YGFRK\8DE:0#[O4!L?A5W^V]2_Z`,__?S_
M`.M0`LFCZM-&8Y-?=T;JK6D1!_2J3:(\I+/KD;%3C)LH>JMGT[,/S%7/[;U+
M_H`S_P#?S_ZU8L-K>1Z@EZVCW7F1L2NV0#(S+@$[<_\`+8]_X10!.=%CB#Q?
MVQ$!%&N5%A#C:^Y%`X[_`#+C\*OP:3J#N9XM>;S!^[+"SB##';I]*S[R.[O9
MI))=&NR'2--ID#`;"Q!Y4Y^^>OM5FPO=2LA-_P`22X<RR!B3*3T14'4>BC/O
MF@"]_9>L_P#0Q2_^`D7^%']EZS_T,4O_`("1?X4S^V]2_P"@#/\`]_/_`*U'
M]MZE_P!`&?\`[^?_`%J`,[0M-U9AJ&S7I$Q?2@_Z-&<G(YZ5J?V7K/\`T,4O
M_@)%_A6?IMYJM@+H/HLK^?<O.-K]`W8_+UJ[_;>I?]`&?_OY_P#6H`5](U:6
M-HY/$$C(PPRFTB((_*J3Z')*2)-;C8J=OS64/\//IVY_6KG]MZE_T`9_^_G_
M`-:L5;6\_M&.];1[K?#+(Z;7`.'9V()VYZR-T]J`+!T9(&"_VU$NQ/,7%A#@
M#[G''H=OXXJ[!I5_($,6O,#`-BC[%$#'P..G'&/TJE>"[O9@\FC79`15VM(&
M'$BN"<J<\J*ETRYU'3DD1=%N7#%,%I<G"HJ#/')^7-`&A_9>L_\`0Q2_^`D7
M^%']EZS_`-#%+_X"1?X4S^V]2_Z`,_\`W\_^M1_;>I?]`&?_`+^?_6H`SM'T
MW5FO]:"Z](A6^`8_9HSN/D0\]..,#\*U/[+UG_H8I?\`P$B_PK/L+S5;.YU"
M9M%E87ER)U`?[H\M$P?EZY0G\15W^V]2_P"@#/\`]_/_`*U`#FTG5W0HWB&1
ME88(-I%@C\JHR:$\I:*76HVV@H5:RA[CD=/0C\ZN?VWJ7_0!G_[^?_6K%FMK
MR?4%NWT>Y!CE:1-KC/S,C$9VYZQXX[$T`63I"P2K_P`3R)&"M.&^PPC`4C+9
MQV++5JUT>\8)Y&N%#;J$1191`Q@C@#C@8JI>_;+V6-Y-&N\1QL@4R[@<LC9.
M5/>->.G6I-.N-0T]G*Z)<,#&D:@R=%7..W7+'\,>E`&C_9>L_P#0Q2_^`D7^
M%']EZS_T,4O_`("1?X4S^V]2_P"@#/\`]_/_`*U']MZE_P!`&?\`[^?_`%J`
M,[3--U8ZSK*KKTBLL\>YOLT9W?ND]N/2M3^R]9_Z&*7_`,!(O\*S[.\U6UU"
M_NFT65EO)$=5#\KM15Y^7_9S5W^V]2_Z`,__`'\_^M0`\Z5K!&#XBE(/_3I%
M_A5!]!D?-O)K49"#84:QAP-P&1T[C''TJY_;>I?]`&?_`+^?_6K&NK:\O-0-
MW)H]RI$ZS)M<9!'E>J_],5Z>IH`L-HZPNN=;B!.Z4$6,/\)WD].Q.[Z\U-9Z
M5<W44+0:V0(E#1J;&(%`W((&.,X_2FS7&H2SQ2C1[L&)9%`,F_.X`<[E/3%-
MT^:^T^9VBT*8(8DB50^``I=NFW`Y<\#@`"@#2_LO6?\`H8I?_`2+_"C^R]9_
MZ&*7_P`!(O\`"F?VWJ7_`$`9_P#OY_\`6H_MO4O^@#/_`-_/_K4`3Z1!<6]U
M?)=7C7<FY#YC1JG&WI@<5+J/_'[I7_7VW_HF6HM(N)[FXO);BU:V8L@",<G&
MWKTJ74?^/W2O^OMO_1,M`%^BBB@"I9_\?5__`-?`_P#14=6ZJ6?_`!]7_P#U
M\#_T5'5N@`JO:WUM>)(\$FY8Y&B8XQAAU'-6*I0:9!%#+&ZJ1+*96"#8N<`<
M`=.G/N2:`%TK_D'I_O/_`.A&KE4=)4#3D`'`9_\`T(U=P*`%HI,"JVHB<:=.
M;4-Y^P^7MQG/;K0!9)`ZG%!91U8#\:R)M+O9;<`W99\$$'C&58`Y'4@D'IU'
M:DO-*NKF:1UFV!VW*0WW3A,=N@*'T^^<$'F@#8#*3@,#^-+699Z?-;W8D9LQ
MXEX+9(W%"!G`SRK<^]:6!0`M%)@48%`"T4F!5?4!,--N3;;O/\EO*VXSNP<8
MSQUH`L$@#).*-P!P2*RGTZ\DA!>Y+MN)\MC@$9.`2/08_*FOIEV9P_G!\.AY
M8C(#1Y_]`8_\"H`UMZYQN'7'7O3JRDTZ7[<L^P0A9F?B3>&!4#H1P3C/!X/K
MG%:F!0`M%)@48%`"T4F!45T'^R3>5GS-C;,=<XXH`E)`&2<"@L!U(%9,=A?2
M6B-/<%I-RL8V]`P;:2/;CI3'TJ\;R/WP;RA'NRQ_>;>JGV/6@#9W+G&X=<=:
M6L:+2;E5B5YB6CN$DW[OO`*H((]\,>#^?(.Q@4`+128%&!0`M%)@4A48/7\*
M`%R`,DT;@.I'KUK%M;'4IK"%[JY82D(S1-CL`64D>ISV[TLFE7CFWQ,/W0CW
M`L?FV[LCZ-N`_P"`CK0!L;USC<,].M.K`_L:\,MNP8(86BWOYI/FA<YR,<=?
M7L.<`@[V!0`M%)@48%`"T4F!1@4`+128%&!0`M%)@48%`"T4F!1@4`+128%&
M!0`4;AQR.>E8T5CJ5S;S^==21%FD6,-C(&Y@IXQVVT76E7D]J(HYA$W[S#!C
M\FYPPQ]`"OXT`;&]?[P_.G5SMSH5_*K[+D*6=W7YC\H)&%^@P1_P(XP<&NAP
M*`*T/_'_`'/T3^1J+4?^/W2O^OMO_1,M2P#%_=?1/Y&HM1_X_=*_Z^V_]$RT
M`7Z***`*5BV;O41Z7('_`)"CJ[52S_X^K_\`Z^!_Z*CJW0`4444`4=';?IJ-
MC'SO_P"AFKU4]*_Y!Z?[[_\`H9JY0`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110!C:IK,]EJ*6L<:$-&'W-GN2/Z5'+K-U'%OV1'VP:I>(
M/^0_'_UP7_T)J;=?\>WX5A*33.R$(N*T-70M7EU7[0)8U0PE0-IZYS_A6O7,
M^#O^7[_>3^M=-6T=CFJ)*32"BBBF0%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`137,%OM\Z5(]W3<<9IGVZUQG[1'C_>K%\5?ZVQ^K_\`
MLM5O^77\*SE.S-X4E*-SI(;RVN)#'#.DC@9*JV3BIZY#PQ_R'YO^O=O_`$):
MZ^KB[HSG'E=BI;MG4KM<=!'_`"-1:D<7VDCUNV_]$2U/#_Q_W7T3^1J'4?\`
MC]TK_K[;_P!$RTR"_1110!3LB#=Z@!VN!G_OU'5RJ-@/],U+WN5_]$QU)+J-
MM#?163N1/*-RKM)XYYST'3'XCU%`%JBBL72M5O;NVO)FLYY&CNVCCB9!$P3`
M(^]C/6@"[I#!M.0CIO?_`-#-7:S]#W?V3%N0J=SY![?.U7\GTH`6BDR?2C)]
M*`%HI,GTHR?2@!:*3)]*,GTH`6BDR?2C)]*`%HI,GTHR?2@!:*3)]*,GTH`6
MBDR?2C)]*`%HI,^U&3Z4`+129/I1D^E`'+>(/^0_'_UP7_T)J;=?\>WX4[Q`
M?^)_'Q_RP7_T)J;='_1NG:N>>YW0^%$W@_K??[R?UKIJYCP?]Z^X_B3^M=-D
M^E;1V.6K\;%HI,^U&3Z51F+129/I1D^E`%2[U6SL9EAN)"KN-P`0GC\!36UF
MQ5=QD;'_`%S;_"L7Q'_R&(./^67]33)S_HW3M64IM,Z84HM)LW['5;/47D6U
MD+F+&_*%<9SCJ/8U<KEO"!_TO4..T?\`[-749/I6B=T8SBHRLA:*3/M1D^E,
M@6BDR?2C)]*`%HI,GTHR?2@!:*3)]*,GTH`6BDS[49/I0`M%)D^E&3Z4`<]X
MJ_UMC]7_`/9:K_\`+K^%3^*O];8\=W_]EJ#/^B].U<]3<[:7P(B\,?\`(?F_
MZ]V_]"6NOKD/#!_XG\W'_+NW_H2UUV3Z5K#8YZWQ%:!@=0NAGD!,_D:AU$XO
MM*][MO\`T3+3[8'^U+TD$`B/^1J/4O\`C_TC_K\;_P!$2U9D:-%%%`%2S_X^
MK_\`Z^!_Z*CK%=()/$R/%)=-Y<N)#)*1&K=E4=^?J!6O8?\`'YJ?_7TO_HF.
MN=57_P"$L$IF+.9VPI1SL4-C.=V!D?+TYQB@#L*2EHH`IZ5_R#T_WW_]#-7*
MS]$_Y!4?^_)_Z&U:%`!1110`45R&IJ&\1W.0#]SK_NBDOHT$'"*/PK-U+.QT
M*C=7N=A16!X/_P"07-_U\-_Z"M;]6G=&,E9V"BBBF2%%%%`!1110`4444`%%
M%%`!1110!ROB#_D/Q_\`7!?_`$)J;=?\>WX4_P`0?\A^/_K@O_H34VZ_X]OP
MKGG\1W0^%$O@[_E^_P!Y/ZUTU<SX/^]??[R?^S5TU;1V.6K\;"BBBJ,PHHHH
M`YCQ)_R%[?\`ZY?U-1S_`/'M^%/\1_\`(8@_ZX_U--G_`./;\*YY[G=3^%"^
M#_\`C[U#Z1_^S5U-<MX0_P"/O4/I'_[-74UM'8Y:OQL****HS"BBB@`HHHH`
M****`"BBB@`HHHH`YWQ5_K;'ZO\`^RU6_P"77\*L^*O];8_5_P#V6J__`"[?
MA7/4W.VE\"(O#'_(?F_Z]V_]"6NOKD/#'_(?F_Z]V_\`0EKKZUAL<];XBM#_
M`,?]U]$_D:AU'_C]TK_K[;_T3+3K;_D*WO\`NQ_R-1ZG_P`?^D?]?C?^B):L
MR-&BBB@"G9#_`$K4/>X'_HJ.L^**&+69$%I)]HDN/-:4(`A4*<9(Y(Y/7^(F
MK]B2;S4@>UR,?]^HZR-=U>?3==M?WSI:K&'F4*"&'S<#OGC/I\OO0!TE%%10
M7$5RK-"X<*Q4X[$=10!7TD`:<@`Q\[_^AFKM4-%8MI<9/7?)_P"AM5^@`HHH
MH`Y'4O\`D9+C_@'_`*"*2_\`]12ZE_R,ES_P#_T$47_^H-<TOB.^/PHO^#_^
M07-_U\-_Z"M;]8'@_P#Y!<W_`%\-_P"@K6_71'8XZGQ,****9`4444`%%4;G
M6+.UNC;2NPD`!("D]::^MV4:[F9P/]PTN9%J$GT-"BJEAJ5MJ4;O:N6"-M;*
MD<]:MTR6FM&%%%%`@HHHH`Y7Q!_R'X_^N"_^A-3;K_CV_"G^(/\`D/Q_]<%_
M]":F77_'M^%<\_B.Z'PHF\'];[_>3^M=-7,^#_O7W^\G]:Z:MH['+5^-A111
M5&84444`<OXD_P"0O;_]<OZFF3_\>WX4_P`1_P#(8@_ZY?U-,G_X]OPKGGN=
MU/X4.\'_`/'WJ'TC_P#9JZFN6\(?\?>H?2/_`-FKJ:VCL<M7XV%%%%49A111
M0`4444`%%%%`!1110`4444`<[XJ_UMC]7_\`9:K_`/+K^%6/%7^ML?J__LM5
M_P#EV_"N>IN=M+X$1>&/^0_-_P!>[?\`H2UU]<AX8_Y#\W_7NW_H2UU]:PV.
M>M\15@`_M"Z..2$_D:BU'_C^TK_K[;_T3+3[=B=3O!G@"/'Y&H]2.+_2?>[;
M_P!$2U9D:%%%%`%&P_X_-3_Z^E_]$QUB:O%#-XTL!,A;$2@*5W*03)D$;AZ#
ML>AK;L/^/S4_^OI?_1,=9VI"W_X2O3VF!W!1Y9+A03\P]RQYZ8`&<Y[4`;]9
M5GHJ107,<['%Q<>>5B9E"G:H(!!SC()_'':M6B@#.T)0NDQ`9P&D'7_;:M#'
MUJAHG_(*C_WY/_0VK0H`3'UHQ]:6B@#D=1'_`!4ES_P#_P!!%)?C]P:74?\`
MD9+GZI_Z"*+_`/X]S]*YI?$=\?A1?\(#_B5S=?\`CX;_`-!6M['UK!\'_P#(
M+F_Z^&_]!6M^NB.QQU/B8F/K1CZTM%,@3'UHQ]:6B@#DM8'_`!4,G^XO\J+T
M?Z/^%+K'_(PR?[B_RI+W_CW_``KFE\1W0^%%KP>/]%N_^NW_`+**Z+'UKGO!
MW_'K=_\`7;_V45T5;QV.6I\3$Q]:,?6EHJC,3'UHQ]:6B@#E?$`_XG\?_7!?
M_0FIMT/]&_"G^(/^0_'_`-<%_P#0FIMU_P`>WX5SS^([H?"B3P>/FOO]Y/\`
MV:NFQ]:YKP?]Z^_WD_\`9JZ:MH['+5^-B8^M&/K2T51F)CZT8^M+10!R_B,?
M\3B#_KC_`%-,G'^C?A3_`!'_`,AB#_KC_4TV?_CV_"N>>YW4_A0OA`?Z7?\`
MTC_]FKJ,?6N7\(?\?>H?2/\`]FKJ:VCL<M7XV)CZT8^M+15&8F/K1CZTM%`"
M8^M&/K2T4`)CZT8^M+10`F/K1CZTM%`"8^M&/K2T4`<YXJ'[VQ^K_P#LM08_
MT7\*L>*O];8_5_\`V6J__+M^%<]3<[:7P(B\,#_B?S?]>[?^A+778^M<CX8_
MY#\W_7NW_H2UU]:PV.>M\12MO^0K>_[L?\C4>I_\?^D?]?C?^B):DMO^0K>_
M[L?\C4>I_P#'_I'_`%^-_P"B):LR-&BBB@"G9'-WJ(]+D#_R%'5<VNGVFL-.
MDJ075SC>&Z2CT&>_R]ORJQ9$?:]1QU^TC/\`WZCK"N[FT?Q*EO)?V<\TQ\D1
M+"A=5RV5W;L@C/ISGIUP`=31110!1TA@VFH1_??_`-#-7JHZ05.FH5Z;W_\`
M0S5Z@`HHHH`Y'4O^1DN?^`?^@BDO_P#44NI?\C)<_P#`/_0127_^HKFE\1WQ
M^%&AX/\`^07-_P!?#?\`H*UOU@>#_P#D%S?]?#?^@K6_71'8XZGQ,****9`4
M444`<GK'/B%_9%_E27O_`![GZ4NL?\C"_P#N+_*DO?\`CW/TKGG\1W0^%%OP
M=_QZ7?\`UW_]E%=%7.^#O^/2[_Z[_P#LHKHJVCL<M3XF%%%%49A1110!ROB#
M_D/Q_P#7!?\`T)J;=?\`'M^%.\0?\A^/_K@O_H34VZ_X]OPKGG\1W0^%$W@_
MK?#_`&D_K735S/@_K??[R?UKIJVCL<M7XV%%%%49A1110!R_B3_D+V__`%R_
MJ:9/_P`>WX4_Q)_R%[?_`*Y?U-,G_P"/;\*YY[G=3^%#O!__`!]ZA](__9JZ
MFN6\'_\`'WJ'TC_]FKJ:VCL<M7XV%%%%49A1110`4444`%%%%`!1110`4444
M`<[XJ_UMC]7_`/9:KX_T7\*L>*O];8_5_P#V6J__`"Z_A7/4W.VE\"(O#'_(
M?F_Z]V_]"6NOKD/#'_(?F_Z]V_\`0EKKZUAL<];XBI`P.HW:]P$_D:BU$XOM
M*][MO_1$M2P%?[1NP.N$S^1J+4<?;M*S_P`_;8_[\2U9D:%%%%`%&P_X_-3_
M`.OI?_1,=8^IQ*/&.EO&K`,3N\M`=Y`?.3VQW/N!6Q8?\?FI_P#7TO\`Z)CK
M(M;+4G\2_:=DL=LDLFXLP56!SC"C!/4'+9'I0!TM9L.IRK!<27=N_P"ZG,2_
M9HWEWC`.0`,\'(/N#6E4%K9VUE&T=K"D*,VXA!@$^M`%70G#:1$P##+.>00?
MOM6AGZ_E5#1/^05'_OR?^AM6A0`F?K^5&?K^5+10!R&HG_BI+GK_``=O]D47
MY_<=_P`J74?^1DN?JG_H(HO_`/CW/TKFE\1WQ^%%_P`('_B5S=?^/ANW^RM;
MV?K^58/@_P#Y!<W_`%\-_P"@K6_71'8XZGQ,3/U_*C/U_*EHID"9^OY49^OY
M4M%`'):P?^*ADZ_<7M[47I_T?OTI=8_Y&&3_`'%_E27O_'O^%<TOB.Z'PHM>
M#S_HMWU_UWI_LBNBS]?RKGO!W_'K=_\`7;_V45T5;QV.6I\3$S]?RHS]?RI:
M*HS$S]?RHS]?RI:*`.5U\_\`$_CZ_P"H7M_M-3;H_P"C=^GI3_$'_(?C_P"N
M"_\`H34VZ_X]OPKGG\1W0^%$G@\_-?=?O)V_WJZ;/U_*N:\'_>OO]Y/_`&:N
MFK:.QRU?C8F?K^5&?K^5+15&8F?K^5&?K^5+10!R_B,_\3B#K_J?3W-,G/\`
MHW?I3_$?_(8@_P"N/]339_\`CV_"N>>YW4_A0OA`_P"EZAUZ1]O]ZNHS]?RK
ME_"'_'WJ'TC_`/9JZFMH['+5^-B9^OY49^OY4M%49B9^OY49^OY4M%`"9^OY
M49^OY4M%`"9^OY49^OY4M%`"9^OY49^OY4M%`"9^OY49^OY4M%`'.>*C^]L>
MO5^W^[4&?]%[]*L>*O\`6V/U?_V6J_\`R[?A7/4W.VE\"(O#!_XG\W7_`(]V
M[?[2UUV?K^5<CX8_Y#\W_7NW_H2UU]:PV.>M\12MN=5O?]V/^1J/4_\`C_TC
M_K\;_P!$2U);?\A6]_W8_P"1J/4_^/\`TC_K\;_T1+5F1HT444`4K%LW>HCT
MN0/_`"%'65J=^\/BVPM!<2*LJK^[`;:>7SD@X[="#TK4L/\`C\U/_KZ7_P!$
MQUC7L]_+XMLU,4D,,<F.)3ME&&Y"XQT8Y^@H`Z>BBB@"CH[;]-1L8^=__0S5
MZL_1/^05'_OR?^AM6A0`4444`<CJ7_(R7/\`P#_T$47_`/J*-1_Y&2Y^J?\`
MH(HO_P#CW/TKFE\1WQ^%%_P?_P`@N;_KX;_T%:WZP/!__(+F_P"OAO\`T%:W
MZZ([''4^)A1113("BBB@#D]8Y\0O[(O\J2]_X]_PI=8_Y&&3_<7^5)>_\>_X
M5S3^([H?"BWX._X]+O\`Z[_^RBNBKG?!W_'K=_\`7;_V45T5;QV.6I\3"BBB
MJ,PHHHH`Y7Q!_P`A^/\`ZX+_`.A-3;K_`(]OPI_B#_D/Q_\`7!?_`$)J;=?\
M>WX5SS^([H?"B7P?UOA_M)_6NFKF?!_WK[_>3_V:NFK:.QRU?C844451F%%%
M%`'+^)/^0O;_`/7+^IID_P#Q[?A3_$?_`"&(/^N/]339_P#CV_"N>>YW4_A0
MO@__`(^]0^D?_LU=37+>$/\`C[U#Z1_^S5U-;1V.6K\;"BBBJ,PHHHH`****
M`"BBB@`HHHH`****`.=\5?ZVQ^K_`/LM5\?Z+^%6/%7^ML?J_P#[+5?_`)=O
MPKGJ;G;2^!$7AC_D/S?]>[?^A+77UR'AC_D/S?\`7NW_`*$M=?6L-CGK?$5+
M=LZE=KCH(_Y&HM2.+[21ZW;?^B):?;?\A6]_W8_Y&H]3_P"/_2/^OQO_`$1+
M5F1HT444`4K''VO4<=?M(S_WZCJ)=%A&I-J#2R23LP(+X8(/[JY'RCUQC/?-
M26`_TS4O>Y7_`-$QU>H`*0$,,@@CIQ2UEV=A=IITEN]P]M(;J:17A(8[6D9E
M'S`]F'Y4`3:/M_LU-O3>_P#Z&:O5G:&K+I,2LQ)#/R1R?G:M#!]:`%HI,'UH
MP?6@#DM2_P"1DN?^`?\`H(HO_P#44:C_`,C)<\_W/_0127_^H/-<TOB.^/PH
MT/!__(+F_P"OAO\`T%:WZP/!X/\`9<W/_+PW_H*UO8/K71'8XZGQ,6BDP?6C
M!]:9`M%)@^M&#ZT`<IK'_(PO_N+_`"I+W_CW_"C6`?\`A(7Y_@7^5%[_`,>_
M7M7-/XCNA\*+?@[_`(]+O_KO_P"RBNBKG/!X/V6[Y_Y;?^RBNBP?6MX['+4^
M)BT4F#ZT8/K5&8M%)@^M&#ZT`<MX@_Y#\?\`UP7_`-":FW7_`![?A3O$'_(?
MCY_Y8+_Z$U-NO^/;KVKGG\1W0^%$W@_K??[R?UKIJYCP>#NON?XD_K738/K6
MT=CEJ_&Q:*3!]:,'UJC,6BDP?6C!]:`.8\2?\A>W_P"N7]33)_\`CV_"G^(P
M?[8@Y_Y9?U-,G_X]NO:N>>YW4_A0[P?_`,?>H?2/_P!FKJ:Y;PA_Q]W_`#VC
M_P#9JZC!]:VCL<M7XV+128/K1@^M49BT4F#ZT8/K0`M%5;J_MK-T2XFV,^2H
MP3G'T^M,.J6@7<9CCUV'_"E=%*,GLB[152UU*TO9&CMY][H,L-I&!^-6L'UI
MB::W%HI,'UHP?6@0M%)@^M&#ZT`<]XJ_UMC]7_\`9:K\_9?PJ?Q4#YMCSW?_
M`-EJ#_EUZ]JYZFYVTO@1%X8_Y#\W_7NW_H2UU]<AX8_Y#\W/_+NW_H2UUV#Z
MUK#8YZWQ%6WV_P!I7>/O8CS^1J+4L?;M)S_S]MC_`+\2T^V!&J7I/<1\_@:C
MU+_C_P!(_P"OQO\`T1+5F1HT444`5+/_`(^K_P#Z^!_Z*CJW5&P_X_-3_P"O
MI?\`T3'5Z@`HHHH`IZ5_R#T_WW_]#-7*S]$_Y!4?^_)_Z&U3ZBS)IETZG#+"
MY!]#M--:L"S17&Z>[RIEW+&JFJW$\`/E2LN/2M/9ZVN3S%_4O^1DN/\`@'_H
M(I+_`/U%+J/_`",ES]4_]!%%_P#\>Y^E<,OB/1C\*+_@_P#Y!4W_`%\-_P"@
MK6_6!X/_`.07-_U\-_Z"M;]=$=CCJ?$PHHHID!1110!R>L_\C"W^XM)>_P#'
MN?I2ZQ_R,,G^XO\`*DO?^/?\*YY_$=T/A1;\'?\`'I=_]=__`&45T5<[X._X
M];O_`*[?^RBNBK:.QRU/B844451F%%%%`'*^(/\`D/Q_]<%_]":FW7_'M^%/
M\0?\A^/_`*X+_P"A-3;K_CV_"N>?Q'=#X42^#O\`E^_WD_K735S/@_[U]_O)
M_P"S5TU;1V.6K\;"BBBJ,PHHHH`YCQ)_R%[?_KE_4U'/_P`>WX4_Q'_R&(/^
MN/\`4TV?_CV_"N>>YW4_A0O@_P#X^]0^D?\`[-74URWA#_C[U#Z1_P#LU=36
MT=CEJ_&PHHHJC,****`.:\4?\?UE_NO_`#6H9/\`CV_"IO%'_']9?[K_`,UJ
M*3_CU_"N>IN=M/X$-\*?\A6Z_P"N0_G765R?A7_D+W/_`%R_J*ZRMH;'/5^(
M****HR"BBB@#G?%7^ML?J_\`[+5;_EU_"K/BK_6V/U?_`-EJO_R[?A7/4W.V
ME\"(O#'_`"'YO^O=O_0EKKZY#PQ_R'YO^O=O_0EKKZUAL<];XBM#_P`?]U]$
M_D:AU'_C]TK_`*^V_P#1,M.MO^0K>_[L?\C4>I_\?^D?]?C?^B):LR-&BBB@
M"C8?\?FI_P#7TO\`Z)CJ]5&P_P"/S4_^OI?_`$3'5Z@`HHK,L->LKVT:Z:1;
M>-2HS,P4'<BNO/N&%`#]$_Y!4?\`OR?^AM4VI_\`(*O/^N#_`/H)J#0V5M)B
M(8$%Y""#_MM4^I\Z5=@<DP/_`.@FG'=`<KI?^KJCK71OI5W3758_F91]35+6
M#O#;#N^G-=*6ID:FH_\`(R7/U3_T$47_`/Q[GZ4:EQXBN">!\O/_``$4E\RM
M!@,"?8UYDOB/4C\*-#P?_P`@N;_KX;_T%:WZP?"(*Z7-NX_TANO^ZM;N1ZBN
MB.QQU/B8M171Q:3$?\\V_E4F1ZBHKH@VDP!_Y9M_*J6Y!Q^E'=$"W/'>J^L,
M45MI*_3BIM+94B&Y@O'<XJ#5R'5MI#<=N:Z=;F1=O23JRD\GR8__`$&I;W_C
MW_"HKT$:HA/`\B/K_NU)>.K6^`P)QV->;/XCTX?"BYX._P"/6[_Z[?\`LHKH
MJYWP@"MK=Y&,S<9_W170Y'J*VCL<M3XV+129'J*,CU%49F!:^))+I05M4&?5
MS_A277B62U&6M4;Z.?\`"L7265(U#L%X[G%)JS!U^4AOH<UT."OL9W9>U6?[
M3J=K<8V^;:1OCTR6-/NO^/;\*KW@(GT\D8Q8Q`Y_&IKEU-O@,I./6N"I\1Z5
M/X43^#_O7W^\G_LU=-7,^$`5:^)&,LF,_C72Y'J*UCL<M7XV+129'J*,CU%4
M9G$:>2\K;CN^8]>:-5)5#MX^E)IY"2MN(7YCU.*3565T.U@WT.:ZG>YD27!+
M1Z4222;).3^-7)_^/;\*IW`(ATK((Q9H#5J9T-O@,N<>M>=5^-GIT_@0_P`(
M?\?>H?2/_P!FKJ:Y?PB"MU?DC`(CQG_@5=/D>HK6.QRU?C8M%)D>HHR/451F
M1FYMU)4SQ@C@@N.*3[7;?\_$7_?8KCXF"ZG=[R!_I$G4_P"T:;J;*T9V,#]#
M6WLR>8TO$S*]Y8LK!E*O@@Y'5:CD_P"/7\*I2AO[.TG(/$<F<_[PJV[H;;&Y
M<X]:XJJM*QWTO@0>%?\`D+W/_7+^HKK*Y/PJ"-5N21@>5U_&NKR/45K#8YZO
MQ"T4F1ZBC(]15&0M%<^_B*=;Z:W\B(+'(5#,Q&0#UIMSXCGA7*PP/]'-7[.0
MKH/%7^ML?J__`++5?_EV_"HM3O9-2L=-NY(Q&SF7*CH,,!_2I-Z?9L;USCUK
MEJJTK'=2^!$?AC_D/S?]>[?^A+77UR/AD$:[,Q''D-S_`,"6NMR/45K#8YZW
MQ%.V_P"0K>_[L?\`(U'J?_'_`*1_U^-_Z(EJ2V_Y"M[_`+L?\C4>I_\`'_I'
M_7XW_HB6J,C1HHHH`IV0Q=ZB?6Y!_P#(4=7*J6?_`!]7_P#U\#_T5'5N@`JM
M:6%M91-%!$%1B"1]``/R``_"K-%`&9;VFHVD7D026IC#,5WJQ."2><'WJ7;J
MW]^R_P"^'_QJ]10!E73:M;V<TRBR9HXV8+Y;\D#..M3>7JOK8_\`?#?XU%K.
MLII2Q@*KR,06#-M")G!8GMZ#U)`K21Q)&KC.&`(S0!2V:J>K67_?#?XU#"^K
MRRW"'[$!%($!\M^1M5L]??\`2M0D*"2<`=35'3M42^>1<8&2T+=!+'TW#VSQ
M^1[T``75AT:R'_`&_P`:7&K?W[+_`+X?_&KU%`%'&K?W[/\`[X?_`!HVZM_?
MLO\`OA_\:O44`9EP=6AMI95^PL40L!Y;<X'UIR+JK(K$V/(S]QO\:-7U9=+B
M3"J\KGA6;:`H(W,3V`!_/`[U=MYEN+>*=,[9$#C/H1F@"ILU4_Q67_?#?XU#
M"^KRS3H?L0$3A0?+?GY0?7WK4Z50L=42\N)8P!M#'R7'251C)'T)Q0`H75AT
M:R'_``!O\:7&K?W[+_OA_P#&KU%`%'&K?W[/_OA_\:,:M_?LO^^'_P`:O44`
M4/+U7UL?^^&_QJ&U;5KBSAF86*M)&K%?+;@D9]:EU?5%TRUWA1),_P!Q"<#C
MJQ/8`<DU:M+A;NTBN4^[*@<?B*`*VS53_%9?]\-_C4*OJ[7DL!^Q;4C1@WEO
MSDL/7_9'YUJUGVNJ)<WLD``\O<5BE'21A]Y1ZX]?KZ4`*$U4=&LA_P``;_&E
MQJW]^R_[X?\`QJ]10!1QJW]^S_[X?_&C&K?W[+_OA_\`&KU%`%#R]5];'_OA
MO\:AM6U:XLX9F%BK21JQ7RVX)&<=:GU;4ETRR:4*))FR(H\XWMC/7L``23V`
M-365TE[9QW*8VN.QR.N.#W'O0!!LU7^]9?\`?#?XU"K:LUY)`?L6U(T<-Y;\
MDEACK_LC\ZU:SX-5CFU&2V&#&#M24=&<9W)[D8S^?I0`H351T:R'_`&_QI<:
MM_?LO^^'_P`:O44`4<:M_?L_^^'_`,:,:M_?LO\`OA_\:O44`4-FJ_WK'_OA
MO\:AMFU:>'S&%DIW,,>6_9B/7VJUJ5^NGVC3%#)(?EBB'61^P'^>E&FWJZCI
M\5TNW#Y!VG(R"0<'N,B@"/9JO]ZR_P"^&_QJ'=JWVP0?Z%M,9;=Y;]<XQUK5
MK/758VU-[48,:X3S1T$AYV>YQS[<>M`"A-5'1K(?\`;_`!I<:M_?LO\`OA_\
M:O44`4<:M_?L_P#OA_\`&C&K?W[+_OA_\:O44`4-FJ_WK'_OAO\`&H;9M6GB
M+M]B4B1UQY;=%8@=_:KE]>QV%JT\@+8X5%&2['HH]R:CTG4/[2T]+C:JL>'"
M-N4,.N#WH`;LU7&-UE_WPW^-0LVKK>1P?Z%M>-V)\M^""HQU_P!H_E6K6>VJ
MQKJGV7AHP`KR#I'(?NJ3ZD'\./6@!0FJCHUD/^`-_C2XU;^_9?\`?#_XU>HH
M`J6=O/'+--<-&9)=H_=@@``>_P!:BU$9OM*]KMO_`$1+6A5#4?\`C]TK_K[;
M_P!$RT`7Z***`*EG_P`?5_\`]?`_]%1U;JI9_P#'U?\`_7P/_14=6Z`"BBB@
M`HHHH`IZEIZ:A;A"=DB,'C?T8$$9]1D`X]AZ5E:;J[V!:PU,2!H5R)6'WAM+
M$GGV8#Z5T-9VK::+V`O$`+A.4;IG&<`_3)(SD`X..*`+S+'/$4=5>-P0RL,@
M@]0:YS5X[G3-1^W0N=K0[`XC#,BALE%[9;*`#_9)SZWM#U%I=UA.A6>'/(7@
M@;3D\GGYP>?7N<UKD!NH!YSS0!5TR^&H6*7&T*265@#D9!P<>V15NL+59KZ#
M6[::,8MDC;)#=NKY'3L@'4\MBMJ&430I*N,.H/!H`?1110!4U&PBU&T>"3*D
MCY6'53_4=.#P:R=-U2;3Y7T_4]^8V^68C@@C.22>F=P'LO-=#5'4]/6^@)4*
M)EY1B.N.@/J,\X/&0.#0!;1TGA5U^9'7//<&N=UBVGTZ[BO;5Q&B0F%&\L$0
M+D$A1TR=JA1CJ>:M:%?N"VFW*$30L5!QG(`4\G)Y^;J>OUS6T0&&"`1UYH`I
M:5J']HVGFE-C*VUAGO@'],X/N#5ZL/6I+Z+5+*2#B!,[B&_%B1T^ZN!_OYQQ
M6O;3"XMTF7&'&>#G![T`2T444`5M0L8=1LY+:8':ZD9'49&/\CN.#6/8ZC<:
M9=M8ZEO<.Y99L<<L!W/3FNAJGJ.GQW]N5*KY@'R,1GWP?5<@9'0XYH`L0S)<
M0)-&<I(H8'V(S6!K5I+8SV]Y:,D4<$;QQYC^2V!`^8#H.%(Z<E@.G2;1;^6&
M8Z;>*WG!L*^,[N"?F/\`P$\]\=NE;A`888`CT-`%#1M2.I6C2-&T;QOL8-US
MM#<^^",CL<UH5B:\U^EU8M:\1K)R0W\1ZDCI@)OZ\9(]*U;2X6[MDG7&&'0'
M.*`)J***`(+NTAOK9[>=24<$'!P1VX-8=E>W.BWQT^_+RQ2$&.;;QDMM]>%'
MR9]V]*Z.JM_8Q7]NT;JN['RL1T]O7!Q@CN*`)H)X[F%9HFW(XR#6'K=E+;26
MUY:&-%MRY0,GR0,RD%SCL`7SZDBET>]FM+U]+O%;S&(9'`SDD,>2/]P]ATQ@
M#:*WB`RE6`(/!![T`9NB:F=1MF\Q7$D6%8N`"<CC('`;')`XYK3K&\0F_'V0
MV7`$O+`\AC\HXZ$`%FY[J*TK.Z6[MQ,N.21P<T`3T444`1SP1W,+12`E6]"0
M1[@CD&N>M+B?P]=&SN]\ML0/*=5X4`8X'````S[GTQCI:KWEG%>P&*5>O0C@
MCUP1R,].*`'P7$5S%YD3!E)(!'L<?TK'UNQDB%O=6@0"WF,@C*?(KMN!<X]"
MVXGGI[FH]*NYM-O7TZ]7.67RW1?[Q(`X[>G''3C`ST!`8$$`@]0:`,K0M5;4
M(7CDW-)"JYD8`;P<@$@<#.TG'H5K6K'\1_;A9P_81R)5)P<<]$_#<03ST7'>
MK]C=+=V^\$$JQ4X.>10!9HHHH`9+$D\31R#*MZ'!'N#V/O7.1S3^&KL0S>9-
M9.-L94?<"K\H'.,X#9]EKIJ@NK6*\@:*4<$'#`X93C&0>QY/(H`=!<17*%XG
M#*&*Y'J#@_J*RM<L'\J*>U13Y5PLQAV_*SY.&./1BK$\\*?7FM87,VD:C]AN
MT!2;B-HUX'S*H`QT4;QQVSW^8GHZ`,;0=6>_5X)F\R2(!O-P%#@D@''8$@X]
ML9YK9K)\0_:TTQ?L48)6125#;2<'*@8[%@H/MFK>G7)N+?#N'DB.QVXY(ZGC
M@<YZ<4`6ZH:C_P`?NE?]?;?^B9:OU0U'_C]TK_K[;_T3+0!?HHHH`J6?_'U?
M_P#7P/\`T5'5NJEG_P`?5_\`]?`_]%1U;H`****`"BBB@`HHHH`8L:([.J*K
M.<L0.6[<T^BB@"&ZMHKRW:"8$HV#P>A!R#^8%8ND1ZG;:D;*7/V>%0[/M`#L
MV?N_[/MUZ>F6Z"H+NW:XMWCCE,,AQMD`S@@YY]1[?RH`?#/'<(6B?<`Q4^Q!
MP0:DJ*WMXK6+RXEVKDL>2<DG)//O4M`!1110`P1HKLZHH=OO,!R?K3Z**`(K
MFWCN[:2VF!,<JE6`..#6)I\6IV>L"S.XVI+S,^T8/S-@#CC[RY_W?SZ"H;J`
MW%N\:R-$[#"R+U4T`.BGCFWB-LF-MCCH5/7!'T(/T(J2H;:VCM8RJ*`7.YR,
M_,W<\_2IJ`"BBB@!@C02&0(H<C!;')'UI]%%`$=Q!'<V\EO,NZ.5"CC.,@C!
MK"M(-2L=86S0L;:0O,TFT8VAN%''!PPS]#Z\=#4<\/GPO&':,LI4.OWE]Q0`
M1SQS-(J-EHFVN.ZG`/\`(@_C4E5[2U2UB(&#(Y#2N,C>V`,X)..@XS5B@`HH
MHH`9Y:>9YNQ=^-N['./3-/HHH`:Z+)&T;C*L""/45SL5KJ&FZM%:VV[[+,^Y
MGP,!%"X'3KA2#ZY^F.DIDL8EC9-Q7<"-R]1GN*`$2>.262)6R\>-R]",]/PJ
M2JUG9K:1G)#S.!YDF"-Y`QG!)Q]*LT`%%%%`##&AD$A1=X&`V.0/3-/HHH`*
MYH65_I.I16U@&^R3N$!`!$:*B]??Y&&3_>'ISTM-=0ZD'C(ZCJ*`&K/&\SPJ
MW[R,`LO<`YP?IP?R-255LK);12S/YLS`*\IZN!G&>?<]/>K5`!1110`PQHTB
MR%%+J"%8CD9ZX_*GT44`%<U<65]I=\B::&$5PPC!`!$2A23GWSG!/MZ?-TM(
M0#UH`8)XVG:`-^\50Q4]<'O534?^/W2O^OMO_1,M265@MIEV<S3$;3*W4J"2
M`?S[8S4>H_\`'[I7_7VW_HF6@"_1110!4L_^/J__`.O@?^BHZMU3%I<QW%Q)
M%=(JS2!]IBSM^55ZYY^[G\:=Y5[_`,_<7_?G_P"RH`M455\J]_Y^XO\`OS_]
ME1Y5[_S]Q?\`?G_[*@"U157RKW_G[B_[\_\`V5'E7O\`S]Q?]^?_`+*@"U15
M7RKW_G[B_P"_/_V5'E7O_/W%_P!^?_LJ`+5%5?*O?^?N+_OS_P#94>5>_P#/
MW%_WY_\`LJ`+5%5?*O?^?N+_`+\__94>5>_\_<7_`'Y_^RH`M455\J]_Y^XO
M^_/_`-E1Y5[_`,_<7_?G_P"RH`M455\J]_Y^XO\`OS_]E1Y5[_S]Q?\`?G_[
M*@"U157RKW_G[B_[\_\`V5'E7O\`S]Q?]^?_`+*@"U157RKW_G[B_P"_/_V5
M'E7O_/W%_P!^?_LJ`+5%5?*O?^?N+_OS_P#94>5>_P#/W%_WY_\`LJ`+5%5?
M*O?^?N+_`+\__94>5>_\_<7_`'Y_^RH`M455\J]_Y^XO^_/_`-E1Y5[_`,_<
M7_?G_P"RH`M455\J]_Y^XO\`OS_]E1Y5[_S]Q?\`?G_[*@"U157RKW_G[B_[
M\_\`V5'E7O\`S]Q?]^?_`+*@"U157RKW_G[B_P"_/_V5'E7O_/W%_P!^?_LJ
M`+5%5?*O?^?N+_OS_P#94>5>_P#/W%_WY_\`LJ`+5%5?*O?^?N+_`+\__94>
M5>_\_<7_`'Y_^RH`M455\J]_Y^XO^_/_`-E1Y5[_`,_<7_?G_P"RH`M455\J
M]_Y^XO\`OS_]E1Y5[_S]Q?\`?G_[*@"U157RKW_G[B_[\_\`V5'E7O\`S]Q?
M]^?_`+*@"U157RKW_G[B_P"_/_V5'E7O_/W%_P!^?_LJ`+5%5?*O?^?N+_OS
M_P#94>5>_P#/W%_WY_\`LJ`+5%5?*O?^?N+_`+\__94>5>_\_<7_`'Y_^RH`
MM455\J]_Y^XO^_/_`-E1Y5[_`,_<7_?G_P"RH`M455\J]_Y^XO\`OS_]E1Y5
M[_S]Q?\`?G_[*@"U5#4?^/W2O^OMO_1,M2^5>_\`/W%_WY_^RJ-[*YFNK666
9Z0K;RF3:(L;LHRXSGC[V?PH`O4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g118721mqi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mqi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`#6`6\#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V">YAM@IE
M?;N.%X)S^51?VE:_\]&_[]M_A1<?\?UI_O/_`.@U:H`J_P!I6O\`ST;_`+]M
M_A1_:5K_`,]&_P"_;?X59)P">OM6;%KUK+]F&R5&N"0%*\H0VW!_'B@"S_:5
MK_ST;_OVW^%']I6O_/1O^_;?X5674KJZU&XM;.&+;;JA9IRR$EL]!CVJ;=JW
M_/*S_P"_C_X4`/\`[2M?^>C?]^V_PH_M*U_YZ-_W[;_"F;M6_P">5G_W\?\`
MPHW:M_SRL_\`OX_^%`#_`.TK7_GHW_?MO\*/[2M?^>C?]^V_PIF[5O\`GE9_
M]_'_`,*-VK?\\K/_`+^/_A0`_P#M*U_YZ-_W[;_"C^TK7_GHW_?MO\*9NU;_
M`)Y6?_?Q_P#"C=JW_/*S_P"_C_X4`/\`[2M?^>C?]^V_PH_M*U_YZ-_W[;_"
MF;M6_P">5G_W\?\`PHW:M_SRL_\`OX_^%`#_`.TK7_GHW_?MO\*/[2M?^>C?
M]^V_PIF[5O\`GE9_]_'_`,*-VK?\\K/_`+^/_A0`_P#M*U_YZ-_W[;_"C^TK
M7_GHW_?MO\*9NU;_`)Y6?_?Q_P#"C=JW_/*S_P"_C_X4`/\`[2M?^>C?]^V_
MPH_M*U_YZ-_W[;_"F;M6_P">5G_W\?\`PHW:M_SRL_\`OX_^%`#_`.TK7_GH
MW_?MO\*/[2M?^>C?]^V_PIF[5O\`GE9_]_'_`,*-VK?\\K/_`+^/_A0`_P#M
M*U_YZ-_W[;_"C^TK7_GHW_?MO\*9NU;_`)Y6?_?Q_P#"C=JW_/*S_P"_C_X4
M`/\`[2M?^>C?]^V_PH_M*U_YZ-_W[;_"F;M6_P">5G_W\?\`PHW:M_SRL_\`
MOX_^%`#_`.TK7_GHW_?MO\*/[2M?^>C?]^V_PIF[5O\`GE9_]_'_`,*-VK?\
M\K/_`+^/_A0`_P#M*U_YZ-_W[;_"C^TK7_GHW_?MO\*9NU;_`)Y6?_?Q_P#"
MC=JW_/*S_P"_C_X4`/\`[2M?^>C?]^V_PH_M*U_YZ-_W[;_"F;M6_P">5G_W
M\?\`PHW:M_SRL_\`OX_^%`#_`.TK7_GHW_?MO\*/[2M?^>C?]^V_PIF[5O\`
MGE9_]_'_`,*-VK?\\K/_`+^/_A0`_P#M*U_YZ-_W[;_"C^TK7_GHW_?MO\*9
MNU;_`)Y6?_?Q_P#"C=JW_/*S_P"_C_X4`/\`[2M?^>C?]^V_PH_M*U_YZ-_W
M[;_"F;M6_P">5G_W\?\`PHW:M_SRL_\`OX_^%`#_`.TK7_GHW_?MO\*/[2M?
M^>C?]^V_PIF[5O\`GE9_]_'_`,*-VK?\\K/_`+^/_A0`_P#M*U_YZ-_W[;_"
MC^TK7_GHW_?MO\*9NU;_`)Y6?_?Q_P#"C=JW_/*S_P"_C_X4`/\`[2M?^>C?
M]^V_PH_M*U_YZ-_W[;_"F;M6_P">5G_W\?\`PHW:M_SRL_\`OX_^%`#_`.TK
M7_GHW_?MO\*FAN(KA"\3[@#@\8P:I/=ZA;SVZW$-L8YI?+)CD8D<$YY'M5BT
M_P!;=?\`7?\`]E6@!+C_`(_K3_>?_P!!JU56X_X_K3_>?_T&K5`",JNI5@&5
MA@@]"*C2UMXRI2WB4I]TA`-O&./PJ6B@#,M/^1BU+_KE!_[/6G699_\`(Q:E
M_P!<H/\`V>M.@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`$R!WI:YC4K:U+S"ZUY`'FYB8`L3D?*`&'/0<"KMW+9GS(H[^
M6']R5)4,[`-@Y!S^'XT`;5%4M+""W<)<&?$ARS+@]O\`]>?>KM`!1110`444
M4`%%%5[R_M=/B$MU,L2LVT%CWH`L450@US3;DR"&Z1C&I8KW('4@=3BI'U*V
MCNTM7+J\F-A*':V>P-`%NBBB@`HHHH`H:G_K;#_K[7_T%JFM/];=?]=__95J
M'4_];8?]?:_^@M4UI_K;K_KO_P"RK0`EQ_Q_6G^\_P#Z#5JJMQ_Q_6G^\_\`
MZ#5J@`HIK@E&"]<''./UK-M[*]#69EFD7R&=G!G+APV>#P,XSQGT[T`+9_\`
M(Q:E_P!<H/\`V>M.L?2XYX]>U07%P)V*0$,$"8'S\8K8H`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`*RKGQ#9VMW);.DY>,X)5`1TSZ^
M]:M<1J__`"';K_?'_H(H,:TW!)HZ)?$5F_2*?_O@?XU*NLV[=(IO^^1_C7,P
M5H0U+9SJO,TA-8$29LW;S6W/N4')_$T&>PSDV;=,?<'3IZU77I2-6;FQ^VF6
MDU2SMPP2WE0,2QP@Y/YTQ_$=FG6*X_[X'^-9TU9UQ5Q;8O;S-QO%VG)UBN?^
M_8_QK2T[4(=3M!<P!PA)&'&#Q7GT_4UV'A+_`)`2?]=&_G5FE*K*4K,VZ*R_
M$&H7&FZ<)[;9O,BK\ZY&#GWK!B\3ZJ_4V_\`WZ/^-2YI.QU'950U7[,8X4N+
M3[5YC[%C&,]"3U]A6/'KNHOU:#_OV?\`&K*:K?-U:'_OV?\`&I]K$=B:2[>%
M)DBTEB`0NPCE@<YZ9'/'?OS3[>ZEGN8@^GX4/@.0<@8/S#/;/X\U#_:=]C[\
M7_?L_P"-1OJ]^O1H?^_9_P`:GVT0Y6;]%<M+K^I)T:#_`+]G_&J<OBK5DZ&V
M_P"_1_QJO:(+':T5R6@^)=2U'6H[2Y\CRF1B=B$'('UKK:M.XBAJ?^ML/^OM
M?_06J:T_UMU_UW_]E6H=3_UMA_U]K_Z"U36G^MNO^N__`+*M,!+C_C^M/]Y_
M_0:AU+6K/2GB2X<[Y"`%7&0">IYZ5-<?\?UI_O/_`.@US_B:\CBUJSBDDB4!
M5?!1=Q.XXRQ.=O!X4<^O-`'54444`9EG_P`C%J7_`%R@_P#9ZTZS+/\`Y&+4
MO^N4'_L]:=`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M7$:O_P`AVZ_WQ_Z"*[>N(U?_`)#MU_OC_P!!%!S8CX4+!6A#6?!6A#4,XT6E
MZ4C4J]*1JP>Y95FK.N*T9JSKBMHD,S)^IKL/"7_("3_KHW\ZX^?J:[#PE_R`
MD_ZZ-_.M#>A\8WQ?_P`@9?\`KNO]:Y6"NJ\7_P#(&7_KNO\`6N5@K"IN=Z-&
M&KT?2J,-7H^E8LHD/2H):G/2H):S&4)^]9EQWK3G[UF7'>MD2RUX3_Y&>#_K
MG)_*O0Z\\\)_\C/!_P!<Y/Y5Z'6]/8DH:G_K;#_K[7_T%JFM/];=?]=__95J
M'4_];8?]?:_^@M4UI_K;K_KO_P"RK6@"7'_']:?[S_\`H-4-51'OT$LDX78I
MCCC)Q(^[V';W..?:K]Q_Q_6G^\__`*#5/78[V3[,+.4QX?YL3^7D?U^E`&JQ
MP"<$X["J*ZS:EX$<21/.2%5TP1\VWGZGI5YU5T9&&588(]156WTNQM5C$%K&
M@B_U>!]WZ4`5-/FCF\0:FT;;@(X`>,<_/6M69:?\C%J7_7*#_P!GK3H`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*XC5_P#D.W7^^/\`
MT$5V]<1J_P#R';K_`'Q_Z"*#FQ'PH6"M"&L^"M"&H9QHM+TI&I5Z4C5@]RRK
M-6=<5HS5G7%;1(9F3]378>$O^0$G_71OYUQ\_4UV'A+_`)`2?]=&_G6AO0^,
M;XO_`.0,O_7=?ZURL%=5XO\`^0,O_7=?ZURL%85-SO1HPU>CZ51AJ]'TK%E$
MAZ5!+4YZ5!+68RA/WK,N.]:<_>LRX[ULB66O"?\`R,\'_7.3^5>AUYYX3_Y&
M>#_KG)_*O0ZWI[$E#4_];8?]?:_^@M4UI_K;K_KO_P"RK4.I_P"ML/\`K[7_
M`-!:IK3_`%MU_P!=_P#V5:T`2X_X_K3_`'G_`/0:Q_%>9%M8U!;9('8`+TSQ
MDGMD5L7'_']:?[S_`/H-9GB>5XQ9!%<[[A5;8>0"1[CJ<"@#=HHHH`S+/_D8
MM2_ZY0?^SUIUF6?_`",6I?\`7*#_`-GK3H`****`"BBB@`HHHH`****`"BBB
M@`HHHH`CFGBMXFEF<(B]6/05%!J%I<SRPPSJ\D(S(!_#]:9JIM5L6>\1GA5@
M2%.#G/'<5G[;*RD?_B7S!A%O`>0MD9/'4XZDT`:1U*R&W_2H\L-P&>V<9JU7
M/17MFL\A7391)"RQ#<QW,K,,G'ISGZ9KH:`"BBB@`KB-7_Y#MU_OC_T$5V]<
M1J__`"';K_?'_H(H.;$?"A8*T(:SX*T(:AG&BTO2D:E7I2-6#W+*LU9UQ6C-
M6=<5M$AF9/U-=AX2_P"0$G_71OYUQ\_4UV'A+_D!)_UT;^=:&]#XQOB__D#+
M_P!=U_K7*P5U7B__`)`R_P#7=?ZURL%85-SO1HPU>CZ51AJ]'TK%E$AZ5!+4
MYZ5!+68RA/WK,N.]:<_>LRX[ULB66O"?_(SP?]<Y/Y5Z'7GGA/\`Y&>#_KG)
M_*O0ZWI[$E#4_P#6V'_7VO\`Z"U36G^MNO\`KO\`^RK4.I_ZVP_Z^U_]!:IK
M3_6W7_7?_P!E6M`$N/\`C^M/]Y__`$&L7Q-%:1WMK<7$UP'DQ'&D4<9Y!)SE
MAD=>Q'05M7'_`!_6G^\__H-8OBJXL_M5C;W,J*5?S<,P!(Z<#(W'V_0T`=&<
MX..M9=K!JC#3C<2LCPJ?M`W`K*2N.<>AK5HH`R=/\W_A(-3\XH6\N#&P$#'S
M^M:U9EG_`,C%J7_7*#_V>M.@`HHHH`****`"BBB@`HHHH`*IZK>/I^F3W<:*
M[1+D*QX/.*N5F>)/^1?N_P#<'\Q05%7DC&3Q;>MUM8!_P)JLQ^([M_\`EA`/
MQ-<U#6A#VI'8J<>QN?VM/,`'@@8`@@')Y'0U+_:US_SSA_6LV*INU9RDT/V<
M.Q9;6;I?^64/YFJ\GB*[3I!`?Q-0251GIQDV'LX=BW)XMO4Z6L!_X$U,M/&-
MY<:A;VS6D`6614)#-D9-8MQ46F_\ANR_Z[I_.K,W"/8].KB-7_Y#MU_OC_T$
M5V]<1J__`"';K_?'_H(IGEXCX4+!6A#6?!6A#4,XT6EZ4C4J]*1JP>Y95FK.
MN*T9JSKBMHD,S)^IKL/"7_("3_KHW\ZX^?J:[#PE_P`@)/\`KHW\ZT-Z'QC?
M%_\`R!E_Z[K_`%KE8*ZKQ?\`\@9?^NZ_UKE8*PJ;G>C1AJ]'TJC#5Z/I6+*)
M#TJ"6ISTJ"6LQE"?O69<=ZTY^]9EQWK9$LM>$_\`D9X/^N<G\J]#KSSPG_R,
M\'_7.3^5>AUO3V)*&I_ZVP_Z^U_]!:IK3_6W7_7?_P!E6H=3_P!;8?\`7VO_
M`*"U36G^MNO^N_\`[*M:`)<?\?UI_O/_`.@UG>)=3FTR&WDB+`2/L8A0WIQ@
M^V:T;C_C^M/]Y_\`T&L'Q<T4MS80"1Q/'()=B1L<J2!@L/N@X-`'31OYD2R!
M2NX`X88(IU!XJDNK63_9L3?\?0S%D$9!Z9],GB@"&S_Y&+4O^N4'_L]:=9=B
MZOXAU,HP8>5`.#G^_6I0`4444`%%%%`!1110`4444`%9GB3_`)%^[_W!_,5I
MUF>)/^1?N_\`<'\Q05#XD<5#6A#VK/AK0A[4COB7XJF[5#%4W:L9#(9*HSU>
MDJC/3B,S;BHM-_Y#=E_UW3^=2W%1:;_R&[+_`*[I_.M492/3JXC5_P#D.W7^
M^/\`T$5V]<1J_P#R';K_`'Q_Z"*9Y&(^%"P5H0UGP5H0U#.-%I>E(U*O2D:L
M'N659JSKBM&:LZXK:)#,R?J:[#PE_P`@)/\`KHW\ZX^?J:[#PE_R`D_ZZ-_.
MM#>A\8WQ?_R!E_Z[K_6N5@KJO%__`"!E_P"NZ_UKE8*PJ;G>C1AJ]'TJC#5Z
M/I6+*)#TJ"6ISTJ"6LQE"?O69<=ZTY^]9EQWK9$LM>$_^1G@_P"N<G\J]#KS
MSPG_`,C/!_USD_E7H=;T]B2AJ?\`K;#_`*^U_P#06J:T_P!;=?\`7?\`]E6H
M=3_UMA_U]K_Z"U36G^MNO^N__LJUH`EQ_P`?UI_O/_Z#6=KMQ;V,\$LKS+]H
M(A81*OS`'(!8].3VK1N/^/ZT_P!Y_P#T&L;Q3B2:S0VDLA21723;\BDL!C.1
MSQT[Y%`'1U4CTNQB,12W4&$`1Y).T#IC-6Z*`,JQ1(_$&IA$51Y4!PHQ_?K5
MK,L_^1BU+_KE!_[/6G0`45@:QKMUI^I?9H8XF3RU;+`YR2??VJ&+Q%>OUCA'
MX'_&ME1DU<AU(IV.EHK$CUBZ?JL7_?)_QJ9=1N2/^6?_`'R?\:ETVMPYXFK1
M66=0N1_SS_[Y/^-0OJUTO18O^^3_`(TE!L.>)M45SDOB&\CZ1PG\#_C523Q9
M?ITAMS^!_P`:OV,A>TB==69XD_Y%^[_W!_,5'X>U>?5X)I)TC0QN%&S/I[U)
MXD_Y%^[_`-P?S%9RBXNS-:;NTSBH:T(>U9\-:$/:H/0B7XJF[5#%4W:L9#(9
M*HSU>DJC/3B,S;BHM-_Y#=E_UW3^=2W%1:;_`,ANR_Z[I_.M492/3JXC5_\`
MD.W7^^/_`$$5V]<1J_\`R';K_?'_`*"*9Y&(^%"P5H0UGP5H0U#.-%I>E(U*
MO2D:L'N659JSKBM&:LZXK:)#,R?J:[#PE_R`D_ZZ-_.N/GZFNP\)?\@)/^NC
M?SK0WH?&-\7_`/(&7_KNO]:Y6"NJ\7_\@9?^NZ_UKE8*PJ;G>C1AJ]'TJC#5
MZ/I6+*)#TJ"6ISTJ"6LQE"?O69<=ZTY^]9EQWK9$LM>$_P#D9X/^N<G\J]#K
MSSPG_P`C/!_USD_E7H=;T]B2AJ?^ML/^OM?_`$%JFM/];=?]=_\`V5:AU/\`
MUMA_U]K_`.@M4UI_K;K_`*[_`/LJUH`EQ_Q_6G^\_P#Z#1<:?;74PFF0M(J[
M5)8_)SG('0'WZT7'_']:?[S_`/H-6J`"BH[CSOLTOV?;YVP^7O\`N[L<9]LU
MG6RZLS6IN&*[))/-&%PZ'.S)'<#'0=:`'6?_`",6I?\`7*#_`-GK3K'TO[3_
M`&]JGVHQ;]D&/*SC'SXSGO6Q0!QWB7_D.G_KBG\VJM;U9\2_\AT_]<4_FU5K
M>O0CLO1?D<DOB9HPU;3I52&K:=*RF-"MTJK-TJTW2JLW2IB#,^X[UF3UIW'>
MLR>N@AG2^"O^/.Z_ZZC^5:7B3_D7[O\`W!_,5F^"O^/.Z_ZZC^5:7B3_`)%^
M[_W!_,5QU?C9V4?LG%0UH0]JSX:T(>U8GI1+\53=JABJ;M6,AD,E49ZO251G
MIQ&9MQ46F_\`(;LO^NZ?SJ6XJ+3?^0W9?]=T_G6J,I'IU<1J_P#R';K_`'Q_
MZ"*[>N(U?_D.W7^^/_013/(Q'PH6"M"&L^"M"&H9QHM+TI&I5Z4C5@]RRK-6
M=<5HS5G7%;1(9F3]378>$O\`D!)_UT;^=<?/U-=AX2_Y`2?]=&_G6AO0^,;X
MO_Y`R_\`7=?ZURL%=5XO_P"0,O\`UW7^M<K!6%3<[T:,-7H^E48:O1]*Q91(
M>E02U.>E02UF,H3]ZS+CO6G/WK,N.];(EEKPG_R,\'_7.3^5>AUYYX3_`.1G
M@_ZYR?RKT.MZ>Q)0U/\`UMA_U]K_`.@M4UI_K;K_`*[_`/LJU#J?^ML/^OM?
M_06J:T_UMU_UW_\`95K0!+C_`(_K3_>?_P!!JU56X_X_K3_>?_T&K5`!1110
M!F6?_(Q:E_UR@_\`9ZTZS+/_`)&+4O\`KE!_[/6G0!QWB7_D.G_KBG\VJM;U
M9\2_\AT_]<4_FU5K>O0CLO1?D<DOB9HPU;3I52&K:=*RF-"MTJK-TJ*:[OEG
M9$LRR"95#8/W.[?R_.IIN]1`&9UQWK,GK3N.]9D]=)#.E\%?\>=U_P!=1_*M
M+Q)_R+]W_N#^8K-\%?\`'G=?]=1_*M+Q)_R+]W_N#^8KCJ_&SLH_9.*AK0A[
M5GPUH0]JQ/2B7XJF[5#%1<231K$88O,W2JK_`.RA/+?A6,AA)5&>K,;S.CF>
M,(0Y"X_B7L:K3U40,VXJ+3?^0W9?]=T_G4MQ46F_\ANR_P"NZ?SK1&<CTZN(
MU?\`Y#MU_OC_`-!%=O7$:O\`\AVZ_P!\?^@BF>1B/A0L%:$-9\%:$-0SC1:7
MI2-2K5*.XO&F1)+;"EG#.`0`!]W@^M8O<L=-6=<5HS5G7%:Q(9F3]378>$O^
M0$G_`%T;^=<?/U-=AX2_Y`2?]=&_G6AO0^,;XO\`^0,O_7=?ZURL%=5XO_Y`
MR_\`7=?ZURL%85-SO1HPU>CZ51AJ]'TK%E$AZ5!+2SR3)+&J1[E8-N.TG!QQ
MR.G-11O+);1O/'Y<I7YT]#68RI/WK,N.]:<_>LRX[ULB66O"?_(SP?\`7.3^
M5>AUYYX3_P"1G@_ZYR?RKT.MZ>Q)0U/_`%MA_P!?:_\`H+5-:?ZVZ_Z[_P#L
MJU#J?^ML/^OM?_06J:T_UMU_UW_]E6M`$N/^/ZT_WG_]!JU56X_X_K3_`'G_
M`/0:M4`-=UC1G=@JJ"68G``]:KIJ=E)Y(2X4F<D(.1D@X(]N>.>]3RQ1SPO#
M*@>.12K*>A!X(JI'HUA')'(L.6C8LNYB<$G)/Y\_6@"*S_Y&+4O^N4'_`+/6
MG6>FE^1?3W5I,(/M"H'01`C*YY_6IO(O/^?T?]^10!S'B8_\3T_]<4_FU5K<
MCUKK'L)I&W27$;GIEK=2:3^S7_YZP_\`@,M=*K))*QBZ=W>YB0D47UI-=QQB
M"Y,#(23AB`P(QSBMO^SI/^>T7_@.M']G2?\`/:+_`,!UJ95$P5,QEM9HQ&?M
M+$A]S*S$KCG@=^XZU&D<D,)2:;SGW,=V,<$D@?ATK82QNS<RJ[P"$*OEL(%R
MQYW9'MQ^=2_V=)_SVB_\!UJ5-(?LSE[@CGFLR<CUKN_[-?\`YZQ?^`RTG]F-
M_P`]8?\`P&6M?;KL3[+S,GP3_P`>=U_UU'\JT_$G_(OW?^X/YBIX[.>($1W*
M(#U"P**5K6Z=2KW:LIZ@P@@UA.7-*YO#W;'`PD>M:,)''-=1_9K?\]8?_`9:
M7^S7_P">L/\`X#+6=CI5=+H8L9&.M4;33;N&=GFU*1X^,*K'.`,8.<CWR*ZC
M^SI/^>T7_@.M-DT^<)F.2%FR.#;KTSS^E2X7'[==CG5MYXWC+S*P0ON`9N<]
M.I[>]1SD>M=1_9TG_/:+_P`!UH_LU_\`GK%_X#+0HV#VZ['"W!'K4.FD?VW9
M<_\`+=/YUW_]FM_SUA_\!EI5TUU8,LT0(Y!%NO%62ZJ9?KB-8_Y#MU_OC_T$
M5UOD7G_/Z/\`OR*C:QF=BS7$;$]2;=:#BJPYU8Y>`BM"$UL?V?)_SWB_\!UH
M^P2_\]X__`=:EHQ^KON8=U9SW$RR17)10`"A9@#@Y['\*5K297C9;MR50J2[
M$Y)&,XZ>_-;?V"7_`)^(_P#P'6HH+*\;S//D@3$A";8%.5[$^]1[/S*]@^YC
MJC16\<<DGF.J@,_]X^M4;@UU?V"7_GO'_P"`ZT?V?)_SWB_\!UJU&Q/U=]S@
M9R,GFNQ\)?\`("3_`*Z-_.KG]G2?\]HO_`=:D2UN8UVI=JH]!"!5%TZ+A*]S
M-\7_`/(&7_KNO]:Y2`CUKO)+2XE7;)=(Z]<-`I%1_P!EG_GI#_X#+6<H7=SI
M.8A(]:M21M-;21)(8V9<!P<$'UK=_LQO^>L/_@,M+_9K_P#/6'_P&6H=)]QW
M.:@L)XT<2WC-G.`DC8/UR2?RH2":*4-)<>8!"(R.>6!^]71-ITP=`KP%23N)
MMUXXXI_]FO\`\]8?_`9:GV+[A<Y2<CGFLRX(YYKO?[,;_GI#_P"`RT?V6?\`
MGI#_`.`RU:I,5SC/"9'_``D\'_7.3^5>AU033I(GWQS1(WJMNH-2^1>?\_H_
M[\BM(JR$1:G_`*VP_P"OM?\`T%JFM/\`6W7_`%W_`/95J-[&::6!YKLLL,GF
M!1&!DX(_K4EI_K;K_KO_`.RK5`)<?\?UI_O/_P"@U:JK<?\`']:?[S_^@U:H
M`****`"BBB@`HHHH`Q=0T>\FO3>V=V8I1*&"%R$8;,<@=\_UJ&YTSQ!=HL;Z
MC%$%(;=$2#N!!!Z?I_/-=!10!BO9ZX;%(VU"-[CS,M(B;1C:1G'^]@X_G4T^
MGWUSI=M;S7>;F.1'>5#M#8.>1CD8[<5J44`9^G6ES:RL';$.WA"Y?#%B>"><
M8(%:%%%`!1110`4444`8TNF:HL$RV6H&%Y;II=TAWX4C&WD<<CIVZ5!:6_B!
MHYDO)R62X4*XV@/&,\C`]QG/7%=!10!F/87L^C+:7%V6N=^6F0[<@-D=O3`(
M[T[3K.[M;B3S9B\3%V`WDA=S9`Y].>?<5HT4`%%%%`!1110`5E:GIM[>7!>W
MO/)0QJNW)Z@DY_4?E6K10!SVJ6OB5'FN+&_61,C9`$4$CH>2.O>K8M=6-VD@
MNPL8>,NK8.Y`H#+TZYR<^XK6HH`R+_2KV[U(W":@T4`1`L2Y&&#$DGGG@^W;
MTK1LUE2UC6<DR`<Y.?U[U-10`4444`%%%%`%>_@EN;">""7RI9$*H^2-I]>*
MSIM,U-8[K[%J'DR3W'F!I/GVKMQ@9'`R`<?K6S10!AP0ZVQNH[B4[4DC$3Y7
MYT!RQ&.A^OI5B6QU.?09K-[]5NW#!;@+T!)QTQSC`S6I10!FVFGRVFI/)&Y\
MB3S'D4L3EB5VXR3C`#9_WJTJ**`"BBB@`JM:?ZVZ_P"N_P#[*M6:K6G^MNO^
MN_\`[*M`$DUO#<`":-7"G(R.AJ+^S;+_`)]THHH`/[-LO^?=*/[-LO\`GW2B
MB@`_LVR_Y]TH_LVR_P"?=***`#^S;+_GW2C^S;+_`)]THHH`/[-LO^?=*/[-
MLO\`GW2BB@`_LVR_Y]TH_LVR_P"?=***`#^S;+_GW2C^S;+_`)]THHH`/[-L
MO^?=*/[-LO\`GW2BB@`_LVR_Y]TH_LVR_P"?=***`#^S;+_GW2C^S;+_`)]T
MHHH`/[-LO^?=*/[-LO\`GW2BB@`_LVR_Y]TH_LVR_P"?=***`#^S;+_GW2C^
MS;+_`)]THHH`/[-LO^?=*/[-LO\`GW2BB@`_LVR_Y]TH_LVR_P"?=***`#^S
M;+_GW2C^S;+_`)]THHH`/[-LO^?=*/[-LO\`GW2BB@`_LVR_Y]TH_LVR_P"?
M=***`#^S;+_GW2C^S;+_`)]THHH`/[-LO^?=*/[-LO\`GW2BB@`_LVR_Y]TH
M_LVR_P"?=***`#^S;+_GW2C^S;+_`)]THHH`/[-LO^?=*FA@BMT*0QJBDY(`
&[T44`?_9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g118721mqi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mqi002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`#.`7(#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#TB^\::#IV
MHSZ?<7-Q]IMRHE2*RFE"DJ&'*H1T(/6H?^$_\._\][W_`,%ES_\`&Z3P]_R-
M_BS_`*^K?_TFCKI:`.;_`.$_\._\][W_`,%ES_\`&Z/^$_\`#O\`SWO?_!9<
M_P#QNNDHH`YO_A/_``[_`,][W_P67/\`\;H_X3_P[_SWO?\`P67/_P`;KI**
M`.;_`.$_\._\][W_`,%ES_\`&Z/^$_\`#O\`SWO?_!9<_P#QNNDHH`YO_A/_
M``[_`,][W_P67/\`\;H_X3_P[_SWO?\`P67/_P`;KI**`.;_`.$_\._\][W_
M`,%ES_\`&Z/^$_\`#O\`SWO?_!9<_P#QNNDK!?QAID%P\5TES;(GF_OY8_W9
M\M]C8()SR*`(?^$_\._\][W_`,%ES_\`&Z/^$_\`#O\`SWO?_!9<_P#QNK,W
MC#0X9(4-YN\YMNY4.%&UFW'_`&<(>?IVYI9O%VAP6\=R]\OD2(SB4*2`%8*<
M\9'+#M0!5_X3_P`._P#/>]_\%ES_`/&Z/^$_\._\][W_`,%ES_\`&ZFNO%^F
MV[L(X[BY"JY9HD``*_PY8KEB,D`9)P:V+6ZBO(?.A)*AW0Y]58J?U!H`P?\`
MA/\`P[_SWO?_``67/_QNC_A/_#O_`#WO?_!9<_\`QNNDHH`YO_A/_#O_`#WO
M?_!9<_\`QNC_`(3_`,._\][W_P`%ES_\;KI**`.;_P"$_P##O_/>]_\`!9<_
M_&Z/^$_\._\`/>]_\%ES_P#&ZZ2B@#F_^$_\._\`/>]_\%ES_P#&Z/\`A/\`
MP[_SWO?_``67/_QNNDHH`YO_`(3_`,._\][W_P`%ES_\;H_X3_P[_P`][W_P
M67/_`,;KI**`.;_X3_P[_P`][W_P67/_`,;H_P"$_P##O_/>]_\`!9<__&ZZ
M2B@#F_\`A/\`P[_SWO?_``67/_QNC_A/_#O_`#WO?_!9<_\`QNNDHH`YO_A/
M_#O_`#WO?_!9<_\`QNC_`(3_`,._\][W_P`%ES_\;KI**`.;_P"$_P##O_/>
M]_\`!9<__&Z/^$_\._\`/>]_\%ES_P#&ZVM0OUTZW29H99@\J18CVY!=@J]2
M.,D#\:S8O%FG217K,DT3V2.\D3A=S*K2*Q7#8.#$_P"7N*`*_P#PG_AW_GO>
M_P#@LN?_`(W1_P`)_P"'?^>][_X++G_XW5J7Q19P&Z$D%POV2.>1^%.5BV;R
M,-S_`*Q?R(.",5+=>(;*QNKJ&[$L$=K&KO.Z?(VX@87')P2,X&!GK0!0_P"$
M_P##O_/>]_\`!9<__&Z/^$_\._\`/>]_\%ES_P#&ZMQ>+M!FWB+4%<QJ[L`C
M9`5=S=NPI'\6:0JRA9G>:(NK6Z1,9"ZYR@&,$Y!'7&>]`%7_`(3_`,._\][W
M_P`%ES_\;H_X3_P[_P`][W_P67/_`,;J[I_B6RU&[2T1)8IGC615D"_,"H;@
M@GL?S4^E:]`'-_\`"?\`AW_GO>_^"RY_^-T?\)_X=_Y[WO\`X++G_P"-UTE%
M`'-_\)_X=_Y[WO\`X++G_P"-T?\`"?\`AW_GO>_^"RY_^-UTE%`'-_\`"?\`
MAW_GO>_^"RY_^-TV3XA^&HHVDDNKM$0%F9M-N0`!U)/EUTU8WC+_`)$G7?\`
ML&W'_HMJ`-FBBB@#FO#W_(W^+/\`KZM__2:.NEKFO#W_`"-_BS_KZM__`$FC
MKI:`*.J7T]C%&UO9O=,Y8%5S\N$9@>GJH'XU4^U75[J%E"RW%DLEH\S@%?O9
MC^7/)XW$=!6P2`"2<`=2:H2G/B"S(_Y])_\`T.&@"3[!)_T$+K\U_P`*/L$G
M_00NOS7_``JTZLT;*KE&(P&`!(]^:JZ2\TFE6TL\S322Q*[,5`Y(![`4`'V"
M3_H(77YK_A1]@D_Z"%U^:_X5<JE!/=/JES!(T)AB167:A#?-GJ<X[>E`"_8)
M/^@A=?FO^%'V"3_H(77YK_A5RJ&H1E[JQ'FRH'F*L$D*Y'EN><'U`H`?]@D_
MZ"%U^:_X55D\/6DR[979URS8:.,C+'+'[O<]:UJ9*C21,BR-&3T9<9'YT`9@
M\/6@;<';(.<^7'UR3G[OJ3^9I)/#=G-&D<CLZ1@JJ%$V@$@D8VXY(!_"K>DO
M+)I-I)-*TLDD*NSL`"21GM]:N4`9=QH-O=@BYE>8$;2)$1LC.<<KZU+%I9@3
M9'>W*KDM@%>I.2>G<DFDT^WBCOM1D5`&\\#/L8T/\R3^-:%`%/[!)_T$+K\U
M_P`*/L$G_00NOS7_``IE\A-[8,)95W3E659"`P".W(!P>0*OT`9US#]DMWGF
MU&[6-!EB`&P/H%IT5JTT:R)J%YM;IN`4_D5S3]7_`.0+??\`7O)_Z":N4`4_
ML$G_`$$+K\U_PJM:JUT\R+=WT9A8*V_8.<`\<>A'YUJU3LO^/O4/^O@?^BHZ
M`(KB":V6.5;ZX;]]&I5BN""X![>AK1JKJ'_'LG_7>'_T8M6J`$/`K#36KZ?3
M+N=],GMFCMDD3IG<R;F^]C[IX/TK=JIJ9!TN\&1D0/D?\!-`$5O9S26T3MJ%
MUED!/*^GTI/*C^T?9O[7E\[KY?F)N]>F,U;M/^/.#_KFO\JKL!_;L1P,_9G_
M`/0EH`=]@D_Z"%U^:_X5%<11VJA[G5Y85)P#)(B@GTY%:-4M5`-HF0#_`*1!
MU_ZZK0`"QD(!&HW)![Y7_"AK)T4LVHW*J!DDLH`'Y5=I"`001D'J*`,[[#%?
M0X&HRW$88=T89'([=1P::-!MUBDA6601RDF1`B8?/7(V\U/I"JFG@*H`\R3I
M_OFKM`&"FC:2UQ):).IE(8R1A(\_-C=D;>^!GUQ5N30X)1(LDTCB7'F!E0[\
M8QGY><8'Y58C`_M>X.!GR(O_`$*2K=`'/S>'-'LG^VRR^00"A<A%&"""#\N.
M15J#0K5;=EAG?RIQEP%3$@/<_+SG/?UJUJX!TFYR/^69JW0!F1Z'!;R>=%/+
M&XW'<BH#SC/1>IP/RI;55O49X-1O2JL5.Y-G(X/516G533O^/9_^N\W_`*,:
M@!/L$G_00NOS7_"J^QOMWV3[7?;@NXM\FW'UQ[5J537_`)#,G_7NG_H34`'V
M"3_H(77YK_A5>\1K.)9'O+YPSA/DV$Y)P.WJ16I5/5/^/1/^OB#_`-&I0`BV
M,I4'[?=C(Z$KQ^E8_B,2+X+\3QR3/-Y=G<!2^,@>0#C@>I-=+7.>)_\`D4?%
M?_7I/_Z3B@#HZ***`.:\/?\`(W^+/^OJW_\`2:.GW-S<#QS90><RQ-;DF$2M
M@_ZS!V]#T'Y>U,\/?\C?XL_Z^K?_`-)HZFC@CLO$[/)?L9+CY_*,*X()95&_
M&0>:`->^M$O[">TD9E6>,H67J,CJ*SK>PCL-:L(HY)6"6$L8WN2,*80..@-:
M5]<M9V,]RL+3-%&7$:]6P.E9T%V;O7+%C!+%NL)7RZX'S&$X^H[T`.UW75T1
M(";<S&8D`!MN,#Z52\,:\+Y8M.-L8W@MA\^_(;;M4]O>J/Q"9T@L73;E6D/(
M]A6+X$U9/[4>>Y#1J;9@,1MG[R5LHQ]G?J1=\UCT:ZN$M+2:YESLA1G;'7`&
M37-VOBVP?5Y&\FY`N/*C0E!P<D<\_P"T*NZUK%C)H6H(LS;FM9`/W3?W3[5Y
MK8ZA$=6MXS=.3'/&6!B[;Q[4H0C)-L)-IJQ[-7%ZUXFOH-;>WBBM]EE-E"RL
M2V8\<\_[9_*NH75;%C@7"CZ@C^=>9^);R%?$U\?MJH))AM``(/R+12C%R]X)
MMI:'I.B7\FIZ3#=RJJO)N!"=.&(_I4&N:\FBM`K0-,9PQ&&QC;C_`.*JKX3N
M[:/PU:K)=1;@9,Y<`_?:L;Q]?VRR:>RRK(`LN=C`XY3WI1BG.SV&VU&YM>%M
M:74+867D&-[2",$[LAN"/_9:T-<N);30[ZX@?9+%`[(V,X('!KD/`&H6LEY?
M2&544Q1X+L!GEO>ND\1WMJWAO452ZA+&V?`\P'G%$TE.R"+;5V<IINMZJ-5@
M#7S,MQ=1^:"B_-DJI[>@%>BUY#I5XKZS9@W%N0EW%OP<8^=?>O5_MUI_S]0_
M]_!5UU%2]TFFVUJ<MJ7BYDU)8ET_<+.Y?YO.QOPKIZ<=<UTVFWG]H:;;7@C\
MOSXU?9G.W(SC->7ZM>HNLW@5HV#7,FT^8.?F->A^&[B'_A&].!EC!^S)D;AQ
MQ2J1BHIH<6VW<K>*M:_L^W^Q"W\UKN"0!M^W;P!Z<_>JQH.OC6VN%^S&`P!#
M]_=G=GV']VN=\?W*1WEBX964129.X<<K4_P_<R2ZBQ7'RPXYSGEZ.2/L^;J*
M[YK'1Z[?3:;H\]W`$,B;0N\9'+`?UKE]$\1ZE-KD4$HMS'>3$R;4((Q'CCG_
M`&!6_P"+"!X:NB3@`Q_^AK7%^'Y(V\2:<%=2?-/`/^PU.G&+@VPDVI)'H>H?
M\>R?]=X?_1BU3\3S30:!<R0R&-AM^=7*D?,.A'//3\:N:A_Q[)_UWA_]&+5/
MQ';K/IJN]RUNL$JR%TC#GN!P?<@_A6!H6-%D:70K"1W+L]M&S,6+%B5'.3R?
MK5/4=(A2'6+P2S![R$%PKE0-B$#&/7O6CISJ^G6Y242@1J-X3;N(&,X[?2L_
M4=2=K?5[<V<Q6VA`#J,^9N0G(]AWH`T[3_CS@_ZYK_*O/F\8:OD7^VUWK`0%
MV'&#@^OM7H-I_P`><'_7-?Y5XK+J#QQ"V:`\PYWCD?=K>C&+OS&<VU:Q[A7&
M^)-?U"WU.6QA$`BB>-P64DDC:_KZUT?]M6'_`#V;_OT_^%<#XKU&S37KF1KA
M`K%,$G_86IHJ+E:0YMI:':^&M4N=6T^2>Z$8D28I^[!`(VJ?ZU%XMOKO3]-@
MDLYC"[W`0L`#QM8XY^@JEX(O+4:1/FYB&;DXRX_N+3_'$L?]C6S^8NW[4/FW
M#'W'H27M+=+A=\MREX/U._GU=K2>Z:6$6\D@4J!AMZ\\#_:-===SBULYK@KN
M$4;/MSC.!FN%\$2QR>(F\N16Q:29VG/\<==IJ_\`R!K[_KWD_P#031624[((
M-N.IRR^-F2[EN#IO#QHN//Z;2QS]W_:_2NUKQYKF-E91NR1_=->PU5:$8M<H
MH2;6I2U=E&EW(+`'RSU-7`P894@_2N`\<-'_`,)$HD8`?9(^"<?QR5K>`2IT
MZ]VMD?:>QS_`M0Z=H<URE+WK'1W5Y;V,/G7,JQ1Y`W-ZUGZ/JUA<@V\-RCRM
M-,P3G)&]C_*J7CEMN@H=I;%PG`Z]ZYOPE)O\2VH\IT^_RP_V#3C33@Y7$Y6E
M8](KDE\:Z;]M>[\FZ\IH%`.Q>Q)]?0UUM>.C_D&#_KC_`$ITJ:G>X3DXGL59
MVKW,$=NB231HWVB`X9@#CS5K1KSOQ6`WB2YSSA8__0:BG#GE8<I<JN>@QR1R
MKOC=77U4Y%<_XG_Y%'Q7_P!>D_\`Z3BE\$_\@:4?]/#?^@K2>)_^11\5_P#7
MI/\`^DXJ9*S:&G=7.CHHHI#.:\/?\C?XL_Z^K?\`])HZA\B%?'L0@"M^[9YV
MV?Q'<0,^V5XJ;P]_R-_BS_KZM_\`TFCI\Y33_$L"!;Z42N)!B0&)&<LI^7';
M^M`'15GRD'Q!9D'(-I/_`.APU<FB$\#Q%V0.I&Y#@CZ&LJWL%L-:L(4GFD2.
MPDC42-GA3",_4]Z`,OQW]VP_WG_D*H^"@!KDF!_R[-_Z$E=E>Z=::BBI=P+*
M$.5SV-4O#^F65IIUK<06ZI++;)O<9R<@$_K6JJ?N^0CE][F)]=_Y%_4?^O67
M_P!`->;VJ*-0M6"@$W$63C_;%>I7$$=U;2V\HS'*A1@/0C!KG;7PKIR:O*,S
MD6XBD0%^^2>>/]D4Z=1133ZA*+;1TC11M]Z-3]5%>9>(+6W;Q'?YA0[91CY>
MGR+7J%<CK/AAKC6!<)<!1>SX(/\`#B,GT_V*5*2C*[":;6AH^%+:!O#EL6@C
M)S)R5']]JQO'EK;F33T\F/:R2Y`4#/*5U6DV`TS38K,/O\O.6]223_6LKQ5H
MMYJSVCVFP^2'#!CC[VW'_H-$))3N]AR3Y;&+X"L[9+R]C$*;5ACP"H/=ZZ/Q
M':VZ^'-1*P1@BW?D(/2L[P;I5W9^;>W`0)=0QF,`Y/<\_F*VM=@DN=!OH(4+
MR20.JJ.I..E*HTYW0134=3S;3+.W35[-EA0%[N+=QU^=:]2^RVW_`#[Q?]\"
MO/=,TO4&U6W_`-"G40747F$I@+@JQS^!KTBKKN+DK$TTTM3R?5[&VEUJZ=H5
MS'=2;<#&/G-=YX>T^SD\.:>SVZ$FW0DX]JYW5/#NI_VK(R0HRW5R_EGS`.NY
M_P"0-=CHUK)9:-9VLP`DAA5&`.>0**DHN,4@BFF[G&^/-,LS=6<7D`*\4F0/
MJM/\#Z58R27Z/`"J+%M&3QDO6KXQT>[OECO;9XE6TAD+A\Y/0\?D:G\+Z%>:
M,]VUW)$YF"!?+SQMW=<_[U'-'V5NH6?/?H1>*-)LXO#UR\49C(*?=8\_.M<=
MX4L([+Q+9%69R\Q.6[?NVKOO%?\`R+=U]8__`$-:XOP^0?$FGX.<2GI_N-54
MTO9R%*_,CT+4/^/9/^N\/_HQ:R_&,<3Z$S28+(ZF,%=V6SCI],FM34/^/9/^
MN\/_`*,6JOB!?^)89PUP&@<.HMY`C$GY<9(Z88US&I-HBE-"L%(PWV:/=QCG
M:,T_5#_Q*KP=_(?_`-!-,T659M(MBD<L:H@0";[V`,<^]5]5TY3:ZG="XN%>
M>W`(#\*$#8QQQG<<T`:%I_QYP?\`7-?Y5Y.UG<_9?(^RR^:83A=ASTQ7K%I_
MQYP?]<U_E4#_`/(<B_Z]G_\`0EK2%1PO8F45(N5YOXMM;>7Q#=!X48`H>5_V
M%KTFN=UWPY:W4[7[3W"R2RQ(RJ5VX+*G<>E.E)1E=BFFUH0>"+6W;2+@&",X
MN2/NC^XE0>.=+LO[*@(@4%K@*2/38]=%I.DP:/;/;V\DKJ[ER9""<X`[`>E5
M/$^EW.JZ?%#:[=\<P<ACCC:P_K2YE[2_2X[/EL<;X)T:P37&A\@%/LTC8R>N
M]*['5-*ACTF\:*:XC`@<[5E(!^4UE>$]%O;343?3A!$89(A@Y.=Z_P#Q)KI-
M45GTF\102S0.`!W.TT56G.\=@@FEJ>0G3@LTD_VB8Y7[N[VKUO\`LL?\_MY_
MW^->:M!,^Z-8G+XZ;3GGI7K%:XBUU8BG>VIYGXYTI9=;6(W-P?\`18SN9\G[
MTE:W@735.G7:K=7,>RX`^23:#\B]J;XRM+M]9%S':32PK:H#(B$@$,Y(_45J
M>"[6YM;&[%S;RP%[C*K(NTD;%&?TI2Y?9+N-7YRKXRLIXM&0B^E<&=0`X!QP
M:YOPC9WL>NVZ?V@VXER&*`X^5O6NX\56%UJ.DK#:1^9(LROMW`<#/K]:P?#.
MCZE%K$-U-:^7#&TBLV\'D!EZ?6E!Q]FTWJ$D^9'4FTU#_H*'_OPM>-C3[KR?
M-^VOY7D@[/\`@->YUY"+>?[%Y/DOY@A^[M.>F*="VMPJ7TL>G_9-0_Z"A_[\
M+7G/C+3)KCQ#,)+QBZB,EP@7(QTXKU6O/?%B.OB*X<HVUECP<<'C'\ZFC;GU
M'._+H;O@6-8M#D11@"X/'_`5IWB?_D4?%?\`UZ3_`/I.*=X+1DT>7<I7,[$9
M&/X5IOB?_D4?%?\`UZ3_`/I.*B?Q,J.R.CHHHJ!G->'O^1O\6?\`7U;_`/I-
M'5YK.\;Q)'>N%$"H8UV9)Q@GYO3DGU[51\/?\C?XL_Z^K?\`])HZZ6@"O?W)
MLM/N+H*&,,;.%)QG`JBET+CQ!9_NI$/V&5B2OR\M"<`]#6KTJC-_R,%G_P!>
MD_\`Z'#0!?JGI'_(%L?^O>/_`-!%6G8(C.02%&<*,D_A531RW]CVBO')&R0H
MC+(I4@A0#P:`+M4K?_D,7G_7*+_V>KM9UK/&^N7L:MEO+CX^A;/\Q0!HU3O?
M^/O3_P#KX/\`Z*DJY5.]_P"/O3_^O@_^BI*`+E%%%`%/2/\`D"V/_7O'_P"@
MBKE4](_Y`MC_`->\?_H(JY0!3LO^/O4/^O@?^BHZN53LO^/O4/\`KX'_`**C
MJY0!3O?^/O3_`/KX/_HJ2KE4[W_C[T__`*^#_P"BI*N4`4]7_P"0+??]>\G_
M`*":N53U?_D"WW_7O)_Z":N4`->-)4*2(KJ>JL,@UGZ?9VL=[?.EM"C)<#:R
MQ@$?NDZ?F:TJIV7_`!]ZA_U\#_T5'0`[4/\`CV3_`*[P_P#HQ:AUNVN;S37M
M[4(6<C=N)'`YX]\@?AFIM0_X]D_Z[P_^C%JU0!7L(VBT^VC?.Y(E4Y&#D`=J
MS]2U'_1]6MS"["WA`S&-Q.Y3V[8_K6Q534S_`,2J\_ZX/_Z":`);3_CS@_ZY
MK_*H'_Y#D7_7L_\`Z$M3VG_'G!_US7^55V9?[>B7<,_9GXS_`+2T`7JIZI_Q
MZ)_U\0?^C4JY5/5/^/1/^OB#_P!&I0!<HHHH`IZ5_P`>"_\`723_`-#:KE4]
M*_X\%_ZZ2?\`H;5<H`J1_P#(6N/^N$7_`*%)5NJD?_(6N/\`KA%_Z%)5N@"G
MJW_(*N?^N9JY5/5O^05<_P#7,U<H`*J:=_Q[/_UWF_\`1C5;JIIW_'L__7>;
M_P!&-0!;JFO_`"&9/^O=/_0FJY5-?^0S)_U[I_Z$U`%RJ>J?\>B?]?$'_HU*
MN51U9T2TC+L%_P!(AZG_`*:K0!>KG/$__(H^*_\`KTG_`/2<5T0((R.E<[XG
M_P"11\5_]>D__I.*`.CHHHH`YKP]_P`C?XL_Z^K?_P!)HZZ6N:\/?\C?XL_Z
M^K?_`-)HZZ6@""\MOMEG-;>8T?FH5WKU&:SUL9K"\LYEDFN8X+5K<J>3G]WA
MNG?8<Y/>M>B@"G]ND_Y\Y_\`OFF0:HUQ;QSI97`61`X!7G!&:S$/BR&2<!+2
M>-KAS$9FP5CW#:/E]LTP/XQ2:5Q#92(P4HCMC:=@R..V[/K0!L_;I/\`GSG_
M`.^:C35"\TD0LKC=%C.5XY%0ZC!K4R6C6-S'"XP+A2!@\J21P>F&'_`O:J\+
M^)VN[<SQ6BP+(!*(VSE2"">>X./3^E`&E]ND_P"?.?\`[YJG?2Q3SVIGLKO?
MYA$90E<-M8Y./8$?C4\<>IMHCH\H6_VOL?C&<G;GC'3&:SIH_%D5HT,$EI-(
M4($S\,#\P!`Z=D/U8]A0!K?;I/\`GSG_`.^:9+<F:)HWL[C:W7;E3^8YI+/^
MT6O=]T-D1MTR@*E1+D[L=\=.OZ52DB\2PWTKPS6T]N7_`':2';A=Q/.!Z,!U
M_ASSG%`%C3KJ./3K<6MA<I`8P8U;)(!&0,G-6?MTG_/G/_WS6=#_`,)&Z.)U
MA1C/`R%",!,#S5/Y$>OS=:M:E;ZM+>6[Z?=I%`.)D8`YY`R./0L?JJCN:`([
M.X"7=V\=M>%C+^\#@8W;5.1^&!^%6_MTG_/G/_WS6?:2>)CJ$+7<%HMMM(D6
M-N<E00>?1LCZ<U9\O5WT9E,L2:@'+`KRA`DR%SCH5P,X[T`17DX>[M'DM[P,
M)?W80#;NVL<G\,C\:N?;I/\`GSG_`.^:QV7Q=':&!&LY90H'GEL$G!YQC`R0
M.W&>_;5LEU$W4DMVRB)H8PL0`^1\'?SSGD_I0!#J5WOTVY6:UNEB\IM_E@;B
MN.0,^U3QW<L<84VURY'\3+R?R%9OE>*;8RE)K6[!8^6)?EP/FQG`']U/Q=O0
M5+;?\)$8X1<?9U9;PF0@_>@.>GH1G]!SR30!?^W2?\^<_P#WS5.QG$,]WY=O
M>.QE'F>8`?FVKR/P('X4NJ0:X;U)=-N(A`%&Z*3C+#=WP3@[@?\`@'O45L?$
M<E^@O%MXK5HV5S"064[00PSGG.1W'UZT`7)II;I4B%M(G[V-BS#@!7!/\JT*
M@L8YXK&!+J4RSJ@\QSCEL<]`!4]`!67=:0\@U)X[N57O44!<C"$*5P.#P>]:
ME%`%""ZEBMXXS9S$HH4X7T%0_:H/[1S_`&6_VGR]WF^4-V.F,]:-876?/MGT
MEH]J*YE23&'/R[1Z_P![I^G44F?Q=(\/[JRB56!DV-DL.<CG\/\`ZU`&M]ND
M_P"?.?\`[YJKJ%Q%-`@NK"Y9!(@`0E?F+``\$="0:--_MVXL[A-4%O:S,FV&
M2W^;:2#EL'T..*JPCQ5"H63['.6.68D_+DC@#`Z`L/?:.G<`U!>N``+.?CVI
M'NVD1D:SGPPP<`C]:@TH:QY=G_:6P.MNZW.P@AI-R[2/PW9[<U7NX?$4>H33
M6<\$ML>8XI<#&=HQP.WSGKW%`$VG7,<=HOV6PN5C8EL.2QSWZDU:^W2?\^<_
M_?-9:?\`"3O'=B=849E4P&%E.QL@'[W;&3SUYZ<5?UB'5)8XCI5RD,BL2XD`
M*L,9'8]P!]&/H*`(8YHUU.:5;*[\\QKN))VD$MCC\#^=6_MTG_/G/_WS6:6\
M4"Z@'EVIMTG'F8;YGC^8?GC:W&.?2M&P2]^S2"]DQ(TKE"N,JF?E!XQP.*`*
M^H74<EHPNK"X>($949&>WMZU82[:-%1;*<*HP.,UE11^++:,`R6ETQX)<XQ@
M#D8`ZG<?P`]ZM6(U_;8B\\@;)7^U$-RR;#LQQ_>(STZ=Z`+AO7((-G/S[55T
M^:*"%_LUC=*ID;(=F;D,03R3WS3;^'7EU!YK">%[;ROEADP/GP>^.F57_OMO
M05"@\322W2S&WBC>W*PO"`QCDW-AL$\Y4@\G&0!ZT`:7VZ3_`)\Y_P#OFJ@E
MC.JO,+*Z\]8UR<G:5.X`8Z=C3M1@UE],MQ8W,<=X@'FEL;7.TCT_O8/0<9JI
M(?%0F152T:*.7E@WS2)G'/OCGC'/''<`U/MTG_/G/_WS4%W>Q^4IN--EE7>J
M@-&&P6(4=?K4EG'J+0WB7DJJ[SR?9WCP=D9^YP1U'XUG0KXK@BC5S9W#D_.S
M$@`$J>``.F6'N%'K0!J"]<``64P`Z`+6/XD#GP7XFE>,IYME<,JMUQY&/Z&K
MVFQ:PT5A)J,VR6-&%RD>TI(>@/3.>_!`XQBF>,O^1)UW_L&W'_HMJ`-FBBB@
M#FO#W_(W^+/^OJW_`/2:.NEKFO#W_(W^+/\`KZM__2:.NEH`****`"BBB@`H
MHHH`****`"LS6+R_M&MS90><&;]XH0DD94=>@ZGK]><8+EU_2GF\H7B;\XP0
M1SD+U(]64?4BII-4L(93%)=Q*ZLR,"W0JF\@^F%.?I0!@?\`"3:M)'&@T26"
M4^4S2.&\OF0!AG;\ORY.3T^HP=3[9?W*6%Q#"T4=VI#I@,T1.&5C[;0P(]2*
MN?VA8O;O+]IB,2LJ,V[@%@"H_$,OYBG07]I<Q"2"YBD0D@,K#''_`-8@_B*`
M,6+7]2DFM8QH]RBN$\R213@9*!CC;U&YO3H3TKHJA:ZMT8*T\8+$J`6'4=14
M=QJ5C:*&GNXHP6V#+#EL$X^O!XH`M45%;7,%Y"L]M,DT3='0Y!J6@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`*CF9D@D=!EE4D#&><>G>H+W5++3B@
MNYQ%YF=N5)SP3V'H"?P-(FK:?);)<+=Q&)W\M6W8RWI]?:@#$3Q#K%NRI<:-
M-<Y9%WQ*R]68$C(Y``!YQUJ[H>K7FH.\5U9F%@'<,<@@>8P52I`(.T*<GKFK
ML6KZ=,L9CO86$NS9ANN[.W\]I_(TY-1L6NQ;I<1M,[,FU>3E/O`_3(H`RI-4
MU6RBC::QFNI!(T3+$F`VW/S]#@,"#CMCK5W1-0NM0@F:ZM)+8HX5!(""P**<
M]!W)''I5_P`Z+_GJG7'WAUIHO+8J6%Q'A6*D[QP0<$?F#0!-15%=9TY[M;1;
MN,S-G"@]<,5//3.X$8]:O4`%%%%`!1110`5C>,O^1)UW_L&W'_HMJV:QO&7_
M`").N_\`8-N/_1;4`;-%%%`'->'O^1O\6?\`7U;_`/I-'72US7A[_D;_`!9_
MU]6__I-'72T`5-0U*WTR))+C?M<L`5&>0K-_)350:NUY>6MO8,@$]LUP6EC;
M[OR;<=!T?]*TI(8IL>9&K[<XR,XR,']":IR*%U^R50`!:3@`=OFAH`DVZG_S
MUM?^_3?_`!5&W4_^>MK_`-^F_P#BJM2%EC8HN]@.%)QD^F:@L+E[RRBN7B\K
MS5#JN[=P1D4`,VZG_P`];7_OTW_Q5&W4_P#GK:_]^F_^*JY5.">X?4KB!_*\
MJ)%9=H.[YL]>?:@`VZG_`,];7_OTW_Q5&W4_^>MK_P!^F_\`BJN53O9[F*>U
M2#RL32%&W@G'RLW&#_LT`9,OA99I&>3R&WR/*RGS,,69&.1NZ9C7CVI7\,%W
M=M\2+(S,R(9%0DQ"+H&Q]P`#TKH:9*CO$RQR&-CT<`''X&@#$7PZZV<EH'A\
MJ5XG8?O,YC"!>=WI&OY51NO`MG=V4=G+%;^3%NVA?,&,A0?XO1%'X5T.E22S
M:5:S3R>9))$KLV`.2,]!]:MT`<DG@C-C]CFGADBWLQ&PJ2"R-@D'UC0_ACI5
MA_"%LXB_T>S4PYVLB."25*DD[N3@FMFSEN9;N\25HS'#+L0*,'[JMS_WU5R@
M#(TW2KK2H&@M7M51G+X\MN.``!\W0``?A5O;J?\`SUM?^_3?_%4MU=S6]U;1
M);B1)WV;_,QM."3QCT4U;H`I[=3_`.>MK_WZ;_XJC;J?_/6U_P"_3?\`Q5+J
MDLL&EW,T#[)(HF=21GH,_P!*L1*Z1*LC^8PZMC&:`*VW4_\`GK:_]^F_^*HV
MZG_SUM?^_3?_`!57*K6EZMW),@AEC,+!6\Q0.<9XY]"/SH`AEDU"W"/(]LR&
M1$(6-@<,P7U]ZOU5U#_CV3_KO#_Z,6K5`"5CCQ+936%S<P>83!`DN&C)^^F]
M1QGMUK8ZU2OH(8-(O!%$J#[.P^48X"G%`"0G4Y84D\VU&]0V/+;N/]ZG[=3_
M`.>MK_WZ;_XJIK3_`(\X/^N:_P`JA,]R-76V_=>0T3/T.[@@>N.]`!MU/_GK
M:_\`?IO_`(JC;J?_`#UM?^_3?_%5<JEJC3I;(UO.86,T:$A0V0SA3U^M`"[=
M3_YZVO\`WZ;_`.*HVZG_`,];7_OTW_Q56QD``G)]:1]VQMF-V.,],T`96H:3
M<ZFL:W4EN1$6*[5=>61D/1O[KM^=4T\*)%"D48@39*LH=?,#[E&!\V[/`K8T
MZ>>XM/-N/+WEV'[L$#`)'?Z5;H`YV+PP8O((DC8V_E;"QD)_=EBG\7.-[5)!
MX>:WU#[>GV;[1YCR!F5SAG^]CYN*U(YKAM2E@;R_*2-7&`=WS%A_[*:M4`<?
M_P`(%%%?)>6TD,,PNEN6.UF#,I)'!8]S4]OX*MH+E[AH;29W!4B5&90"<XQN
MQQ6_J,\UM8R3P;"\8SAP2"/PJPF[8N_&['..F:`,"+PTT%O%!`UO'%'/YP4*
MY^;S!)W;IO`/X`5J[=3_`.>MK_WZ;_XJK9R0<'!]:J::UP\#M<3>:?-=!\H&
M`K%>WTH`-NI_\];7_OTW_P`51MU/_GK:_P#?IO\`XJKE9XBSKSOYDG$"L%WG
M;DEATH`DVZG_`,];7_OTW_Q5&W4_^>MK_P!^F_\`BJN50U=&:UC*RRQ'SXES
M&Y4D,ZJ>GL30`_;J?_/6U_[]-_\`%5D>)99Y/!7B5+@QEHK*X0&,$`CR-W<G
MUKHE&U0N2<#&2<FN=\3_`/(H^*_^O2?_`-)Q0!T=%%%`'->'O^1O\6?]?5O_
M`.DT=6IM6G7Q9:Z:A3[/+"78$C=D;^W7'RBJOA[_`)&_Q9_U]6__`*31U)!;
M77_"6/<W<,+C&()"X#1I\_0#KG/>@#9OXIY]/GBM9?*G>,B.3^ZV.#6=;P7,
M&LZ>MS<^<ZV$JMQ_$#"&.>IR>:T[NZBLK26ZG;;%"A=CCL*SDO;>\U^S,$F[
M-C*_3LS0D?I0`NNZZNB)`3;M,9F(`#;<8%4O"^O"^6+3C;&)X+8?-OR&V[5/
M\ZI?$!S'%8,%W8:3/..,"LSP+?12:S([O&B_9FP3(.?F2ME"/L^;J1=\UCO;
MNY6SLY[IP2L,;2,!U(`S_2N7M?%T#:L[&TD5;DQ1`[AP<D?^S"MG7+RV;0-1
M"W,))M90!O']TUYC9WZG5;>-IH<I<1EP,\#>*5.$9)MA)M-6/8ZXS6O$U[!K
M;6\4$!2RGRI;.6S'CGG_`&S^5=*=9TX'!N1G_=/^%>9^(]3L1XDO6,S$2S#:
M5+#^!:*2BY6D$VTM#TO1;]]3TF&\E14>3<"%Z<,1_2LOQ7K%[I<EFEI(J><)
M"Q*@]-N.OU--\*ZK8Q>'K6)K@!@9."#_`'VK*\>7=E.VGOYR,BK*2=V,<I2@
MDYV')OEN:'@W5+N[::SN)`\=M#&(\*`1U']!6UKL\EMH-]/"Y22.!V5AU!QU
MKD?A_<V2W=](DT:H\4>"7Z\OZUT7B2_LSX<U!!<(2UNX`!Z\4324[((M\IR>
MF:IJ"ZK;_P"FSL)[J+S`7)#9*J<_@*](KR#2KVQ;6;39-S%=Q;LL>/G6O5EU
M"S89%S%^+8JZZ2EH33O;4Y#4_%6H+JC1QP6VRSN7V;MV6P&3GGWKK-)O'U#2
M;2\D55>>)795Z`D=J\PUBYMAK=V&N@#)=2;0&X/SFO0_#5Q!_P`(YIR">,L+
M9!C>,]*52,5&+01;;=S/\8ZI=6?E6<#JL=U#()"5!/8?U-3>%=9O-5DNTNV5
MO)$94A0.N[/_`*"*RO'\JQ7M@S`D>5)T'NM2>`'$DVHD*P^6+J,=WI\L?97Z
MA=\]CK;N[@L;5[FY?9$F-S8Z9./YFL?2_$&F7&I7,$5SF2YN`8AM(W8B7_XD
M_E4OBT[?#5T>>#'T_P!]:XGP],K^)=.`5A^];J/]AJF$%*#EV&Y--(]%U#_C
MV3_KO#_Z,6J^OW\NFZ//<P%1(F-N[@?>`/Z9JQJ'_'LG_7>'_P!&+5'Q-!<W
M.F)%;JCJ9E,J.0%9>>#G_:VUD67M+N'N])L[F0@O-`CMCIDJ":S[^TOQ%K,K
M7F()81Y"`9\L!#N'/J:T=.01Z;:HL:1A844(C;E7`'`/<#UJEJ>JV?V/5+<R
MXDMH=L@P>"ZDJ/RH`T+3_CS@_P"N:_RK$;Q+HW]JQS_;D\H6[@MM.,[E/I[5
MMVG_`!YP?]<U_E7B<MVT<0MVF8$PYSL&/NUI3@I7N3*5CW*N:\0>)(K2X:P^
MSN[Q2Q.S`X'#*_\`(5LQZM82MM2Y3/OD?SKS[Q9>HOB.Y*%'4[,,)!_=6BE%
M2E9A-M+0[W1]6CUBT:XBC:,)(4*MZX!_J*75]7@T:U2XN$D=7D$8$8R<X)_H
M:R/`C,VC3EEVDW)XSG^!*/';;-'MFP3_`*4.@_V'HY5S\OF%WRW)?#GB"VOW
M^P1Q3)*JR2Y=<#&__P"R%;LTJ6\$DTAPD:EF/L!DUP?@B42>(WPK#%I)U&/X
MXZ[35_\`D#7W_7O)_P"@FBI%1E9!%MJ[,1/%^F#4992LX1XHU!,?<%R>_N*Z
M>O'WFRC#RY!D=UKV"JJTU!JPH2<MS%\0:S86=O-93S[9Y(=RI@G()('\C5_3
M]3L]4B>6SF\U4;8QP1@X!_D17%>.)HXO$:!VQFSC_P#0Y*U?`$BR:=?,AR/M
M/_LBTG32IJ5P4GS6.CO;ZUTZ#S[N811[@NX@]3]*SM&UO3;H_98;I7F>65E3
M!Y&]CZ>G-5?'#!=#0L<`7"<_@:YSPI(C^)+4*P)^?H?]AJ(TTX.0.5I)'HU<
M^OB71O[3>?[>GEF!0&VMC.YCZ>]=!7C8=/[-`WK_`*GU]J*5-3O<)RY3V2J6
MJLHM4!8`_:(._P#TU6KM>=>+!O\`$EP&+$!8\#<>.*F$.=V'*7*KGH@((R""
M/:N=\3_\BCXK_P"O2?\`])Q2^"<_V-*,DXN&QDY_A6D\3_\`(H^*_P#KTG_]
M)Q4R5FT-.ZN='1112&<UX>_Y&_Q9_P!?5O\`^DT=12HX\=V\<\GF>9$6`VGY
M%!<J,_5<^]2^'O\`D;_%G_7U;_\`I-'2G;8^*4-Q=PAYG)5=K;V5MRJ,].H_
M2@#HI(TEC:.10R,,,I'!%4'18]=LD10JK9SA5`P`-T-79Q*8'$)42;3LW=,^
M]9%I#>PZOIRWMPLL@T^17PO\8,.XY[Y/M0!F>/E#16(894M(#^0K*\#6-F-6
M>-;>-HQ;,0"H(^\E>@20Q3*%EC20`Y`90:I:)!#%H]FT<2(S6\>2J@$_**T5
M3W.6Q/+[UQ-0TBVNM-NK:*VMTDFA=%8QC@D$`]*XVR\%W::N/EM%,#Q22,,\
MKNSZ?[)KT.J5O_R&+S_KE%_[/4QDXZ(;29<`"C```]J\S\1(C>);\NJDB88R
M/]A:]-K,U&RM);ZQ>2UA=GN"&9HP2W[I^OY"JISY'<4H\RL0^%`#X:M@1D9D
MZ_[[5A>/+6W,VG@P1X99<_*.>4KM(XTB0)&BHB]%48`K'\0Z`^MM;,ET(#`'
M'*;MV[;[_P"S1"24[L)+W;(YWP'8V@O;U/LT158H\`H#CEJZ3Q%:VZ>&]1*P
M1J1;/C"`=JJ>$]$?3H3?/<B4WD$9VA,;>I]>?O5O7%O%=VTEO.F^*52KJ3U!
MZT3DG.Z"*:C9GEVFV\*ZM9D1(-UW%NXZ_.M>GFRM6^];0GZQBL?3_#NDI?W,
MBV@#6]RIB.]CMPB,._J2:WZ=6:F[H4(\J/)]5L;5M8NR;>/*74FWY1Q\YKO/
M#^GV<OAO3R]M'DVZ$D+@]/456U+PO82ZC!+OG4W5RWF!7&.4=CCCU%;]G:QV
M-G#:PY\N%`BY.3@"B<U**2Z!&+3;.$\>:19FXM(51E5XI,X=CW7U-2^!=/7S
M+Y([BXB54B^X_7E^N16IXQTJ[O/*O+=59+6&0R`M@]CQ^1J;PKHUYI+W;W80
M><(PH5L_=W9_]"%5>/LK=16?/?H)XILI(_#URR7L[8*9$A#`_.M<=X5BN8O$
MMG]HF$NZ<[<#&!Y;5W?BSCPU='T*?^AK7%^'I$?Q+IP5@3YIZ?[C55.WLY"E
M\2/0]0_X]D_Z[P_^C%K-\7B0Z!*RR;45E+C!.X9``X]\?E6EJ'_'LG_7>'_T
M8M4_$D>_35D,D<<<4@9S(I8$8*XP/<BN8U)]"`_L*Q<#!D@1S@8Y*@GCM3M1
MAC33K^58U5Y(&WL!RV%.,T:/+'-I%J8YEF"Q*I=>C$#!/-5=4AU!H-4<7$:6
MYM@(1MW$$!]^1QUR/RH`T;3_`(\X/^N:_P`J\A.W[`1CYO)].>E>O6G_`!YP
M?]<U_E5%K.U_MN(?9H<?9G/^K']Y:TIU.2^A,H\QHR0Q3+MEC20>C*#7FGB[
M3;.;7KF-H$"*4("C;_`OI7IU<?XC\/7ESJ,E]#+!Y<KQ)M<D$$E4[#\:=*45
M*\A33:T%\&:59S:5.TD18BX(SYC#C8OO3?&VE6D6DP>4C(6N`I(=CQL?U-;?
MAS29]'L)(+AXW=Y3)F/.`,`=_I1XBTF;6+&*""1$>.829?.#\K#M]:5U[2_2
MX[/EL<7X'TT1:XT275PH^S2-D/S]^/CI79ZKIY72+P_;;HXMWX+C!^4^U9GA
M;0;FRO3J$TL10Q20A4))SO'/(_V/UKH=0A>XTVZAC&7DA=5&>I((%%1IRNM@
M@FEJ>0-:7*S22?:V,97`0CI7K/V&[/74I/P05PO_``C>M/*\`L<.$#']ZG`.
M0._L:])K2NXMKE9---+4\T\;V-PVM",7TF[[+&=^/]J3BM;P-;7G]GW8BOMF
MVX`.8@V?D7WJQXLT.]N[YM1@:'RH[=48.Q#9#,?3_:%:7A?2+K1[2XCNVB+R
MS;QY9)`&U1W'M2<H^S2Z@D^>YF>,[:]&BKYM\LBF=?E\@#L?>N9\'VE\FO6X
M:ZC60E\,(@<#:U=]XDTNXU;3!;VS1K(LJO\`O"0"!GT^M8GASP]?VVIQ7LS0
M>5$TBD*Q))&Y/3UHA**IM/<;3YD=']EU'_H)+_X#C_&O&ULKD1>9YL9A\D':
M4YSMKW*O)QI6I?9OLW]G77FB$97R6],>GJ*='EUN*I?2QZ3G5_[MD??<_P#A
M7G7C%M1'B"8^4#(?+#")_E`QUYKU2O.O%KJGB6YW'&5CQG_=J:/QCG\)T/@4
M%=#D!))^T'D]?NK2^)_^11\5_P#7I/\`^DXH\$$-HLI'0W#?^@K1XG_Y%'Q7
M_P!>D_\`Z3BHG\3*CLCHZ***@9S7A[_D;_%G_7U;_P#I-'4SK-/XO4W-BB01
MQ[896VMYC#+<9&1C/&/0_A#X>_Y&_P`6?]?5O_Z31UTM`$5S<1VEK+<R[O+B
M4NVU2QP/8=:SQ=P7'B*T6*56864S%>X!:$C([5I2Q1SQ-%-&LD;C#(XR&'H1
M5*1537K)5`51:3@`#``W0T`:%4](_P"0+8_]>\?_`*"*N53TC_D"V/\`U[Q_
M^@B@"Y5*W_Y#%Y_URB_]GJ[5&W_Y#%Y_URB_]GH`O53O?^/O3_\`KX/_`**D
MJY5.]_X^]/\`^O@_^BI*`+E%%%`%/2/^0+8_]>\?_H(JY5/2/^0+8_\`7O'_
M`.@BKE`%.R_X^]0_Z^!_Z*CJY5.R_P"/O4/^O@?^BHZN4`4[W_C[T_\`Z^#_
M`.BI*N53O?\`C[T__KX/_HJ2KE`%/5_^0+??]>\G_H)JY5/5_P#D"WW_`%[R
M?^@FKE`"$`C!&15*QC07>H$(H(N!CC_IE'5ZJ=E_Q]ZA_P!?`_\`14=`#M0_
MX]D_Z[P_^C%JGXF-R=%D2ULQ=N[`%#T"YR3[]/UJYJ'_`![)_P!=X?\`T8M6
MJ`*NFQQQ:;;K$%"^6IR@`!R.O''-5=5U&U2QU&"23RVA@^8N"H^93MP3UZ'I
M6I5'488H].OY4B19)8&WN%`+84@9/>@"Q:?\><'_`%S7^50/_P`AR+_KV?\`
M]"6I[3_CS@_ZYK_*F?8@=0%X9Y=P0H(_EVX./;/4`]:`+-4]4_X]$_Z^(/\`
MT:E7*IZI_P`>B?\`7Q!_Z-6@"Y1110!3TK_CP7_KI)_Z&U7*IZ5_QX+_`-=)
M/_0VJY0!4C_Y"UQ_UPB_]"DJW52/_D+7'_7"+_T*2K=`%/5O^05<_P#7,U<J
MGJW_`""KG_KF:N4`%5-._P"/9_\`KO-_Z,:K=5-._P"/9_\`KO-_Z,:@"W5-
M?^0S)_U[I_Z$U7*IK_R&9/\`KW3_`-":@"Y5'545K5"5!/VB#DC_`*:K5ZJ>
MJ?\`'HG_`%\0?^C4H`MA0HPH`'M7.^)_^11\5_\`7I/_`.DXKHZYSQ/_`,BC
MXK_Z])__`$G%`'1T444`<UX>_P"1O\6?]?5O_P"DT==+7->'O^1O\6?]?5O_
M`.DT==+0!#>+</9S+:2+'.4(C=AD!NU91EELM5L)-4O+<`64B,Y&P&3,6>2<
M<D$@8%;=(0#U%`%%]7TMT91JMJA(P&6=,CW&>*AL=0TFTLXK=-9MYDC4*C//
M'G:!QTP*I)XAODDF2;0+U]D[HC10G#(&`#<^HR?PJ*+Q%=V[-"/#5\((T3RA
M'"<XV`XZ=CQ^%`&U_;.E?]!.S_[_`*_XU!'?Z#'<R7$=[8+.XP[B9-Q^O--U
M&^U"W2TDM--,PFP)%(^:(DKU]L%L_0>M5;?69Y+^)5T"[A6>0)-+)$1@8."<
M9X&`/Q].:`-/^V=*_P"@G9_]_P!?\:JW=]I5S+;O_;L,!A<LHCGB^8[2.=P/
M8FIDO+J317O!8E+E5=A;L#D[2<#H#R!Q]:R[C6M0BM@TOAZXFNHPS1B.,E5<
M!UZ^^T_@Z^M`&Q_;.E?]!.S_`._Z_P"-,EU;3)(RBZO;1$]'2=,C\\C]*+.]
MFN;ORVLWBB-NDH9T8$,2<J<C&1QQUJE)K&HV]]+%+HT\D*/M1X4SN^8\]?[N
MT_7([9H`LV6HZ1:64-NFL6TJ1H%5WGCR0.G3`Z5/_;.E?]!.S_[_`*_XUG6N
MK7)MRD>C3P"*6"..-H6&8V"[B.,#:-WY<XR*M:E=W]M>6\=I8"XBE^^X'^K.
M0.?^^@?HK>E`#;:^TJ"XN)1KD$GG/N9&GBPIP!QC!Z`=35G^V=*_Z"=G_P!_
MU_QK.LM9FFU%(O[!N[>.?+22R1$?-M7&?PXY[BK?VV\;1S>#3F2X5SFW89;:
M'P<8ZG:,CUXH`CN;[2I[FWE.NPQ>2^Y46>+#'!'.03T)Z&K7]LZ5_P!!.S_[
M_K_C6-)KE^+9'E\.73W48W`+&2H?:V<'\QGW_/7L[JXN;J19+0Q0>3&Z,5()
M9LEE.0.G']<=*`(;_4M+NK">W_MBSB$J%2YF0X!'/?TJ:/6--6,"35;-W'5A
M,HS^&:RY-7U!4GBO=!FFC^9,0)N$@PP[]CL/X,OK5BVUB\GCB9]'N(B]V87#
M(?D3G#\]NG/U]@0"]_;.E?\`03L_^_Z_XU5L]1T^&:Y>36;"0S2!R$D5=IV@
M8^\>P%&IZA?V5ZB0::US;E0S/&N6&-V1UZ_<Q]3Z5!9ZM<SZAY":)<6RSJS-
M--&0N\*N,D#\/P]>*`+5UJ=A<1QQ07UM+(T\6$256)_>+V!K4JO8O-+902W,
M2QS.@9T`QM)'3FK%`!61?PZF8-6)N(C`\/\`HZ>66*#8=X.,9)/3FM>B@#-M
M=8TM;2%6U*T!$:@@SKQQ]:D_MK2<X_M2SSUQYZ_XU!K&I76G36_V?39;R-PY
ME\I"Q7&W'3UR?RK/;7KIKB%X_#EZKMA7=X3\J'/I[@?G0!L?VSI7_03L_P#O
M^O\`C45QJ.@W*!;F]T^5000))48`]NIJ+3M5NM3L[B0:3/9S1I^[2Z7:'8@X
M'TR!GZU476;R2-5O/#]T2SAE"19"C<I4GW`()]"I_``U!K&E``#4K,`=O/7_
M`!I'UC2V1E75;121@,)TX]^M1:7J-S?1V;3Z=);&:!Y)0ZL#$ZLHVG([Y)'T
MJO=ZKJ-IJ$T?]D27%LG*O"A)?[F/U9L^RT`36&H:5:6WE?VU;3C<6#--'GDY
MQQCOFK/]LZ5_T$[/_O\`K_C65!K-W]GNA%H<\`@53"DD+?/D@$?*#SR3Q^O-
M:&KW5[91Q/96(N]S$.H'(`&<C\`1]2M`$<>I6"ZC+.=9L"CQJOEB10P`+$'.
M[W/:K/\`;.E?]!.S_P"_Z_XUF?VU<K?1)_8-T"\HAFF\H[0H+@,,9XR,_1JT
M[&>>[MY'DM_(=975-Z$;E!X;!P>10!6U#4M-NK.2!-8L8MXP6:56P/\`OH58
M76=,"`/JED6QR1,H!/TS62-:U!K?%]X>N'W\;(H\@$!2<Y[9.!_NGZ5<LM5O
M+E;'S-)FB,\KI,64@0A5)!.>Q(`';GKGB@"T=9TO!QJ=F#_UW7_&J]CJ.G6T
M3(^M64V79@1(BX)8DC[Q[DTR_P!2U"SU!XX]+>XMECWB2)223@G;CU^5OS7U
MJ"+6+QGNH8-#G@V0M+$9HV"O)O;()`/7@_B:`-/^V=*_Z"=G_P!_U_QJO]MT
M/[<;O^T[?S]H4_Z9QCG'R[L>O:C4+Z_MM,M[JVT\SRL`98=OS+\I/0=\@#\:
MI-K=W'=!1H%WO,@BEE\H[2H)&1C/&23]#0!J_P!LZ5_T$[/_`+_K_C4%W?Z'
M=QJEQJ-H55@1BZ"\YXZ'UJ6TN;FZAO"UF;>2&:2*$2CB0#[K_0_Y]:RTUJ]D
M@C^V>'KHEV!V)'G9AE*D_P#?0^A5O2@#576-)50HU.TP!@?Z0O\`C6-X@GAN
M?!OBJ6"5)8S:3X9&#`_Z..XK0TZ_O[Z.QEDT_P"S+,C&X25&#1D?7U./P^E,
M\8@#P1KN!_S#;C_T6U`&U1110!S7A[_D;_%G_7U;_P#I-'72USPT+5[76]3U
M'3=5LHDU&2.1HKBP>4H4C5.&65>NW/3O5C[+XI_Z#.D?^"J7_P"2*`-FBL;[
M+XI_Z#.D?^"J7_Y(H^R^*?\`H,Z1_P""J7_Y(H`V:*QOLOBG_H,Z1_X*I?\`
MY(H^R^*?^@SI'_@JE_\`DB@#9HK&^R^*?^@SI'_@JE_^2*/LOBG_`*#.D?\`
M@JE_^2*`-FBL;[+XI_Z#.D?^"J7_`.2*/LOBG_H,Z1_X*I?_`)(H`V:S=6U@
M:4T&Z'S$E;#$/@KRHZ=3RWTSC)&:@^R^*?\`H,Z1_P""J7_Y(IIL_$[$$ZOH
MY*G()TF3C_R8H`JCQSILD<8@CDDG?RCY!(#;7D"9'8D$]._TY&B=9#BS>"#?
M#>@B&1FQEN"!@`\%=S9]%]ZK-IWB1D*G5='`(_ATJ4$<8X(N.*<MEXG1%1=7
MT@*HPH_LJ7C_`,F*`&)XNL))K:%%=GG"8P,`;B@!YQD?/^G3TWJPETWQ$N-N
MIZ*,=,:1)Q_Y,>P_*I/LOBG_`*#.D?\`@JE_^2*`-FBL;[+XI_Z#.D?^"J7_
M`.2*/LOBG_H,Z1_X*I?_`)(H`V:*QOLOBG_H,Z1_X*I?_DBC[+XI_P"@SI'_
M`(*I?_DB@#9HK&^R^*?^@SI'_@JE_P#DBC[+XI_Z#.D?^"J7_P"2*`-FBL;[
M+XI_Z#.D?^"J7_Y(H^R^*?\`H,Z1_P""J7_Y(H`V:*QOLOBG_H,Z1_X*I?\`
MY(H^R^*?^@SI'_@JE_\`DB@#9HK&^R^*?^@SI'_@JE_^2*/LOBG_`*#.D?\`
M@JE_^2*`-FBL;[+XI_Z#.D?^"J7_`.2*/LOBG_H,Z1_X*I?_`)(H`V:*QOLO
MBG_H,Z1_X*I?_DBC[+XI_P"@SI'_`(*I?_DB@#9IDT@AA>4XPBEN2!T'J>E9
M/V7Q3_T&=(_\%4O_`,D4GV7Q3_T&-(_\%4O_`,D4`54\:V$;*E[&]NY**<?,
M`68K@]#D%3GC'H35O3/$4>K0R_9+<F95D>-&<;7"NR+\W;)7TXSW[L%AXE&,
M:KHPQTQI,G'_`),>YI$T[Q)'(SIJVD`L`/\`D%RX`'H/M&!^%`"MXGAMX4DO
M8?(S(T3JK%RKKG<.@XZ$'C(.:N:1K$&L1320*5$+A#GOE%;([XPW<"J;6'B5
MR"^JZ,Q'3.DR''_DQ2I8^)HUVQZMHR#T729!_P"W%`&W16-]E\4_]!G2/_!5
M+_\`)%'V7Q3_`-!G2/\`P52__)%`&S16-]E\4_\`09TC_P`%4O\`\D4?9?%/
M_09TC_P52_\`R10!LT5C?9?%/_09TC_P52__`"11]E\4_P#09TC_`,%4O_R1
M0!LUC>,O^1)UW_L&W'_HMJ/LOBG_`*#.D?\`@JE_^2*JZGHWB35=+N].GUK2
9UBNX'@=DTN0,%92IQFX/.#0!T=%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g118721mqi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mqi003.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`#5`5X#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#U)IM7FO+I
M+9K)889`B^8CEON*QS@XZL:7;KW_`#TT[_OV_P#C4]E_Q]:A_P!?`_\`14=7
M*`,S;KW_`#TT[_OV_P#C1MU[_GIIW_?M_P#&M.H;JZBLXA),6"E@@VJ6)).`
M,"@"EMU[_GIIW_?M_P#&C;KW_/33O^_;_P"-6/[2A_YXW7_@-)_A1_:4/_/&
MZ_\``:3_``H`K[=>_P">FG?]^W_QHVZ]_P`]-._[]O\`XU8_M*'_`)XW7_@-
M)_A1_:4/_/&Z_P#`:3_"@"OMU[_GIIW_`'[?_&C;KW_/33O^_;_XU8_M*'_G
MC=?^`TG^%']I0_\`/&Z_\!I/\*`*^W7O^>FG?]^W_P`:-NO?\]-._P"_;_XU
M#J]Y/<6!BL#=P3F2/]X+9_E4."W4?W<UC177BR!)(E>.90\ICDFM9=Y&7*9P
MN.Z#V&>M`&_MU[_GIIW_`'[?_&C;KW_/33O^_;_XUCZ?=^)8KL"[9);<R2,W
M^BR[@#DJ!\O0'%0V]YXKDM)(YF2)C$`C?9)"X;!R>F,YQ0!O;=>_YZ:=_P!^
MW_QHVZ]_STT[_OV_^-9&D7&M6U\@OWN9[<*0[&!SDA4`(`48)8,?Q^E;_P#:
M4/\`SQNO_`:3_"@"OMU[_GIIW_?M_P#&C;KW_/33O^_;_P"-6/[2A_YXW7_@
M-)_A1_:4/_/&Z_\``:3_``H`K[=>_P">FG?]^W_QHVZ]_P`]-._[]O\`XU8_
MM*'_`)XW7_@-)_A1_:4/_/&Z_P#`:3_"@"OMU[_GIIW_`'[?_&C;KW_/33O^
M_;_XU8_M*'_GC=?^`TG^%.BOX99EB"S(S9V^9"R`X]R*`*NW7O\`GIIW_?M_
M\:-NO?\`/33O^_;_`.-:=%`&9MU[_GIIW_?M_P#&C;KW_/33O^_;_P"-:=4D
MU6VD!:-+AUR1N6W<@X.#SCVH`AVZ]_STT[_OV_\`C1MU[_GIIW_?M_\`&K']
MI0_\\;K_`,!I/\*/[2A_YXW7_@-)_A0!7VZ]_P`]-._[]O\`XT;=>_YZ:=_W
M[?\`QJQ_:4/_`#QNO_`:3_"C^TH?^>-U_P"`TG^%`%?;KW_/33O^_;_XT;=>
M_P">FG?]^W_QJQ_:4/\`SQNO_`:3_"N=UA]:FO9GTVYO8HF6,(I@8!3^\WG[
MF<<Q_D:`-K;KW_/33O\`OV_^-&W7O^>FG?\`?M_\:R7N=:-U$2;CRQ]GWF.%
MP/E9S*<%,_,I08]CSQS&)=>DTR>$W%S%<M;6Z1R_9F;;(O\`K6^[WH`VMNO?
M\]-._P"_;_XT;=>_YZ:=_P!^W_QK!U35O%4-S=/8VPEMOD$"_9)#)T7<3G`/
M.[\*F:_\2?VE<"%5%J6/EF6UD)'/'0=,8_'-`&QMU[_GIIW_`'[?_&C;KW_/
M33O^_;_XUA6\GB*&[62:YFFB,N646SCY3*AP!MZ!`X'/\0KI?[2A_P">-U_X
M#2?X4`5]NO?\]-._[]O_`(T;=>_YZ:=_W[?_`!JQ_:4/_/&Z_P#`:3_"C^TH
M?^>-U_X#2?X4`5]NO?\`/33O^_;_`.-&W7O^>FG?]^W_`,:L?VE#_P`\;K_P
M&D_PH_M*'_GC=?\`@-)_A0!7VZ]_STT[_OV_^-8GB/7M?T+[-@:=)YV[K')Q
MC'^U[UT1U.$`DQ70`_Z=I/\`"N5^(+K(FFNIRK"0@^WR4`=59?\`'UJ'_7P/
M_14=7*IV7_'UJ'_7P/\`T5'6;X>F:XN)Y7AN8G*@L9C_`*S/<#<?Z8S0!O5G
M:S_J;7_K\A_]#%+JMW?VOD_8;7[1N)W\'Y1CZU2NY[V>TM&N;9(3]MB!&XY'
MS#&!CGG/IT_"@#=HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"JE
MU_Q^V7^^W_H!JW52Z_X_;+_?;_T`T`6Z*P=7E9M;MK8PW+J0A#QG"QDL1DG<
M.>/0UM3,Z02.B[W5257&<G%`$E9^A_\`(*C_`-^3_P!#:H+"_P!7GD"W.GK$
M-N<DE1G'X]_\\<S:%G^R(MP`.^3(!S_&U`&C1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`1S_P"HD_W3_*N(\;_\>.C_`/7)_P"25V\_^HD_W3_*
MN(\;_P#'CH__`%R?^24`=?9?\?6H?]?`_P#14=87A,/]NNLW?VA$0*C`\-SC
M*\#C@5NV7_'UJ'_7P/\`T5'5#298'UO4((X)%-OA=[7!=3G.0%/W<8'YB@#;
MK.UG_4VO_7Y#_P"ABM&LW5W5X+4JP8?;81D'/(<9H`TJH7NKV]CJ-C8RAS)?
M,ZQD#(&T`G/YBK]86L>)[+2?$&E:5-"TDU^S!7`_U7`P?Q)QQZ&@#=HHHH`*
M*Q;?Q-:7'BFXT!<>=#%OW[Q\QXRH'KAOKP>!WVJ`"LS2+EYYK]6N3-Y=RR@%
M2-@R>.?R_"M)F51EB`/4FN?\-:_)JUYJD,\$<`@NBL!4$&6/^%CGN1@_C0!T
M-%%07UTME8SW3D!88V<Y.!P*`)Z*Q/"&O'Q)X<M]2<(LKEUD1/X2&(`ZGM@_
MC6W0!'//%;0M-/(L<:]68X`IZL&4,I!!&01WK)\1ZK8:=IDINRC_`'?W6\@]
M<Y^4%@!C.0.U6],OK2^LHI+1D";%/E@C,8QT('2@"Y117,^)_%;:/+8Q6/V:
MX>6[6.Y#3H#&G\1P6&#[G@=Z`.FJI=?\?ME_OM_Z`:F@N8+J/S+>:.5,XW1L
M&&?3(J&Z_P"/VR_WV_\`0#0!A:\&_P"$FT\I=;26AW0@\X$A^8\=#DCK745B
MZ])!%=:>LD,DC7$ZP_)<&/@D=0/O`9)Q[5M4`%9^A_\`(*C_`-^3_P!#:KV]
M0X3<-Q&0N><51T/_`)!4?^_)_P"AM0!H45E>)=2;2O#M_>1.1-%;NT6%W'=C
MCCZT>&M3.K>';"\D?=-+`K29&#NQSQ]:`-6H+J[@LHQ)<2"-2VT$^O\`^H$_
MA4]9/B'4[32[..2[MUN%>4*L9`//KS^0]R.G6@#6HIJ.LB*Z,&5AD$=Q3J`"
MBLC4]:ET_6--L4L)9TO&823(K8AP..@YSSWXQ6O0`44576^MWNC:JY,PZKL;
MCKWQCL:`+%%%%`!17/>&;]KN[U9'N1+LNW\L;LX3)QCD\8Q[=..YZ&@`HJ*Y
ME,%M+*%+%$+``9R<51\.ZE-JVC0W=P@29BP8!&4<$XP#STP:`+\_^HD_W3_*
MN(\;_P#'CH__`%R?^25V\_\`J)/]T_RKB/&__'CH_P#UR?\`DE`'7V7_`!]:
MA_U\#_T5'69H/F/J=[<RJZFZ"R*#"R8'H2P&XCCGI]*T[+_CZU#_`*^!_P"B
MHZHZ7]O_`+;OC=-B!L>2IF#8]0%'3%`&U6)?Z;:VD-H8XP66]AVLW)'S*,`_
M0`?A6W6=K/\`J;7_`*_(?_0Q0!HUP>M^!]&?Q#I6R)(HI7?S(MF=V`#QZ=?\
MXKO*:41F5F4%E^Z2.10!0M?#^DV=LMO!80+&F<#8#WS3I=#TR:!X7LH=KJ5.
MU0#@^]7Z*`.#M_!/A<^*[BW6*Y-PD0D=2<)M.!@'KW'Y>QKKUT?344*+&#`&
M/N"K0CC$AD"*'(P6QR1Z9I]`&;=>'='O(O*N--MW3.<%!UK!T/P1H,%Y<S'2
MF#13`(9X@`=IX9>!Z9_*NPHH`I_V3IW_`#Y0?]\"J.K>$]&U>U:&>QA#;6".
M$&4)[BMJFNNY&7)7(QD=10!R_ACP#I/A^Q1)+>&YN@6W3,G8GH/PQ6]_9.G?
M\^4'_?`I^GVGV"QCMC*TNS/SL,$Y)/\`6K-`'->(?!>EZO:/Y=C"MR<`.%`)
M'<=/0G\<5:TGPII&EVB(MA;F4HHD?8/F(_\`UFM._M?MMG);^88]^/F`SC!!
M_I4L2>7$B;BVU0-S=3[F@"K_`&/IO_/C!_W[%<[KW@:RO;BVGL+"S1Q/NF+K
MC(/4\5U]%`%:QT^TTV`P6<"0QEMQ51C)]?T%-NO^/VR_WV_]`-6ZJ77_`!^V
M7^^W_H!H`S-;\R;5]/C"-L@ECE)$+/DLV.H!"XQG)['M6]6-K?VXWNG_`&4E
M8A.IF/G!-R[AG@]<#/'O6QU&10!7FL(+BX$TJ;SMVE3T(Y'3_@3?G5?05":/
M$J@!0T@`';YVK1K/T/\`Y!4?^_)_Z&U`&5XXT.SU+P]J%T]LKW<-HYB?`W<`
MD#Z9J'P=X7TNU\.:?.]A$;F6V1I&=!G)`)%=//#'<P202KNCD4JP]0>M$$,=
MO!'!$NV.-0JCT`H`K'1[`]+=5_W>*XCX@>#H'LX[W3H&>YDN8UD#3,!MZ<<@
M#H/SKT2J]Y90W\(BG#%0V[@X[$?R)H`R]*\*6&D6WDVTMVF[!?;=2`%L8SUJ
M]_9,7_/S>_\`@5)_C5ZB@#SK6/`6-?TU;**YEM)'8W$GF_<^N:["PT/^S;-+
M2VOKA8H\[02#C))]/4U8N[:\EO[.6WN1%!$6,R?\]`0,?U_.KM`&=<:4]U;2
MV\M_<&.5"C@8&01@]J\\MO!"-\1;C393<_V:EF)E;<PR<@`;L]>3^1KU2J:W
MD3:PUGY)$BP[_-QP1GIG\?YT`1IH\*($%S>X``'^E/\`XU'=>'[.]@,%Q+>/
M&V,J;J3M^-:E%`'FO@CP?`-5UF2Z>Z_T6^:.V/G,I*JQPW!]OYUW@TF(?\O-
M[_X%2?XU:CABA+F.-5+MN;`ZGUJ2@#G/$'A2PU'3Y'FDNI)((W,1>YD(4X],
M^PK(^&OA^TCT*SUAU;[4_F!3YC8`!*\@GGI7<2*7C90<$@@'&<55TFR;3]-B
MM7*DQYY4<<DG^M`%B?\`U$G^Z?Y5Q'C?_CQT?_KD_P#)*[>?_42?[I_E7$>-
M_P#CQT?_`*Y/_)*`.OLO^/K4/^O@?^BHZQ="TZ=M:GU.\C@C>X02QI$[$KG(
M^;/M_GTVK+_CZU#_`*^!_P"BHZFAM+:V:1H+>*)I#ERB!2Q]3CK0!4U*[OK=
MT6TM6ER>25R",=1CICWQGM5*\N+Z:WLS<V@B)O8MWS?=^9?SY)&?;/>MZL[6
M?]3:_P#7Y#_Z&*`-&BBB@`HHHH`****`"BBJMG8K9O<.)YI?/D,A$C9"Y[#V
M_P#K4`6J***`"BBB@`HHHH`****`"JEU_P`?ME_OM_Z`:MU4NO\`C]LO]]O_
M`$`T`8_B&SN-2U2SA5(1;VSQRR2.Q#?,^W"@#T'>MR7-K:!8(V;8H50.2!Z^
M^/SI9+2VFFCFEMXI)(CF-V0%D^A[5-0!D65_JTS$3V&T;<CJN[@^O3D#_OKV
M-3:"2='B+#!+/D>GSM6C6?H?_(*C_P!^3_T-J`-"BBB@`HHHH`****`"BHI+
MF&&:*&20*\V0@/?'_P"L5+0`445"+J`W1M1(#,%WE.^/\D?F*`)J***`"BBB
M@`HHHH`CG_U$G^Z?Y5Q'C?\`X\='_P"N3_R2NWG_`-1)_NG^5<1XW_X\='_Z
MY/\`R2@#K[+_`(^M0_Z^!_Z*CJY5.R_X^M0_Z^!_Z*CJY0`53U*UEN[=%@=%
MDCE212X)'RL#@XJY10!GXUG^_8_]\O\`XU'OUIFC\LV#HV<L`^!^M:9Z5C6O
MA][6XMI%OI62+;N3H&P,`X_`?J:`+0_MDC(>P/\`P%_\:1CK"C+26`'J5?\`
MQJW:V_V:$Q[R^7=\G_:8MC\,XI+NW^U6YBW[/F5LXST8'I^%`%/?K0=MS6`C
M50P<A\=\]^V!^=/']LD9#V!!_P!E_P#&H;+1&M&<-=R31LA4*_;(`Z>V#^=:
MBJ$0*HPJC`%`%`G5PP4R6`)Z#:^3^M-5M;W.'-@H#84D/\PP#GK]?RJ34M,_
MM!T87#0E$905'/)4YS]5'YFJQT)I=-%G+>RDAI"9`?F.Y67K]&S0!8QK/]^Q
M_P"^7_QI,ZQNV^98;L9QM?/\ZT!P.O2LO4-'-]=_:%NVB8*H"KQG&3R?3YOY
M4`+$^M-&AD:P21E!9,/D$]NM28UG^_8_]\O_`(TQ=(;S;61KEF,"*"<9+D')
M).>]:=`&7(^M"&1H6L)'0'"@/R1VZT\-JY;:);`GTP_^-5I?#[M.94OI$S(6
M95X!!<MC\-Q_(59BT@1ZJU^9V)))V`8'(`YY]J`%QK/]^Q_[Y?\`QIA?6B8S
M&U@ZLV"P#\#!YZ^H`_&M(C((K'LM`:RG@87LKQQA=R'@'`(']"?I0!.K:N_W
M9=/;C/`?_&GQ0:A)=127;VVR(D@1*P))&.Y]Z=I^G+8&5A(7:7!)(QW)_K_*
MKM`!1110`5E6UIJMG#Y$,EFT89BI=6S@L3SS[UJT4`9CMK(#!7L&<+D)A\G]
M:53K15=S6`8C)7:_'ZTFH:.;ZY:=;MX&**J[!R"I;G/_``(\>PJ>TL3;_9RT
MK.T,)C.>=Q)!)S^'ZT`1XUG^_8_]\O\`XU&[ZT%_=&PD8,H(`?@$@'OV&3^%
M:E8T^@R22M)'>R(69FV@8'+,>?IN/Y"@"P&U=B0)+`E>"`'X_6@_VPH):2P`
M'4E7_P`:N10)$\CJ,&0@G\!BDO+?[793VV\IYT;)N`Z9&,T`9TL6JR3P2-%I
MLI3)64HQ,?'4'/?VJ8?VR>CV!_X"_P#C4=KH[VM^9_MCNA5L1GH&/H/3KQ]*
MM:?8#3X6C$SR[RIRY]$5?_9:`(6.L(,M)8*/4J_^-0^5JBWCSF/35?8%\_RV
MW')^[G.>P_.KFI60U"V\@R^7A@V0,U3BT5TMYH6O&D\P`!G&[^(D\>O('X"@
M"<?VR1D/8$?[K_XTA.L!@IDL`3T&U^?UJW:6_P!EM4@WE]G\1[\U6U'3?[0*
M$3M"41ERHYY*G/MRH_,T`1"360SB1K!`&PI(?YA@'/7Z_E4F-9_OV/\`WR_^
M-56T!I;&*VEO')21G+D98YX'/:M>)!%$D8)(10N3WQ0!1SK&[;YEANQG&U\_
MSID<FM&)#*UA'(R@LA#\$]NOK1J&C->W?VE;IXF"J`JC&<9ZG\?T%*-'!DM9
M)+AV>W503_>(.23^/\S0`YTUET92]C\PQ]U_\:YCQ['Y,&EQ9SL61<_0)7<5
MQ?Q#_P"8=_VU_P#9*`.HLO\`CZU#_KX'_HJ.KE5;10+F]/\`>G!_\AI5J@`H
MHHH`****`"BBB@`HHJKJ5X;"PENMFX1C<P]OS%`%JN;N-&UU9[J6PU)(3+O\
ML.Q;:6D#`G*XP%R`.V>I&,6%\3VZ6U]+<1NK643RL@`RP1I%('S<G,3'Z8]\
M/?Q);1M,K0RDQ&3)780=C(IZ-ZR#\C0`W3K'5H=0D:]N0\,I+R!<%6.U%`&0
M"/NL2.G(Y/-1MI&L0K;K9WT*^6&21G!)=04"=CSM4Y]SFK<NNV\6J?V>8Y?,
MWA"=H(Y"^_\`MK^1]*9:>*-&OIXX+:[:221=RKY,@XZYY7@<'K0!9TBVO+33
MDAOIEFG#,2Z],%B0!P.@./PJ]6/;>*=(NDW)<E3L5RK1L-H(R,G&.Q[XXINC
M^)[76)8DBAGC\Z%9HS(F`00#C.3S@Y^F*`-JBBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHK";Q(L-WY4\#JOF%"0`<$/&G][UE7\,T`3:]IE]J,:?8+
MH6\J1NH8N0,G&#@#G&/P]^16?/IGB=G$K:A%)Y4S20JF`1\C*`<J`1E@3Z`'
M&3C%V\\3VMDUQNBE=;=9&8H4.0D:R$CYN1M8?CZ5-/KUO!$9&BFP+A[?A03N
M568GKTPIQWZ<4`)=Z9=R.\D%ROF-:F/,@ZR@$(V.F/F;/'9:CT^PUF+4UN+Z
M]BFA$3H43C+%@5/3L`1^--'BO2X88#>S/;2S1"3RWA?*@D@`X!P<J1CKQ4LG
MB;2H98HY9W3SD1XRT3_-NSCMD=.^.HH`UJ*PY_$]L)9$M8Y+D0JCRE`HVJV[
ML6!SA">E;2.LD:R(<JP!!]10`ZBBB@`HHHH`*XOXA_\`,._[:_\`LE=I7)>.
MH%G^P[B1CS.G_`:`.DMO^/B\_P"NP_\`1:59JM;?\?%Y_P!=A_Z+2FVMU-/*
MX>!8X\90[SN(]U*C'X$T`6ZIZF3]GC4.ZAYXU)1BIP6&>1S4T]U!;;?/D$>\
MX7/<^E5;V:*>W@>)U=?M,0RIS_$*`)O[.@_OW/\`X%2__%57GM#'<V\<45S)
M'(3YDGVR0>7CIQNYS_2M*B@"K_9T']^Y_P#`J7_XJC^SH/[]S_X%2_\`Q56J
M*`*O]G0?W[G_`,"I?_BJ:VF6SJ59KA@>H-S(?_9JN44`4O[)M-K+^_PQR1]I
MDY_\>I/['LL8VS8_Z^)/_BJO44`4_P"R[7<6S<;CU/VF3/\`Z%4+^'],DFBF
M>&0R0DF-OM$F5)]/FK2HH`HQ:19PKMB$\:@8PMQ(!C_OJE&DV@=7'GAE!53]
MIDR`<9'WO8?E5VB@"K_9T']^Y_\``J7_`.*H_LZ#^_<_^!4O_P`55JB@"K_9
MT']^Y_\``J7_`.*H_LZ#^_<_^!4O_P`55JB@"K_9T']^Y_\``J7_`.*IHMUM
MKJ$QO,=Y((>9W!XST)-7*KS?\?-M_O-_Z":`+%%5+FZFBG2.&W60'!=F8J`"
M<#!VD$\="1VYJTS!5+'H!DT`+6;96J7%L)99;@NSODBYD`^\>P;%6H+ZUN2!
M#.DA(R-I_P`_Y!]*CTO_`(\$_P!]_P#T(T`._LZ#^_<_^!4O_P`51_9T']^Y
M_P#`J7_XJK5%`%7^SH/[]S_X%2__`!5']G0?W[G_`,"I?_BJM44`5?[.@_OW
M/_@5+_\`%4P:3:!MP\_=DG/VF3.?^^JNT4`43H]F221,2>I-Q)S_`./4O]D6
MF,8GQG/_`!\2=?7[U7:*`*$NB6,\9CE29T9=I#7$AX]/O4V+0M/@5%BCE01J
M%7%Q)P!T'WO<_G6C10!2?2;25623SW5AA@US(01Z'YO>G?V=!_?N?_`J7_XJ
MK=%`%7^SH/[]S_X%2_\`Q5']G0?W[G_P*E_^*JU10!5_LZ#^_<_^!4O_`,51
M_9T']^Y_\"I?_BJM44`4Y-/A6-B)+G(!_P"7J3_XJN?\6DM!IS$Y)5B3^"UU
M,O\`J7_W37*^*_\`CVTW_<;^2T`=);?\?%Y_UV'_`*+2LKP[.)9IE$=PNU0"
M9G9_P&XG'.>!QTK5MO\`CXO/^NP_]%I5+2X7AOKG?,DTG'F.9P[GDXR`HVCK
MQTZ_6@#0N+6&ZVB92P4Y`W$#\AUJG?6=M!%;>5`B[;F/:0O*_,!QZ<`#Z`5I
M53U/_50?]?,7_H0H`N445&]Q#%+'%)*B22Y\M68`OCK@=Z`)****`"BBB@`H
MHI,YH`6BBB@`HHHH`**0D`9)P*6@`HHJM>:A:V'D_:9-GGRB*/Y2<L>@X''U
M/%`%FJ\W_'S;?[S?^@FK%5YO^/FV_P!YO_030!D:K/Y6OVB&.=MYB`*NX0?.
M>J@[3CCJ#_*MYE#J5.<$8.#@UEZI#(][:R><NP,NR*2<1KO!SG&T[CT&,\<8
MYYK5H`JQZ;9Q9VP+R,'=EL_7/7J?S/J:9I*A=.C50``S@`=OF-7:IZ7_`,>"
M?[[_`/H1H`N44UW6-&=V"JHR6)P`/6A'61%=&#*PR&!R"*`'4UW2,9=U49`R
MQQR>E.JAJ_E_95\RTFNAO'R0YR.#D\=L9'ISSQ0!?HHHH`**C>>*.6.)Y462
M7(168`O@9.!WXJ2@`HHK/74IFU]],-A,(5M_.%V0=A;(&SIC/.>N>#QZ@&A1
M110`450TUX6ENQ%>/<$3L&5B?W9R?E&>PZ<<<?6K]`!12-NVG;C=CC/3-06+
MSR6<;W/E>:<[O*.5Z\8Z]L4`2R_ZE_\`=-<KXK_X]M-_W&_DM=5+_J7_`-TU
MROBO_CVTW_<;^2T`=);?\?%Y_P!=A_Z+2L[2'2;6]4E22.0;D4,C`X`SQP/7
M/Z]ZT;;_`(^+S_KL/_1:51TJ1!J-S;*UVQMU"!IP-I'^R0!F@#7K*NFO?)MQ
M<1Q?\?4>2&.1\PZ#'/.>XXQWK5JGJ?\`JH/^OF+_`-"%`%RO/?%,GBC_`(3/
MP]Y5KIP7S)/)!F=@>F[<=@V\8QCO7H50365M<7$%Q-"KRVY)B8]4SUQ^0H`A
MBDU7R@9K:S\SN$N&P/Q*4KR:F$;R[2T+X^4-<L!GW_=U<HH`\^MK[QU_PL*]
MC-K9/:"V`6W>\<0KC!W*VPG=\W/R_P!*[=;BZ"CS+%LXY\N12/UQ2I8P)J#W
MP!\Z1`A.>P_S]!SCJ<V:`,Z]O-22W)L-*,TV1A9YUC7'?D;C^E<3X'U/Q2^J
M:NL^A1"(WS-,S3&,J2QSL!'SX^HZ=?3T>LW2;-[26^9X6B$URT@)<'<">O']
M>>W:@"S]JF_Y\+C_`+ZC_P#BJS]9U#6X;-FTG1Q/*$8GS[A4V\<8`W;N_'%;
M-,E"M"ZNI92I!`ZD4`<EX(UGQ-?Z-!+J^EAU;=_I"S@2-SQE"`/QSVZ9S73&
M>[/W+/'_`%TE`_EFH="AM[?1X(K6&6&%=VU)OO#YB3GZG)K0H`XOXA/XA?PO
M=1VUI8)`VSS)#<NS@;QT7R\'G'?N>*UO#TWB!M&M/M]E8*_D)S'=N2>.X*<'
MIW-;-Q;Q74#0SIOC;&1G'0Y%/1%C1410JJ,`#H!0!7\V_'6T@_X#<$_S05Q/
MC=?%=Y<Z4MMI-D88-126-OM)8EE^[N!4;1UZ9/H:]`JGJ.F0ZE]F\V25/L\Z
MS+Y;;<E>Q]1[4`2V;7C09O8H8I<_=AD+KCZE1_*DF_X^;;_>;_T$U8JO-_Q\
MVW^\W_H)H`SM<D0WNF0^8@8W*L4+#+`$8X(]>>W3UQ6S61JSI!?VCEKLF>6.
M/;"`4&'R"W!.,G_]5:]`%>4W0G'E(C1[?XCCGGOS_L]O7VJ+2=QTZ/<`&W/D
M`Y`.XU=JGI?_`!X)_OO_`.A&@##\?MK`\*ZD-.2#R?LC^:[.1(HP<[1C'3W%
M1>!G\0?\(II@NH;-H_LJ>6YF;>1C@D;2.GO737EN;NRGMA*\)EC9!)&<,F1C
M(]Z6SMS:64-N97F,480R.<LV!C)H`B_XF)[VR_@S?X5QOQ#N/&-KIL#:3-;(
MGVE`7@\Q93]1R-N>O/0>F17>TA`/44`9M@NOM;+_`&A-IT<V!D01.ZGCGJP[
MU8\O4?\`GYMC_P!N[?\`Q=6Z*`/.O%$?C)_&OAU[>&V:%)).8O,,8Z$^;Z<`
M8]QQ7;PKJS1*9YK..3NJ1,X'XEA_*KU%`%.2/5!&QCN;0O@[0UNP!/;)WUPM
MNOC7_A9LY:2U,?V'[C._D!=PP0,9SG/OU^E>C5"+6`79N@G[XKL+9/3CMT[#
M\J`(@-2`&7M6/?",/ZFHKI]:6`_9+>Q>7C'FSNJ^_136A10!YQX%3QA!JFL-
M<6MDT4M\SR^;=$;6).X+A3_0?K7>>9J/_/K;?^!+?_$54T2SBM9]1:/[-F:[
M=V\EB3DD_>SW]??-:U`&'KLOB,:9.=-L].,GE/GSKE_3C'R`?F1]:POA4-;3
MP?91WT<'V93*$9F;SB-['D'W)'..G3N>W=!(C(>C`@U6TO3H-)TZ*QML^5%G
M;D`=22>G'4T`6)?]2_\`NFN5\5_\>VF_[C?R6NJE_P!2_P#NFN5\5_\`'MIO
M^XW\EH`Z2V_X^+S_`*[#_P!%I65I5^MWK=W':'3Y((S\TD'WR,<9]>1^5:MM
M_P`?%Y_UV'_HM*2SM9;8D22QN@`6-4C*X'OR<GWXH`DGNH+7:9Y`@<X4D=3Z
M54O;F">&W,4R.#<Q8P>OS`_R(/XU:GLK>X8-+'N/L2,^F<=<=L]*J7MK!!#;
MB*%$`N8\8'3Y@/Y8'T%`&E5>;[7]I@\CRO(R?.WYW>VW]:L44`%%%%`%=8)Q
M?/.;DM"RX$.WA3QSG\_S]A5BBB@`ID<L<I81R*Y1MK;6!VGT/H:?4,%K#;-(
MT2;3*Q=SDG)//?IR3Q[F@":BBB@`HHHH`ANH6N+9HDE,3-CYESQS[$'VX(J2
M-2D:J6+D``L>I]Z=10`57NK>2X\G9</#Y<@<[?X@.Q_S^%6**`"J\W_'S;?[
MS?\`H)JQ5>;_`(^;;_>;_P!!-`&7KU_%;7MC`AL6N995`2X^^`3@%?0YZ5LA
MF6(-)C<%RVW)&>^*KS6LKW:S12QHN%$@:,LS!3D`'(QU]#5B2))DV2*&'\O<
M>AH`ABU"SG_U=PC<9Z_Y]#^1]*9I1!T]"#D%GP1_O&GQ:?:0G*0C)&"22<_7
M/7J?S/J:9I0`T]`!@!GP!_O&@"Y1110`4444`%%%%`!1110`4444`%%%%`$<
M4$,!<Q1)&9&+.54#<?4^]2444`%%)38I8YXQ)%(LB-T9#D'\:`"7_4O_`+IK
ME?%?_'MIO^XW\EKJI?\`4O\`[IKE?%?_`![:;_N-_):`.DMO^/B\_P"NP_\`
M1:59JM;?\?%Y_P!=A_Z+2K-`!5'56V6T4A#%4GC9MJEB!N'.!5ZB@"E_:]G_
M`'Y?^_#_`.%(=9L00#)(">@\E^?TJ[67;W]\\]NEQIWW\?O<[=N1SP<G@Y'7
MWH`L?VO9_P!^7_OP_P#A1_:]G_?E_P"_#_X58MWDDB+2IL;>PQCL&(!_$8-%
MR\D<.Z)=S;E'0G@D`G`]!DT`5O[8L=Q7S)-P&2/)?/\`+VI?[7L_[\O_`'X?
M_"HK6\O)GD62P\B4(<.3G.`,<=>23@9[-SZZ*[MHW8W8YQTS0!3_`+7L_P"_
M+_WX?_"JUIJD:O/Y]V\P,AV`6[#8O4`X7T(_GGGBU?7-U;NGV>W\X;&9EP>2
M"N!GMP6/X5`;V]-CY\.GXF9GS%NSG"G!)X[@"@";^U[/^_+_`-^'_P`*1M6M
M"I"R2`XX)@<X_2KM4+R\O+>YVPVGGQ;5R>5QG.3GVP.,=_:@"*QU6$6<?VBZ
M>>0@DR+`V&!.1T4#ICM5C^U[/^_+_P!^'_PIL=S<9ME2U\N-T4M'L/[L$],C
MCIV[5?H`HMK-BBEFDD55&23"X`'Y4O\`:]G_`'Y?^_#_`.%5Y;^^5VC?3O.B
M=RF<[1C<1SG.<C;]<U82YNVU$PF`&W!/[S:1C@8'/7OR/;WP`']KV?\`?E_[
M\/\`X56O-4C<P"WNWA/F@OFW8[U[J,K6J>AK+MKZ]EEACN=.VEL'S,X"\'/!
MR1CD=><CUH`L?VO9_P!^7_OP_P#A35O(;N\@6$N2I8G,;*`,>I%2V<UU*7^T
M1J@&-I`(SR>Q]L'\:M4`%%%%`!658ZC;V]J(I?-5U=P1Y+_WC[5JT4`43K%D
M`27D`'4F%_\`"@:Q9$`AY"#W\E_\*;>W=W!,RQ6?VB((I(`P3G=GGIQA>/>I
MK:>:40%H!$KQ%B`<[3D8&?H3^5`#/[7L_P"_+_WX?_"D;6;%1EI)`,@9,+]3
MP.U7JRY[Z\C=E;3_`#HPQP?NXPQQUSDG"X]S0!/_`&O9_P!^7_OP_P#A1_:]
MG_?E_P"_#_X59C,I>3S-NT$;<#V_7]*2Z>2.UEDA7?(J$HN,Y..!0!6.LV((
M!DD!/0>2_/Z4O]KV?]^7_OP_^%1P7EU+>>3-8[`H8B8GJ.Q"]>>.,U8LIKB:
M-FN8/)8$8&>HV@G]21^%`$?]KV?]^7_OP_\`A2?VQ8[BOF2;@,D>2^?Y>U37
MLL\,&ZWCWOG&-I/\JJQWMU)'*[67D2J`.<R$_,0!@#/O[!@?6@"7^U[/^_+_
M`-^'_P`*/[7L_P"_+_WX?_"K%N\DD"O*FQSU&,8J"^N+F`H;>#SAM8E<'D@C
MC/;@D_A0`T:Q8DD"20E3@XA?C]*7^U[/^_+_`-^'_P`*KM?7IM%FAL0DKR,&
MC(+9P,9+`<=!U],5IH6,:EAAB!D>AH`IMJMBRE6:0@C!!@?G]*CMM2TV&W1+
M=Y/*ZJ1%(V<\YSCGK3KR\O+>YVPVGGQ;5R>5QG.3GVP.,=_:A+B[_P!&$5HL
M<3HI9#G,8STXXZ=O;Z9`%DU:S,3@-+DJ?^6#_P"%87BP$6^G`C!"-Q^"UUE<
MOXT_Y<O^VG_LM`&_;?\`'Q>?]=A_Z+2K-5K;_CXO/^NP_P#1:59H`****`"B
MBB@`HHHH`****`"L*?Q/'9R7`NK9]D&\YB(;(5PH]!DY'&<CG/J=VB@#+L=;
MCO[J2"*)\!B(Y.""`JDD\Y!RV,?_`%\1'Q`D(@^U1,C3*PVHN=K*55@<GH&8
MC\,UK[%\SS-HWXQN[XIU`%33+]-2LEND4J&9A@]>"1G\<9_&K=%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`9FL:N=)19/(\U/+=R`WS?+@X
M`]\GGH.,]<U4D\66@F5(X96"RLDV0,JJHS%ASSC;SC^HSO4UT612KJ&4]0:`
M*%SJ;VS.7B*QK;F<$CG`!W`]LCY._P#%[4RSUV"^U!;6*.0;HFDW,`,;2!CK
MWS^E:E%`!1110`4444`%%%%`!7+^-/\`ER_[:?\`LM=17+^-/^7+_MI_[+0!
MN?9[Q)YGAN8525PP5X"Q'R@=0P]/2G>7J'_/U;?^`[?_`!=%%`!Y>H?\_5M_
MX#M_\71Y>H?\_5M_X#M_\7110`>7J'_/U;?^`[?_`!='EZA_S]6W_@.W_P`7
M110`>7J'_/U;?^`[?_%T>7J'_/U;?^`[?_%T44`'EZA_S]6W_@.W_P`71Y>H
M?\_5M_X#M_\`%T44`'EZA_S]6W_@.W_Q='EZA_S]6W_@.W_Q=%%`!Y>H?\_5
MM_X#M_\`%T>7J'_/U;?^`[?_`!=%%`!Y>H?\_5M_X#M_\71Y>H?\_5M_X#M_
M\7110`>7J'_/U;?^`[?_`!='EZA_S]6W_@.W_P`7110`>7J'_/U;?^`[?_%T
M>7J'_/U;?^`[?_%T44`'EZA_S]6W_@.W_P`71Y>H?\_5M_X#M_\`%T44`'EZ
MA_S]6W_@.W_Q='EZA_S]6W_@.W_Q=%%`!Y>H?\_5M_X#M_\`%T>7J'_/U;?^
M`[?_`!=%%`!Y>H?\_5M_X#M_\71Y>H?\_5M_X#M_\7110`>7J'_/U;?^`[?_
M`!='EZA_S]6W_@.W_P`7110`>7J'_/U;?^`[?_%T>7J'_/U;?^`[?_%T44`'
MEZA_S]6W_@.W_P`71Y>H?\_5M_X#M_\`%T44`'EZA_S]6W_@.W_Q='EZA_S]
M6W_@.W_Q=%%`!Y>H?\_5M_X#M_\`%T>7J'_/U;?^`[?_`!=%%`!Y>H?\_5M_
MX#M_\71Y>H?\_5M_X#M_\7110`>7J'_/U;?^`[?_`!='EZA_S]6W_@.W_P`7
I110`>7J'_/U;?^`[?_%UFZOH5[J_D[]0@C\K=C%J3G./]OVHHH`__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g118721mqi004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721mqi004.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`#4`5H#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T.&'4M5UC
M6`-?OK.*TNT@BAMX[<J%\B)SR\3$G<[=ZM?V'J/_`$->K_\`?JT_^,4:'_R%
M_$?_`&$D_P#22WK9H`QO[#U'_H:]7_[]6G_QBC^P]1_Z&O5_^_5I_P#&*V:K
M&[QJ26>W[T+2[L^A`Q^M`&?_`&'J/_0UZO\`]^K3_P",4?V'J/\`T->K_P#?
MJT_^,5LT4`8W]AZC_P!#7J__`'ZM/_C%']AZC_T->K_]^K3_`.,5LT4`8W]A
MZC_T->K_`/?JT_\`C%9"WD+7CVG_``FFL+,LOE8:WM0"P<(<'R.S$#\:["N>
ME\&:?(DS*S1W$UT;AKA1\W,GF;?IG'Y4`-2U:01E/'-\WFY$>/L1WXZX_<\X
MJ-%62[CM4\<Z@TDJ;H]HLR'&<<'R>3GM5>W^'MM`FS^T)F#*RO\`(N2&]/[I
M]Q1!\/;2%H2;Z5O+(+8C4%L.K#!_AY4=/?UH`N-:R+:-=+XTU.2%7";HTLV&
MXD`#B#KD@?C33$JKN;Q[>`9VY+677T_U/6G6WA0:?I+6MO<&63[3!.&=0H_=
M%,#`]0G7N3FHK?P%I<2;)9)9!A`,$+RH(S^.?TH`JM?VZ[R?&NL;8YC"S?9K
M8@,#@\_9^F>]:=KIMW>VZW$'B[5VC;(!\JTZ@X(_U'8@BJA\#H)':/4I$62X
M$SQ^4I5L$D`COR<Y[\>E;FCV4EAIXAE8-(TLLK;>@+R,Y`^F[%`%3^P]1_Z&
MO5_^_5I_\8H_L/4?^AKU?_OU:?\`QBMFB@#&_L/4?^AKU?\`[]6G_P`8H_L/
M4?\`H:]7_P"_5I_\8K9HH`QO[#U'_H:]7_[]6G_QBC^P]1_Z&O5_^_5I_P#&
M*V:*`,;^P]1_Z&O5_P#OU:?_`!BC^P]1_P"AKU?_`+]6G_QBMFB@#&_L/4?^
MAKU?_OU:?_&*/[#U'_H:]7_[]6G_`,8K1O+G[)`LNW=F6./'^^ZKG_QZK%`&
M-_8>H_\`0UZO_P!^K3_XQ1_8>H_]#7J__?JT_P#C%;-%`&-_8>H_]#7J_P#W
MZM/_`(Q6-/?1VUS<6\OB_7!);LJR#[+:]6;:N/W'.2:[*L:_\.K>SW4Z73PR
MSO;R!@H;8T+;EX/7F@#.9@FF1ZDWC755MI'V*QAM02V=N,>1G.01^!J-[F*.
M26-_&VK(\,JPL&@M1EF8J`/W'/*L/P-:'_")6K:>]K)<2N\AW/(V.6,AD+`=
M`22?P--_X15)'OGN+UYC>7$<P+1KF/8^X*#Z=OQ/K0!55E:QN[U?&NJM;V3F
M.9Q#:85@`2/]1SU%2K"QM8;E_&VI11SC,9E2S3</8&#W%76\.P?8-2M$D*KJ
M$YF/R`A#A1@#N/D'YU4F\&VEQ86-G)<2,ME&R*Q`);<Z,3[?<Q]#0`Z.RDED
M2*/QOJ#R2+N15%D2P]0/)Y'!J)(M_P#S/&H*<N,.+-2=I(8X,/0%6Y]C5;3O
M!LVF>);6[AG5K.`%OF'SEBC)CV'S?I4T7@FW<*;F9BT;%5VCJ@>8CGU(FY_W
M:`(Y)X8[B.`>.-3E>56=?)BM)!A>O*P&IM/1]4.+3QCJ[G9OP8+0'&XJ>L'9
ME(I3X(LH[BWEM;F:`09(Q@MD@X.[MUZ58T;PX=(U`3?:#,BP.@)&"6>0NW`Z
M#ICZF@"7^P]1_P"AKU?_`+]6G_QBC^P]1_Z&O5_^_5I_\8K9HH`QO[#U'_H:
M]7_[]6G_`,8H_L/4?^AKU?\`[]6G_P`8K9HH`Y;7[+5M*\.ZEJ,'BG5&EM+2
M6=%>&T*EE0L,XA'&174UC>,O^1)UW_L&W'_HMJV:`,;0_P#D+^(_^PDG_I);
MULUC:'_R%_$?_823_P!)+>K;:Q9+JZZ49?\`2F7<%Q[$]?H,T`1ZSJK:6MN5
MA\P2R;6/]T8R?QJ-)S+XI"&*1/+M'&YA@-\Z\BM.18V"^:JD!@1N`X/;\:HO
M_P`C+#_UYO\`^AI0!HT444`(3@$X)QV%5-,O_P"TK3S_`"&A^;&UCGL/\?TJ
MY10`4444`%%%%`%*SU#[7=74'D-']G;&YC][DC^F?Q%7:**`"BBB@`JE::A]
MJO+FW\AX_LY`W'^+DC^F?QJ[10`4444`%%%%`!4%Y<?9+&>YV%_)C9]HZM@9
MQ4.J:K::/;+<7LA2-Y!&"!GD_P#ZC5M661`RD%6&0?44`8-UJ3W>D6<CV[[I
MKR)6*#Y4VW"CD^^*Z"LW55C338EB"J@NK<`(.!^^2M*@`HHHH`****`"BBB@
M`JDVH;=62P\ASN3?YG8=?\/U%7:87Q*$QU4G/Y?XTF[`/HHHI@%%%%`!1110
M`4444`8WC+_D2==_[!MQ_P"BVK9K&\9?\B3KO_8-N/\`T6U;-`&-H?\`R%_$
M?_823_TDMZHR$K\0H\6RX>#!E()/W6/!Q@=,8SGOBKVA_P#(7\1_]A)/_22W
MK-@L]4D\<&\GLE2V1F59`?O`(P#?>ZX*CI_$WIR`;6L:;/J26RPWAM_)G24X
M4,'VL#C]*:4"^)HR"V6LW)RQ/\:=/2IM2OFL8X62(2&241[=V"<^GJ?_`*]5
MEN$F\4A%60&*T<$LA4'YUZ$]?PH`UJ***`$/0UG:%`EOIH2.^-\-Y/FG^76M
M$@,"",@\&J.CP0P616%-B^:XY8G[K%1R?91^5`%^BBB@`HHHH`R]+MI(=1U.
M1[AY%:90J-T0;0W'_?>/PK4JG9_\?=__`-=Q_P"BTJY38D%%%%(8445!!.TL
M]S&0`(7"CWRH/]:`)Z***`"BBB@#F_'&1HL3"W6<K.&VLI8#".<X`.?R]^U;
MK(\UB45S"[Q8##DH2.OX5S_C6VU.]MK>WL+03(1([OG!1@,`?>'W@77\:Z#+
M6]CNV*&CBSL#8`('3)[4`8[:8VG:!:VLL[3O#>1'>,KNS<*>0..AK?K"O=2%
MSI5F[Q.K7%W#MV*S+@3H,YQP",$9QG-;M`!1110!$+F`W)MA*IF5=Q3/('K4
MM5$LX%U22Z"$2E!D[CCG@\=.BK^56Z2=P"BBBF`5$?\`CZ7_`'#_`#%9VM^(
MK70W@CF1Y)I\E(U(&0,9.6('<5F?\);*9!*-,?`!&/.3.#^/M7/6KTJ=E*21
MI"G*6J1U-%8NC>)K36+N2T2)X;A$WE&96RN0"<J2.I%;5;1DI*\7=$--.S"B
MBBJ$9DL"'Q##-]OV,(<?9?[P^;G]?_':TZJ/:0-J<=RR9F5#AMQ[<#CIT=OS
MJW23N`4444P,;QE_R).N_P#8-N/_`$6U;-8WC+_D2==_[!MQ_P"BVK9H`QM#
M_P"0OXC_`.PDG_I);US^FR!_B/<Q-<3R/&[L`#\JC:?E.2/[W8'[J\\9/0:'
M_P`A?Q'_`-A)/_22WK&L82/'<DSH'E::5=[F-D5`@($9R9`_*[ATP3QTH`ZN
MXAM9?+^U11/M8;/,4'#=L9[U5?\`Y&6'_KS?_P!#2EU?2SJD<2"81^6Y/*;N
MH(R.1AAG@]JA6)X_%(9KB24/:.55@N$^=>!@`_GF@#6HHHH`\:U;QCXCDU&Z
M1;]XXDF=42+:N`&(';/ZU0M?%?B.W7,=_/&<D[2RL,GD]0>]>C7?PVT6ZNI9
MQ/>0F5RY6.1<`DY.,J35*R^&NDSP>9)>7Q/F.N`Z8P&('\/M7H1JX=15T_N1
MP2IXCF=FOO9L>&-7U?4O#UI=SV<<LCA@SB4+NPQ&<8]JU?M.I?\`0/3_`+_C
M_"GZ9IUOI.GPV-J&$,((7<<GDY))^I-6ZX':^AW*]M2C]IU+_H'I_P!_Q_A7
MFGC/Q)X@B\17%FEP]M!$$Q%')C&5!/(&3UKUFN;UGP-I6MZ@]]/+<Q32`!S$
MXPV!@<$'L!6E&4(SO/8SJQG*-H;GDT>O:ZDDC+>W*DMG/VEOFXZG\A7HW@'7
MM9U'2K@WL3WK13[5<.@(&T''.,U';_#7299[I&O;_$,H1<.G38K<_)ZL:Z?0
MM`LO#UH]M9&1A(^]VD;))P![#H*WKU*4HVBM?1&-"%6,KR>GJ_U)_MMWWTNX
M_"2/_P"*H^VW/_0+N?\`ON+_`.+J[17&=9Y)XV\5:W#XCN;.*XFM((@FV$2*
MA&5!))4G/7UKFXO$>L!V8:C.A)SDW3?-]?TKUO6?`VE:WJ#WT\MS%-(`',3C
M#8&!P0>P%9%O\--(DN+E&O;[$4@5<-'T*J>?D]Z[:=6DHV:_!''4IU7*Z?XL
MN?#G6+_6-(NGO[G[0T,^Q'XR!M!QD=:Z^LO0O#]EX>M'MK(R,)'WNTC9).`/
M8=JU*Y)M.3:V.J*:BD]PHHHJ2CB?B)*(VTY6GF1)1*ACB/+D[,'J!P0#RP_4
MUV*1JUJL<@WH4VL),'(QW[&N6\=Q>:+7>C21I%,X0&(J7&S:760[3&.<G&1Q
MTS72S6QNM,DM698S+"8R4'"Y7''M0!4U%((]*A6V6-8?M5OM$8`7_7)TQ6I6
M%>Z?)::7;)]J8!+Z-W2)%5'WW"MC!!(`SQ@BMV@`KD_$UYJ@U86MG<>7`MNK
MLH?86+,PZ[2?X>V*ZRLO4M"AU&Y%R;F>"4($)B*_,`21D,#ZG\ZY\3"I.DXT
MG:1I3<5).6QPTFJ7,=S]E(NS<8W';=2-QQSD9]>F*V_#.N7QOKBVOWN)HUB5
MXU$+NRG)!Y"`XZ=?SJ^/"J?:&7^U+SA0V=L6><C^Y["M'3-$@TR>2=9YYY9%
M"%I2O`!)P`H`[UPX2AB833F].NK>OS-ZM2G*-DM?0D&HNY_=:?=N/4J$_P#0
MB*7[;<_]`JY_[[B_^+J[17K'(<;XCENIM6M0]BJ#[/)A99!R-R>F:PFL[K^T
M4QIEA]FV'<>,[OKMS^E=]J>BPZI+%*\\T$D2LH:(KR#C((8$=A6<?"Z^<$_M
M6\P5)^[%ZC_8]Z\/&8*O4K.I"UGIK<[J->$8*+N9>AO=P:[&(K*)L6LN$CEQ
MQOC]0*ZG[;=`<Z5<9]I(O_BJ@T[0H=.NC<BYN+B788P92OR@D$X"J/[H_*M2
MO1P=&5&A&G+=7V]3FK34YN2*7VZY`R=+NO\`OJ(_^SUS7B;6]2%[;6]F+BV1
MHG:12A5FY4#D*W'7I^==E6;J>B0:G-%,T\T$L:E0T17D'!P0P([5K7C.5-JG
MN3!Q4DY;'"1ZI=277V;9>"<@,"UU(HQSW./3ICG\..A\,WFJ'5S:WEQYD#6[
MNJE]Y4AD'7:#_$?6K1\+J)U3^U;S!4G[L6>,?['O5[3="ATZZ-R+FXGEV%`9
M2OR@D$X"J/0?E7FX:ABH5E*3]WKJWT\SIJ5*3A9+7T1J4445[!QF-XR_Y$G7
M?^P;<?\`HMJV:QO&7_(DZ[_V#;C_`-%M6S0!C:'_`,A?Q'_V$D_])+>IXM#M
M(=3-^K3;][2+$928U=AAF"^I!/YFH-#_`.0OXC_["2?^DEO6S0!2O]3BL2BE
M?-=G52B,-PST..IJLMS'-XI$:;MT5HX;<C*,[UZ$CG\*O7-A:7AC-S;QRF)M
MR%USM/J*K/\`\C+#_P!>;_\`H:4`:-%%%`!4-K!]FA\O=N^=VSC'WF)_K4U%
M`!1110`4444`4[/_`(^[_P#Z[C_T6E7*0*JDD``L<GWI:;=Q(****0PJ&&#R
MIKB3=GSG#8QTPH']*FHH`****`"BBB@#/U31K;5MAG>>,HK)F&0H61L;E..H
M.T?E5J66*SMP3M55&U%R!DXX49[U-3)H8[B%H9D5XW!5E89!!H`QK_4X;G3+
M-RKHUQ=PA!L+`[9T&=P&,'J"<9!K<K+U&VAM-*A@MXEBB2ZM]J*,`?OT-:E`
M!1110`P)B4OGJH&/IG_&GT44DK`%%%%,`J(_\?2_[A_F*EIA0^<'[!2/Y?X5
M,E<:'T4450@HHHH`84S*'ST4C'UQ_A3Z**5K`%%%%,#&\9?\B3KO_8-N/_1;
M5LUC>,O^1)UW_L&W'_HMJV:`,;0_^0OXC_["2?\`I);ULUC:'_R%_$?_`&$D
M_P#22WK9H`*JW>FV5\R-=6R2L@(4L.@/7^56J*`,TZ!I`&?L$7Y5C6][X2G@
M$KVZ09Z++&0>@.>/8UU586I^'["/3F^QZ;$TP*J@QG`+`'K[9H`KM+X3$@41
M0L-Q3<J$@,.U06P\-QQQPQ6XOI))9`#$F3U+8Y(Z`X_"G6EM<6NH16SZ);M\
MYD,R_+E]H;/IG/%4HH98;7:-$2<.GF-F(IB7`RHP>@SU[X-`S3@D\)7#(D:0
M;Y,!5*G))[5>@TC1KAYT73T!@D\MMPZG:#QSTPPK,T>V6\U0-/HD=GL43!UR
M"7XP#[<D_@*ZA8T1G95`+G<Q]3@#^0%`%#_A'])_Y\(ORJE?6>A:?+$DVG`^
M:"=RKD*`57)Y]7%:>IO=1V#M9KNGW*%&!W8`]?8FN?OI]2>6*.ZTF.[FA<*L
MNTX4-@YXX/('_?)H`FL+/PY<-<RV\<5R')E5%4Y5555(&?\`:!_$UH6^C:-<
MVT5Q'81[)4#KD<X(S6-"+O3+N-[/3O+1[9`T:KE0N9"6SU')!Q[U<L=7U0W-
MM:G2?*A.U2>1L7`X^O7\!0!H_P#"/Z3_`,^$7Y4?\(_I/_/A%^5:--<,R,%;
M:Q&`V,X/K0(P;RW\/V%VMM/IXRT9E+JA*JHZD_E5:VM_#9N[MPB2)A'QY;8C
MZ+CZDD?G4=Q+J#);RW>E)>2^2P+E2K#]VK$8'&,L1_P$TR%[UQ/(V@P_OWC6
M5,,"P*[CW[$?J*!FM8:=H6I6YN+>Q0Q;V4,5(W8.,CVJS_PC^D_\^$7Y5FZ7
M?ZF/LD(TR.UMV<AP`?E&?ZY_G71T"*=MI5A9R^;;6J1/C&Y?2KE%%`!1110!
M%<6\-U`T,\:R1MU5NA[U3_X1_2?^?"+\JT:*`.9N6\,V=[-:W-FL1A7<\C(=
MG13C/K\PI)9_",0;]W"S*<%54YZXK9N=&TV\DDDN;2.5Y``Y;OC'^`KFY-.G
MMFNI_P"QK>9/,D,8*\X\S;GCU!!Y_NF@996/PQ]OD=1$Y:,(L`1L[EW$X]R&
M'Y4Z";PM,(Q):I;O+@HDJD$C:&SQGC!S4-S'/%J<%PFD*&2-7"[-P4X;+;AS
MQM3BH+>W^T7$%K)X>2&)\HTBY!C5D`;!]<$_@*`-J/3=#FN(X8[!#YD/G(^T
M[2N0/SY%6?\`A'])_P"?"+\JO"*,.KA`&5=H('0<<?H*?0(Q;W3-&L8XV?3!
M(9'$:K&N2203Z^U9]K%X7OM2B:`PDO#M$&TY))!S]:AENM:DT^&/4M,2[,JB
M4`C&P[.^WI@Y_P"^A4<<%Q%+;7T&E"VN,S,!&F=[[L*K`]/E)Y]S0,W+32=%
MO(/.CT]%7>Z89<'*L5/?U!J?_A'])_Y\(ORK%&O:Q`NV'1/E*F3@$#>6RWZD
MCZUU7:@1G_\`"/Z3_P`^$7Y53U&QT/3(XGETT/YLGEJ(TW'."?7T4UNUR^J2
M:D6ECFL!J$23DQ;UV[1@8(Q_O,*`%6W\-3ZE!Y*1M\KQE`C`9(#AB3[(WYU9
ML;3P]J,LB6MG&XC56+;"!R6&.?\`=-9UM+>R7XD31(8F5UC1V5N%(*DGGL,#
M\Z=:WVIVEG-]CT2.WV(V!@DG!X'YL3]*!FY_PC^D_P#/A%^5.BT33(95EBLX
MU=#E6`Z&KU+0(QO&7_(DZ[_V#;C_`-%M6S6-XR_Y$G7?^P;<?^BVK9H`QM#_
M`.0OXC_["2?^DEO6S6-H?_(7\1_]A)/_`$DMZV:`"BBB@`HHHH`***S]8UB#
M1;9+BXAN)4=PG[B(N020!G'3)('U-`&A16%:^+M.NM0%F(KJ)C*8M\L!5-XS
M\N?7Y3^537GB?3;-KQ6:61K+9YRQ1EB-^['Z*2:`,SQ%=>(K?6#_`&5%+)`+
M1BH$6Y/,PYY/?HH`]2*KW.M>+))1##I@C3S0K2^0_(\PCCYNFP`Y^M;!\6Z/
M\^+@MMDACX4\M+]T#^M6-1U_3M+N#;W4I606[W)4+GY%(!_4\4`8PU/Q#?\`
MARUO[>W5;F:4QF.-3A5*E`YR3T?#?[M4YM6\8A)X(M-Y16,4OE,2QP<`\\\X
MKI8M>TU]/@O&N%@BF)5!+\I!!P01V((Q4L6KZ=-+%%%>1.\PS&H;EAST_(_E
M0!8MFD>VB>48D9`7&,8..>.U2UG+KNFF5HVND1Q(T8#G&XJ2#C\01^!J&Y\4
M:/;1PR->*RS2-&I3GD+N.?8#^8H`UZ*RM)\1:?K+!+5I`Q5FVR)M/RD`CZC<
MO_?0K5H`****`"BBB@`HHHH`****`"BBB@`HIDLGE0O)M9]BEMJ#+''8#N:Y
M]?'&F&))6M[Y(W\PEFMFPJH0'8^B@L`3]:`.CK!\33ZM`]@VF),Z^=^_6),E
MEXXSV[]:NWNN6-A=):S2$RR1/*%1<_*@R?Y54C\7Z0ZH3+)&S122E'C(9!&V
MULCL<Y'X4`8\.N>,%@5)-*1I0H+2&W?'WD!X#>[_`)"K&F:IXBO-%O1+`BW=
ME%%MVH0990-[J03Z;5/N3^&W)KMA%:6%R\C!-0:-;<;>6+XV_3J*CL/$6FW]
MK<743M'!;R^6\DJ[03G''J,T`<^=3\7P(T9L#*98Y'W>6V48PJR@<XX<E?PK
MI=%EOYM-#ZD@2Y$D@("[1@.0O'TQ0->TDQ"4:A!L+;=V_OC/\J=<:S86EQ+!
M<W"Q&)4+%S@?-NP/KA&/TH`O45EWOB32;"UN;B6\0K:C,JIRPYQC'UID7B2Q
MDU.33REQ%+',(29(BJEB&*X/<'8<?A0!KT444`%%%%`&-XR_Y$G7?^P;<?\`
MHMJV:QO&7_(DZ[_V#;C_`-%M6S0!C:'_`,A?Q'_V$D_])+>MFL;0_P#D+^(_
M^PDG_I);ULT`%56NR-42SVC#0-+NSZ,HQ^M5=;U.?35MC##O$LNUSZ#&<#GJ
M>U-661_%(5[=XE2T<*S,I#C>O(P>/QH`UJ***`"JU_8Q:C:_9YBP3S(Y/E.#
ME'#C]5%6:*`,'_A$+`WLEQ)/=2)),TY@,@$>\[N>!GC><<U)?>%K*]AEA$US
M`DL<,3")^J1EBHY!S]\YSUP*VJ*`,I_#UG)YV]Y29O(WG('^I;<O;N>M/U70
MK/6"#=>9Q#)"-AQP^W)^HVC%:5%`&%<>$=.NM/@LIGG=(/-(8L-S&0DN3QUR
M2:J1^#A;>([;4+:XVVT3M*\;<EG)E/IT_>G\OQKJ**`.='@^REG>6Z9W(F9T
MVG&%,K2X/_`F(^F*=)X(T)W@=+>2)H'WJ5F8]NAW$\=/RKH**`,/2/#%OHMY
M%);2,T<<4B_/@LS2,A8G``Z1J!6Y110`4444`%%%%`!114%[.]M87%Q''YCQ
M1,ZH/XB`2!0`V^N3:6ZRJH8F:*/!_P!MU7/_`(]5FN?GU"XN]&LY6MR_FWD2
MO(I4*FVX4`XSSG';-=!0`4444`55U"!]1>Q&[S47<?EX['K_`,"%9<_A&QG@
MB@^T74<:)-&P1P/,25P[JW'3([=JV_*C$IE\M?,(VE\<X],T^@#*F\.V4A5H
MVF@=?-*M'(<@R+M8\Y_#L*9:>&;.TAM8EEFD%I'+&A<C)$F-V<#D\=:V**`,
M\Z-:MIUE8$R>59-"T9R,_NR"N?\`OD9JG;^$]/MK6YMPTK)<SQS/N*]48,HX
M&,?*/K6Y5)[V==72S%HYA9-QFP<`\^V.P[YY'%`',ZE\/+>2".+3KAH>-DAD
M.<I@`XP.O`_Q%:]]X7MM2U"YGN78QSJIVJ>0PCEB)Y']V7CW%;E%`'/W7@C0
MKRVEADMI`90=TBS/NS@C/7&>3VQ5B3P]#OC,4C`?;4NI=YR3L3:J@^GRK^M;
M%%`!1110`4444`8WC+_D2==_[!MQ_P"BVK9K&\9?\B3KO_8-N/\`T6U;-`&-
MH?\`R%_$?_823_TDMZG;7K)->312S_:G3>!MXQ@G^0^E0:'_`,A?Q'_V$D_]
M)+>J3^<GQ`4H^(I(0KJ)!@_*QY&[.>!QMZ<YXQ0!TCNJ#+L%!(&2<<DX`_.J
M#_\`(RP_]>;_`/H:4_4],&IK;@W$D/V>=)EV`$$J0><@U62V2'Q2)%:4F6T<
ML'E9@/G7H"<+]!0!KT444`%16\K31;VQG<PX]F(_I4M5[+_CW/\`UT?_`-#-
M+J+J6****8PHHHH`BBE:26=3C$;A1CTV@_UJ6J]M_P`?%W_UU'_H"U8I(2"B
MBBF,*2EJG::;%9W=S<I([-<'+!L8')/89/7OG`P*`+E%%%`!1110!GZSK5GH
M5FEU>LPC>01C:,\G)_D#5Y'$B*Z]&&1QBN>\;";^QX6MW*2)/O#*X4C".>[+
MGWYX&3SBMPQFXLO+,C(9(]I>-N5R.H/K[T`5=6D233XWC8,IN[?E3D?Z]*T:
MP+K1XK'2;.$33/\`9KR(H0Y0'=<*<,JX4XS@9%;]`!1110!"LK&[>'`VK&K#
MUR2P_I4U5D_Y"4O_`%Q3^;U9H`****`"H6E87B0X&UHV8^N00/ZU-59O^0E%
M_P!<7_FM`%FBBB@`HHHH`A:5A=QPX&UHW8^N05']34U5G_Y"4/\`UQD_FE6:
M`"BBB@#&\9?\B3KO_8-N/_1;5LUC>,O^1)UW_L&W'_HMJV:`,;0_^0OXC_["
M2?\`I);UGP:=JC>-C?7`M_)4L$P5W%-I`.,9S\RC.?[W8C&AH?\`R%_$?_82
M3_TDMZYO3!&/B5<QLDF]9'D5W8)GY6X4$98?.>A]/04`=;J^HMIT=NR>46FF
M6,+(V-V>P_Q/ZU`D_F^*0GE2)Y=HXRXP&^=>E:4TD$80SO&H+`+O(&6]!GO5
M-_\`D98?^O-__0TH`T:***`/-[[QGKCWLZ1?N(XY71/)C1L@,0"2V>>*KQ>+
M==A&$FE89)VM#%@DG)]#6=/]H%W=;?+*_:)<9R#]\U4A34U0J\L#').YE)X_
M.O,E5GS/4\F=>IS/4]9\/:C/JVAV][<QI'-)N#JF<`JQ7C/TK3KE_",>I'PU
M;;+BW"[I>#$3_P`M&SWK:\O5?^?FV_[]'_&O2B[I,]6+NDR]7#>)/%FK66M7
M-A:(J0P%0)%0,Q)0,<[CCOZ5U?E:I_S]6_\`WZ/^-><>(X;W_A)]0+W2YWID
M+'Q_JTK&O)QA=&&(FX0NF2)XMUR-W9+B9BYW,##'@G`'IZ`5V?A'6[O7-/GE
MO8DCEAF\OY!C<-JG)&3SS7F207ZO*6NU(8_*"G2NU\!QZBNGWPCGMV_TKDR1
MG.?+3T(K'#U)2E9NYAAJLI3LW<[:BJ._54/,5M+_`+K%/YYH^T:E_P!`^+_P
M)_\`L:[3O+U0PR,\TZD\(X`_[Y!_K7FGBJ]UB;Q!=1.Y2*(HJP"4E5^13VP#
MUK&ADNI'8"-82G1CGGZ8-<TZZB[=CEGB8QE;L>U45RO@*YO)]/O([NY><Q3@
M(78G:"H.,GG%=56\9*2NCHC)22:"BBBJ*.9\:6.I:A;00V9A$(#M(9"H*M@;
M<9!Z_,I]FK?=VMK!G;RU:*+)R=J`@?H*X[XC^6K::TJ2.C"6,@,%3G9@LQ!`
MP0#SZ5V<01+1`2-@09).1C'K0!B7.IF[T>RE:)G^T7<.'B'R`"=0">>,C!QV
MZ5T%9FJ/%)ID3P,C1FZM\%""/]>GI6G0`5RWBGQ@^@7L=E#9B:1XA(9&)VJ"
M2`,`9/W3Z5U-><>/_-_X22/RRG_'FF=P/]^2@",?$+4!<--Y5H2RA2ODR=`2
M?7WKJ/"GBMO$3W,,MIY$ENJMN!)5P<]B`1T]Z\O9=1^T%D:$1XQM8$\^M=9X
M`AOI-2OQ]J2(^3'DQQ]LMZYH`]'HJC]BO/\`H*S?]^H__B:0Z?</_K-3N&'H
MH5/Y`4`87C+Q+J&B3VMM81(QG1F=V7<5P0!@9`[]\URA\9ZX9Q(;J7S`I4#R
M8NAQGM["KOC[3VAU.Q$5S,Q,,A)EE=NZ].>*Y,Z?(;D3[QN"[?O-T_.@#T7P
M?XHU+6-1DLK^)-JPF19`NUB0RC!P2/XO:NQKS#P+8--K\B37$JC[*Y!BE=#]
M].^:[_\`LA!RM[?`^]RY_F:`-"N5\9^)-0T.2T@L(D8W"NSNR[BNTKC`R!_%
MWK;&GW"?<U.X'U"M_,5Q'Q!M[Q+_`$X"^:0F*7EXUXY3T`H`SSXQUXRK*;F;
M>H*C]Q'T.,]O85TG@_Q3J>L:G)8W\2;5@:59-NUB0RC!P2/XO:O/E@OA<B0W
M",@7&TK@9]>*ZSP`)?\`A)9/,9#_`*')C:"/XXZ`/1Z***`,;QE_R).N_P#8
M-N/_`$6U;-8WC+_D2==_[!MQ_P"BVK9H`QM#_P"0OXC_`.PDG_I);UBZ?"T?
MCJ28*H\VXF1I=^5<!,[`N.&'!)SV/X;6A_\`(7\1_P#823_TDMZLQZ)8Q:HV
MHI&1.Q+?>^4,1@L!ZD4`.U32UU..-&E:/8Q)P,Y!!!'MUZU76`1>*0XDE;S+
M1R0[DA?G7H.U2ZEJ\=@\<8422/(JE-VT_-TQZ]*A2X6;Q2(Q'(IBM'!++@-\
MZ]/6@#7HHHH`Y^X\%Z1<322XGC:1BQ"2D#).3Q5:T\$Z5)%OD>Y)WL/]<1T8
MC^E=35>R_P"/<_\`71__`$,UFX1OL9NG!O8+&R@TZSCM+9=L4><`G/4Y/ZDU
M8HHK0T"L;4?"NF:G=O=3K,LLF-QCD*YP`!^@%;-%)I/1B:35F<K!X)TMYIU9
M[DB.0*/WQ'&U3_6MW2])M-'MV@M%8*[[V+-N).`.OT`J6V_X^+O_`*ZC_P!`
M6K%3&,5LB8PBMD%%%%668^H^%M,U.[:ZG2597QN,<A7=@8&?P`K/A\$Z2TTZ
MDW6$<`?OV_N@_P!:ZBHTB"22.#GS&!/MP!_2H<(MWL0Z<6[M%;2](L]'@>&T
M1E#MN8LV2QQCK^%7:**O8M*P4444`<AX[A,S6C"/S#%#/(`'VE"-F'/!RH[C
MW%=/+`+O37MWDR)H2A=/<8R*@U/1K+5Q']K1CY>0"K$94XRI]C@?E4]U<Q6-
MMO;"@?*@/`)QP,]OK0!EW^FBVTVV4SRL8KV)_E.U6+W"L<J.,#/%;E8%YJJW
M>DV4ODR#[3=P[2HRH`G09)]#U%;]`!63JWAK3M:G6>[23S%38&CD*G&2<<?4
M_G6M10!R2^!=)-[)$7NMBQJP'G'J2W^%;6D>'[#1#*UFC[I0`S2.6)`S@<_4
MU:3_`)"4O_7%/YO5F@`HHHH`S-7\/Z?K;1->(^Z($*T;E3@XR./I6*W@721>
MI$'NMC1LQ'G'J"O^-=;59O\`D)1?]<7_`)K0!2TGPWIVBS/-:))YCKL+2.6.
M,YQS]!^5:U%%`!69J^@6&MF(WB.6A!",CE2`<9Z?05IT4`<DW@721>QQ![K8
MT;L1YQZ@K_B:U])\-:=HL[3VBR&1DV%I)"QQD$CGZ#\JNO\`\A*'_KC)_-*L
MT`%%%%`&-XR_Y$G7?^P;<?\`HMJV:QO&7_(DZ[_V#;C_`-%M6S0!C:'_`,A?
MQ'_V$D_])+>MFL;0_P#D+^(_^PDG_I);ULT`12V\,^SS8U?8VY=PS@^M4)YH
MH?$<+2R)&#9N`78#/SI6I4,UI;7)!GMXI2O0N@;'YT`-^WV?_/W!_P!_!1]O
ML_\`G[@_[^"F'3-/`S]AMO\`ORO^%<]!XC\./;B6XT^.!F&0A@5CC`/8>AH`
MZ3[?9_\`/W!_W\%16]W:11;3>0'YF/$@[L3_`%K'_MGPZTH2.QCD_>&+*6X/
MS=,`8YJO::CH2QI!9V45XSS2#+1JF#DMC)[<X_"D%CI?M]G_`,_<'_?P4?;[
M/_G[@_[^"L.VUGPU=3)"EI$)'*@*;8=3T'2M.WM=.N)+A!IL"^1+Y9S"OS?*
MK9Z?[5,"S]OL_P#G[@_[^"C[?9_\_<'_`'\%-_LS3_\`GQMO^_*_X50U%M+T
MZ:%)-,@82@DL(T&T!E7/ORXH`NQ75FDDS?;(#YCAO]8./E`_I4GV^S_Y^X/^
M_@K%TR30KLW,UK;13&7=.(S;@%0H5"!^*G\<UIVUGIMU:PW"V%N%E17`,2\`
MC/I0!/\`;[/_`)^X/^_@H^WV?_/W!_W\%-_LS3_^?&V_[\K_`(4?V9I__/C;
M?]^5_P`*`'?;[/\`Y^X/^_@H^WV7_/W!_P!_!67?SZ3I]ZEM+IL!S$TK.(E^
M51UXQSTJM:S:%]LO9%M5<'8S*;<?(?E7:!ZY(_$T`;OV^S_Y^X/^_@H^WV?_
M`#]P?]_!5+3H]+U.U^TPZ=`L9=E0M"OS`'&>G3BK?]F:?_SXVW_?E?\`"@"6
M.ZMYFVQ3Q.V,X5P34M0165I;OOAM88VQC<D8!_2IZ`"FNBR(R.H96&"#T(IU
M%`&9JR16VEQJ@6.-+FW..@`\Y#5O[?9_\_<'_?P5+)%'-&8Y461#U5AD'\*@
M_LS3_P#GQMO^_*_X4`.^WV?_`#]P?]_!1]OL_P#G[@_[^"L.]U30].OI[>ZT
MV)$@7<THA4@G"G`&,_Q"HY=>\,Q[E6TA=U8J5%N!T.#VH`VUNK,7;R_;+?#(
MJX\P=BW^-2_;[/\`Y^X/^_@KGUOO#W]IN4MD::5!$D)MP`2N6&..^X#\*6#6
MM`?REN-/A@>894&)6&-@?)(Z<']*`-_[?9_\_<'_`'\%'V^S_P"?N#_OX*IP
MQ:9/<11)IT&V6#SE<PJ!C(XZ=>15K^S-/_Y\;;_ORO\`A0`[[?9_\_<'_?P5
M$;JT-VDOVRWPL;+CS!W(/]*KZA%I]A%&_P#9EO(TD@C5=B+R<]S]*S;*Z\/:
MAJL30P1^:T6P0FW&,G#9^H`/ZT`;_P!OL_\`G[@_[^"C[?9_\_<'_?P56M+7
M3KN`RC3H$Q(Z8:)<_*Q7T]JG_LS3_P#GQMO^_*_X4`.^WV?_`#]P?]_!1]OL
M_P#G[@_[^"F_V9I__/C;?]^5_P`*HZI_9FEQ0N^F02>=+Y8`C4<[2>X_V:`+
M;75H;N.7[9;X6-EQY@[E?\*E^WV?_/W!_P!_!6&D^@W&J0&.UCRJ/&5-N`H!
M4.&/'HAQ]35O3GTC4Y95M].AVQJK%F@49R6&.G^S^M`&C]OL_P#G[@_[^"E6
M]M78*MS"S$X`$@)-,_LS3_\`GQMO^_*_X4J:=8QN'2SMU93D,L2@@_E0!G^,
MO^1)UW_L&W'_`*+:MFL;QE_R).N_]@VX_P#1;5LT`8VA_P#(7\1_]A)/_22W
MK9K&T/\`Y"_B/_L))_Z26];-`!1110`5EZAI-N;(I:6<"2%D4%8ERJ[@"?P7
M-:E%`'.16VH6FH)`+"WG@1B5E$(4L=H.<]CGOWJE#!J<5N%72XY`R;F$L`)\
MS:-W&!QR2/7&,\UV%%`'-Z1!<W-\K:AI4-N$02KMBQB3C^+OU)QV/TKH@JJ6
M(4`L<D@=3T_H*=10!5U$7)LF6T)65F0!@,D`L`3^6:PM0_M9)4B^Q)?F*0*D
MSP]%.#GTZ]?]P>O#?$,7B4ZP9-(,OD?9&``*;1)A\'!.22=@Q]#GJ*ANI_&4
M[^5':+#$)0#(NS<0)#_M\#9CWSQCF@"2*/4K2\2:WT\PYA1'54RNP>82W^]D
MJ=O7DU9LM0UO[9;V[Z9Y5M\H9@I`4;1Q^'//MBJ_F^)=2\.VMU$!#>RR,KQJ
M-@6-E*;_`)O0X<>W%5)F\;F.:"*W10%8PRAEW9P<9RWK_+\P9VM-=2Z,H8J2
M"-PZCWIMN9#;1&7/F%!OR,<XYXJ2@1RDQU=(H&ETX7D@A8,SIEL^6K8R.Q9F
M'_`?>D@&KO'+(VD0[I6C#QF+:7!7+<^S#K[^U=910!SVG7.L9M$:Q6VMRY$B
MK%C:,^G;)/Z5T-%%`!1110`4444`%%%%`%>6PLYW9YK6&1F^\6C!)_S@5S\N
MG7UL)YHK6"7S))"(VME)0"7`QCKE#G_@/O7444`<O<1ZDNH1S1::BE44D+&&
M4??W-T^\,1X&:CM[>^GN8K:XT6WCMG&V1EA`P&4!E!'3C//X5UE%`#=BA@VT
M9`P#CH/2G45@^)H]9=K%M(\T[)LS)&RJ&'&,EN@Z]`?I0!6E36X[.&.>);WS
M(Q(_F0AO+;9R/P8<>N[VJ%;?4R;:X&G""Y7S"IB0`;RWRAN.@4GGC.>U1P7/
MC9(%BDM$=E4;IB$R>5!XWC)QO/;M4VFR^);G1KR&<!;NTCB6%@,&:50'8$GC
M'1">F=U`R0ZAXCC`6/3E"E-Q(C^ZQ89X[\DC_P`>KIJX[_BM((VB6%9O-21F
M8LN5<PJ0`=W02%A^%='HWV\:<!J9S<B20$X`RN\[>A/\.*!%^N:U!=61Y5%J
M;V(3DIYBYVC`P1CZL/\`]5=+10!REJVKS7GF-I45OB141C#G:IR&.>.@('T'
MO2P7&N0V<WV?2H[9U5MJK'UY&T>_WBWYBNJHH`2EHHH`QO&7_(DZ[_V#;C_T
M6U;-8WC+_D2==_[!MQ_Z+:MF@#)N/#.FW-Y/=EKZ*6X8/+]GU&XA5V"A0=J.
M!G:JC..U,_X173O^?G5__!S=_P#QVBB@`_X173O^?G5__!S=_P#QVC_A%=._
MY^=7_P#!S=__`!VBB@`_X173O^?G5_\`P<W?_P`=H_X173O^?G5__!S=_P#Q
MVBB@`_X173O^?G5__!S=_P#QVC_A%=._Y^=7_P#!S=__`!VBB@`_X173O^?G
M5_\`P<W?_P`=H_X173O^?G5__!S=_P#QVBB@`_X173O^?G5__!S=_P#QVC_A
M%=._Y^=7_P#!S=__`!VBB@`_X173O^?G5_\`P<W?_P`=H_X173O^?G5__!S=
M_P#QVBB@`_X173O^?G5__!S=_P#QVC_A%=._Y^=7_P#!S=__`!VBB@`_X173
MO^?G5_\`P<W?_P`=H_X173O^?G5__!S=_P#QVBB@`_X173O^?G5__!S=_P#Q
MVC_A%=._Y^=7_P#!S=__`!VBB@`_X173O^?G5_\`P<W?_P`=H_X173O^?G5_
M_!S=_P#QVBB@`_X173O^?G5__!S=_P#QVC_A%=._Y^=7_P#!S=__`!VBB@`_
MX173O^?G5_\`P<W?_P`=H_X173O^?G5__!S=_P#QVBB@`_X173O^?G5__!S=
M_P#QVC_A%=._Y^=7_P#!S=__`!VBB@`_X173O^?G5_\`P<W?_P`=H_X173O^
M?G5__!S=_P#QVBB@`_X173O^?G5__!S=_P#QVC_A%=._Y^=7_P#!S=__`!VB
MB@`_X173O^?G5_\`P<W?_P`=H_X173O^?G5__!S=_P#QVBB@`_X173O^?G5_
M_!S=_P#QVC_A%=._Y^=7_P#!S=__`!VBB@`_X173O^?G5_\`P<W?_P`=H_X1
M73O^?G5__!S=_P#QVBB@`_X173O^?G5__!S=_P#QVC_A%=._Y^=7_P#!S=__
M`!VBB@`_X173O^?G5_\`P<W?_P`=H_X173O^?G5__!S=_P#QVBB@".;P?I-S
<!)!/)JDL4JE'C?5[ME=2,$$&3D$=JW:**`/_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g118721moi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721moi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$/`:$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T'4(M9U+Q
M3<V5CK\VF6]M96\NR*WBDWL[S`DEU)Z1K2_\(_XC_P"AVO?_``!MO_B*MVO_
M`".VJ?\`8-L__1ES6S0!S?\`PC_B/_H=KW_P!MO_`(BC_A'_`!'_`-#M>_\`
M@#;?_$5TE%`'-_\`"/\`B/\`Z':]_P#`&V_^(H_X1_Q'_P!#M>_^`-M_\14N
MO:Y=Z3=$0Q1S1BW:38`2Y8*Y`/HIV=0#CG(Y!JG/XU(DNH;:Q25[=)'W^<=C
M!"`<?+D\D_D>:`)_^$?\1_\`0[7O_@#;?_$4?\(_XC_Z':]_\`;;_P"(J36?
M$<MC,]K!:DR!XT\QSA1N*?-T^[AB,^JD8IVJ:M=Z5=G=+%+%%92W3ILPS;-@
MV@YXSENWIZ4`0_\`"/\`B/\`Z':]_P#`&V_^(H_X1_Q'_P!#M>_^`-M_\127
M7C`6Q>/[%OF201&,2\EMVTX^7ID@\X)4Y`JK;^/5=5,VG,!MRS1R[N=KDX&/
M]D#_`(%^8!;_`.$?\1_]#M>_^`-M_P#$4?\`"/\`B/\`Z':]_P#`&V_^(IB>
M,6ENHX([%?GF6/?YX88)AR1@<C$PP>^#73T`<W_PC_B/_H=KW_P!MO\`XBC_
M`(1_Q'_T.U[_`.`-M_\`$5TE%`'-_P#"/^(_^AVO?_`&V_\`B*/^$?\`$?\`
MT.U[_P"`-M_\17244`<W_P`(_P"(_P#H=KW_`,`;;_XBC_A'_$?_`$.U[_X`
MVW_Q%=)10!S?_"/^(_\`H=KW_P``;;_XBC_A'_$?_0[7O_@#;?\`Q%=)10!S
M?_"/^(_^AVO?_`&V_P#B*/\`A'_$?_0[7O\`X`VW_P`17244`<W_`,(_XC_Z
M':]_\`;;_P"(H_X1_P`1_P#0[7O_`(`VW_Q%=)10!S?_``C_`(C_`.AVO?\`
MP!MO_B*/^$?\1_\`0[7O_@#;?_$5TE%`'-_\(_XC_P"AVO?_``!MO_B*/^$?
M\1_]#M>_^`-M_P#$5TE%`'-_\(_XC_Z':]_\`;;_`.(H_P"$?\1_]#M>_P#@
M#;?_`!%=)10!S?\`PC_B/_H=KW_P!MO_`(BC_A'_`!'_`-#M>_\`@#;?_$5T
ME%`'-_\`"/\`B/\`Z':]_P#`&V_^(H_X1_Q'_P!#M>_^`-M_\17244`<W_PC
M_B/_`*':]_\``&V_^(H_X1_Q'_T.U[_X`VW_`,17244`<W_PC_B/_H=KW_P!
MMO\`XBC_`(1_Q'_T.U[_`.`-M_\`$5)JFOS:;J=XI\N2WM;19]F0&8D2DKDG
MK\B]!WYJ.S\3R7^NV]A'`(E#3)-N.XDH6`*GCY<J>?P[4`'_``C_`(C_`.AV
MO?\`P!MO_B*/^$?\1_\`0[7O_@#;?_$5)8^()]4U2VMXH1;Q/"\K;SEC@1$#
M'_;0@^A4^G-=/$MU:&7[4B706XFB'E+L*B)=Q..<DCM^O-`$G_"/^(_^AVO?
M_`&V_P#B*/\`A'_$?_0[7O\`X`VW_P`15:Z\="!]J6`<*I=V$W&!&7P#C!S\
MN#T.[\*L+XQ3[2;=[+:^_8K"8;3^\D0\X'/[LD#N#0`O_"/^(_\`H=KW_P``
M;;_XBC_A'_$?_0[7O_@#;?\`Q%2Z#XF?6[YX/L?V=%@67)DW$EL'`X'0,,^Y
MK?H`YO\`X1_Q'_T.U[_X`VW_`,11_P`(_P"(_P#H=KW_`,`;;_XBNDHH`YO_
M`(1_Q'_T.U[_`.`-M_\`$4?\(_XC_P"AVO?_``!MO_B*Z2B@#F_^$?\`$?\`
MT.U[_P"`-M_\11_PC_B/_H=KW_P!MO\`XBNDHH`YO_A'_$?_`$.U[_X`VW_Q
M%)I\6LZ;XIMK*^U^;4[>YLKB79+;Q1[&1X0""B@])&KI:QKK_D=M+_[!MY_Z
M,MJ`-FBBB@#%M2/^$XU-<\G3;,X_[:7-.L8+F^BFG?4[I#]IG0*GE@!5E90!
ME?0"H8[:&X\;ZIYR!P=+M$*GH09;G.1^`JWX?C2'37CC4(B7=R%4#``\YZ`)
M/[-F_P"@M>_^0_\`XBC^S9O^@M>_^0__`(BK]%`%#^S9O^@M>_\`D/\`^(H_
MLV;_`*"U[_Y#_P#B*OT4`4/[-F_Z"U[_`.0__B*CDL+A985&K7N'8@_ZOT)_
MN>U:=03_`.OM_P#?/_H)H`K_`-FS?]!:]_\`(?\`\13)+)X8S)+K-XB#JS&,
M`?\`CE:5%`&9!:_:8_,@UNZE3^\C1$?^@5)_9LW_`$%KW_R'_P#$5+IG_(*M
M/^N"?^@BK5`EL4/[-F_Z"U[_`.0__B*/[-F_Z"U[_P"0_P#XBK]%`RA_9LW_
M`$%KW_R'_P#$4?V;-_T%KW_R'_\`$5?HH`H?V;-_T%KW_P`A_P#Q%']FS?\`
M06O?_(?_`,15^B@"A_9LW_06O?\`R'_\11_9LW_06O?_`"'_`/$5?HH`Q+Z*
M[M9((H;V^N))V("[XE`P,DY*5%Y.M>E[_P"!,/\`\15K6+6*]O+&VFW^7(9`
MVQRI^[V(Y%0?\(=I7]Z]_P#`V7_XJJ2CU8%6*XU">9H8I[EY$SE5NX<\'!_@
M['BI_)UKTO?_``)A_P#B*K6_@>Q28"2ZN'CA!5%2XD5N>F3O]/0#^E7H_"6E
MQ2I(K7FY&##-Y*1D?\"JW&GT?X"U*,UY=V\C1S7DL;KC<KWUN",].-G>K/DZ
MUZ7O_@3#_P#$4W5M!MK^[NY9KZ*.258A$&'^J*;LG&X9)#D=L9J*V\-7R0OM
MUU95?#!C"Q"D=<8D^ZW.X=_4$9K(9)$=5FW^5)=2;&*-MNX#M8=0?DZT[9K&
M_9F\W8SC[5#G'_?%5D\(F-I3'K#QF0$N%!P04*@G+$D@_,ISP1WJUJGAVXU&
MYG*:@T*R*,-@EE(BD0#@C@%PX]P?K0!'.^IVJ"2XFN84+!0TEY`H)/0<IU-)
M#+J-R6$%Q<2E20=EY`V",9'">X_.M"YT:VO8%\IU7,@D\U<DJ1GE"",'D\\]
MQ@TV'2;A+^*YEFA9EN&GD>.(H6S'Y80C<>,8_P"^1QWH`K>3K7I>_P#@3#_\
M11Y.M>E[_P"!,/\`\16_UIIEC#%3(H88!&>>>E`&"T>LJI8_;<`9_P"/F'_X
MBKMK:2W5I#<+JE\JRQJX!\O(!&?[E:$W,#_[I_E5?1_^0+8_]>T?_H(H`9_9
MLW_06O?_`"'_`/$4?V;-_P!!:]_\A_\`Q%7Z*`*']FS?]!:]_P#(?_Q%']FS
M?]!:]_\`(?\`\15^B@"A_9LW_06O?_(?_P`140L;C[48_P"UKW:$#?\`+/KD
M_P"Q6I4`_P"/]O\`KD/YF@"O_9LW_06O?_(?_P`11_9LW_06O?\`R'_\15^B
M@"A_9LW_`$%KW_R'_P#$4?V;-_T%KW_R'_\`$5?HH`H?V;-_T%KW_P`A_P#Q
M%']FS?\`06O?_(?_`,15^B@"A_9LW_06O?\`R'_\11_9LW_06O?_`"'_`/$5
M?HH`H?V;-_T%KW_R'_\`$4?V;-_T%KW_`,A__$5?HH`H?V;-_P!!:]_\A_\`
MQ%9OV9[?QMIV^[GN-VFWF/-V_+^\MNF`*Z&L:Z_Y';2_^P;>?^C+:@#9HHHH
M`QK7_D=M4_[!MG_Z,N:L:)_QXR_]?ES_`.CWJO:_\CMJG_8-L_\`T9<U8T3_
M`(\9?^ORY_\`1[T`:-%%%`!1110`5!/_`*^W_P!\_P#H)J>H)_\`7V_^^?\`
MT$T`3T444`5=,_Y!5I_UP3_T$5:JKIG_`""K3_K@G_H(JU0);!1110,****`
M"BBB@`HHHH`RM7M_M5Y8P>=+#O,@\R%MKK\O8U#_`,(T?^@[K'_@4/\`XFIM
M7BEGO+&*"X:VD8R;954,5^7T/%0?V+K/_0T77_@-#_\`$TN5/<:JSAI']!D?
MA9UEE8ZYJP#D$8N1D\`<_+4T?ATQRH_]MZN^U@=K7((/L?EZ5GVWAO6XI(G;
MQ!,H"L`%AC/E9.<#*X_+&.@XJ_'H^KI*C/XDN9%5@2AMX@&'I]VCDB/ZQ5>Z
M_(36]#?4Y96C2W`DL9[?+]=[[-K=.VSZT#1;GS;J87"1+<1"-K:-08WPA7+$
MC.>>H`X`'.*CUW19-0GE>"WB)DL9XMS$`^:VS8?P"'GMFGQZ9J"&Z:)H8+>>
M+;]EP6)8(1N#`@(22,\'A1W)IDE6;PW<RZ<UJ8;/S!IGV-)MYR6*J"2-O3*C
M'/;WXTHM-E2[U69Q&RWP7:JN5/";2"0,CIU%94NBZA)8-"+=5N!I?V83"?[\
MA5>3]"O!^OK6O:6EQ%J.IS2KF*X,9B7?G.$`(QVY%`&=/H&HQZ=86>G7OV9;
M8L6`E9<@L"JY`^;`XR>O4]34-AIGB!?MUO=7,V3:&&"X-QN7?L4!MO7.03GK
MR>O&)M(T;5+2>QDN+@$0V\:2`2$D[8MA3W&[Y\U0N(O&%K;(S7CNS*%<QQK(
M0VR/D!4Z;Q+^!7\`#4LM'U%;^6::\DAM)%_=V\<Q)BX7:/08P_3U%1WOAEKI
MK[8R(;OR\N[F0@IG#X8'GH-HP,`\\T:G;Z_-*S:?,86:!`C-M^4[9-P/!`.X
MQ$XZ@>U3ZOIFJ7FFM%:WJ)*[HQ#AL`!@2,@__KQCO0!;LK::VLKH3'[\TLB)
MUV*22!_7\<5)H_\`R!;'_KVC_P#016/;Z1?V-TLGVB1XVE8L&;/[L1ORQZ%B
MS)^"#WK8T?\`Y`MC_P!>T?\`Z"*`+E%%%`!1110`5`/^/]O^N0_F:GJ`?\?[
M?]<A_,T`3T444`%%%%`!1110`4444`%%%%`!6-=?\CMI?_8-O/\`T9;5LUC7
M7_([:7_V#;S_`-&6U`&S1110!C6O_([:I_V#;/\`]&7-6-$_X\9?^ORY_P#1
M[U5MF4>.=33(W'3+,@>PEN?\15K1/^/&7_K\N?\`T>]`&C1110`4444`%03_
M`.OM_P#?/_H)J>H)_P#7V_\`OG_T$T`3T444`5=,_P"05:?]<$_]!%6JS;6^
MM[33+$3N5+PIMPC-GY1Z"M$$$`CH:!+9"T444#"BBB@`HJGJ@<6$KQS/$R*6
M!0BK,:>7&$WL^/XF.2:!7U'T444#,;76E%S9""[BM)29`DTJ[E4[?3(S^=4<
M:[_T-FF?^`8_^.5T<L$,ZA9HDD4'(#J"/UJ+^S;#_GRM_P#OTO\`A2:N-.QR
M-F_B4W;.^O6L7GC+F2!&5".``!+W'7'?\ZTHO[:65&E\4Z:\88%E%H`2.XSY
MG%;G]FV'_/E;_P#?I?\`"C^S;#_GRM_^_2_X4E&PW(P]<+7$\K65XWS6,X!C
MO=@\\[/+P-XQT;VY]Z5+B[62Y\NZA6UDBP(Y;L&4/L.2A!(&3MX)XP3WK31-
M(DNFMEM83*O5?L^,=>^,=C5C^S;#_GRM_P#OTO\`A5$G,RR7CZ>P2XG6[&F>
M5N%\FUYRJX/W^""#SCG)YZ9UK2["ZCJ33W2_9Y"A@!N%/&P!@OS?+S]*T/[-
ML/\`GRM_^_2_X4?V;8?\^5O_`-^E_P`*`,/2Y)TFTZ:ZU`YCL%BN4DN59#)@
M988;ELYR2",=".<Y<VN>)+6V1Y)K<LZA3@Q-M?9&>S=-QE'/&%'<@UV']FV'
M_/E;_P#?I?\`"C^S;'_GRM_^_2_X4`<]J>J:H97.FW$))@0IN=`,[9-V03C.
MX1#V'XU/JT]_)IS"QU*W:9W0[#.L11=P)`89^GTS6N;+3%;:UM:AO0QKFG_V
M;8?\^5O_`-^E_P`*`,/S!:WF^*^9HY[ERZR79E"Q>4W/S,0N9-I`&.#]:V='
M_P"0+8_]>T?_`*"*?_9MC_SY6_\`WZ7_``JP``,`8`H`6BBB@`HHHH`*@'_'
M^W_7(?S-3U`/^/\`;_KD/YF@">BBB@`HHHH`****`"BBB@`HHHH`*QKK_D=M
M+_[!MY_Z,MJV:QKK_D=M+_[!MY_Z,MJ`-FBBB@#`CM8;CQQJ9F02#^RK1"K#
M*D&6XSD=^@JYH$:1::\<:*B+=W(55&`!YS\`5#:_\CMJG_8-L_\`T9<U8T3_
M`(\9?^ORY_\`1[T`:-%%%`!1110`5!/_`*^W_P!\_P#H)J>H)_\`7V_^^?\`
MT$T`3UE^)+S^S]`NKH(S-&H*!&VG?D!>?J16I6#J_P#Q,?$&FZ4.8X3]MN![
M*<1C\6.?^`TT1-^[H8]G?ZKI&G61U>Q:6V,D<GVRW)<@;>C1]1@<<<<=*ZZR
MO[34;<7%E<1SQ-T9&S^'L:I1_P#(,TKZQ?\`H-,O?#=I/<&\LY)-.O3_`,O%
ML=N[_?7HP^HI=1)2C%6U-BBN?_M;5='^76K/[3;C_E^LE)`'J\?5?J,BMBSO
MK74;=;BSN(YXFZ/&V13L4I)Z%BBBBD45=3_Y!EQ_US-6JJZG_P`@RX_ZYFK5
M`NH4444#"BBB@`HHJK>7%Q`\(AACD$C[,O(5P<$]E/I0)NPD?_(6N/\`KA%_
MZ%)5NJD6?[6N,]?L\7_H4E6Z2*84444Q!1110!1N((FU2V<Q(S[)#DJ.VW'-
M/LKFXN'F6:"*(1/LRDI?)P#W4>M+-_R$[7_KG)_[+3;#_67G_7P?_05I,2ZE
MRBBBF,****`"FNI="JNR$CAEQD?GD4ZB@"GI9F>T$DUP\S,S#+A1C!([`>E2
MC_C_`&_ZY#^9J+2_^/!/]Y__`$(U*/\`C_;_`*Y#^9I+8;W)Z***8@HHHH`*
M***`"BBB@`HHHH`*QKK_`)';2_\`L&WG_HRVK9K&NO\`D=M+_P"P;>?^C+:@
M#9HHHH`QK7_D=M4_[!MG_P"C+FK&B?\`'C+_`-?ES_Z/>J]K_P`CMJG_`&#;
M/_T9<U8T3_CQE_Z_+G_T>]`&C1110`4444`%03_Z^W_WS_Z":GJ"?_7V_P#O
MG_T$T`3$X&36%X9_TUK[6V_Y?YL0^T*?*GY\G\:F\47,L.CM;6S8N;]UM8?8
MOP3^"Y/X5I6EM%96<-K"NV.%`B#V`P*?0C>7H4(_^09I7UB_]!K5K*C_`.09
MI7UB_P#0:U:GJ4MD%8]YX;M9KAKRQDDTV]/6>VXW_P"^OW6_$5L44P<4]S`_
MM?5-'^76[/S[<?\`+]9*64#U>/JOU&16Q9WMKJ%NMQ9W$<\3='C;(J>L:[\-
MVTEPUYI\LFFWAY,UM@!_]]/NM^//O3)M);:E_4_^09<?]<S22W-PE_';);QL
MDBEMYE((`*@\;?\`:]:P-3UC5=)L9(M:LEE@92OVZTR5]MR'E?PR.:T-.UFR
MUB]M9K6XA<F"4E$D#,GS)@''0_YYI-.P1FG*QM4444%A1110`54O?]9:?]=Q
M_P"@M5NJE[_K+3_KN/\`T%J!/8(_^0M<?]<(O_0I*MU4C_Y"UQ_UPB_]"DJW
M213"BBBF(****`*LW_(3M?\`KG)_[+3;#_67G_7P?_05I)Y8UU*`F10$20-D
M_=^[U_.EL/\`67G_`%\'_P!!6D^@EU+E%%%,84444`%%%5DNR]XUM]FF!0!B
MY*[<'.#][/.T]J!7&:7_`,>"?[S_`/H1J4?\?[?]<A_,U%I?_'@G^\__`*$:
ME'_'^W_7(?S-);%/<GHHHIB"BBB@`HHHH`****`"BBB@`K&NO^1VTO\`[!MY
M_P"C+:MFL:Z_Y';2_P#L&WG_`*,MJ`-FBBB@#%M2/^$XU-<C)TVS('_;2YJS
MHG_'C+_U^7/_`*/>J4=M#<>-]4\Y!(ITNT0HW*D&6XSD=#T%6_#\:0Z:\42*
MB)=W(55&`!YS\`4`:=%%%`!1110`5!/_`*^W_P!\_P#H)J>J6I745E$MU,=L
M4.]W/L$8T`9P_P")GXQ)ZP:3#C_MM(/Z(/\`QZMZL?PO:RPZ.MQ<C%S?.UU-
M[,_('X#`_"M626.&,R2R+&@ZLQP!^--D0VN^IF*RKIFD[F`RT(&3U.VM:O/-
M8CN/$E]H^F6%\8H+&&.6:6(_<F8809'<`$^WXUT*6OBO347R;^TU=`.8[E/)
MD^@=<@_B*SYM7H:)>ZM3HJ*Y\>+8;0[-:T^\TINADEC\R'/M(F1^>*V;6\M;
MZ$36ES%<1GH\3AA^8JDTP::)Z***8BEJT4;Z?*[(&:-"5)_A.,9%9]]X=T>[
MU&WCFT^''E2MN0;&!W)C##![FM/4_P#D&7'_`%S-)+_R%K;_`*X2_P`XZ'L3
M9-ZF;_8.HV?.EZ[<HH_Y8W@%PGTR<,/SH_M/7K'_`(_]%6Z0=9=/EW'_`+]M
M@_D36[13N+DML[&/;>*='N)1`UV+6?\`YXW2F%_R;&?PK7!!`(.0>A%17-G;
M7L7E75O%/&?X94##\C60?"=G`2VEW5WIC=<6TQ\LGW1LK^E&@>\O,W:J7O\`
MK+3_`*[C_P!!:LW'BBPZ-9:M&/4&WE/\U/Z50U+Q>EI)`-0TF_LV5]P#Q[@[
M`$;59<@]1_\`6HL)S26NAT,?_(6N/^N$7_H4E6ZX,_$6S;5)Q;6Z*QAC5C>7
M*0*I!8]\D_>],U(?%)NO]?XNT2P7^[:CS6_[Z<X_2I37<MM]$SN*S;SQ%HVG
MMMN=2MT?IL#AG_[Y&37,?:?!LW.I>)WU+_9GO#L_[Y7`_2M"S\1^"--&+*[L
M(/>*/!/X@4<T>X6J/H7/^$EDN>-,T34+O/1WC$$9_P"!/@_I1_Q55Y_T#M,0
M_P"]<2#_`-!7^=-_X3GPS_T%HS]$<_TI/^$Y\-?]!-3](I/_`(FCGB'LY/>Y
M0NO#.IR:K%<G7YGN]I,3M"FP;2#\R`8(Y./3KFI[/6K[27NAK-BSQ"8[KVS4
MO&#M7[R?>4>_(I9/&OAYKZ"1;]BJ(X)%O)WVX_A]J@TSQUH+R7N9YQFX)3%M
M(V]<`!AA3P<'KZ4.<=-11I-7L=/9WUKJ%N+BSN(YXFZ/&P(J>N(O+[P[/<&[
ML%U6RO#_`,O%E83+N_WEV;6_$4^Q\9ZC;R^3?:1J%["!Q=V]A+&V/]I&&/R/
MX4<T>XUS+1H[2BN8M?'EC?AC9:9JUR$.&\JUSM/OSQ5C_A*I#]WPWKA_[=E'
M\WI<R*LV;]58_P#D*S_]<(O_`$*2LK_A)+]ON>%M6/\`O>4O\WJE/XDU.TGN
MKN3PS=JB0(7#7$(*@%\'[QSG.,#GBCF0.+NCH-+_`./!/]Y__0C4H_X_V_ZY
M#^9K"\$:Z-:T>02((KJVF9)H@>F22#]"#^AK='_'^W_7(?S-$7=`U9D]%%%4
M(****`"BBB@`HHHH`****`"L:Z_Y';2_^P;>?^C+:MFL:Z_Y';2_^P;>?^C+
M:@#9HHHH`QK7_D=M4_[!MG_Z,N:L:)_QXR_]?ES_`.CWJO:_\CMJG_8-L_\`
MT9<U8T3_`(\9?^ORY_\`1[T`:-%%%`!1110`5@>)XAJ,VG:,&_X^I_,F'_3%
M.6_/('XUOUS>G?\`$Q\2W6JGF.*4V5N?]E%)<_BYQ_P&FB)Z^[W.CK*N=3?3
M(;^\O9T-O9INVK'@GC(&<]<\?C6M7*WT3ZQXN&E;<VEJR7EV>S$#$:'\06(_
MV142=C:'4FTC3YK/3;:XO1_IU]=BYN?9F!POT48'X5TE4[_K:_\`7PO\C5RA
M*VA+=Q"`1@C(-8MUX1T>XF-Q#;M8W)_Y;V3F%_\`QW@_B#6W13:3W!-K8Y[[
M%XHTW_CSU*WU6$?\LKY/+DQZ"1."?JM(?%JV2D:UI5YIK`??9/-A)_ZZ)D#\
M<5T5)UI6[,=^Z,==6@U?1;J>WVF,*0&657!ZCL3Z5>E_Y"UM_P!<)?YQU@WG
MAG2+BPN;T6OV>Z5YL3VS&)^';J5QG\<UF7EGXKM?$5O;V>JW,MLB%4FF@C=]
MI*;SV#8^7D^A_%-M+4;2<W8[RJ=[J^FZ:";Z_MK;OB655/Y&LO\`X107/.IZ
MSJ=]G[T9G\F,_P#`8PM7++PUH>G$-:Z5:HXYWF,,_P#WT<G]:>HM"G_PF6G3
M<:=;7^I'UM+5BO\`WTV%_6C^T?%%YQ:Z';62GH]]=;C_`-\Q@_SK?I:+/N%U
MV.?_`+'\07?_`!_>(S`IZQV%LL>/H[;C4%QX/T@2VKW:W&H2-,%+WMP\N1@G
M&"<=AVKI)1(8R(F57[%EW#\LC^=9ZRS3VNGS3LA>657^12H&4)QR30HJXG=Q
MN4+#PMI%CKDDEO:JGEQ*ZJ/N@L9`>/3@?D*W1;0#I!&/^`"H8_\`D+7'_7"+
M_P!"DJW322!MC!%&.D:C_@(IP4#H`*6BF(****`*=PH?4+=&Y5HY`>?]VJFB
MZ58V-Q>26UN(V$ICR"3\N%..35V;_D)VO_7.3_V6FV'^LO/^O@_^@K2:U0+J
M7****8&7J'A[3]0F%R4>VNQ]VZMF\N4?B.OT.:J>=X@T?_7Q+K-J/^6D($=P
MH]T^ZWX8/M6_13N0X+=:&?INMZ?JVY;2X!E3[\+@I(GU4\BIH_\`D*S_`/7"
M+_T*2H=2T/3M5*O=0#SD^Y/&2DB?1AS7.12:CX>U=Y=0N+J[TM`H,SL#)$"6
M"M)C[RYW?3()'H$N3C;F+-U87-O##K^E1E[VVWK-`/\`EZAWDE/]X=5/KQWK
M:TZ_MM4\N]M)/,AF@5E/XG@^A'0T_2'5]-C=&#*Q<A@<@C<>:PK@Q^%-=>\1
M"-+OF!NL=+:0G`D`[*Q^]Z$@UFM-3??0ZJBD!R,BEJR0HHHH`****`"BBB@`
MHHHH`*QKK_D=M+_[!MY_Z,MJV:QKK_D=M+_[!MY_Z,MJ`-FBBB@#&M?^1VU3
M_L&V?_HRYJQHG_'C+_U^7/\`Z/>JMLZ#QUJ498!VTRT(7/)`EN<G]1^=6M$_
MX\9?^ORY_P#1[T`:-%%%`!1110!G:]J#:7HMQ=1C=,%V0K_>D8X4?F13--T]
M=*T_3;$')AX9O[S;6+'\22:JZC_Q,O%-AIXYAL5-[/Z;ONQC\]Q_"M>?_7V_
M^^?_`$$TR%K)L;J-]!IFG3WURVV*",NWOCL/<]*Q_"5K<PP7=Q?#%[>2"XG!
M_@+*"$^BC`_"DU?_`(G7B"TT1?FMK;%Y>^AP?W:'ZL-Q'HM21>)=&AU:\@FU
M*WB?<H`D?;SM'<UG?4Z(1DXM)7-*_P"MK_U\+_(U<K.N+JWNA:M;SQ3+]H7F
M-PPZ'TK1JD9M6"BBBF(****`,U;>6ZTV6&*5(]\TP8LA;CS&]Q4I#C4[42,K
M/Y$N2JX!^9.V33]/_P"/=_\`KO+_`.C&I)?^0M;?]<)?YQTNA4E[S9;HHHID
MA1110`5EQ?\`(.TGZQ_^@&M2LN+_`)!VD_6/_P!`-'4;^%EF/_D+7'_7"+_T
M*2K=5(_^0M<?]<(O_0I*MTD#"BBBF(*@N[G[);M,8GD5`2P3&0`,YY(J>JNI
M_P#(+N_^N+_R-#*CJT,:.[FNX;A5CC1`04D^]SC/0D=J6P_UEY_U\'_T%:N5
M3L/]9>?]?!_]!6DR5U+E%%%,`HHHH`*J*JOJ5RK*&5K>,$$9!&9*34/.7R3%
M</%ND5"%53D$^X-.B&-4G!.?W$7)[_-)0#6S.<L6N/#%N)U#SZ*[MYD8&6L_
MF/S*.Z>H[=:Z`K;:@SJ=EQ;7%N`>ZNI)_,$4NF`'3U!&06?(_P"!&L.2)_"E
M])/:0O+I3C=/`O)M<D_,@_NYR2O;J*%JB'[C\OR)=&GET/4!X=O9&>%@6TVX
M<YWH.L1/]Y?U%='69J5A:>(]("I/PV);:YB.3&XY5U/M46@:M->QRV6H*L6I
MV1"7*#HWI(O^RPY]N14K1V-7JKFQ1115$A1110`4444`%%%%`!6-=?\`([:7
M_P!@V\_]&6U;-8UU_P`CMI?_`&#;S_T9;4`;-%%%`&#';QS^-]4$JAT.EVBE
M&4%6!EN>H/TJWH$:1::\<2*B+=W(55&`!YS\`5#:_P#([:I_V#;/_P!&7-6-
M$_X\9?\`K\N?_1[T`:-%%%`!2,RHI9B`JC))["EK$\4S2'3$TZ!BL^I2BV0C
MJJG[[?@H:@4G97&^%U:YM[K69`0^IS&1,]1$/EC'Y#/_``*K^JWL&G6XO;EM
ML,&YW/L$:K4,,=O!'#$H6.-0JJ.P`P*YCQ1>6=UJEMIET^VTM!]MO6[`+G8A
M_P!X@G'M[TI.PZ<-D,LYKO2]($YC#:]KLID6,_P$C@'_`&8TQG_Z]:FBZ-;6
M$=U9LHN"65I9)1N,KE<LQSZFDT.TGN9Y-<U",I<W*[88F_Y=X>H7ZGJ??Z5H
M6W_']>?[R?\`H(J8HZ)2Y4X+Y^O_``#*U/PGIUU)&]OI-DI5MSNK&%C[90?K
M3QX8$2_Z'J^J6A'15N3(@_!P:W:*?*B%6J;7,/[#XEM^8=9M;H?W;JTV_JA'
M\J/MWB2WXGT:UNA_>M;O;^C@?SK<HHL'M;[Q3_#\K&'_`,).L(_TW1]4M<=6
M-MYBC\4)J6#Q7H-P^Q=4MT?^[*WEG\FQ6O44]K;W2[;B"*9?21`P_6BS#FIO
M=?B4M/U&R^RL?MD`!FEY,@_YZ-3)=4T\:I;L;^V`$,H)\Y?5/>H+#PYH;0NS
M:18LWG2\M;H?^6C8'2G/H.CKJENJZ38A3#(2!;I@\I[>]+6Q4O9<SW+AUO25
MZZI9CZW"?XTP^(=$7KK%@/\`MY3_`!IXT725Z:99CZ0+_A3QI>G+]VPMA](5
M_P`*?O$_NO,JGQ1H"]=:L?\`P(7_`!IA\7>'5ZZS9_A*#6B+&T7I:PCZ1BGB
M"%?NPH/HHIZA>EV?W_\``,@^,?#@_P"8O;GZ$FH=-U7P[J.GVBR7=A++'"@V
M2.NY3@<8/-;X50.`!^%9UIIFGW>E6@N;&WF'D(/WD2M_"/44O>*_=.+T?W_\
M`G@9&U2<H05^SQ8*GC[TE7*YP>$M$;5)UCLOL^(8V!MY'BP27S]TCT%3_P#"
M.30\VFOZI"1T$DJS+^3@_P`Z$WV%RTWM+[U_E<W**Q/L?B:#F+5[.Z'I<6A0
M_FC?TI/MOB6#B;1[2Z']ZVN]OZ.H_G1<7L[[-/\`#\[&Y574_P#D%W?_`%Q?
M^1K-_P"$CEBXN]!U6$CJ4A$JC\4)_E5>]\8:%-I]U%]M,4AB<!)HGC.<'CY@
M.:=]+CC2GS+3]3I*IV'^LO/^O@_^@K1#JVF70Q!J-K+G^Y.I_D:?:V5M:EGM
MT*E_O'>3G\S1N9M-;EFBBBF2%%%%`%2_^[;_`/7=/YT!U34KEW8*H@B)).`/
MFDHO_NV__7=/YTX6,`N6N,2%W&&S*Q4CGC:3C')[4#ELB'1YHI=/7RY$?#OG
M:P./F-6!_P`?[?\`7(?S-2JB(,(BKGT&*B'_`!_M_P!<A_,TEL)F'/;3^&)W
MO=/B:;2Y"6N;-!DP'O)&/3U7\13]6M6OX;;Q!H4B27MNFZ(J?EN8C]Z,GW[>
MAKH*YVYM+CPY<2:AI<+36$C;KNQ3JI[R1CU]5[TVKD+W'=;&MI6IVVL:?%>V
MK'9(.5889&'56'8@\5))>P17"P,7\QN@$3$'\0,=Q7-S7,.D70\2Z;()M'O\
M&^6/D(>@F`_1A^/:N@9UDU"U=&#(T,A#`Y!'R<U*;V-DD]>A8CN()B1%-'(1
MR0K`U)5.RC1+B\*HJ_OL<#'\"5<JC-!1110,****`"L:Z_Y';2_^P;>?^C+:
MMBL:Y.?&VE_]@V\_]&6U`&U1110!C6O_`".VJ?\`8-L__1ES5C1/^/&7_K\N
M?_1[U7M?^1VU3_L&V?\`Z,N:L:)_QXR_]?ES_P"CWH`T:***`"L&/_B9^,7?
MK#I,6Q2./WT@^;ZX7'TS6O?7<6GV,]Y,<1P1M(WT`S6?X9M);;1HY;D8NKMF
MN9_]]SG'X#`_"F1+5I&E=7,5G:RW4[A(H4+NQ[`#)K@=#MY/$NHR7-[&?)N)
MUFN2ORYD4$Q1CV5,;N^3U[#3\<37.J3V?A73SB>]/FW+=HX5/4_4C],=ZW[/
M3[?2K>QLK9<1Q,1D]6.ULD^Y/-9/WI>2.J+]G#FZO;_,T:J6W_']>?[R?^@B
MH=1M;>:\L6E@C=C,5)90<CRW./SYJ6VANH[N:27R=DI!^4G(P,"M&MC);,N4
M444$A1110`445FM:VYU^.7R(]_D,V[:,Y#*,_6FE<"QI_P#Q[O\`]=Y?_1C4
MY[7?=I<^?*I12H0;=N#C/;/\([TW3_\`CW?_`*[R_P#HQJM5/0J7Q,****9(
M4444`9MI;)'J]T0S'8JD`XXW9S_*K&F_\@NT_P"N"?\`H(IMO_R%;S_<C_\`
M9J=IO_(+M/\`K@G_`*"*J6Y2^%C(M(LH;]KZ.(BX;.6W'OGMT[FKM%%3:Q(4
M444`%8\T23:#J*2#*EKCO_M-6Q6.DT4NB:B8I$?#7&=K`XY:G]EE0^)$%WX(
M\/7I+3V!9CW$T@_]FJ*#P+I%FV;-[FW(Z;9`W_H0-=)14<D>QI[>K:W,S.CT
MRYB7"ZQ>D#H&2''_`*+J.6'7(_\`CWN;:7_KN#_[*!6K13L1SOLON.>D?QFC
M96/1I$]%\W=^I`I5U3Q%#S=:(T@[FV*']#)704R4R",F%59^P=MH/XX/\J7+
MYE^U76*.=OO$R*L'VC2M4M@LZ%FDM20!GU4FM*T\1Z+?-MM]2MR_]QGV/_WR
MV#1Y\MW8V5Q-$D9DEC=55R^`>>I`YJS=Z;8:@NV\LX+@?]-8PW\Z+23&W3:5
MU;^OZZEGK4(_X_V_ZY#^9K*_X1.PA.=/GO=./_3K<,%_[Y.5_2HA9>(;6[(M
MM5M[PB,<7D&TXR>-R8_/%%WV)Y(/:7W_`-,Z&BL/^V-9M?\`C^\/R2*.LEE,
MLH_[Y.TTZ/Q;HQ<1W%P]E*>-EY$T)'XL,?K1S(/8SZ*_IK^13OM/DT!)I;*!
MI],N79[^W^\ZAAAFCQ@_7)/L*JZ#=#3]6L],\])=,DMV_LNXR#YB\91CQ\PQ
MP,=.I)KH;V\+:9+=:?=0MY:E]P`D5L#IP:Y7Q#X=:T826RR2Q2!YI8H!M:&0
M%3YT([,."5[X/K525U=&4?<=NGY'4F5X(=3F3&Z-RPSTXC4U=C),:ECDD9KD
M_#^OKJVC:E%/-&]\D;-)Y>=KKY8`<>@..G4<CM761?ZI/]T4KW$MA]%%%,84
M444`5'GM;N22P=)6)'SJ8G`QS_%C'8]ZP-.M(+3Q-I/D1[-^G7I;DG)\VV]:
MZ"/_`)"D_P#UPB_]">L6V_Y&?1_^P;??^CK:@))<RL=)1110!C6O_([:I_V#
M;/\`]&7-6-$_X\9?^ORY_P#1[U4BB6;QEJT;YVMIEF#AB#_K+GN.15GP_&L6
MFO&F=JW=R!DDG_7/W/)H`TZ***`,'Q'_`*?<Z?HB\B[E\VX'_3&/#$'ZG:/Q
MK3U34K;1]-FO[M]D,*[CZGT`]STK,T7_`(F.MZEK!YC5OL=L?]A#\Y'L7)_[
MYKG-7D;QKXGL]+C).EPN97QTE5#AF^A;Y%_X$:4W9:#H0YVYO;^OS-_PC:33
M6\VOW\86^U0B3'_/*+_EF@_#GZFMN?\`U]O_`+Y_]!-3````#`'0"L;5M=MK
M*\AM85>]O@Q(M;?YG^Z1D]E'(Y-.$6]$$G=W+=_-%'>Z<DDJ(S7!VAF`)_=N
M./Q(_.K]<'J_AG6=<U&TN]0NH;0SOY8@A))A4*S?>_B/!]!^=;__``BZ]];U
MH_\`;Z?\*WE""2]XF[-VBL+_`(16,]=9UD_]OS4?\(I;]]4U<_\`;^_^-1RP
M[_@&INT5A?\`")6?>_U1OK?R?XT?\(AIQ^]<:@WUOI?_`(JBT._X?\$-3=K+
M>^M!XDCMC<1^=]G8;-W.25./KCG%5O\`A#M([_;#];V7_P"*K&E\`Z<?$*E9
MI3"8S+Y3.Q.00,;LYQD_7^=7!4];M_=_P0U.LT__`(]W_P"N\O\`Z,:K)('4
MUS=IX(TE%875HDF6)4K++W).#EOI5D>"_#@_YA41^K,?ZUFE#N_N_P""5+=F
MPUQ`GWIHU^K`5"VI6"_>OK<?65?\:H+X0\.ITT>U/UCS_.I5\,Z"G31K'\;=
M3_2G[G=DZDS:UI*_>U.S'UG7_&F'Q#HB]=9L!_V\I_C3ET'1E^[I-B/I;I_A
M3QI&F+]W3K4?2%?\*/<\PU.<B\;Z*VJWBK?+"&50DSIN1MN<\`YYSQ5NS\5:
M5!:QV\<]Q>M&H5?L]E+R`,#M_6K&FZ%IMEKUY<6]JJ.%0KCHN[.<#M6Y53=.
M^B?WC3=K&%_PDTC_`.HT#6)#VW6X0?\`CS"C^U]>D_U7AEE'8S7L:_H,UNT5
M/-'^7\Q&%YWBV7E;/2K<>DD\DA_111]D\4S?ZS5K"V_ZXVC/_P"A-6[11S]D
M@L<_-H&KW4+Q7/B>Y*NI4B*WCCZ_AG]:P-,\+:KING:A/#K(CXDC:/RA(L@7
M.<YQC\*[^LV"V^UV-Q`9I(E>>8,4VY(+,,<@U2JRY6OT0XI<R93^U>*;3_7:
M=9:@OK:SF)OR?C]:/^$MM(.-2L;_`$[U:>W)3/\`O+D5MQJ40*TC2$?Q-C)_
M(`4^IYHO="L4[+5]-U$`V5_;SD]HY`3^76KE9M[X>T?4"3=:;;R,3G?L"M_W
MT.:I_P#",&VYTS6-0LL?=0R^=&/^`OG^=%H/9V_K^N@:F]16%M\56?W9=/U)
M!_?5H)#^65J"\\67&F6LDNI:!>P%!PR%9(R>V74\?E0J;?PZA<OP_P#('TO_
M`+8_R%:M<5IWC32I](LDG:2"6!XU9?*=QA0.00OZ5L?\)IH'_/Z__@/+_P#$
MTY4I\ST95URHW:@'_'^W_7(?S-97_"9^'_\`G_/_`'XD_P#B:B'C#0!=F0Z@
M`IC`R8GZY/M2]G/LR;HZ&F21QS(4E170]589!K%_X33PY_T%(_\`OAO\*/\`
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M^^EP:SSX1OK/G1O$VH6H'2*X(N(Q[`-R/SJKOL+DCTDT6_\`A*%B_P"/O1M6
MML=6-J9%'XH34D7B[P_*^S^U(8F_NSYB/_CP%9;7?CK3/]=8:?K$8_BMY#%(
M?P;C\JBD\?::N(-?T:^T\GJ+FWWI^??\J7/'KH/V53[+3.A@O[.2^N)X[J%X
MA!%EU<%1\S]Q65:2QOXKTJ-7!9--O=P!^[F6VQFJ4%GX0\27=PMBEB2T*!&C
MCV,"2^<#@YQC]*ET>Q33_$6D01-F$:=>E%(Y7][;9Y[_`(U2LUH*:G&=I*VA
MUU%%%`&-:_\`([:I_P!@VS_]&7-6-$_X\9?^ORY_]'O5>U_Y';5/^P;9_P#H
MRYJQHG_'C+_U^7/_`*/>@#1K-\0:@^FZ+<3PC,[`1P*.K2,=J_J:T6R%.T`G
M'`)QFN(\0^(E34H#=11K'II:;RQ+D23DE(E)P,8P[?09IHEW?NQW9<NU6RTV
MW\,6D_E+%;[[^Y!_U,(Y8Y_O.<X_$U%H%S8:-ICZU?E;9]2(^S6X&76!1B)%
M4<DXY/NW-8RO<ZVB^'[%9!)J>;F_U*5,"1`>=BGG9G"C.._O7:Z7X=LM,D^T
M?/<WA&&NISN?Z#LH]ABDHKFO/[C>;48J$-BGC7->^\7T6P/88-S(/Y1_J:O6
MFDV.D_9X;*W6(-(2[=6<[6Y8GDGZUIU!/_K[?_?/_H)JW-M66B,;$=Y_Q]6'
M_7P?_13U;JI=6;W,\,JW<D7DMN5552,X(SR#V8U;J7LAA1112`****`"J;?\
MAJ/_`*]F_P#0EJY58V$!O!=GS?-'`/G/C'IMSC''I330%FBBBD`4444`%%%%
M`%.W_P"0K>?[D?\`[-5RL^UDD.JW):UF1'50KL!@[<Y[^]:%5+<`HHHJ0"BB
MB@!&)"DA2Q`Z#J:I:9YRI*LUK)#F5W!<J<AF)_A)J]13OI8`HHHI`%%%%`!4
M<\$5S"T,\:R1N,,K#(-244`8^F:5:G1K%(P\*B)),1.5RV`<GU-:X&`!DG'K
M572O^019_P#7NG_H(JW3E\3'=VL%0#_C_;_KD/YFIZ@'_'^W_7(?S-(1/24M
M%`&7X@L+6^T:X6YA601H77/!!`Z\54NO#&ARW=K`^F6^P1/RJX;@KCYAR>I[
MUIZM_P`@F[_ZXM_*FSRA=4@!28A4=2RQ,5!)7'(&.QJ^:2BK,J*NSGKG0(+*
MSU%[;5[ZQ2-BJQFXW1G]VIP0^?YU=MT\2QP+)::EINIQ$<&6(QGZ;D)'Z5M0
M65O;.S1(5+_>RY.?S/M4]'M)7UU(2T,/^W-6MO\`C^\.7.W^_9RI./RX/Z4Z
M/Q?HI<1W%R]E*?X+N)HB/Q88_6MNF21QS(4E170]589!I\T'NON_IAJ,M[JV
MNTWVUQ%,O]Z-PP_2JFLVEM<P0_:+>*;]_&/WB!N"XR.:@N/">A7#^8=-BBD_
MOP9B;\U(KG_$/A2\#6K6FH75U`)`ODW5P6"L3@$$\XZ?E[U4(P<E9V#4U9?"
M>BSZK.T=J;.00QE9+-S`P)+Y/R$>@Z^E4=&L+BQ\5Z:)-1N+N)]-O/+2<*3'
MB6WS\P`)SQU]*Z*QCDAN3%+)YDB6L*N_]X@ODUE6W_(SZ/\`]@V^_P#1UM6%
MDBYMW7I_D=)1113),:U_Y';5/^P;9_\`HRYJJ-3_`+*TDS&:",-?W"XESSFX
M89&/3.:LVK#_`(3C4UR,G3;,@=_];<UCZGI":KHZC=*'6^N5^2`R@JT[;L@=
M..?SJZ:3DD]@9=O?$YGMIH=(A&H2QQGSKA'*6\/'),G?Z#GWKFO#^GDP7/BG
M7+9+S>WF(96"QJ`<%\'OQW'3GZ;%SH,D]UIVDP)-%IHB+7'[PJ95!7`V]!R>
M1BK7B70YKC1?L$,\TT$DFZ2(QYW<YQ\BC`R<_@*F<]U%;&G(H\KOJ_P+'A6*
M2[2X\07492?4V#1H>L<"\1K^(RQ_WJZ"JFEQRPZ7;13/O>.,*6VE<XX'!Z&K
M=3%61#=V%03_`.OM_P#?/_H)J>H)_P#7V_\`OG_T$TQ$]%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!3)8EFC
M,;[MIZ[6*G\QS3Z*`(;:UBLX1#`&"#H&<MCV&2>*FHHHW`*@'_'^W_7(?S-3
MU`/^/]O^N0_F:`)Z***`*VH6\UW9R6\,J1&12K,Z%N".P!%31B01@2LK/W*K
MM!_#)_G3Z*=]+`%%%%(`HHHH`*I:DEU(D2VT*2;9%=BTFW&U@<=#Z5=HIIV=
MP*:KYM_.K@KNMXLA6((Y?H1S68;6*T\9Z9'#O"_V=>'#2,V/WEMZDUL+9VJ3
MFX6WB68]9`@W'\?Q-9MU_P`CMI?_`&#;S_T9;4ARLW<V:***!'/I9PW/CK4W
ME4MC2;6/&<?*TMP3_P"@BGZ5>6^E6DEG);7J&.YG*A+.9QM,K%<,%(/!'>I+
M7_D=M4_[!MG_`.C+FMF@#'-_IAN1<FWU#S1T;[#<_P`MN*E3Q!8R*61+Y@"5
MR-/GZ@X(^YZ@U0MO&%L\,;7-O)&T@!58R),_(&]O7'X=LT@\76$5P8D@=8BZ
MJ,!0S.S/GC([KR?4G-`VV]S2_MRT_P">-_\`^"^?_P"(H_MRT_YXW_\`X+Y_
M_B*DTS5;;5H7FM=Y1'*$L,9(J[0(SO[<M/\`GC?_`/@OG_\`B*BEUFV:6%A!
M?D*Y)_XE\_'RD?W*UJS=0U9M/O(HG@5XI%W;A)AOO(G0C'5QW[&@!?[<M/\`
MGC?_`/@OG_\`B*/[<M/^>-__`."^?_XBJ$OC'3XXU=8;AP4,AP%&%!P3R>OM
M3SXMTX.R>7.763RRNU>N0.N<=6'^2*`+4?B"QEC62-+YT<!E8:?.00>A^Y3O
M[<M/^>-__P""^?\`^(JF_B".#2[>\M[(FU9VBP&P453C(`!XVJQ_`#O277BN
MVM8IE>&07,,;,T9'R[@NXC/7]/?I0!=_MRT_YXW_`/X+Y_\`XBC^W+3_`)XW
M_P#X+Y__`(BI8=1CN)[9(P"ES`\RMN&0%*#&!_O^O:KE`&=_;EI_SQO_`/P7
MS_\`Q%']N6G_`#QO_P#P7S__`!%076OBQO)HKJ`>7$,[HGW-]UVY4@?PHQZG
MMUZU!+XPL(G(,,Y58Q(Q&WC+``=>3D_H:`+DGB"QAC,DB7R(O5CI\X`_\<IW
M]N6G_/&__P#!?/\`_$52?Q3I<K>0\4KYF$#*R+@-SUR>G'6I)-?D7[$R61*7
ML2NA+_=+`\'`./F,:Y_V_:@"S_;EI_SQO_\`P7S_`/Q%']N6G_/&_P#_``7S
M_P#Q%4)O&%@B@QI(>5+;P%`4OMS]0?7&,<XK5AO?-U&>T_=8B16!64%N<\%<
M<=O7.:`(?[<M/^>-_P#^"^?_`.(H_MRT_P">-_\`^"^?_P"(K1K#_P"$FC@)
M6\M]AWN@\E]_*N$.<XQR1CZT`6_[<M/^>-__`."^?_XBFMX@L49%9+Y2YVJ#
MI\_S'!.!\GH#^54V\86"O@PSE?E`8!>22P_O?[.<^XI)?%FFLR;8)9F61EC)
M51AAD$C)XXSS]:`+_P#;EI_SQO\`_P`%\_\`\11_;EI_SQO_`/P7S_\`Q%5[
MG7GM-1EM9K3"1HTGF!B<H`&SC;UQOP,]4--B\4V<^HP6D:./-X+/A<,0"!^1
M_EC.10!:_MRT_P">-_\`^"^?_P"(H_MRT_YXW_\`X+Y__B*GL;QKLW`:,)Y,
MQC!5MP8``YS@>OX8JPY8(Q0`OCY0QP"?<T`4/[<M/^>-_P#^"^?_`.(H_MRT
M_P">-_\`^"^?_P"(JE%XKMA%&;F%D:2-)!Y;!EPP)Y)Q@_*WY9I$\7V#2JC0
MW"[W"J2%[J&R1G(ZX_"@"X?$%B)%B*7P=@6"_P!GSY(&,G[GN/SIW]N6G_/&
M_P#_``7S_P#Q%4H/%&GWEY;)#;RM)-PCL%&U21GOD<[>/I2GQ(8)KI+NS,2V
MI&]E8G.6VC&0/53]&SF@"Y_;EI_SQO\`_P`%\_\`\11_;EI_SQO_`/P7S_\`
MQ%06?B.UO=3:SC1AA206X)()##'X?7KQP:OZ?>?;[03^4T67=-K=1M8K_2@"
MO_;EI_SQO_\`P7S_`/Q%']N6G_/&_P#_``7S_P#Q%3ZC=/8Z=/=I&LA@C:0J
MS[00!D\X-9LOBJSMA*+B*020YWA,,.&VG!R,\_CT]1D`M_VY:?\`/&__`/!?
M/_\`$4T>(+$R-&$OMZ@,5_L^?(!S@_<]C^54_P#A,-/5RDT4\;!Y$/"D?(,G
MH?0BIK/7[:_O3#:6S>>T+ONDVKG8Q4*2,GKN^G/%`%C^W+3_`)XW_P#X+Y__
M`(BHAK-M]K9_(O\`:8P,_P!GS]<G_8JM#XJB,'G75K+"ID\L!06);!;T'\.#
M^G-36OB.*]COC;0[WM@&1&D5?,!4$<DX&2<9Z=/6@"Q_;EI_SQO_`/P7S_\`
MQ%']N6G_`#QO_P#P7S__`!%78)/.@CE*E=ZAMIZC(Z56U&^DLC;+%`)GN)O*
M`+[<?*S9Z'^[0!'_`&Y:?\\;_P#\%\__`,11_;EI_P`\;_\`\%\__P`16=_P
MF%M]O\KR'\G[/YP;^,G=@#'3WZ^W7BKB>(K9TN&^S7:BW<H^8NXZ\@XP,'DX
MZ4`/3Q!8R%PB7S%&VL!I\_!QG'W/0BG?VY:?\\;_`/\`!?/_`/$55M_$%M<V
M-Q>65JV(]DDN_"_*3@M\N<D*,XZX`IH\56T4"O=V\L+LBOY:C<5R=I!SCD/D
M?@#WH`N?VY:?\\;_`/\`!?/_`/$4?VY:?\\;_P#\%\__`,145KKL=S917"QK
MEKD6[+OZ'.,__KQ^6"=:@#._MRT_YXW_`/X+Y_\`XBC^W+3_`)XW_P#X+Y__
M`(BC4=4-A=0Q>1YB/%)+(V[!14VYXQS][_/44+?Q7#-?7%L;:3]VT:QA,%G+
MC/(.`,<=SW/04`7_`.W+3_GC?_\`@OG_`/B*S(M2MM2\9Z9);><4&F79W26\
MD8.9+;IN`ST[5:'BBR_L\WQ@NA%D]8L<#OG..>,<Y.:IVE];7_BS3'M8FBC3
M3[Q0I4#'SVIXP<=_YT`=-1110!C6O_([:I_V#;/_`-&7-;-8UK_R.VJ?]@VS
M_P#1ES6C>W]EIML;F_NX+2`$`RSR!%!/3D\4`6**J6^J:==VT5S;7]M-!.^R
M*6.9661N>%(.">#P/2K=`!1110`45'%-%.A>&5)%#,A9&!`9258<=P001V(-
M"7$$DS0I-&TB*KLBL"P4D@$CT)5L'V/I0!)1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`07%Y;6@!N)XX@V<;V`SCK^53!E894@C)''J*S]7TK^U
M$C`F$+1AMD@3+HQXW*01COQR#GD&L<^#I4D5K?5/)"N6"K!P?FD;!PW(/F`'
MU"]NP!TD%S!<P">"59(CG#J<@X.#^HJ&WU6PNB!;W<4I;;C:V<[@2OY@$UFZ
M%H!TBZD;>60+@':`&8LQ+`9..&"_\!IJ^%A"]R]O?21-.CJH"\)EBR8Y'"[W
M&.,ANV!0!M37$-N8Q+(J>:X1-QQN8]`/?@U+7+W'A"YGV_\`$U";&5D_<LVT
M@`%0&<C;D9`.2,D9.:Z:-2D:J=N5`!VC`_`=J`'4444`%%%%`!1110`4444`
M%%%%`!1110`E+110`R.&.'<(D5-[%VVC&2>II]%%`"4M%%`!24M%`!6')#';
M^,=)BA18XUTV\"JHP!^\MJW*QKK_`)';2_\`L&WG_HRVH`V:***`,:U_Y';5
M/^P;9_\`HRYI?$MO>3Z?";%;II8KA'_T0PB4`9R5\WY._>JVJZ%K-QK;ZGI&
MO1:=YMM'!+')8B?=L:1@<EQC_6'C':H/[$\9_P#0Y6W_`()U_P#CE`%34-&U
M[7+6T3S)+9K-&E5]5@AFD>;=E"/(=55D"\$<8;H3FK/B1M0N;G3(8(+X336T
MSF"UNQ"4D'E[2Q#`,%)Y&3GG@]"[^Q/&?_0Y6W_@G7_XY1_8GC/_`*'*V_\`
M!.O_`,<H`HZK!KMM!J%P7O$D6*0M<K=XB=2/D6--QV,#C+;1WY.<"2*U\16]
MM(D%M?F*=94@BFO5>6VR$(,CM(=QR),$%B-P'3I:_L3QG_T.5M_X)U_^.4?V
M)XS_`.ARMO\`P3K_`/'*`,M])\21W=JEK:SPI'J<MQ)*EV0KPO>2.RE!(!DQ
ML""4;J1\I`I(M&URUC6$6NJOI\442-;PZEMFD8/<[BKF4$#YH2?F4D8'\.VM
M7^Q/&?\`T.5M_P""=?\`XY1_8GC/_H<K;_P3K_\`'*`*^DZ5XC@U:WN[VXNI
M/],"S`W>Z(P?8P"=F<9\\=0H/4\`FNPKE_[$\9_]#E;?^"=?_CE']B>,_P#H
M<K;_`,$Z_P#QR@#J**Y?^Q/&?_0Y6W_@G7_XY1_8GC/_`*'*V_\`!.O_`,<H
M`ZBBN7_L3QG_`-#E;?\`@G7_`..4?V)XS_Z'*V_\$Z__`!R@#J**Y?\`L3QG
M_P!#E;?^"=?_`(Y1_8GC/_H<K;_P3K_\<H`ZBBN7_L3QG_T.5M_X)U_^.4?V
M)XS_`.ARMO\`P3K_`/'*`.HHKE_[$\9_]#E;?^"=?_CE']B>,_\`H<K;_P`$
MZ_\`QR@#J**Y?^Q/&?\`T.5M_P""=?\`XY1_8GC/_H<K;_P3K_\`'*`.HHKE
M_P"Q/&?_`$.5M_X)U_\`CE']B>,_^ARMO_!.O_QR@#J**Y?^Q/&?_0Y6W_@G
M7_XY1_8GC/\`Z'*V_P#!.O\`\<H`ZBBN7_L3QG_T.5M_X)U_^.4?V)XS_P"A
MRMO_``3K_P#'*`.HHKE_[$\9_P#0Y6W_`()U_P#CE']B>,_^ARMO_!.O_P`<
MH`ZBBN7_`+$\9_\`0Y6W_@G7_P".4?V)XS_Z'*V_\$Z__'*`.HHKE_[$\9_]
M#E;?^"=?_CE']B>,_P#H<K;_`,$Z_P#QR@#J**Y?^Q/&?_0Y6W_@G7_XY1_8
MGC/_`*'*V_\`!.O_`,<H`ZBBN7_L3QG_`-#E;?\`@G7_`..4?V)XS_Z'*V_\
M$Z__`!R@#J**Y?\`L3QG_P!#E;?^"=?_`(Y1_8GC/_H<K;_P3K_\<H`ZBBN7
M_L3QG_T.5M_X)U_^.4?V)XS_`.ARMO\`P3K_`/'*`.HHKE_[$\9_]#E;?^"=
M?_CE']B>,_\`H<K;_P`$Z_\`QR@#J**Y?^Q/&?\`T.5M_P""=?\`XY1_8GC/
M_H<K;_P3K_\`'*`.HHKE_P"Q/&?_`$.5M_X)U_\`CE']B>,_^ARMO_!.O_QR
M@#J**Y?^Q/&?_0Y6W_@G7_XY1_8GC/\`Z'*V_P#!.O\`\<H`ZBL:Z_Y';2_^
MP;>?^C+:J']B>,_^ARMO_!.O_P`<J?2M"UFWUM-3U?7HM1\JVD@BCCL1!MWM
2&Q.0YS_JQQCO0!T-%%%`'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g118721moi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721moi002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$3`<T#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#TTPZI>:A?
M>3J[6\44RHD8MT;`\M&/)&>K&G_V;K'_`$'Y/_`6/_"K-A_Q^:E_U\K_`.BH
MZNT`9/\`9NL?]!^3_P`!8_\`"C^S=8_Z#\G_`("Q_P"%:U%`&3_9NL?]!^3_
M`,!8_P#"C^S=8_Z#\G_@+'_A6M10!D_V;K'_`$'Y/_`6/_"C^S=8_P"@_)_X
M"Q_X5K5R1\5W5K)(URD,D0EVADR`%(F9>>>?W:@@@$<]B*`-?^S=8_Z#\G_@
M+'_A1_9NL?\`0?D_\!8_\*I:-XI?6-1@A6U6&&6%G+-)EMX2%]N/I+C_`("?
M2DLO$-SJVJ6MM`BVT;PR2MYG+$@1$#'_`&U(/NC>G(!>_LW6/^@_)_X"Q_X4
M?V;K'_0?D_\``6/_``K*C\3W=JDSW2QW06XGB`A3856+))/)SD8^F*ANO'@@
M8A+(,(UWR'S."/)>3Y3T.=J@'H=PH`V_[-UC_H/R?^`L?^%']FZQ_P!!^3_P
M%C_PK+?QLD5P\$EG\RMA6$@VM\[H1D_Q?NV('<58T#Q0^N:@]O\`91"B0"3)
M;)))'`_!AGW-`%S^S=8_Z#\G_@+'_A1_9NL?]!^3_P`!8_\`"M:B@#)_LW6/
M^@_)_P"`L?\`A1_9NL?]!^3_`,!8_P#"M:B@#)_LW6/^@_)_X"Q_X4?V;K'_
M`$'Y/_`6/_"M:B@#)_LW6/\`H/R?^`L?^%']FZQ_T'Y/_`6/_"M:B@#)_LW6
M/^@_)_X"Q_X4?V;K'_0?D_\``6/_``K6HH`R?[-UC_H/R?\`@+'_`(4?V;K'
M_0?D_P#`6/\`PK6HH`R?[-UC_H/R?^`L?^%']FZQ_P!!^3_P%C_PK6HH`R?[
M-UC_`*#\G_@+'_A1_9NL?]!^3_P%C_PK6HH`R?[-UC_H/R?^`L?^%']FZQ_T
M'Y/_``%C_P`*UJ*`,G^S=8_Z#\G_`("Q_P"%']FZQ_T'Y/\`P%C_`,*UJ*`,
MG^S=8_Z#\G_@+'_A1_9NL?\`0?D_\!8_\*UJ*`,G^S=8_P"@_)_X"Q_X4?V;
MK'_0?D_\!8_\*UJ*`,G^S=8_Z#\G_@+'_A1_9NL?]!^3_P`!8_\`"M:N.@\9
M3P6D<EVD<[RR,H6+"[47/S=3U`.!QT]#0!M_V;K'_0?D_P#`6/\`PH_LW6/^
M@_)_X"Q_X50T_P`4/=6%W>M$I474<<*YQY:O%&WSGL0S,#Z$8J)/$&H76@:S
MJL1CMS9[S##+&6(VQ;MK<C#%B![8(H`U/[-UC_H/R?\`@+'_`(4?V;K'_0?D
M_P#`6/\`PJC+XI-G<R03Q+*L=P(1.A"A\HK\#GG:_`SSM-4?^$^(03&Q!C90
M0!)\WWI@QZ=,0Y'^\/6@#<_LW6/^@_)_X"Q_X4?V;K'_`$'Y/_`6/_"L:3QZ
MJ0%QI[%U)4J9`/F`)^NT[2`?4'TKH-%U$ZKI_P!K*!,RR*%!SPKD`GW(`/XT
M`0?V;K'_`$'Y/_`6/_"C^S=8_P"@_)_X"Q_X5K44`9/]FZQ_T'Y/_`6/_"C^
MS=8_Z#\G_@+'_A6M10!D_P!FZQ_T'Y/_``%C_P`*/[-UC_H/R?\`@+'_`(5K
M44`9/]FZQ_T'Y/\`P%C_`,*/[-UC_H/R?^`L?^%:U%`&3_9NL?\`0?D_\!8_
M\*/[-UC_`*#\G_@+'_A6M10!D_V;K'_0?D_\!8_\*A\+W5]<PZBE]=FZ>WU"
M6!',:I\B[<#"CZ_G6Y6!X4_YC7_86G_]EH`TK#_C\U+_`*^5_P#14=7:I6'_
M`!^:E_U\K_Z*CJ[0`5@W?B*VF\-37]O+)`\L,OD%U^8.`>PR!SZUO5EZO;06
MWAK4(H84C1;64A5&`/E-`$G]F3_]!:]_./\`^)H_LR?_`*"U[^<?_P`36A10
M!G_V9/\`]!:]_./_`.)H_LR?_H+7OYQ__$UH44`9_P#9D_\`T%KW\X__`(FC
M^S)_^@M>_G'_`/$UH44`945A<--,IU:]PC`#_5^@/]VI?[,G_P"@M>_G'_\`
M$U8@_P"/FY_WU_\`015B@#/_`+,G_P"@M>_G'_\`$T?V9/\`]!:]_./_`.)K
M0K/B6?\`MF96NG:)(T<1D#'S%Q]?X12&']F3_P#06O?SC_\`B:/[,G_Z"U[^
M<?\`\36A13$9_P#9D_\`T%KW\X__`(FC^S)_^@M>_G'_`/$UH44`9_\`9D__
M`$%KW\X__B:/[,G_`.@M>_G'_P#$UH44`9_]F3_]!:]_./\`^)H_LR?_`*"U
M[^<?_P`36A10!G_V9/\`]!:]_./_`.)J@8M2ENKB*UNKB1;=Q&S27"(22JMP
M!$>,,*WZP#HUIJU_J)NO-_=78V^7*4ZPQ>GTII*^H"2P:Q!$TDMRR(HR6-XO
M'_D&FP1ZO<Q^9#=,ZYP<7:\'T/[GBBX\%:9+"5C>Y5\@@M.Y&0<\C--M?!>F
MK&SR23N9&W9CG<+C`QCGVK3EIVW_``%J3&TUL#)G?_P+7_XS5:WFOKN01VVI
MQS.RE@(]01B0,9/$7^TOYBM33M!LM+F::U\[>R;3YDK.,9ST)]JYQO"]J+&*
M&UU>VBF^S/!+,&!+[F1ACGC`BX_&LVE?09JS0ZO;P//-=&.*-2SNUXH"@=23
MY-/^QZY_SW?_`,"U_P#C-5+[PQ<7T+P3:FH6<3IP,%]XX/7E@`1],_6K.FZ1
M';W\=TFIK(@=W$:-\O)?*CG[HW@X]5%(!5M=:<96X8C)&1>+U'!_Y8U!/)?V
MLACN-2CA<)YA634(U(7.-V#%TSQFH;3PV+>:UNKK4D\A8TBX?`E`4J#G/5B5
M;ZUHW'A_-PT]HT4,GD&%7926*D@G<<\XYQZ9H`ABAU>9-\5V9%]5O4(_]$T_
M['KG_/=__`M?_C-7-+T]M.>=F*(CB-$C3A5"H%X^O]!6B3@9-`&%]CUS_GN_
M_@6O_P`9IOE:G%=6T-S=3HEQ(8PT=PCD$(S=#$/[I[UM1W=M+M\NXB?<-R[7
M!R,XR/QXJKJ/_']I7_7VW_HF6@`_LR?_`*"U[^<?_P`31_9D_P#T%KW\X_\`
MXFM"B@#/_LR?_H+7OYQ__$T?V9/_`-!:]_./_P")K0HH`S_[,G_Z"U[^<?\`
M\31_9D__`$%KW\X__B:T**`,N'3[AT);5KW(=A_RS[,1_=J3^S)_^@M>_G'_
M`/$U:MO]4W_71_\`T(U-0!G_`-F3_P#06O?SC_\`B:/[,G_Z"U[^<?\`\36A
M10!G_P!F3_\`06O?SC_^)H_LR?\`Z"U[^<?_`,36A10!G_V9/_T%KW\X_P#X
MFC^S)_\`H+7OYQ__`!-:%%`&?_9D_P#T%KW\X_\`XFC^S)_^@M>_G'_\36A1
M0!G_`-F3_P#06O?SC_\`B:/[,G_Z"U[^<?\`\36A10!G_P!F3_\`06O?SC_^
M)I^DO*]B?.E:5TFF3>V,D+(RC./8"KM4=(_X\I/^OJX_]'/0!>K`\*?\QK_L
M+3_^RUOU@>%/^8U_V%I__9:`-*P_X_-2_P"OE?\`T5'5VJ5A_P`?FI?]?*_^
MBHZNT`%4->_Y%_4O^O27_P!`-7ZH:]_R+^I?]>DO_H!H`OT444`%%%%`!111
M0!7@_P"/FY_WU_\`015BJ\'_`!\W/^^O_H(J:1Q&A<AB!V49/Y4`.JG'_P`A
MBY_Z]XO_`$*2IH+J*XA65"0C#*EAMR/7FH8O^0Q<_P#7O#_Z%)2'M<N4444Q
M!1110`4444`%%%%`!6$-,&HW^I$WEW;^7=C_`(]Y-F[,,77CVK=K!-C=WE_J
M/V749+/9=C=L0-N_<Q>O^>:&KC4G'5#SX;0==8U0?]O(_P`*CM_#"QV\<9UC
M4MR*%8)<#`..W%1W>@:O+;LBZ],Y)&`8@,<]>O;K1;:!K$9FW:_,NZ0L&$0.
MX'OU_#\*GDB/ZQ5V_P`C3T_2!I\S2B^O;C<NW;/+N4<]<8Z\5D+HLD<L3PW%
MA^[OY;@!@3E&1U5>O;?^E:NG:=>VD[/<ZK)=H5P$:,+@YZUD+H5Q!+$RV0=4
MOY9"/,',)CD5!U]7!_#Z4[)"<G+5EZ'1+FVM]+A6],HLG!83`$8$3H0N`#_%
MGG/2H+'0[V'4+>]EFL]RO.\JQ*P5BZHHP,]MG^34EMI>J6T6EI<7(N_LTB^9
MM&W:ODNAY)^;YF!_"J^GZ3>PZA;7+6LD,8>=I8C.&"[E0*!ST^4_B2>,TQ$_
M]@W#>'])T][B/S+'RMTJYY*+C*__`%ZJZMHFN3WMS>66J;$+[XH@S9`'D_+Z
M?\LY?^^ZLKIM^/#VB6I4_:+-[;S_`-YV0`,<YYZ?K5:'2=<M-%:""Y(N&DA!
M*N/NK&JNV3_>()_&@!EMI>LRZ';QO<R"X664[WR"NZ-U4XZC:S#\LUHV>ASI
MIAAO;D7%R!(`_."&+$`]^`V/PK.TO_A)8=9MX-1,[PXWLZX*?=.03_O$?@!Z
MU+:V7B$WD.^XDCASB8[EP3^^W,!UZF+'MF@".?PW=Q66Q;E&:*SEMXL$@Y<C
M#$GLIP<^U;>H_P#']I7_`%]M_P"B9:RM1T75I]0AE2[\Z&*!EP3@EO-B<9'0
M@["#[9]:2SL;O3[W38)Y6DC26--['[T@MY@[#VQM'X&@#IJ***`"BBB@`HHH
MH`AMO]4W_71__0C4U0VW^J;_`*Z/_P"A&IJ`"BBB@`HHHH`****`"BBB@`HH
MHH`*HZ1_QY2?]?5Q_P"CGJ]5'2/^/*3_`*^KC_T<]`%ZL#PI_P`QK_L+3_\`
MLM;]8'A3_F-?]A:?_P!EH`TK#_C\U+_KY7_T5'5VJ5A_Q^:E_P!?*_\`HJ.K
MM`!5#7O^1?U+_KTE_P#0#5^J&O?\B_J7_7I+_P"@&@"_1110`4444`%%%%`%
M>#_CYN?]]?\`T$58JO!_Q\W/^^O_`*"*L4`8QMXI='TUI(U8X@7)'8[<BKL0
M`U>X`&`+>'_T*2JR?\@73?K;_P`UJC;>);&7QS=Z,&_>K;H`Q/#.I8E1[X<?
MD:FZ2137O2.CHHHJB0HHHH`****`"BBB@`KF;DWAU'4%LM9M=/(N@76>,.7_
M`',6"/F&.AKIJ@ELK6=]\MM%(Q_B9`32:N-.QRUT?$"6[&'Q1I\KG`VI`JG!
M."<F3'`Y_"F6"Z^MOY3^)K&%8B$C\R%'9E`')(D/TYYXKJ?[,L/^?*W_`._8
MH_LRP_Y\K?\`[]BIY!\S,S2YKNWN&;4O$-C=Q%,*D<8C(;(YSN/O64D7E2Q$
MW$DB+?R%P-0','EN$ZO_`'F7WXYKJ/[,L/\`GRM_^_8H_LRP_P"?*W_[]BJ2
ML)NYA6MU?HFFK>WUI(89%\UH;E=Q7R7!W9(!^<KTSTS45C+)'J%M(T[1VVZ<
MR127B-L!"[!G>2>0?H2>@Q71?V98?\^5O_W[%']F6'_/E;_]^Q3$82W$XT#1
M8C=I]K@>W^U?Z4F<*`),G=AN_KFHA/>V>EW*V5]&\\U[O4SW$;.(V`W9^;:,
M'.`.,8XKHO[,L/\`GRM_^_8H_LRP_P"?*W_[]B@#E=,U_5QK,%KJ<T"QL`[,
MC(1@JV1D$]&P/8#GJ#4UKJ.K274*O>V\<).)G,D9VM^^W$`MD@$0X]B>O6ND
M_LRP_P"?*W_[]BC^S+#_`)\K?_OV*`.?O6NYKX*]_;7-F+.93LO/)9Y"R,F0
M,8^Z1D'IGIW=:R+'JNG627HN8H9457:3<S.+>8.1R21C9^)-;W]F6'_/E;_]
M^Q3H[&TAD$D5K"CCHRH`10!8HHHH`****`"BBB@"&V_U3?\`71__`$(U-4-M
M_JF_ZZ/_`.A&IJ`"BBB@`HHHH`****`"BBB@`HHHH`*HZ1_QY2?]?5Q_Z.>K
MU4=(_P"/*3_KZN/_`$<]`%ZL#PI_S&O^PM/_`.RUOU@>%/\`F-?]A:?_`-EH
M`TK#_C\U+_KY7_T5'5VJ5A_Q^:E_U\K_`.BHZ=+JEA!,T,MW$DBD`J6Y&1D?
MS%`%NJ&O?\B_J7_7I+_Z`:OUBZOJ=G<>&;V6.92DUM*L9/\`$=I'%`&U1110
M`4444`%%%%`%>#_CYN?]]?\`T$58JO!_Q\W/^^O_`*"*EFFC@B:65PB+U8]!
M0!EF1(M`L))&"H@@9B>P&*YGP_X?M==AO[^]B,4^I%;N)UX>`%Y`FT_10?QJ
M;7=5M;SP;8V-O<KOOO)@#@\*,#?^0S^8KI[*..+4)(XDV1I:0*BXQM`,F!6=
MN:QH[QE+N9NGZQ<Z9?+HVNR`N1_HMZ1M6X'HW8-^/-=%534=-M-6LWM+R(21
MN/Q4^H/8UA6FHW?AJXCTS67,MFQVVM^?T23T/O3OR[DVYMCJ**0$$9!R#2U9
M(4444`%%%%`!1110`4444`)TZT`@]"#221K+&T;C*L,$52T>&.&Q_=KC=(^>
M<_Q$4NHR_1113$%%%%`!11574GFCT^:6"41O&A<$KNS@$XH`M45'"DB1!99?
M-<=6V[<_A4E`!1110`4444`%%%%`$-M_JF_ZZ/\`^A&IJAMO]4W_`%T?_P!"
M-34`%%%%`!1110`4444`%%%%`!1110`51TC_`(\I/^OJX_\`1SU>JCI'_'E)
M_P!?5Q_Z.>@"]6!X4_YC7_86G_\`9:WZP/"G_,:_["T__LM`&E8?\?FI?]?*
M_P#HJ.LV\L7.K3'^S/M)N7C*7#"/;"%`!SGYNQ/OQBM*P_X_-2_Z^5_]%1U%
M=R?\32UB+.S*QE1?+;`XV'YAQT?.".O<<4`:58^JZ?9VOAB^AAMT5([64H,9
MVG:?6MBJ&O?\B_J7_7I+_P"@&@"_1110`4444`%%%%`%>#_CYN?]]?\`T$5F
M^*+B3^SX]-MVQ<ZE(+=".JJ?OM^"YK2@_P"/FY_WU_\`016*;F";7[_59V_T
M718#$&[;R-TA'N%"C\ZF6UC6E\7-VU_R_$X6ZTI;W6X;;3('>WT^U@::-9"`
MTS@#Y3V;&#]172Z/J6H6]U-):F75H(HHTGC==ES!@O\`*5_B(Y_.I?"6G&U\
M-PWTJD3ZC=I</GJ%+#8/IMQ^=:6H:3)<:Y/>Z?,+6_BMXMKXRDF6?*N.X.!S
MU&.*E7202Y9SES.S[_YFEINL6.JHQM9@SH</&PVNA]"IY%6+JU@O;62VN8EE
MAE7:Z,."*YY8K+7KORKZ&33-<MUR6A?:Y']Y6Z.OUSBI_P"T=7T3*ZM`;ZT7
MI>VJ?.H_VX_ZKGZ5HK-:&,N:F[3*T4]WX0E6WOI7N=%8[8KIN7MCV5_5?]JN
MG1UD0.C!E89!!R"*KV]S8ZO9&2"2*ZMI05.,,I!Z@C^AK`*7'@QR\*2W.@GE
MHQ\TED?5>[1^W45'P^A>DCJ:IS/<C4(8DE01NK,5*9/&.^?>I[>XAN[>.XMY
M5EBD4,CJ<AA4,W_(4M?^N<G_`++5D,;8SW<T]PEPD*B%P@,;$Y.U6[C_`&JN
MU3LO^/K4/^O@?^BHZN4D4PHHHIB"BBB@`JIIG_'D/]]__0S5NJFF?\>0_P!]
M_P#T,TNH^A;HHHIB"BBB@`JKJ7_(+N_^N#_^@FK59,QG-GJBRW!D6)&105`_
MY9AL\?4T/8.IK4444`%%%%`!1110`453U,RK;HT,[PGSHU)0*<AG53U![$U:
M12J!2Q8@8W'&3^5`$=M_JF_ZZ/\`^A&IJAMO]4W_`%T?_P!"-34`%%%%`!11
M10`4444`%%%%`!1110`51TC_`(\I/^OJX_\`1SU>JCI'_'E)_P!?5Q_Z.>@"
M]6!X4_YC7_86G_\`9:WZP/"G_,:_["T__LM`&E8?\?FI?]?*_P#HJ.LK6O$8
ML-5AM8%1IE;;*)()&.UMI&PJ,?7)XQ6K8?\`'YJ7_7RO_HJ.N:UR^E/B7R))
M0\4+*8XR0JH<*2Q[MC((%`'950U[_D7]2_Z])?\`T`U?JAKW_(OZE_UZ2_\`
MH!H`OT444`%%%%`!1110!EZAJ":59:E?.-WD@$+_`'FV@`?B<"N;U.QFA\/Z
M9X:WDWFL3[KMQUQG?*W\A6KJ.-0\26^DXS&D@O)_3:B@(/Q8C_OFFZ;)'JGB
M[4M38CR-.064+'IO^](?S*BLWJS?X8)=]?T1?B54T+3$485?LX`]!\M6X[)D
MOGN_M,K%P%*'&W`S@=.VXU26:(:+IW[U.L'\0_V:U^M7T1C+XF4=4T>VU6-/
M,W1SQ',,\9P\1]0:HV>KSV-TFEZY@2MQ#=@8CG]C_=;VZ>E;M07EE;ZA;-;W
M42R1MU![>XI-=4:1FK<LMOR,R\\.1&9KS2IFTZ];DR1#Y7_WEZ&H1KT^FNMM
MX@MA$&X%W""T#?7/*G]/>F1W-YX9<0ZA(USII.([KJ\/H']1[UO8@NX.=DT3
MCV(84U*YG.DXZQV_`Y>[M[WPW'+J>@-'<:8X,DMG]Y4[EX\=NY&<5L65]#J4
MEA=P3QS))%(=\8P.J]NWTK.U+P_-86]Q<:+=&V4QL9+5^8G&.<#L:YVYU1M!
M\0+=0Z>]E.P/VFS9OW4P.,LAZ`\?I2M9Z;"<TXVEHSO++_CZU#_KX'_HJ.KE
M<QI'C'0KH7ES]N2)7G!"R<-_JT'3Z@C\*GE\;Z!'PEVTQ](HF/\`2DI1[E.+
M['045S8\:VTW%II>I7#=ML&!_.GKXAU:7_5>&;K_`+:R!/Z4^=!RLZ&BN>:]
M\62?ZO2;*(?]-)]W\J8;?QE/R;[3K4>B1%OYT<WD'+YF\MW;O.8%F0RCJ@/-
M1:8<V*D?WW_]#-<S/H'B*::X/]OL+H1*5\F)4!R6ZG\ZK^'_``C?FQ9+S6;^
M.-781I%<$#&3G]<_G2<G?8$E;<[FBN<'@JP/^MOM1D/^U=-3AX'T;^);A_\`
M>F)IWEV"T>YO/)'&,NZJ/]HXJ!]3T^/[]];+]95']:S$\%^'TZZ>C_[[$_UJ
M9?"F@KTTN#\C1[P>Z3OK^C1CY]6LA_V\+_C6'>^+-"ALM7SJ4+M)N,:HV2_[
MI1Q^(Q6TOAW1DY73;<?\`%9M_H6F7-AJ:-:QJ(G+IL4#!$2D?ADTGS6#W;HV
M-/U6QU6W2:RNHIE90V%<$KGU':KE8!\$Z%Y/EI:M&P)(E1RKC/O4']@Z[IYS
MI6O/(G_/&]7S!CT!ZT7DMT%D]F=-17.'6]=L%_XF.A&91UDLWW#'^Z>:L67B
M_1;UO+^U&WESCR[A3&?UX_6GS(.5FW13(Y8YDWQ.KJ>ZG(IQ(4$D@`=2:HDJ
M:G_QZI_U\0_^C5JY5'4)(Y+1#&ZN!<0YVG/_`"U6KU+J/H0VW^J;_KH__H1J
M:H;;_5-_UT?_`-"-34Q!1110`4444`%%%%`!1110`4444`%4=(_X\I/^OJX_
M]'/5ZJ.D?\>4G_7U<?\`HYZ`+U8'A3_F-?\`86G_`/9:WZP/"G_,:_["T_\`
M[+0!I6'_`!^:E_U\K_Z*CK#U+3)+O7)I$^SE%DC9LE=Y(51M.>0`#N/KE<5N
M6'_'YJ7_`%\K_P"BHZR?$&A"]U2SNH+;?)NQ*1)MXRN"PR,@#/0$YQVH`Z.J
M&O?\B_J7_7I+_P"@&K]4->_Y%_4O^O27_P!`-`%^BBB@`HHHH`*1F"J68X`&
M23VI:QO$]RZ::MC`<7.HR"VCQU`;[S?@N32;LKE0CS22,:#61::+K7BF5,/,
M<6X/4H.(Q^).?QK8\+:3_9?AJUM;A0TSKYL^X=9&.XY^F<?A6'K$,=[XGTOP
MQ$F+:)UNIEQQY<:@(OT)X_*NVJ4M2IRYFVB'[+;[0OV>+`Z#8.*E`P,"EHJS
M,****`&NB2(4=0RL,%6&0:YZ2TN_#3O<:;&USIS'=):`Y:+U*>WM71T4FKEP
MFXZ=#/:^MM1T2>YM91)&T+\CJ.#P?0U%?Z;9WFHQ+/`DGFQN6+#/(V8K/UW1
MKFV%SJ6C.D4DD;&Z@<D),-IY`QPWO0WB)K>^@?6-/N-/V)(&<CS(SDKT9<^G
M?%2I6>I<Z7-%.&OYF=:?#[3$NKM[6::"6*0(K###[B-D@CGDFM.*WU_25_=P
M6>H1KTV*(I,?R_6M#2+ZUOI+Z:TN(YXVG!#1L"/]6G^!K3JHVMH8SB[Z[F%!
MXKLMXBU"&?3I?[MRA`_/I6Q!<P7*!X)4D4]U;-.DBCFC,<L:R(W56&0?PK&G
M\):<9#-8M-ITQYW6K[03[KT_2J(]Y>9N57N;Q+5D#I*V\X&Q"W/IQ62T?B;3
MP/*EMM4C7^&3]S(?QY4_I4,_B:!&MQJ=I<Z:RR@DW$?R=#T<97OZTF5&2O[Q
MMQG.HS'UACZ_5Z;IG_'D/]]__0S5&/7](^V23_VC;^4\:J'\P8R"^>?R_,>M
M5+'Q18?9/+M([F_D#O\`+:PLX^\?XL8_6BVHE*-MSI**P!?>);TXMM*@LHST
MDNY@6_[Y7/\`.E?0M3O?^0AKLP4]8[1!$/S.33L+FOLC5N=0L[-2;BZBB`_O
M,!67)XLL68I8Q7%_)V%O$6!_&IK7PMHUJPD^QK/+WDN"9&/_`'U6LJJBA54*
MHZ`#`%`_>9@#4/$%YQ#86]B&Z&ZERW_?(K%BL/$=C%J$I>VN5\IEDC8E?+^1
M3A?P(_[YKJ[F"%]5M6>%&;8_)4$\;<5%/_QZ:S]6_P#1*4KZ,'!7B[E:'Q3`
MD@AU2UGTV7_ILOR'Z-TK9AN(;F,202I(I[J<TLD<<T9CE171N"K#(/X5C3>%
M+-93/ILTVF39SFW;Y"?=#Q_*F'O+S-RJUUI]E?*5NK6&8$8^=`:R6G\2:81Y
MMM#JL`ZO`?+E`]=IX)^AJS:^)M,N9Q;23-:W)_Y87*F)\_0]?PI6!37H4I?!
MEDDAETRZNM-E[&"0E?\`ODT?9_%=@A59[/58AQME'EN1_+]:Z*H5O;5KDVRS
MH9AU3//^>#4<J6QJFWYG%3^+4TO2E34-(N;1OM*MO"`H^V4,P##C@`_E7<QR
M)-$LL;!T<!E8'@@]ZPKS3;/4-'A^UP"7;=!0"3T:<`_F*KV$C>$[^/2;J1FT
MNY;%C.__`"R8_P#+%C_Z"?PHNT]1))Q5CHK;_5-_UT?_`-"-35#;?ZIO^NC_
M`/H1J:K)"BBB@`HHHH`****`"BBB@`HHHH`*HZ1_QY2?]?5Q_P"CGJ]5'2/^
M/*3_`*^KC_T<]`%ZL#PI_P`QK_L+3_\`LM;]8'A3_F-?]A:?_P!EH`TK#_C\
MU+_KY7_T5'6-XK5CJ.E>4TJREV7*/(@"%H]Q8H?N@#HW&2/>MFP_X_-2_P"O
ME?\`T5'7*>-K6UM];TNZ2"(7%Q(2TAV[F*F,+U&>/:@#N*S=9ECF\.:D\;AU
M%M,N1ZA6!'Y@BM*L+6-'L8O#5Y'Y`D$$$\D1D^8HQ!8D'ZT`;M%%%`!1110`
M5S\3K?\`BFYOI#BUTB(PQL>GFL,R-^"X'XFM75+^/2],N+Z7E8$+8]3V'XG`
MKC_$-U/H'@)+0G.I:F2'QU9Y#E_Y[?Q%2]S6+Y8.7?1?U^'S+'@9O[9U#5?$
MLH.ZXE\B'/\`#&IZ?R'_``&NMCN[:64Q1W$3R#JBN"1^%9_AS3$T;34TY,?N
M%16([MM!8_B<FK4"J-3NB%`^2/M_O545IJ9>1<HHHH`****`"BBD;=M.W&['
M&>F:`(-0_P"0;=?]<7_D:9-_R%+;_KG)_P"RU7,MU-I5X]R8>$E5?+4C[NX<
MY)]*GF@NGOHIXY(A'&"NUE))!QGG/M1:S&_A1E_\(UI=[?WTY@-O.DX"S6SF
M)Q^[0]5QGDGK3WL/$%CS8:G'>QCI%?1_-C_?7!_,&M"Q@NXI[E[AH2)G#@1@
MC!VJO<_[-7:A11I[66SU7GJ88\1RVG&L:5<V7K)&//C_`#3D?B*T;'5+#4DW
MV5W%..X1@2/J.HJT0",$9%9EYX<TJ]E\Z2U5)O\`GK$=C?F*?O(+TY;JWI_7
MZFE)(D49DD8*J]2>U4II[>\2W:)TFC,P!QR#\IK/?2]<LCG3]5^TQC_EA>KN
MS[;NM4+?7+BUT_34O-)GC5?+Q)#AU<;3]#FCF5M2HTKOW7<N0^%-)379;K['
M`S[5<J85V<EAPN,#&!SU_.M;2E"V"JH``=P`.WSFL<^)XENYY(["]9C$@53#
MCD%NO/O2:=XC$-MY=QIUZ&#,1LBSG))]?>DYJ^Y$:$DM$=+16)_PE%O_`-`_
M4/\`OQ_]>C_A)X/^@=J/_?C_`.O1SQ[C]C/L;=%8G_"3P_\`0.U'_OP/\:BN
M?%BPP-)'I-^^WE@T84`>N<FFI)NP>RGV-6;_`)"=K_USD_\`9:@:"6Y34H(I
M$C,DNTLR%N#$@/&164WB=3>VLDVF7T1"2!E\O/ITYYZ4ZR\1Z5;S2O/J4RF5
MMQ2>W*8.`.P]`*7-'57'*C4TLCH81*(P)G1W[E%*C\B3_.I*HP:UI=R`8=0M
MWSV\P9_*KBLKKN5@P]0<U2:,G%K=#JKWMA9ZC`8+VVBN(S_#(H;'T]*L44Q;
MF$/#L]@I_L35+BS':"4^=%]`&Y'X$54_MG5],O+A]4TDSD0QYEL6W#`+X.T_
M,,\^O2NHJD8TFU&ZBD&4>WC##U&Z2BXE&R=M#*T[4H-3T02VIWPK>1@/TR3.
M">.HZCK6SJ.GVVJV$ME>1"2&5<,I_F/0BN7O-+DLK5=7TM2)?M*_:+93A;@"
M;CZ,#C!KI=,U2VU:T%Q;,<`[71AAD;N".QH:U%!NR3W,?0=2DL;L^']2=C,A
M8VEPY_X^D!.<G^^.<C\:Z2LC4='AUG36A=C'-'*[P3+]Z)PQPP-1Z!K4MX9-
M-U)!#JEJ/WR=I!V=?8_I4IV=F:/75&W1115$A1110`4444`%%%%`!1110`51
MTC_CRD_Z^KC_`-'/5ZJ.D?\`'E)_U]7'_HYZ`+U8'A3_`)C7_86G_P#9:WZP
M/"G_`#&O^PM/_P"RT`:5A_Q^:E_U\K_Z*CK`UW;>^(+>&1U*V<BR$Y8*BG8<
M-QR<KP/>M^P_X_-2_P"OE?\`T5'6/XJU6^TV[TZ&R956[D991Y08MR@'4C'4
M\_2@#I:H:]_R+^I?]>DO_H!J_5#7O^1?U+_KTE_]`-`%^BBB@`HHI"0`23@#
MJ:`,+6E.I:UI^D#F)#]KN?=5.$!^K?RKGKK/B7XG06_WK32!O8=BR_\`V9`_
MX#6I::D+?2]6\42C/VAL6RGNB?+&/^!,2?QJ+X=Z<T6FW6J3-OFOICA_55)&
M?Q;<?Q%1O\S2KI)0_E_/^OR.H@_X^;G_`'U_]!%1V\B-JEVJNI8(F0#SWJ"]
MU.WTF*\NK@G:KJ%4<L[%1A0/4UR>B^%]9DU*6[GU)[&0HK%8_F8;LX!SW]:Z
M803BVW8R;._HKG_[#UM?N>)93_OVX/\`6E&G^)H_N:S;2?\`72V_^O4\B_F7
MXA<WZ*PA!XJ7_E[TY_JC#^E.W^*(^L.FS?21U_\`9:.3S07-NBL(WWB5>NCV
MS_[MR/ZU'-K/B""%Y'\.LVU2?DN$;],YH]F^Z^]!<OE99-*N(H8_,>1YUQN`
MQEVK00LR`NFQCU7.<5Q7A[Q1K5U'.@T9[C;(6W(P4*68D@Y/K6S_`&GXB;IX
M?`_WKE/\:J=*2D[V^]#YM+&]16$+_P`2GIHMNO\`O7(_I3A<^)VZ:=8I_O7!
M_H*GV;[K[Q7-NBL3'BEO^@8G_`G/_LM-,/BH_P#+UIR_16/]*.3S07-VLJVP
M=+TGZ1_^@&L[4-/\67%C-&NI68++C;'$03[`]JR]$T[Q-;Z7:$WMNJ22!HDE
M4L0"O!SZ8[57LUR7YD5%ZG8I_P`A*?\`ZXQ_S>K-<W'8>*(KMKG[992,PP59
MF"XYP,;?<U9-QXG3@V%A+[K.PS^8J>3S1*-NBL+^T/$B]=#B;_=N5_K33K>M
M1?ZWPY.?^N<J-_6CV;\OO07-^JFJ_P#((O/^O=__`$$UE?\`"378^_X<U,?2
M,-_*L_7?&(@TF9&TF^B:53'^_A*`9!YS51I3YEH%T=+-_P`A2U_W)/\`V6IY
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M0:AI5Y;W"ZMI6P7@`^T0#A+D?T/H:J6.CWUDK7&D2/;L'8O9W`/E.,G&W^Z<
M5HV/B&*:?['?PM87@_Y93=']U/0BGS6>IFZ7-&\=?S1/HFHPZE8^;'E7#MYD
M3?>C;<3@BJ_B#1Y;Y(K[3G6'4[0[H)#T8=T;V-5[O2)UF.KZ0PCO5=_,C)^2
MY7<?E/OZ&M+2=7M]7MC)%N25#MEA<8>)NX(JFKHRC)IV9'H>LQZS9L_EF&XA
M;R[B!OO1..H^GI6G7/ZYIUW:WBZ]I";KJ)=MQ;CI=1^G^\.WY5JZ9J-OJVGQ
M7MJVZ.09P>JGN#Z$5*?1FC75%NBF)+&Y(1U8CT-/JB0HHHH`****`"BBB@`J
MCI'_`!Y2?]?5Q_Z.>KU4=(_X\I/^OJX_]'/0!>K`\*?\QK_L+3_^RUOU@>%/
M^8U_V%I__9:`-*P_X_-2_P"OE?\`T5'6#XH:YGU*U1=.GV6TJL+@K"T;@LC8
M&YP=V5Q@`GN`>*WK#_C\U+_KY7_T5'4-SH<5WJ'VV6XG+KCRD)!2(XZJ",`^
M_7GK0!IU0U[_`)%_4O\`KTE_]`-7ZH:]_P`B_J7_`%Z2_P#H!H`OT444`%8W
MBB:4:4+*V;%QJ$BVT9_NAOO-^"AC6S6!'(-1\63W+,!:Z1$8@Q/'FN,N?P4`
M?B:F6UC6DM>9]-?Z^9A>.)##!8:#IZX\M4**.[D^7$/SW-_P"NM@CM/#^AQ1
M/(L=M90!2[<<*,9^I_K7':*?[:\6/J]RP6W@5KP[N`H.4A!],('?_@5;EO%)
MXHOEOKD$:3;ONM82,?:&'_+1O;T'XU<(W;;V1BG=7ZO431[:76=3;6]0A>%8
MS_HEJ_\``"!B1A_>(Q]*VX?^0E=?[D?_`+-3H/\`CYN?]]?_`$$5%;I=B_FD
MEAC6.0``K(2>,]L>]6Y<UP+M%%%9C"BBB@`HHI&(52QZ`9-`%:P`%N^!_P`M
MY?\`T8U6JI:9/'+"X0G(ED)RI'!=B.M7:<MP"BBBD`4444`%8\,PCTS2LI*V
M$C8^7$SX&SV!]:UI)%B0NYPHZG&:J:/(KZ3:@9RD**P((((4>M.WNC3LRX#D
M`^OK2T44A!1110`51UJ&.;1KQ98U<"%R`PS@A3@U>JEK$L<6CW9D=4#0NHW'
M&3M/%5'XD!5U#P[9ZC+%YL%MY,2[0AAYQQT8$$=*@7P[=V)SI.LW$*]H;@>=
M'].<$#\:W(Y$E0/&ZNAZ,IR#3J:G):`]3`.JZ[IY_P")AH_VJ(=9M/?>?^^#
M@_EFK=EXCTF^;RX[Q(YN\,W[N0'_`'6P:U*JWNFV6HQ>7>VL4Z]A(@./IZ4^
M:+W7W"U+5%8*^&6L@?['U2ZL@/NQ%O-B'_`6S^F*;_:'B+3C_ING17\(_P"6
MMFVU\>I1OZ&CD3^%A<U-2_U4'_7Q'_Z$*='_`,A6X_ZX1?\`H4E<_J?C+2DC
MMTE^T12^<C&*6(HR@$'G/'Y&MFSE^UW;7EO>VTT,J*-J*=VT9(YSU^;TI2A*
M*5T5%K4T:K7VGVFI6YM[RW2:,]F'3W!['Z59HJ`3:=T<W#!K&B0EK(G4[)'8
M?9W.)D`8CY6Z-]#S3)#;ZO/_`&OH$Z1ZK`NV6WE&PRK_`')%/(/HW]*Z&V_U
M3?\`71__`$(U4U/0[/4V29PT-U'_`*NYA.V1/Q]/8\5-FMC1N%16GOW7]?UY
MBZ1J\.KVS.J-#/$=D]O)P\3>A'\CWK#U21/"VKR:I:RHUI=.#?V88;E/_/9%
MZ_[P[]:IZM#K>E7:Z@W[V>)=J7T,?$B?W)D'4?[0Z5KZ1KUGXAFM)8BHE6.0
M30DY*'Y?S'O35I$6E#?5=^C_`."7K"2QC:[NHVMTB>5=LJE0I!C0C!]*LOJ=
MBA4-=P_/]WYP<_3\C7).S>%)M0M0@&AW#,B'_GVE9`0#_L'.!Z&NHG_UFF?]
M=O\`VD]2GH.?Q%^BBBK("BBB@`HHHH`*HZ1_QY2?]?5Q_P"CGI&^T?VPD8NG
M$31-(8]JXR"HQG&>Y[TND?\`'E)_U]7'_HYZ0%ZL#PI_S&O^PM/_`.RUOU@>
M%/\`F-?]A:?_`-EI@:5A_P`?FI?]?*_^BHZNU2L/^/S4O^OE?_14=7:`"J&O
M?\B_J7_7I+_Z`:OUG:U(DOAS47C<.IM9>0<C[I%`&C1110!5U*]33=-N+V3[
ML,9?'J>P_$\5S-W;RZ;X1@TUY=E[JDG^DR9Y&[+RL?HH(_*M+6S_`&CJ^GZ,
MO*;OM5S_`-<T/R@_5L?E7)>++F\U_P`3I86#$6X9;'S0>-S\R8_X",'V!]:2
MU;?8N>E-0_F_+^K_`($WA2QE\1I<3,C0Z7-.7=>AF5<+''_NJH'XFO0T18T5
M$4*JC``Z`5':VL%E;1VUM&L<42A451P!4U4WHD0]RO!_Q\W/^^O_`*"*L57@
M_P"/FY_WU_\`015BD`4444`%%%%`!1110`@`'04M%%`!1110`4444`)1@#I2
MT4`%%%%`!1110`4UD5QAE##T(S3J*`$`"C"@`>@I:**`"BBB@`HHHH`Q/$6B
MV.J"W>ZBW,)D3(.,J6&10_@_0GQML5B([QDJ:O:FRK'!E@/](CZG_:%7.M:<
M\E%68K&&?#`B&+/5=0MAZ"<L/R-,.E>(X.+;7EE7TN(`3^8KH**/:2ZA8YN"
MY\4VZ'-C972!VR4D*,3N.>OO4X\07T?-UH%Y&HZF(B3'\JU[;_5-_P!='_\`
M0C4U'.GO$#"_X2_2@=MP+BW]?.@('Z9KF=5O-#&M17>A7JVM^58F1!B-SQA6
M!]><UZ"\:2+M=%8>C#-<]J/A;2+O7;::2U4;U8NJ\!BNW''XU4/9-ZI@[VL8
MT'B=;VRU6SU?3F$CY\T1C>JG8JCCKC(SFH=/\3VFCWECIMY?BXLDF+VMR>2B
M>6PV/WR"P`]C5O6O"EI]EU&?34DMKJ.0*C1,<;?+4D-[<FN:N_!^LW#027-N
MTCES&/F4[L*QXS]*P<+ZJ7WFKJ1YK2CTZ'I4'B'1KD9BU2U/UE`_G5V*Y@G_
M`-3-')_N,#7DHT[6-+?-SI8FB])K4G_QX5=75_#@0"]T%X).[6\K<?AFD^=;
MCY8/X9?U\SU*BO-[>\\(SG$.KZG9-[RD`5K6UF9QFP\;SL.PD*M_,BJY9I7Y
M2+*]KG0F.3^UI?+FDR(0ZH[DIDEATJ/[9J)LEG'V;+3"/&UN[A/7\:Y^/_A(
M%UE[:W\06%Q<")?]9%C(R3CCOW_&GK-XIBT]%:TL9XQ<+AED*DMYH]?]JB3=
MU=#M[C.D&_\`M>#S,;_LK[MO3.Y:-(_X\I/^OJX_]'/7-67B:_D\81VNH6`M
MT$9@)1MPWD@YR.W`'U-=+I'_`!Y2?]?5Q_Z.>IBTQ231>K`\*?\`,:_["T__
M`++6_6!X4_YC7_86G_\`9:HDTK#_`(_-2_Z^5_\`14=7:I6'_'YJ7_7RO_HJ
M.KM`!6#JVE1)X8NTG(D>"">16CS&N2"WW0?YYK>JAKW_`"+^I?\`7I+_`.@&
M@"_2,P52S$``9)/:EKG?%>L_9XH]&LVW:CJ7[J,#_EFK<%S]!G\O:@J$>:2B
M<[<:W--%JU_IQ+27;%/M(&5AB3Y44'^^YR0O^T#5[PMI9CUF&`?-%HUL5D<<
MAKJ7E^>Y5<#\:)].L='^PZ)#S;62'4;^0CF01_=S]6[>BUM>$+26#0DN;D8N
MM0=KN?V9^0/P&!^%$K:10G+FG*?R7]>AN4444"*\'_'S<_[Z_P#H(JQ5>#_C
MYN?]]?\`T$58H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`(IK:"XQYT2OMZ;AG%2`!0`!@#@"EHH`****`(
M;;_5-_UT?_T(U-4-M_JF_P"NC_\`H1J:@`K/N9X4U>T1I45MDG!8`\[<5H5!
M)96TLPF>%&D'1R.13BTMP*DO_'MJ_P!6_P#1*5),&+Z<0K$)+N8A2<#RW'/X
MD?G4<]F;:ROI#=32^;$S,)-N,[<9X`[`5?A_U*?[HJ>@V_>'U%+;03C$T$<G
M^^@/\ZEHIB,FZ\+Z'>`^;IL`)'6-=A_3%<SJ/PPMW8R:=?/">R2C</S'3\J[
MRBG=]&"271'E=MX?USP_JQ*K*Q4K('AC^T#(R!D##8Z]JW%NO$9L+22..":%
MY^5".C`^8""0PP#NQQGN?PZQ?^0S)_U[I_Z$U54`72(P!@?:U_\`1XIRE*4E
MS.XY*+@[*P^!<ZC:LVYF-HQ+.FUB=R]1V-2Z1_QY2?\`7U<?^CGH=E_MR(;A
MG[._&?\`:6C2/^/*3_KZN/\`T<]0@+U8'A3_`)C7_86G_P#9:WZP/"G_`#&O
M^PM/_P"RTQ&E8?\`'YJ7_7RO_HJ.KM4K#_C\U+_KY7_T5'5V@`JAKW_(OZE_
MUZ2_^@&K]4->_P"1?U+_`*])?_0#0!BZWXB-CJR6EG)+/<R`I'!@;#+E0`3Z
M#))K*T>VN(-<U#5+K9>7&G*_FR,VS=(02V.O"J``.VZMVZT6TD\11W3VMPR`
M,SX'R;_EP?Y_E5.[TF%M$U&.VMOLS2-*[RD;2%PW3UR./H:TJ-6C&/S+C+EA
M)]>AS]VB:WJ5J61#<:_<,".ICMHV7!'U6-O^^C7I@&!@5QT6@6-OK=@&N&BE
MAC`58\E5*%`H!]#EC^)KLJP6[9.T4@HHHJQ%>#_CYN?]]?\`T$58JO!_Q\W/
M^^O_`*"*L4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`0VW^J;_KH_P#Z$:FJ&V_U3?\`71__
M`$(U-0`4444`1S017$?ES1K(A_A89%$,,5O&(X8UC0?PJ,"I**`"BBB@`HHH
MH`K+80+=FZ`?S3U.\X_+\:HYD_LR)8X))3]HW'9C@+-D]3Z"M5UWH5R1GNIP
M:CMK5+6,I&SE22?F;/7FB[N/3E:&K:VTDBW)M464X;<RC<#_`(U#I'_'E)_U
M]7'_`*.>KU4=(_X\I/\`KZN/_1ST"+U8'A3_`)C7_86G_P#9:WZP/"G_`#&O
M^PM/_P"RT`:5A_Q^:E_U\K_Z*CJ[5*P_X_-2_P"OE?\`T5'5V@`JEK,4DVB7
M\42%Y'MI%51U8E3@5=HH`R?[<;_H%7__`'X-07NM0FUD>ZTF^,,:EVS`V``.
M?TJ]K-[)I^GFXA"E_,C3#8Z,X4]2.@)/X5DKXP'EQE].G#O&&8#HF>#DGH`>
MI],&@"XFKK&H5=(O@!T_<&G_`-N-_P!`J_\`^_!K-B\9!6=)[.7>)9EPN/E"
M*",\]\XSTR#Z5TD$AFMXY2A0N@;:V,KD=#B@#-_MQO\`H%7_`/WX-']N-_T"
MK_\`[\&M:B@#%CUB1)IG.E7^'8$?N#Z`5)_;C?\`0*O_`/OP:I/XDN;-Y5N;
M;SRKLJ^3@?=95.<GN7&/H:/^$M4W`B%C*%:6.(,2!R^3D^P&,GL30!:E\1+#
ML\S3;]=[A%S`>2>@I_\`;C?]`J__`._!J@/&*R(A33YE,B2,GF$#[B;L'&2,
M]!5J\U:_L]3D@-HTD"(9`Z(3D`!@/J=LH^H7U%`$O]N-_P!`J_\`^_!H_MQO
M^@5?_P#?@U3C\4F74;>W^R-%'(X1G=@0=R@@@@GCGKWS6Q97371N-RA?)G:,
M8/4#'/ZT`4_[<;_H%7__`'X-']N-_P!`J_\`^_!K3DWF)O+(#[3M+=,]LUST
M7BF2*"`SVC3-+`DQ:'`"[E)*\G[PP>.I`)H`O?VXW_0*O_\`OP:8?$06=83I
ME_YCJS*/(/(!`/\`Z$/SJDGC$>=Y;Z?,,N%&WDX*;NGYC\*FLO%0OKVUMEL9
M(OM&26D884`9[9Y.1Q[T`6O[<;_H%7__`'X-']N-_P!`J_\`^_!JHVO7]M+=
MBXLF9+4@$JNT/E]JX).,8(8GL,^E26/B,WFK2V;VS6ZK'E#*<9(+ANF?[HXZ
M\-0!/_;C?]`J_P#^_!H_MQO^@5?_`/?@U;TR[:]L([AFB8N6^:)MRL`Q`(/O
MBDU:YFL]+N+J#87AC:3#=\`G'X]*`*O]N-_T"K__`+\&C^W&_P"@5?\`_?@U
M5F\4&U602V4LIBW;FCQAL.4R!G/4?AN7UJ(>,`ORRZ?*'WNA"D$#:JG)ST&&
MZ^S>E`%T>(09FB&F7^]5#$>0>`<X_D:=_;C?]`J__P"_!J*RU^34;K[+#:&%
MVAD?,K?=97V`'&>I!/TJM%XFNH[<376FSG,GE[$3!S@MW//R[?QR.U`%[^W&
M_P"@5?\`_?@T?VXW_0*O_P#OP:JVOB*6[BU'9#&DMLJM"LD@`?*@CYNAY)YS
MW'K6Y!(9K>.4HR%T#%6&"N1T-`&;_;C?]`J__P"_!H_MQO\`H%7_`/WX-6-6
MN;FUMDDMC&"98XSO!/WG5?TSG\*RCXM'DI(NG3DOY849!Y<9'3MSU]58=J`+
MO]N-_P!`J_\`^_!ID?B(2/(B:9?DQ-M<>0>#@'^1%4X_&"MY2G3YB\B%OD88
M&'V8).,9(XSZCUJ>T\0RZC:W,UM:F,PVZ3`2<ELY)7`[@`?B10!8_MQO^@5?
M_P#?@T?VXW_0*O\`_OP:I+XFN;>WB:\TZ4/(#D`!0A7"L22>FXGGT&:DA\1R
MRZ3<70M'::&Y:$Q`'(&[`)QGMWZ9H`L_VXW_`$"K_P#[\&C^W&_Z!5__`-^#
M6M67K6HSZ8L<R!'C^8M'CYB%1F./^^0![F@!O]N-_P!`J_\`^_!H_MQO^@5?
M_P#?@U4D\5%)A"+"3=]I\C+,-H^;!8D=``">>V.QJ-/&4;PQR#3KCYX3+C*C
M`RPQR?O?*3CTYH`N0^(EN(EEBTV_9&Z$0&G_`-N-_P!`J_\`^_!JNVNWD^ER
M7EG9[F5U58_O%MT:LOT^=PI],$]J0^)71TC:QF_>LNV0@*%5\E202#T&/J".
MM`$T.LO&A!TJ_P`EV/\`J#W8G^M/_MQO^@5?_P#?@TRPUF>^L]*N%B0?:P?.
M3/S)@=AZ9QGTR*V:`,G^W&_Z!5__`-^#1_;C?]`J_P#^_!IFH:Q<6.HRH+<S
M6\<2LQ0<ACNPO7J=O'NPJC9^*IY8YP]B\SQ.`#$."NW<3^&#GZKZT`7IO$0M
MX))I=,OUCC4LQ,!X`&33_P"W&_Z!5_\`]^#56Z\4_8[2.YFTVY5'A:7D8X`!
M`Y[X/3V-.OM;OHEM9;>R9XYR5("EB"&VYX['((/<9H`L?VXW_0*O_P#OP:/[
M<;_H%7__`'X-4+SQ6]MO3[#+NBF$;N<;6`<*Q`SGN?IE>QK:AO#+J$EMA=JV
M\<JLISNW%P<>PVC\Z`*G]N-_T"K_`/[\&C^W&_Z!5_\`]^#6M7.7GB&\M/MK
M&T+I$[QPLHX+#'7GWSVX!]*`+O\`;C?]`J__`._!IDOB(0('DTR_4%E4'R#U
M8@#]2*JCQ2ZQ2-]AEG\N652\2Y!56(##V(QCU(;TJ6\\3?89DBGL)D+;!EB`
MH+-MZ^@]:`+']N-_T"K_`/[\&K&CB0:?NDB>)GFFDV.,$!I&89'T(JA<:QJ$
M>H6\4=D_DW$:N"8R63(R0WN,'/U%5T\7>;):C[#)"DTBJS2$8`(;!X/3('/3
MAO2@#I:P/"G_`#&O^PM/_P"RUJ6MV9[V[@W0L("H^1\D$@\,.QX_7VK+\*?\
MQK_L+3_^RT`:5A_Q^:E_U\K_`.BHZNUC2Z@-,&IW)MIKD_;8HUBAV[W9TB4`
M;F4=2.I%+=^(XM.TZ*\U*QNK(RS"$0R&-G'4EOD<KM"AF/.0%)Q0!L455OM2
ML-+A$VH7UO9Q$X#W$JQJ3Z9)%-?5M-CNFM'U&U6X2(S-$TRAUC_OD9SM]^E`
M%RBJMOJ>GW<7FVU];3QY9=\<RL,K]X9![=_2H&U[2XBHN+^WMC),88A/,J>:
MW'"Y/S=1TH`T:*RXO$>DRPSS_;K=(+=G269YD5496VD')XY_#D5/_;&E_:H+
M3^TK3[1<+NAA\]=\HQG*C.2,>E`%VBBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"J4FKV$5Q)!)<JCQG:^X$!3@$`GIG!'&>]7:Q-1\,0:E
M>273W,L;OC[@`X&T@'CD`KGGU-`&E/?VEM$LLLZ!&D2,,#GYG("CCU)%$]_:
MVT2RR3#8\BQ@J"WS,<*.,]21^=8$7@>"WD21+^X;RW1PC!<':T;*.GK&O/UK
M0MM"C'AY],E+1B4'HVXQ?W`#_L`*`?\`9%`%VSU.SOXUDMIMZLJLI*E<@YQU
M'7@\=:D2]MI+I[59E,J*KE?9BP'/0_<;\JQY/"5HT,<*3RI&DLDA7`;.]@V.
M1Q@J,$<BETWPO'INI+?1WLK/Y:QNHC15<`N<D`=?GZ^WN:`-ZBBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@!LD:2QM'(BNC##*PR"/0BE`P,"EHH`****`
M"BBB@`IDD<<JA9$5P"#AAGD'(/YT^B@`HHHH`*P/"G_,:_["T_\`[+6_6!X4
M_P"8U_V%I_\`V6@`U'2?[;M-5L-UN-U[$_\`I,'G1G8L+89,C<#MQU%0IX-@
MGM8+6_>W6W@$@6#2XI+&/+X!)"2$]-PQG!W'(JW=^&DNKZ>[75]4MC.P9H[>
MYV("%"\#'HHJ+_A%/^I@US_P,_\`K4`)J&C:E+#H\-M=Q--9DB2YF@#@CRRN
M2FX<G/8\$^G%4+KP9-#ITUM9W8EMT@8PP/$/-:7[/Y(S*6^[CMC.?XL<5H?\
M(I_U,&N?^!G_`-:C_A%/^I@US_P,_P#K4`1+X;U`VY?^TX([N0X=UM/D$>P)
MM"[_`+P`^]DC/;'%,U'PE>7EJMI#K)@@.XR((F^9OE*GY77IMY!W`@D8'6K'
M_"*?]3!KG_@9_P#6H_X13_J8-<_\#/\`ZU`#&\,W(F>>+48EE2X>>VWVQ94W
M,6PXWC?RS="O;N,E]MX76V(8709O,AD8^4!DQNS$=>`2QP.WO1_PBG_4P:Y_
MX&?_`%J/^$4_ZF#7/_`S_P"M0!OT5@?\(I_U,&N?^!G_`-:C_A%/^I@US_P,
M_P#K4`;]%8'_``BG_4P:Y_X&?_6H_P"$4_ZF#7/_``,_^M0!OT5@?\(I_P!3
M!KG_`(&?_6H_X13_`*F#7/\`P,_^M0!OT5@?\(I_U,&N?^!G_P!:C_A%/^I@
MUS_P,_\`K4`;]%8'_"*?]3!KG_@9_P#6H_X13_J8-<_\#/\`ZU`&_16!_P`(
MI_U,&N?^!G_UJ/\`A%/^I@US_P`#/_K4`;]%8'_"*?\`4P:Y_P"!G_UJ/^$4
M_P"I@US_`,#/_K4`;]%8'_"*?]3!KG_@9_\`6H_X13_J8-<_\#/_`*U`&_16
M!_PBG_4P:Y_X&?\`UJ/^$4_ZF#7/_`S_`.M0!OT5@?\`"*?]3!KG_@9_]:C_
M`(13_J8-<_\``S_ZU`&_16!_PBG_`%,&N?\`@9_]:C_A%/\`J8-<_P#`S_ZU
M`&_16!_PBG_4P:Y_X&?_`%J/^$4_ZF#7/_`S_P"M0!OT5@?\(I_U,&N?^!G_
M`-:C_A%/^I@US_P,_P#K4`;]%8'_``BG_4P:Y_X&?_6H_P"$4_ZF#7/_``,_
M^M0!OT5@?\(I_P!3!KG_`(&?_6H_X13_`*F#7/\`P,_^M0!OT5@?\(I_U,&N
M?^!G_P!:C_A%/^I@US_P,_\`K4`;]%8'_"*?]3!KG_@9_P#6H_X13_J8-<_\
M#/\`ZU`&_16!_P`(I_U,&N?^!G_UJ/\`A%/^I@US_P`#/_K4`;]%8'_"*?\`
M4P:Y_P"!G_UJ/^$4_P"I@US_`,#/_K4`;]%8'_"*?]3!KG_@9_\`6H_X13_J
M8-<_\#/_`*U`&_16!_PBG_4P:Y_X&?\`UJ/^$4_ZF#7/_`S_`.M0!OT5@?\`
M"*?]3!KG_@9_]:C_`(13_J8-<_\``S_ZU`&_16!_PBG_`%,&N?\`@9_]:C_A
M%/\`J8-<_P#`S_ZU`&_16!_PBG_4P:Y_X&?_`%J/^$4_ZF#7/_`S_P"M0!OU
M@>%/^8U_V%I__9:/^$4_ZF#7/_`S_P"M5W1-$AT*WGAAN;FX\^=IW>Y<.VY@
M`>0!QQ0!I4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
C`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g118721moi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721moi003.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$0`:`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T+5+WQ--X
MBFT[0WTJ.*WM(9Y&O8I&8M(\J\;6'`$?ZU'Y?Q!_Y^O#?_@//_\`%U?M?^1V
MU3_L&V?_`*,N:V:`.7\OX@_\_7AO_P`!Y_\`XNCR_B#_`,_7AO\`\!Y__BZZ
MBB@#E_+^(/\`S]>&_P#P'G_^+H\OX@_\_7AO_P`!Y_\`XNK^I^(XM*NGBN+>
M3RTCWB0$?/P20O8D8&1G.#G&,TC^*],68P(9I)1,(618FX)9%Y)XQF1._>@"
MCY?Q!_Y^O#?_`(#S_P#Q='E_$'_GZ\-_^`\__P`76C?^(K6TF^SQJ9[GS5B$
M8R!DL@.6QV\Q,_6BXUW[%>RPW5N(XH8TD>57+G#L57"A<D[AC\:`,[R_B#_S
M]>&__`>?_P"+H\OX@_\`/UX;_P#`>?\`^+J]<^*]+M+8SR-,5PY4")OGVKN.
M"1@\#\Z=_P`)5I7G^299%DWE,-"XRV67&<8SF-Q_P$T`9_E_$'_GZ\-_^`\_
M_P`71Y?Q!_Y^O#?_`(#S_P#Q=7XO%.F3WT5E"TS3RR",*867:=I;G<!T`Y^H
MK9H`Y?R_B#_S]>&__`>?_P"+H\OX@_\`/UX;_P#`>?\`^+KJ**`.7\OX@_\`
M/UX;_P#`>?\`^+H\OX@_\_7AO_P'G_\`BZZBB@#E_+^(/_/UX;_\!Y__`(NC
MR_B#_P`_7AO_`,!Y_P#XNNHHH`Y?R_B#_P`_7AO_`,!Y_P#XNCR_B#_S]>&_
M_`>?_P"+KJ**`.7\OX@_\_7AO_P'G_\`BZ/+^(/_`#]>&_\`P'G_`/BZZBB@
M#E_+^(/_`#]>&_\`P'G_`/BZ/+^(/_/UX;_\!Y__`(NNHHH`Y?R_B#_S]>&_
M_`>?_P"+H\OX@_\`/UX;_P#`>?\`^+KJ**`.7\OX@_\`/UX;_P#`>?\`^+H\
MOX@_\_7AO_P'G_\`BZZBB@#E_+^(/_/UX;_\!Y__`(NCR_B#_P`_7AO_`,!Y
M_P#XNNHHH`Y?R_B#_P`_7AO_`,!Y_P#XNCR_B#_S]>&__`>?_P"+KJ**`.7\
MOX@_\_7AO_P'G_\`BZ/+^(/_`#]>&_\`P'G_`/BZZBB@#E_+^(/_`#]>&_\`
MP'G_`/BZ/+^(/_/UX;_\!Y__`(NNHHH`Y?R_B#_S]>&__`>?_P"+H\OX@_\`
M/UX;_P#`>?\`^+K0E\0Q6]_>07$1CBL]N^4;FR&"D<!?5@,9SWHMO$MC=W*I
M`V8#;R3O,V5";?+)!!'I(#[4`9_E_$'_`)^O#?\`X#S_`/Q='E_$'_GZ\-_^
M`\__`,76A!XABO=0:RLH6E>.(R.9"8]OHO(ZG@_0YYI(?$<.0MU$86=Y4C";
MI-WER>6W(7CYBN/7<*`*'E_$'_GZ\-_^`\__`,71Y?Q!_P"?KPW_`.`\_P#\
M75V?Q;I5M+Y<C3`@*7S"P*`HS`D8ST1NV1CFE7Q;H[QO(L\A$8+./(?*@`9)
M&,X&<4`4?+^(/_/UX;_\!Y__`(NCR_B#_P`_7AO_`,!Y_P#XNMC3]:M=3N)8
M;;S#Y*AF9EVCEG3'/.<QM6A0!R_E_$'_`)^O#?\`X#S_`/Q='E_$'_GZ\-_^
M`\__`,77444`<OY?Q!_Y^O#?_@//_P#%T>7\0?\`GZ\-_P#@//\`_%UU%%`'
M+^7\0?\`GZ\-_P#@//\`_%T>7\0?^?KPW_X#S_\`Q==110!R_E_$'_GZ\-_^
M`\__`,74FEWOB:'Q%#IVN/I4D5Q:33QM912*P:-XEYW,>")/TKI*QKK_`)';
M2_\`L&WG_HRVH`2V(_X3C4QW.FV?_HRYI]C<:K?VWVA)[.-3)(H4P,Q`5RO7
M>/2H$M8+GQKJBSQ)*ITRS!5QD$>;<GD'Z"K7AQ5318T10JK+,``,`#S&H`E\
MO5_^?NR_\!G_`/CE'EZO_P`_=E_X#/\`_'*OT4`8T^CW-T[M<?V;*7&&+V;'
M(QC^_P"A(J*/PZ8BQCATI"W7;9,,\J1_'ZJOY"MZB@#&DT>YFF\Z0Z<TF\/N
M-HV=PQ@_ZSK\J_D/2FW.FW=Q=8G.GR-+'AF:U?D*P('^L]3FMNH7_P"/V+_K
MF_\`-:`,9_#0D9F>WTABS,Q)L3R6^\?O]\<T-X;W@AX=+8'.0UFQ!R6)ZO\`
M[;_]]&M^B@#"B\//#.D\4>EI(AW*PLVRIZ<?/QTJ]Y>K_P#/W9?^`S__`!RE
MO3=K<VRP3HB2OL8-'N/W6;(.1Z5=H`H^7J__`#]V7_@,_P#\<H\O5_\`G[LO
M_`9__CE7Z*`*'EZO_P`_=E_X#/\`_'*/+U?_`)^[+_P&?_XY5^B@"AY>K_\`
M/W9?^`S_`/QRCR]7_P"?NR_\!G_^.5?HH`H>7J__`#]V7_@,_P#\<H\O5_\`
MG[LO_`9__CE7Z*`*'EZO_P`_=E_X#/\`_'*/+U?_`)^[+_P&?_XY5^B@"AY>
MK_\`/W9?^`S_`/QRCR]7_P"?NR_\!G_^.5?HH`H>7J__`#]V7_@,_P#\<H\O
M5_\`G[LO_`9__CE7Z*`*'EZO_P`_=E_X#/\`_'*/+U?_`)^[+_P&?_XY5^B@
M"AY>K_\`/W9?^`S_`/QRCR]7_P"?NR_\!G_^.5?HH`H>7J__`#]V7_@,_P#\
M<H\O5_\`G[LO_`9__CE7Z*`*'EZO_P`_=E_X#/\`_'*/+U?_`)^[+_P&?_XY
M5^B@"AY>K_\`/W9?^`S_`/QRCR]7_P"?NR_\!G_^.5?HH`Q)M#GN9)))O[.=
MI2&?=:O\Q`P"?WGI26^@R6DIEMX]*C<J4++9-D@XR/O^P_(>E;E%`&-;:/<V
M<OFVQTZ*39LW+:,/E]/]94!T6621[=TTQD",<-:,0?,8EQ@OW*@GWKH*@3_C
M^E_ZY)_-J`,8^&5(8?9](PV,XL2,X!`_C]&/YFD/AA3DFWTDDYY-DW?.?X_>
MNAHH`Q[72KNR=GMFTZ)G&&9;1@3R3_ST]6)_$U9\O5_^?NR_\!G_`/CE7Z*`
M*'EZO_S]V7_@,_\`\<H\O5_^?NR_\!G_`/CE7Z*`*'EZO_S]V7_@,_\`\<H\
MO5_^?NR_\!G_`/CE7Z*`*'EZO_S]V7_@,_\`\<H\O5_^?NR_\!G_`/CE7Z*`
M*'EZO_S]V7_@,_\`\<K.*WB^-M.^URPR?\2V\V^5$4Q^\MLYRQS705C77_([
M:7_V#;S_`-&6U`!:_P#([:I_V#;/_P!&7-3>'O\`D#I_UVF_]&M4-K_R.VJ?
M]@VS_P#1ES4WA[_D#I_UVF_]&M0!IT444`%%%%`!4+_\?L7_`%S?^:U-4+_\
M?L7_`%S?^:T`2U'-<16\9DFD2-!_$[`"I#S62EK!`FIF.)5()48]/+4X_,T!
MT+,L\5Q+8R0R+(AG.&0Y!_=OWJ]5!O\`F&?]=/\`VD]7Z`Z!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5`G
M_']+_P!<D_FU3U`G_']+_P!<D_FU`$]%%%`!1110`4444`%%%%`!1110`5C7
M7_([:7_V#;S_`-&6U;-8UU_R.VE_]@V\_P#1EM0`6O\`R.VJ?]@VS_\`1ES4
MWA[_`)`Z?]=IO_1K5#:_\CMJG_8-L_\`T9<U-X>_Y`Z?]=IO_1K4`:=%%%`!
M1110`5"__'[%_P!<W_FM35"__'[%_P!<W_FM`$U9K?ZK5/\`?/\`Z*6M*LUO
M]7JG^^?_`$4M`=&0W>H6MI-HT,\RH\\VV,'^(^6W]2!^(K7K@M4TBV\3>,+:
MVN&D-M96RQR;6QB1U9QCT("@_B*V/*UWPYS"TNMZ<O\`RS<C[5$/8])!['!^
MM1S.[*Y=$=-15#2]:L-9@,MC.)-IPZ'Y7C/HRGD&KU4G<D6BBBF!!<WD%FJM
M.^P,<`X/6I8Y%D0.IR",@U6U+_CV7_KM%_Z&M1-"?[9C_?S!3$SE!(=N05'3
M\:&);FA1110,****`"BBDH`C2XAD<HDT;,.H5@34M4+.&--1O66-0=R\A1_=
M%7Z$`4444`%%%%`#6#%3L(#8X)&0*JZ?+<S1.]Q)$V)'0".,K]UBO=CUQ5NJ
MNG?\>S_]=YO_`$8U("W1113`****`"BBF2RI!&9)"0J]2`3_`"H`?4"?\?TO
M_7)/YM2VUU#>1>;`^]#T.",_G2)_Q_2_]<D_FU`$]%%%`!1110`4444`%%%%
M`!1110`5C77_`".VE_\`8-O/_1EM6S6-=?\`([:7_P!@V\_]&6U`"6O_`".^
MJ?\`8-L__1ES4_A[_D#I_P!=IO\`T:U4TMEN/&^I[V<#^R[1?D<H>9;@]1@C
MI5OPXH318U&<"68<DD_ZQNYZT`:E%%%`!1110`5"_P#Q^Q?]<W_FM35"_P#Q
M^Q?]<W_FM`$I.!7#ZAXRM((M55EGMW$K",O&"DK*BJ4R"1G.>G3K[5U.MWYT
MS2KB[4;F1,(O]YSPH_$D5YYK]J\5I8^$HF+2W%P);EQUP(U9F_$[C^%2W8T4
M5[-M]=$:/AW6EL+2&ZU/3[VW-U>/<R7/DEXR&C8*`1D@!=O45VECK&FZFNZR
MO8)^.0C@D?4=17//INI:+]ADTJ<W=OOR+&X?[O[MON.>0,9X.14T2^'?$=P8
MKJQ6"_3EHI4\J=?<$8)'N"1336Q#ISM>+NC1U3PY::C.+R)Y++4$'R7EN=K_
M`$;LP]C5)==O]"(B\10!H.BZE;*3&?\`KHO5#[\CZ5+_`&!J5H,Z5KURJCI#
M>*)T^F3A@/QI#J>O62E-2T1;R/&&EL)`V1_US;!_4T<O5$>T_F1NPSQ7,*S0
M2))&XRKH<AA[&I*X2.?38+MY?#VIKI%TQS)IU\ACAE/?Y&QM/NOY5M6?B:.X
MF&GZC&^E7[CY%<@I)[QO]UOIU]J5[;EJTOA9K:E_Q[+_`-=HO_1BT-_R%XO^
MO=__`$):IJTSZ8LDTS2DW*`;@!@"4#L!Z5;;_D,1?]>[_P#H2TV*UI-%NEI*
M6F`4444`%5KB^@MI4CE\S<_"[8F8'KW`]C5FJEY_Q\V/_78_^BWH$Q+0YO[W
M_?3_`-!%7*IVO_'_`'O^\G_H(JY213"BBDIB%HI**`*$L"G6(6WR\QNY42MM
MR"F.,X[FI=-_X]7_`.N\W_HQJ9<RQPZG`\LBHH@DRS,`/O)4&@:G9ZC9S-:7
M"2B.YF5MIZ'S&/\`(@TFP2W-6BDI:8!1110`4E+56&]:6ZDM_LLJ>7U=BN.>
MG0YH`32_^039_P#7!/\`T$5(G_']+_UR3^;5'I?_`"";/_K@G_H(J1/^/Z7_
M`*Y)_-J2`GHHHI@%%%%`!1110`4444`%%%%`!6-=?\CMI?\`V#;S_P!&6U;-
M8UU_R.VE_P#8-O/_`$9;4`%K_P`CMJG_`&#;/_T9<U-X>_Y`Z?\`7:;_`-&M
M4-K_`,CMJG_8-L__`$9<U-X>_P"0.G_7:;_T:U`&G1110`4444`%5Y#B\B_Z
MYO\`S6K%5IB%NXBQ``C?K]5H`Q]6/]I>(M/TT`&*U'VV?GTXC'_?63_P&N=T
M%$UOQ3K^OA08((S;6Y['C!(_`#_OJK%WJGV+PQJ_B-FVS:DY2V)ZB,?(GZ;F
M_&KO@W3FTSP;+!(,2,#*X/8M&K8_#./PJ-S6IH^7LOQZF[)%=2+9-!'"4BPY
M+R%2?E*XX4_WLTNI:+9:M$$NX=S+RDBG:\9]58<BK=M_QZQ?[@_E4M58SBVK
M-'.;M:T#A@^L6(_B4`7,8]QT?]#6II^KV.K0^=97"R@<,O1D/HP/(/UJ\1FL
MG4O#MI?3_:XFDL[Y1\MU;G:_T;LP]C19K8TYHS^+1]_^`7[JRM;^+RKNWBG3
M^[*@8?K6!?\`@+2;JV>"W>>TC;GRXWW1Y]=C9'Y8J5=8U'1/W>N6XEMAP-0M
ME)4?]=$ZK]1D5N6]U!=P+-;RI-$XRKHP(--,SG2MJ_O//Q;^*/#]E&EM<QZM
M9F3Y('0K*I5QCYNXR!U/\57M.^(.D2ZC&FH//93Q0M'*+F+!#97KCIT/7%=$
MO_((C_Z^5_\`1U9E_P"$--U'Q,EY>`SNR&0K(JLORE0%P1TP3^>>M0[I*PI+
MWV[FY#K.F7$8DAU"UD0]"LRD?SJ0:C8_\_EO_P!_16/>>`_#-ZFU](MX_1H5
M\L_^.XK+;X>PV7.G_8)U'2&_L8W_`/'U`;\\U6HF['6?VC9?\_EO_P!_11_:
M-E_S^6__`']%<C_9]G9<:GX%M'4=9K"%)E^NW`8?D:M64/@2_D\J&QTM9NGE
M2VRQN/\`@+`&E:0*<.YTG]HV7_/Y;_\`?T55N]0LS<V1%W`0)CG$@X_=O5.Z
M\->'K:V>8>';"4(,E5MT!Q^-0'PYH,C6;?V!8P^9*0R>0AR-C'G'T%"YBFE:
MY9A\0:/!J.H+-J=I$49,[YE7J@]>M-;QOX?W%8+QKM^RVL#RD_\`?((JGH_@
MO2+#5[B:.%6,1P%>-"/F`)XQQSTQTKJ5544*J@`=`!@4ES6&^4P?^$GNI^++
MPUJLQ[&5$@7\W8']*/MGBRY_U.D:?9#UN;MI#^2+_6M_)[BH+B^M+09N;F&$
M?]-'"_SIV?<5TNAC_P!F^*;GF?7[6T_V;2R!_5V/\J3_`(1-IN;SQ!K%QGJH
MN?*4_@@%3R^+_#\+;&U6W=O2)O,/_CN:A?QC9$%K:QU*Z7(&Z.S<+SP.6Q3Y
M"543=DRM+X*T`WR0FP#^9!)N>5VE8'*C(+D\\FHM-\!Z#Y4DK6\AD\QT5UD*
M,@5V`P4P>E02^)]2&L1R-HMZL"Y0D(K2`$KE=H;U`YS_`!=/72TGQ5I#HT$M
MT+68S2GRKH&)N78_Q8]:'!=A1K+57'?\([J=I_R#/$EX@_YYWBK<+^9PP_.@
M7OBFQ_X^-)L]17^_9S^6V/\`=?C_`,>K?219%#(P93T(.0:`<GI2Y>Q=S`'C
M3383MU*"]TMO^GNW95_[Z&5_6MBSU&RU"/S+*[AN5]8I`P_2K!4$$$9!Z@UC
MW?A+0;V3S9--ACE_YZP9B?\`[Z3!H]X-#8S52W_Y"-W]$_D:R3X=U*SYTSQ'
M>QC_`)YW:K<+],G#?K5&75O$.B/=W%]I]G?HBIO>UF,1[@?*P.2?0&CFMN*V
MJL=+I?\`R";/_K@G_H(J1/\`C^E_ZY)_-JR?!VL1ZUX;MIE79)$ODS)G[KJ,
M?X'\:UD_X_I?^N2?S:FG=#:L3T444Q!1110`4444`%%%%`!1110`5C77_([:
M7_V#;S_T9;5LUC77_([:7_V#;S_T9;4`%K_R.VJ?]@VS_P#1ES4WA[_D#I_U
MVF_]&M4-K_R.VJ?]@VS_`/1ES4WA[_D#I_UVF_\`1K4`:=%%%`!1110`5S_B
MR:5;6*TMB1/?DVL9';<1N/X*&/X5ODXKG'NTO/%LKRX%MI-NWSD\"5@"Q_!"
M/SI,TIZ/F?34P/$T$>J>)-%\+6X_T:VVM,HZ!0,X_!5(_P"!UV2:;(RSI/<[
MHYSEA&FP]`.N>F!7&>"YGOO$5]K<UO*[W+&.$J!A<X9NI[+Y8_`UZ&!BA+J9
MINVO4CMX%MH1$K.P'0N<FI:**8!28I:*`&E0PP>:P;SPVUM(]YH%Q_9]TWS-
M'U@F/^TO8^XP:Z"J:7=P]_);&V0(BAC)YN3@[@.,?[/K1:Y49RCL<U'K=[::
M:D>J:5/'&LX/VFW_`'L9Q+DY`^9?;@UL66L:?JFJ1O97<4X$#@A6Y7YEZCJ*
M<!G2(_\`KY'_`*.J+4=!TS4M6C^UVD;OY#$2+\K@[EYW#!_6IUL:2<'-W5O3
M_+_@FWFBL`Z)JUA\VE:R\BC_`)87Z>:#[;QAA^M`U_4;'Y=6T2=5'6>S/GQ_
M4@88#\*=^XO9W^%W_K^MC?Q56]TNQU&/9>VD-PO821AL?2HM/US3=4'^A7D,
MS#J@;##ZJ>15[=^E-/L9RBUI)'.7?A:*SLIVTS4;VQ"QL?*67?$>.FUL_IBL
MV^E\5VDUO&CVMXHP5E$31E/E;DCG)VY.!GH..QZ26]>YMKZ(VLL7E1LI9BI&
M=N>Q]"*DE^_I_P#UT_\`:;4]GJ1*FN730Q;:#Q1/=W0-[IUH2R[S'`\I^Z.F
M2.U6_P"P=5F/^E^)KQAZ6\,<7ZX)K2M?^/\`O?\`>3_T$5<I)@X+J8/_``B%
MA*<WEUJ%[[3WDA'Y`@5/!X4T"W.8])M2?5XPY_-LUKT4[L7)'L0P6L%LNV"&
M.)?1%`%0:F`+3/??'_Z&*MR*S1L%<HQ'#`9Q60&G?2W>><RDS[1E0,`2X[?2
ME;0UC\2+K@#58/\`KA)_Z$E16UI;W=D\=S!',AGF^61`P_UC=C4LV[^U(=H!
M;[/)@$X!.4I=/BN88G2X2(9D=P8W+?>8MW`]:"%U,QO!^FQL7L'N=-<][.8H
M/^^>5_2F&R\3V)S;:E:ZBG]R[B\M\?[R<?I70TE.Y/(NFA@CQ'>6@_XFF@WE
MN.\EOBX3ZG;R/RJW8^(](U%]EM?P,_3RV;:__?)P?TK3Q5.^T;3=27;>V,$_
M&,R1@D?0]11H%I+J,OD+W5KB>6,/(48(V`1M8_S`IT4:2WUVDBJZE8\AAGUK
M&N?#"6DMJ-+U&]L<RD*@E\R-?D8YVOFJ>EWFH:9KPMM:G>2*?"07&-@+\X60
M9."1]WGZ\]"P2FU:Z'R0/X>BM/$%E&3;/;QKJ4"#J@48E`_O+W]1]*Z:VFCN
M)VFB=7CDAC964Y#`EL$4W3`&TBT4@$&W0$'O\HK!L"GA77?[*<M_9]\0;-V/
MRP.23Y/T)W%?RK->[Z&NYU5%)2U9(4444`%%%%`!1110`4444`%8UU_R.VE_
M]@V\_P#1EM6S6-=?\CMI?_8-O/\`T9;4`%K_`,CMJG_8-L__`$9<U-X>_P"0
M.G_7:;_T:U4TADF\;:GLN'A_XE=H,H`3GS;CGD$=CV[U;\.`KHL:EBQ$LPW'
M&3^\;GB@#4HHHH`****`*VH7<=A83WDQQ'!&7;\!FN$UMY=(\'Q?:`?M6J>9
M)=8//S8=Q_WR-OY5TGB0_;KK3]%7D74GFS@?\\H\$Y^K;1^-8&IJ?$7CFWL0
M0UK:.%D7J"$P[_\`CWEK^=3?J7+2FH_S?E_5S;\/Z:VE6>DVTH'G&.22;C^-
ML,WZG'X5T=4IQC5+/_=D_D*NU6R1`M%)10`M%)10`M4T_P"0M<?]>\7_`*%)
M5O-4M^S4KE]I;%O&<*,D_-)0MF!#!:&[TZ-!.\065F^0`Y(<D=0>XIWF,FKQ
M*8YW"Q-&93&<$DJ>HX[&I-*9_LFQXI(V5VX=<=6)_K5W-+H5+XFPHP?6C-%,
MDS]0T#2M4(:\LHI''20+M<?1AR/SJ@="U2P^;2M:E91T@OE\Y3[;N&`_$UT%
M)2LC15))6OH<B^LZE8PZDFI:/*VXD--9'S4!\M>HX8#&#G'>II/%FDEK$EKE
M=DF6S:2\?(P_N\]:U9`##J^?[Q_]%+4DH&[3^W[W_P!IM3=[C<H..L?N?_#F
M1;^+]$2\NV>ZE4.RXS;2_P!T?[-6?^$U\/\`>^8?6"0?^RUJ0:?;6\S311A9
M&ZL">:LXJ4F%Z?9_?_P##_X37P[_`-!)1]8W']*/^$T\.'IJL/X@C^E;9%&T
M>@_*C4+T^S^__@&-_P`)CX=/_,7M1]7Q6>/$NB'2S&-5M2_V@MM\T9QYV<_E
MS73F&-NJ*?\`@(K':UMWTEMT*'_23SM'_/:GK9CBZ?,M']__``!W]NZ1+JD#
MQZI9NHAD&5N$/)*>_M6G'>6TW^JN(I/]UP:I2^&M'GG\Z73X7<>HX_+IVJ.7
MPGX?E/S:/9_\!B"_RHU)2I^?]?<:^?:C-8?_``AF@#[EB8_^N<TB_P`FI#X1
MLU_U%]J=N/2.^D_J31J.U/N_N_X)NY^M&?7%87_",2)S%XAUA#[SJ_\`-34=
MQIFJV41D_P"$JN%C'4S6L3_R44:]@Y(_S?F:]V?](LO^NQ_]%O56YT^WU22_
ML[I-T4J(#ZC@X(]"*Q+I?$4:6EW::I;ZIB4E8FM?*W_(V>0WIG'OBM32-6CU
M,W5Q:+F0;%:*7*-&PSE6X."*$R:E/W4[W16\+:G-%#%H^H\74<*O!)VN(L#!
M'^T.A'X]ZTM1TVWUA+JRNE)BEA0<<%3EL$'L0>:J7>B37NCV\+LEO?604VT\
M3%MK``9Y`X/0CTI^@ZJVHO.+B+R+R!4BN(3_``L"W(]5(((/O3M=&*;3LQGA
M[4KGS)=&U1@=0LP#YG07,719!_(^AK=K'\0:3+?QPWM@XBU*R)>VD/1O5&_V
M6'!_.K.BZM%K.GK<HABD!*30O]Z&0<,I]P:E::,T>NIH44450@HHHH`****`
M"BBB@`K&NO\`D=M+_P"P;>?^C+:MFL:Z_P"1VTO_`+!MY_Z,MJ`"U_Y';5/^
MP;9_^C+FIO#W_('3_KM-_P"C6J&U_P"1VU3_`+!MG_Z,N:F\/?\`('3_`*[3
M?^C6H`TZ***`"D.:6LOQ%?OIVC3S0C,[`1P`=3(QVK^IH'&+DTD9$%\JRZWX
MDF.8;=3;V^>ZQ]<?[SDC\!6?X#LI3?W6HSG,C;H,GNP(:0^_SL1]%%'BB1-&
MT*PT:#]YY*":1>N_9C:#_O2E?UJW+%<Z-I6F:#I[@ZA/$T9D!SY><&24_CNQ
M[D4HQ;:B.<E*;:V6B,S5+?4=>\9%M-NC##;N(Q<]0CJ!N"@]<9_,UTG]C>(/
M^AKD_P#`&+_"I[33X-*ETZRMUQ'%'(!GJ3QDGU)/-;%;RJO1+;T1%C`_L;Q#
M_P!#7)_X`Q?X4?V-XA_Z&N3_`,`8O\*WZ*GVDO+[E_D%C`_L;Q#_`-#7)_X`
MQ?X4?V-XA_Z&N3_P!B_PK?HH]I+R^Y?Y!8P/[&\0?]#5)_X`Q?X5S]OX9\1+
MXIFF&M[6"AS<^4IW*=P`V=.W3I^0KOJJQ_\`(7G_`.N$7_H4E5&K)7V^Y!8S
M!IOB9!\OB&WD_P!^P`_DU(8O%T?W+O29?]^"1?Y-6]14>T?9?<@L8(/C`'F/
M17'L\J_T-+]L\41?>T>QF_ZYWK+_`#2MW%&*.?\`NH+&#_:_B->OA<'_`';^
M/^H%!UW5T&9O"]X/^N<\3_\`LU;U'XT<Z_E7X_YA8\^T[QC?WLNI0MHTT@E5
MGQ%@&/Y0OS$G&,`5KR7^NW)@DAT"\00X90;B``G!&>2>QK4=8H8=8?")N8Y/
M`S^Z6M&V97MT*L&&T<BKE.-](_F.WNF,-7\1GIX7Q_O7\8_D#3OM_B=_NZ'9
MQ_[]\3_)*W,45'.OY5^/^8K&"9/%[_=MM'C_`-Z:5OY+28\8GJ^BI_P&5OZB
MM_%%'/Y(#G+JT\6SVLJKJ6G1N4(`BMW!_`EN/K6!HZ^)-)TN9KNT^V6SSCY5
MF'F(0_S$`\')XQFO0C60/^00W_7TW_H\U2J/E::145[R"Q\4:7>R_9S,;:ZZ
M&VNE,4F?3#=?PS6N#FJM[IMEJ</E7MK%<)Z2(#CZ>E9)\.76G?-HFK36RCI;
M7'[Z''H,G<OX&IM%[.Q.IT%+7/+KVHZ;\NM:1(J#K=61\Z/ZE?O*/P-:FGZO
MI^JQ^98W<4Z]]C<CZCJ/QI.#2N.Y=J&[_P"/2;_KFW\JES45W_QYS?\`7-OY
M5*W`I@?NM,_WA_Z*:LV_TB>76)]0TN86U]$B#D?NYQ@_*X_KU%::_P"ITO\`
MWA_Z*:IHK(QW3W'VF5B^`58+CCIT%#W92DXM-%72-;CU(/#)$UM>P<3VTGWD
M/J/53V(JEK%A=#4?[6TP?Z9:Q+NAS@7$9+;D/OQP?45;UG14U!HKF&4VM_!_
MJ;E!ROL1W4]P:KZ1JTDVHR66IQI:Z@L:C9G*S`$_.A[CGIU'X4D[;E3A&:O'
M_AC3TS4;?5K".\MFRC]B,%3W!'8@\5BZS#)H&I'Q#9HS6\@"ZE`G\2#I*!_>
M7OZCZ4:A&_AW47UFU5FL9R#?PJ,[#_SU4?\`H7J.>U=%&\=S"'0K)'(N01R&
M!HDKF,)/9A#-'<0I-$ZO'(H964Y!!Z$5)7,6);PMJZZ5(3_95\Y-DY/$$AY,
M)]CR5_$5TU"=RVA:*KWEU]CMVG,,DJH"6$>W(`&<\D5+$[21AFC:,G^%L9'Y
M$BF(?1110`4444`%8UU_R.VE_P#8-O/_`$9;5LUC77_([:7_`-@V\_\`1EM0
M`6O_`".VJ?\`8-L__1ES4WA[_D#I_P!=IO\`T:U0VO\`R.VJ?]@VS_\`1ES4
MWA[_`)`Z?]=IO_1K4`:=%%%`"$D#@9K`O6_M/Q3:68YAT^,W4OH7.5C!_P#'
MC^5;DKK'&SNP55!))["N1M[R:T\,WVM`'[;JLN;=3U^;"1#\!@_B:3[&D7R1
ME-]/Z_(R+N]@O_%#7UR^+2W<SDXSB&`[5QZ[I6/'?:*Z;P_8W#7AUC4%*WE]
M&3Y9_P"6$0(V)^N3[FN8\):1_:^LW$Q&[2["1(4)'$[1C"_ADLY]2P]*]"(Q
M>1?]<W_FM7\*MU?Y&23229%<#_B:6?\`NR?TJY4$EC:S3B:2VA>08P[1@L/Q
MJ>I?08M%%%`!1110`53C_P"0O/\`]<(O_0I*N556P@2[-TID\UN"?-<@CGC&
M<=S^="`LTM)2T`%%%%`!1124`4K>))9[Y7567SUX89_Y9I5N.-(DV1J%4=E&
M!5*PFWW=V/)F0/*&4O&5!&Q1U/N#6A3>X!1112`****`$-9]G:P75EMGACE"
MS2D!T#8_>-ZU>D5F0A&"MC@D9`/TJ"PMIK6)HY9DER[,"L97&22>Y]:?0">.
M-8D"(H50,!5&`*=2T4@$Q67?^&M+U"7SY;81W`Y%Q"3'(#Z[A_6M6BFFT[H#
MGC8^(M*(-E?1ZI`/^6-Z-DN/02+U/U%0WGC&VM+.:/5K"\TZ<H55)(]R.<?P
MN/E/XD5TV*H:UIUOJ6F30W"DJ%+`CJ"!P16D9)OWD(HZ??G5+&PN+"-9(H3\
M^]]I!"%2,8/J#6Z*YFR\'6<%E#+IUU=Z?<%`S202G#G'\2G*G\JF\WQ/I?\`
MKH;?6(1_'$?(F^I4_*?P(I2C%M\K^\=]#H*RM3TBVU:5XIMR/&B-#-&</$V6
MY4]JBMO%NES3"WN'DL+D_P#+&\0Q-^&>#^!K21@UY*1R/*3G\6J)1:TDAQDT
M[HQ[+5;BTN1I&NJOG2?+;W(7$=T/3'\+>J]^U16CMX7U!+"0G^R;M\6KD\6\
MA_Y9G_9/\/Y5MZAI]KJ=H]K=Q"2-QR#V/J#V/O7.SLVG0MHWB#_2M-N?W<-\
MW4>BR>C>C=_K4IVW+E!5-8?%V_R_R-?Q%;K>Z5):RVR312E4;,I0H2P`92`>
M03G\*RM!N]0.IMI>J2R_;;.(LVU_DN5R`KK]>0?>BVOI[13H6I2>9<(\36UP
M?^7F(2+S_O#N/QJUXBTRXO;ZUN;"01:A9Q/+;L>C'*@HW^RP.*)*RNB*<KHN
MW-V;O2+XFWDA"1R+\Y4Y(!!Z$^E:=<]IVHIJ?A6]N`ABD_?B6%OO1/SE3[BN
MAH$MA:***8!1124`+6-=?\CMI?\`V#;S_P!&6U;-8UU_R.VE_P#8-O/_`$9;
M4`%K_P`CMJG_`&#;/_T9<U-X>_Y`Z?\`7:;_`-&M5)89)?&^IB.9X3_9=H-Z
M$9!\VX[$$'H>M7/#8*Z+&"Q8B64%CW_>-S0!J444A.*`,/Q1(\UO;:3"Q#ZE
M+Y+E>"(L9D(/;CC\:Y7QUJL\>KZ?HNF*OF1!2B@<+(WR(?P!R/<@\UN2ZE;1
MZMJ>NW3?Z+ID?V:+_:<_,^/?.U?PK&\.6CZQXFM[^Y0><4.H7'<*6RD"?@NY
MOQH6B<GZ%U/LT_F_Z^X[C2=-M](TR"PM4VQ0H%'J?4GW)YJ5_P#C\B_ZYO\`
MS6IATJ)_^/V+_KF_\UH()J***`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"H;O\`X\YO^N;?RJ:H+Q@MG-N(`\MN
MOTH6X!9?\>,'_7-?Y"IJ@L6#6,!4@CRUZ?2K%#W`@N;.VO83#=6\<\9ZI(@8
M?D:QK?PQ;6=^_P#9MY>V"*BL8H90T;$EOX7##MVQ705`G_']+_UR3^;4U)K1
M`8MU<>*+.X+I;6=Y:C^&+/G$?B57\J<OB+1M0#6%_FUDD&UK:^C\LL/QX/X$
MUO5#=65M>Q&*Z@CGC/59$##]:KFBU9K[@UW1QWB#29--L+<0O)/IUM,LJR%M
M\]I\PP4..5`XP=QK1\/:V^K7BI<&(W4$+[_*^XZEEVNIR<@C]<\"LSQ/X/:*
MUB.C3301>8N^V\XF/)("D*QP.3[5FQ^$O$>D:M;75A=6CS1H9/+&Y`PX#*>H
MYS[=,]:IP2@K,NZE>3W_`#_X)H^(A+HEE>ZSIY7S;N5X+F!\E91E@&"C^,#O
MGH#UK9M?'7AZX2,R7PM6<=+F-HOU88_6N6?Q[IL]K<V.IZ1+'/NDQE5D$;DG
MCG!'7'2NHM_%'AJ2%;=IH;6-O^6-Q"8AS[,`*R]E.]T2I+E5S;M;ZUO4WVMS
M#.O]Z*0,/TJ>L`^&_"NJ_OHK&R<_\]+4A#_WTA%(?"TEOSIVOZK:D?=1YA.@
M_"0'^=3>2W061T-9VIVT<UQ9E]WS3;#AR,C8QQP?4"L\6WBZTXBU#3;]?^GB
M!H6_-"1^E5[K6=;AFM#?^')<)-G=9W"3;CL8<*=I[Y_"G&6H['07J$V4FV1X
MRJDAE//%85H'_P"$JTEY)I)6?3KTDN<_\M;:F2>.-*9)[>]CNM-DV$`7L)CR
M<>O2H]*U"RO_`!-I)M+N&XV:;>[O*D#;<RV^,XZ4)I[$M-/4U+7_`)';5/\`
ML&V?_HRYJ;P]_P`@=/\`KM-_Z-:H;7_D=M4_[!MG_P"C+FIO#W_('3_KM-_Z
M-:F!IU1UF_72]+N+TC<8HR57^\W0#\3@5=KD/&GVK5K_`$WP_8.5DF?SYY!_
MRRC7H3^/3W`HM?0NFDY:['.3VTFJ6EEI>_\`T=9_*9P?]=.<M/)[J@W`>Y]J
M[#P;"LMC<ZKMV_VC,7C&,;85^2,?]\C/XUS^K1(LLMAIP")`J:3:>TDO,K?4
M)U/KFN]M+:.SM8K:)=L<2!$'H`,"G-IR26R(3<FYOJ2U$_\`Q^Q?]<W_`)K4
MU0O_`,?L7_7-_P":T@)J***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BDI
M:`"BBB@`HHHH`****`"BBB@`HHHH`*CFACG39*BNOHP!%244`1Q0QP)LBC6-
M1_"J@"I***`"H$_X_I?^N2?S:IZ@3_C^E_ZY)_-J`)Z***`*6J?\>?\`VUB_
M]&+23QB34XD).&MY`<'!ZKWIVJ?\>8_ZZQ?^C%H?_D+P_P#7!_\`T):'L-&3
M-H^G/H]\[V<#%!,HW1@C`+8X]JH:I\/K*5C)I4TE@_4Q*S&)OJ`01^!_"MFY
MFBAT._\`-D1-S3@;F`R<MQ6K'(DT8DB=71NC*<@T=28V2O8\PN/"\-C(3J7V
MG36SQ=QHLT)]RRA77\?SK3@T/Q5!$LVD>)8[N'^#,I96'_`@X_6N]90PP>E8
MMQX8MA,USI<\NF7+<EK?&QS_`+2'Y3_.K]K476Y7)3E_=?X&`-7\=Z=G[3H\
M-\H_BCQG_P`=;_V6J5_\0;P7EHEUI)TUHG+M]JW88[2,#@'OZ=Q73#5=7TGC
M5]/^T0C_`)>[$%OQ:/[P_#-6&OM.U9K&:UGAN4$_;!VG8W4=C5PJQOK']!.E
M..M[HB@UC3[VWNY4NH'$J*`%D#8)7IQ[\50TR.S3QAI[6T<*RG3KP3-&@!)\
MVW(R>_!_7WJQJ7AG2=1%X9;*!63#;UC`;[N2`1TS5;1K%-/\1:3#"Q\G^SKW
M8AYV?O;;//?\:QT);ES6>UC6M?\`D=M4_P"P;9_^C+FIO#W_`"!T_P"NTW_H
MUJAM?^1VU3_L&V?_`*,N:KV/G+HMNT-U)#FZ=#M"G(,S#N#32NRC4U74H-*L
M);RX.(XUR0.I/8#W)XKE-`U(6NCW_BG5G1+B]+/&C'_EFG"HOX_GQ5/7[^XU
MJYEBBFWVUK,L%KM0_OYVRI;@\[,,>!U'2KNLWEH+32]&@5EM(Y4>XWH5`AB9
M0<Y]6Q^1HDK:=31^Y3\V)X;LWN-;M5F^=M/MS=7#>MS<<_HG\Q7<5@>#XG;2
M'U*=2L^IS-=.#U"M]P?@@6M^HCW(M;3L%0O_`,?L7_7-_P":U-4+_P#'[%_U
MS?\`FM4(FHHHH`****`"BBB@`HHHH`****`"BBB@#$UU-][;?\2\Z@5@E9;<
M,%W'=$,_,<<`FLL^:`?^*'D/_;>+_P"*K9U.Z-EJ=O.+>:XVVTW[N!=SG+Q=
M!4/_``DK=]"U?_P&'^--3C'=?F4H2DKHYO3KJ>>;'_"++=;DW,L;Q*8SGI][
MCZ'G@^^-6WC:6XCCE\&/`C,`TC31$(/7`;)JU%XH9GE']AZJ=CX&VV&1P#SS
MUY_+%3P^(7FN(X?[%U2/S&"[Y+<!5SW)STINK![17XE.E-;F'?M':WMULTZP
M-I:WD,,CLGS!7\K/\7)^=^P''M@D6LZ!+:&?^R8%*J249P/^6A0-D_P9'WCT
MXK7U36[ZPN+U$BMV2UM/M(W;LL,L,?7*_K3KCQ";:VU3=;EY[!9&4JK>7)MC
M#\M@A3SC!-29F);ZCIX$BW.@JSK))M:->"HDD`7_`']J`[<\YR*L:E>:1IEY
M)%)H\3HLXAR,`\(CEN?9P,>W7FM;4-9NK&>8?9HI(4\H!A(007D52",>C9X]
MO45,E[*W]K/#:(]Q:2>4@#`&7]VKKDG&/OXH`R[ZTB@:U":191>9<*CB1MS%
M"<$J..1D$G/`SP:9I<=A=W<<+VEC<1S&;RY;9.,)LQD;CC.X]^P]<"^?$B0V
M=A)<6LS37D0?;$H`4ET3'S,/XI%%,@\3V%W97&I0VL^VWMQ)O=`NX-G"@Y..
MGZ@T`7_["TK_`)\(?^^:/["TK_GPA_[YJ"V\0PW,\\"6MRTEN</M0$'YW3(P
M>F8VZX[56FU^\@N)UDLU1(KJ*,9.28G;;OXSWSQU'<<YH`EU;1M-AT>]ECLX
MD=+>1E91@@A3@BMH=*R;R[^V^&-0EV;"L-Q&P_VDW(<>V5-:U`"T444`%%%%
M`!4"?\?TO_7)/YM4]0)_Q_2_]<D_FU`$]%%%`%:\LH[U`DCR*%(/R/MR001^
MHJ$0727\;JL;0QQE-S2G>02#G&WV]:OTUEW*1DC(QD4#3L5M/YBE_P"N\G_H
M1JU5>TLEM-^V65PY+'>0<$G)[>]6:"5L%%%%`Q-H/6L'6/#]C<7EK<1*UI=O
M+M^TVYV/]QCU[].^:WZJ7=DUS)$XNIH?*;<H0)C.",\J>Q--6ZC4G'8RM-@U
M.W348[^[CN@%XD$6QC\O&0#BHK7_`)&;1_\`L&WW_HZVK49E1=0+,`-HY/\`
MNUE6;J_B?2-K`XTV]S@_]-K:I6P3=Y7+MK_R.VJ?]@VS_P#1ES7,:RVJG0;:
M"Q,J1R32C?#'N._SFP/4<=/?].C03'QCJH@=$D_LVSVLZE@/WMSV!'\Z@L)&
M30;56225_M;,QBB9AQ,23QG%:4Y<LDQ%*QTVXMM7L6>Q"0:;8C$4;9.\[ANQ
MW/WN_?O7/:@M[K%MJ4MM;3O'=7'V6.41D@0J^2!_O.P'T!]*[YF%SJ$T92=4
MDA5-X1EZ%B><<=15>VM(;73<PKL5KM/D7[HQ.!P.U9O5/S*FVYQ[(U;(AK*`
MK"T`,:XB88*<=/PJ>BBF2%0O_P`?L7_7-_YK4U0O_P`?L7_7-_YK0!-1110`
M4444`%%%%`!1110`4444`%%%%`&3J=[#I^IVUS.)"BVTV?+C9SR\0Z*":KGQ
M?I>#A+[/;-C-_P#$U8U6_M=,U*WN[V=8($MIMSMT&7B`JJ?&_A@@@ZO#@^S?
MX4KI;DN,GL06WC?3I7P;:[3Y<R$6LK?-G&.%YZ'DX[>^+L/BC3KFYC@C2\WR
M,%7=9RJ,GU)7`K/MO&GA7>V+Z&'R?W<9*D97CI@<#(Z>U7[;QAX?N[F.W@U2
M&265@B*`<L3T'2CFB"C4ZO\``AU;4UM;B^672K><06@F=GD&7CRV!C:>Z]*?
M<:W96UGJ-O-;P"6S1RUIO&)E$8D.WCD8;GCK3-6O[""YO1=Z2\YCM=\SX0[X
M<GCD\C(/%23:CI,.GZE!-;*OV=':XM#MW2@(&8@9^;*D<_G3*&W]Q;V5Q/OT
M>!TQ#F5=OS;I`@#<<8Z@<_=[<59>[MUM=8<V49%H["5>/W^(E?)X]&`YSTJK
M?2Z5;7,Z7.DLV1$6DV*P<%U1>_8[>N/N\9Q5MI[!;;6'-F=L#,+M=HS,?*5B
M>O/RL!SCIB@"M%J]A>77ES62CRHBX=E#;=JQ2$`8_P"FBXQW4^U9]KK'A*'S
MW@C*BX4B53$_S*0Q(`/;"DX';%:=O>:6UT]NMD8E^Q"4R/&`K1$`;1W;`VYQ
MD#@9Z5FRMX/N$5HI8(/*(;=#%M)`#>J],*3QT`S[T`:4VKZ3I$\V^+RMCB-Y
M$B));89"#@9X4[B3ZGO27FKZ98"*1H(E=[I$7=L4EG<*7'TSDTV_E\/QW4PO
MTC)!".9$++N\L_KY9Y/]W%6[O5-.\I/,'G@W$4879T<R*%//HV#F@#(?7+>?
M0[NT%F]J6MY556SP_DB0J>,[L.<^X/X]37,7=U93:?=H]A)9S1P7,<*R;""V
MP%B-I(R0?KPWO73T`+1110`4444`%0)_Q_2_]<D_FU3U`G_']+_UR3^;4`3T
M444`%%%%`!1110`4444`%(:6D(S0!3BBCEN;I)$5UW+PPR/NUGRP10>-=,$4
M:H#IMYD*H'_+2VK3M[1X;B65KAI!)R5*@`?E5"Z_Y';2_P#L&WG_`*,MJ!RW
M"U_Y';5/^P;9_P#HRYJOI&L65E8_9KEIHY4FEW+]GD.,R,1T6K%K_P`CMJG_
M`&#;/_T9<UL,2JD@9(%`C*DU_2I$*--/@C!VV\H/YA:IQWWAMH@OSSIN)'FP
M2R@'/.-P..?2I+7Q;830AI@\+E0VPJ3P0I'8?WOT/;FF1^*=*MB8U5H[<0B=
M7"-R&8@G&..>?QH`N)X@TF-`B22JJC``M9``/^^:7_A(]+_YZS?^`TO_`,35
MNQOX-0@,UNQ9`Q7)4C)]L_6K-`&7_P`)'I?_`#UF_P#`:7_XFHF\0Z:;J-A)
M-M","?LTO&2/]GVK9K,N]8%E>-#/#B)50F0-D_,=H^7'][CK0`G_``D>E_\`
M/6;_`,!I?_B:1O$NE(I9IY54#))MI,`?]\U$?%FE@(5:5@P))$9^4!2Q//LO
M;U%-E\3Z/+;R+([M$8@T@,38VMP,_6@"P/$>ED9$TO\`X#2?_$T?\)'I?_/6
M;_P&E_\`B:AN/$,5K;VTYMRL$[%=SM@J0P4\`'MEOHII+CQ396\9W!O.4E73
M!PI4@/\`-C'&3]2/>@"?_A(]+_YZS?\`@-+_`/$T?\)'I?\`SUF_\!I?_B:M
M17R2WBVZH1N@$P8GL3C%6J`,O_A(]+_YZS?^`TO_`,31_P`)'I?_`#UF_P#`
M:7_XFF2^((K6>6.\B\H)*8E96+[CM5O3CAQ4;^+-,1\%I2HWY;RSA2H4D$=>
MC#M0!,WB724&6GD49`YMY!R3@?P^M+_PD>E_\]9O_`:7_P")JK<^*='-N[.9
M)5C59<"(]1M9?;.2M6+G7!;:E%9-;\S`&-M_7/X>Q_+WH`=_PD>E_P#/6;_P
M&E_^)H_X2/2_^>LW_@-+_P#$U`OBK3Y)+=(2[B>0)DJ5QD$CJ.^!^>>U:4%T
MTMU/`T6T1;<,&!W`Y[=CQ^1'T`!C7NLVTEW!<VET%:.-T99;28@ABI[`?W?U
MJ,Z]*5(-S;<^EE<"NE8D*2HR0.!G&:R(_$5N':.ZC,+B0H`F7!^9U[#_`*9N
M?H/>E8#'MKR*T=7AN(@43RUW6]TX"\<`$GT%6CXA=64&[M06.!FRGY/7^E6A
MXNTL[B6E"*"=_ED@X(!Z>A(%*WB+2IYX`H>60.AB_=D<N2@()]B?PS19#N95
MU=P7CS//+;L9X1#)BUN1N3.<<>Y/YTCW-M)!-#(UJZW`82L;.X+,&&#\W7H`
M.O0"M=_$<4%]/:W$/E>1RS;B?EYYZ>\?_?8J2W\0V=W?PVL`8^<)-K,I7E",
MC!'N?RIB,.6X@F,AEN(W\W:7#0W9!VD$<9XY4=*E_M"/9=H9K<K>$F<?9;GY
MR5"_AP`./2NCL+S[;"[F,QLDC1LI.>0<9_$8/XU/*SK&3&H9AT!.!^=`'*+?
MQHI43PX,7E8-M='"8`P,].@Z=<5F3:?ISA/)GCMRA!S%;W.2,8QSGUKI[?Q/
M9R0QM.KQ2.N[8`6`&U6ZX]'7\Z:GB[2F3>SR1IP0S1G!!)`/'K@^]`&+<RV=
MW._VF>WD,WSF,VUP,G9Y9;`QSM(7\JLWFH0WZQK=M93")U=-]A.=K`@@C\0*
MU8=<TZZU&&.))&N"3$I9-NT%=YZ]OE'3VJ.'Q/`S2"XA:$Q-L<`ER&XXX'/(
M<?\``#0!D7=Q'=Q%&NH$^255Q93G:9,[F^O)_,UOCQ'I>/\`6S?^`TO_`,32
M6?B"TO;J2*+.Q(!.'((RI)'0_3]:NV%XFH6$-VBE5F0,`2#C\J`*?_"1Z7_S
MUF_\!I?_`(FC_A(]+_YZS?\`@-+_`/$U:U&\:QM&N%B$@4C(+;>/RJB?$VGQ
MDI,SI(@.]=A(7!*GG'JK?7!H`D_X2/2_^>LW_@-+_P#$T@\3:2S%1/(2O4"W
MDX_\=J%/%FEE,NTL;8CRIC)(+C*CCN13H-;LYY;HV%O)-.JN7&W;O:/`V\\Y
M^88XH`E_X2/2_P#GK-_X#2__`!-1+XATT7<CF2;:8T`/V:7J"W^S[BFQ^*;$
MPF:;Y(_GPRY?(4\G@=,%"/4.*DCU^.>SO)X;=G:U(RF<$@@$'ID<')&"?3)H
M`?\`\)'I?_/6;_P&E_\`B:/^$CTO_GK-_P"`TO\`\36FIR`?6J.IZH--:$-%
MO63=N;)^0*,D\`]J`(O^$CTO_GK-_P"`TO\`\31_PD>E_P#/6;_P&E_^)JNO
MBFT^V/"Z,J*74/R22@4MQCMN/_?/O4B^)]->U:X#2A$8*<QG@G''_CP_.@!Z
M^)=)<$K/(P!(XMY#R.#_``TO_"1Z7_SUF_\``:7_`.)J#^W;2+39KFQ@,J12
MG>N"G+,>>G.6_GFG)XGL#Y8=F#2J&C"HS;E.<'IW`)Q0!+_PD>E_\]9O_`:7
M_P")H_X2/2_^>LW_`(#2_P#Q-.LM8BO;2QN$3Y;QM@^;.T[&8_7[I%:5`&7_
M`,)'I?\`SUF_\!I?_B:/^$CTO_GK-_X#2_\`Q-/O-76SOTMFA+*R!RX)XR=H
M&,>N!R1UJE#XML761Y$=$52Z%06+*'9,XQD<J./]H4`66\2Z4JEFGE``R2;:
M3C_QVL^+5+/4_&FG-9RM(J:;=Y)C91S);8QD#/3M5N?Q)I369>4R-!*"O^K)
M##.TC\\C\#5.UNK2Z\5Z6;(%8H].O$"E2N/GM3_(B@"[:_\`([:I_P!@VS_]
M&7-;!`(((R#U!K'M?^1VU3_L&V?_`*,N:ENM9D@U0Z?!I%[>,D:222PM"$C#
M%@,[Y%)^Z>@-`%X6=LH`6WB`7IA!Q3#I]F3DVL)/3)C%00:U:7&MW.D1[_/M
MD5W)`VG."5!SG(#(3QP'7UJ4:MIIO9+(:A:FZB0R20><N]%'5BN<@>]`%E(T
MB7;&BJ"2<*,<GK3JSAXAT0VT5R-8L#!.Q6*7[2FV0@@$*<X)R0./6I[G4+:U
MA:1Y%;:=NU&!8GC(QGMF@"U4;P1.X=XD9ACDJ">#D?K6?<>)=$MA-YFJVA:W
MD2.95G4M$S,%`89^7D]_>ITU?3VFCMVO+>.XD0NL#3)O*CJ0`>1[B@";[';8
M"_9XL`8`V"C[#:D8^S18Z?<%,L=2L-31WL+ZWNUC;8[02K(%;T.#P?:K5`#!
M%&%"A%"CH,<4QK2W<DO!&V3DY0')X_P'Y5-10!&L,2$%(U4A=H(`&!Z?2I**
M*`(6M;=R2\$;%LY)0'.1@_I0UG;-]Z"(\D\H._6IJ*`(/L5K_P`^\7_?`]O\
M!^52[$X^4?+TXZ4ZDH`A-E:D`&VB(`P,H..O^)_,U(D,4;NZ1HK2'+L%`+'W
M]:?10`5"+2W'_+"/KG[@ZYS_`#)-34E`$)LK4C!MHCQC[@Z4HM+<-N\B+=G.
M=@SG.?YDU-10!!,]M&0L[Q+YOR@.0-V<#'/7M^E*+6V#^8(8@P.0VP9!]<U1
MU;2I-0N+::*18G@SA^20"RDC'1@0O0]\$8(K(M?#6LVBPI'J_P"[AC1?++/A
ML>6".O`(C/TWG\0#I8I;86HFBDB%OMWJZD;-O7(/3'>FQWMG<?+%<PR;CMPK
M@Y.-V/RY^E9?A_2+G3(_L\\\DL44,<2!SP2$56*C<?E.U2`>A+>M5X?#-W91
M7`L]0P[HBQ;E.%VM@9P>\81"1Z9]J`-MH;*)HXVC@5I#M12J@L=O0>ORC\A3
MQ:6P.?L\6>.=@[=*YR7P[K+R0N=41S;RAT+F3D>6ZE3S_MXW#G'?/-=.N0HS
MUQZT`1I:6\9#)!&A'0J@&.W\J<T,;C#(I!.2".O.?YU)10!"EK;QR>8D,:OT
MW*H!]?YDU*%"@```#L*6B@!KQI(I5U#*>H(R#4?V2WS_`*B/_O@>N?YDU-10
M!`;*U((^SQ?-U^0<TZ.WAB8M'$B$]2J@9J6B@"-K>%P`T2,!TRHXXQ_+BFI:
M6Z9VP1KNQG"#G'2IJ*`"F-&CLK,H++]TD<C/7%/HH`A%G;*V];>(-ZA!G_/`
M_*GF*,J5**5)R1C@T^B@"&"T@MHC%#&$1G+D>I)R3^=*UM"Y!:&-B``"5'0'
M(_6I:*`(DMH(PJI#&H0Y4!0,'&,C\*EHHH`8T,3L6:-6)&TD@<CTIBVENC%D
M@C5B<DA`"3_DFIJ*`(9K2"X@:"6)6C8$%<>OIZ5C?98;/Q?I,%NFR-=-O,+U
M_P"6MM6_6-=?\CMI?_8-O/\`T9;4`%K_`,CMJG_8-L__`$9<U6U7PNVH:^NK
M(-)=EBC0"^TS[0\91F;*/YB[?O>AZ`U!K5AXNC\12:CX<;1O*GM(H)5U`R[@
MT;RL-NP=,2=_2JW_`!='_J4__)F@#5MO"\5KJ::HEY.;OSI))F:1S'(KYRHC
M+;5Q\G(&?D&<Y-4IO"EQJ5YJ!N[E8;66>22%$B&\LT/E[BV[!7!/RE>HZXP*
MK_\`%T?^I3_\F:/^+H_]2G_Y,T`27'A?59;Y)3?6S2W"3BZG6SQ&`RQ(%6/?
MD$JAY+-R.>.*O/X:G:X8?V@HM02T47D?.I(7.YMW/W>.!U/6LW_BZ/\`U*?_
M`),T?\71_P"I3_\`)F@"T_A/4)+RYNY=;$DL@`AWP.RQ[9EE3*F3!QMVG;MR
M,=".9AX6E$A47Z?9W=99$,&7+J,+M;=\J^HP<\\C)K/_`.+H_P#4I_\`DS1_
MQ='_`*E/_P`F:`.@TK2%TLG;*'!MX80`FW'E@C/7OGIVK2KC?^+H_P#4I_\`
MDS1_Q='_`*E/_P`F:`.RHKC?^+H_]2G_`.3-'_%T?^I3_P#)F@#LJ*XW_BZ/
M_4I_^3-'_%T?^I3_`/)F@#LJ*XW_`(NC_P!2G_Y,T?\`%T?^I3_\F:`.RHKC
M?^+H_P#4I_\`DS1_Q='_`*E/_P`F:`.RHKC?^+H_]2G_`.3-'_%T?^I3_P#)
MF@#LJ*XW_BZ/_4I_^3-'_%T?^I3_`/)F@#LJ*XW_`(NC_P!2G_Y,T?\`%T?^
MI3_\F:`.RHKC?^+H_P#4I_\`DS1_Q='_`*E/_P`F:`.RHKC?^+H_]2G_`.3-
M'_%T?^I3_P#)F@#LJ*XW_BZ/_4I_^3-'_%T?^I3_`/)F@#LJ*XW_`(NC_P!2
MG_Y,T?\`%T?^I3_\F:`.RHKC?^+H_P#4I_\`DS1_Q='_`*E/_P`F:`.RHKC?
M^+H_]2G_`.3-'_%T?^I3_P#)F@#LJ*XW_BZ/_4I_^3-'_%T?^I3_`/)F@#LJ
M*XW_`(NC_P!2G_Y,T?\`%T?^I3_\F:`.RHKC?^+H_P#4I_\`DS1_Q='_`*E/
M_P`F:`.RHKC?^+H_]2G_`.3-'_%T?^I3_P#)F@#LJ*XW_BZ/_4I_^3-'_%T?
M^I3_`/)F@#LJ*XW_`(NC_P!2G_Y,T?\`%T?^I3_\F:`.RHKC?^+H_P#4I_\`
MDS1_Q='_`*E/_P`F:`.RK&NO^1VTO_L&WG_HRVK&_P"+H_\`4I_^3-6=%L/%
?TGB*/4?$;:-Y4%I+!$NGF7<6D>)CNWCIB/MZT`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g118721moi004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g118721moi004.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`$0`:$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T+5+WQ--X
MBFT[0WTJ.*WM(9Y&O8I&8M(\J\;6'`$?ZU'Y?Q!_Y^O#?_@//_\`%U?M?^1V
MU3_L&V?_`*,N:V:`.7\OX@_\_7AO_P`!Y_\`XNCR_B#_`,_7AO\`\!Y__BZZ
MBB@#E_+^(/\`S]>&_P#P'G_^+H\OX@_\_7AO_P`!Y_\`XNMC4M5_LZ>VC:`L
MD[;3*6PJ'<H`)QU.[C.`<8SD@&DOC#23#&Y,X>6)95B\EBV&0N.G'W5)ZXXH
M`J>7\0?^?KPW_P"`\_\`\71Y?Q!_Y^O#?_@//_\`%UH7OB:QLK'[3)OR;<3B
M/'."K,H)Z`G8P_"GW&K7-M-9QO9(?M1(&)C\N%9CQMYX7\S0!F>7\0?^?KPW
M_P"`\_\`\71Y?Q!_Y^O#?_@//_\`%UH?\)3I7V7[2991#M#%S"^`"`1GCC@@
M\]C44'C'1Y]@\V6-G(&'B;C)4#)`Q_&O?O\`6@"IY?Q!_P"?KPW_`.`\_P#\
M71Y?Q!_Y^O#?_@//_P#%U??Q7I4:JQDF(<$J1`^&PRKP<8^\ZCZFM.SN4O;*
M"ZC#!)XUD4-U`(R,_G0!SOE_$'_GZ\-_^`\__P`71Y?Q!_Y^O#?_`(#S_P#Q
M==110!R_E_$'_GZ\-_\`@//_`/%T>7\0?^?KPW_X#S__`!==110!R_E_$'_G
MZ\-_^`\__P`71Y?Q!_Y^O#?_`(#S_P#Q==110!R_E_$'_GZ\-_\`@//_`/%T
M>7\0?^?KPW_X#S__`!==110!R_E_$'_GZ\-_^`\__P`71Y?Q!_Y^O#?_`(#S
M_P#Q==110!R_E_$'_GZ\-_\`@//_`/%T>7\0?^?KPW_X#S__`!==110!R_E_
M$'_GZ\-_^`\__P`71Y?Q!_Y^O#?_`(#S_P#Q==110!R_E_$'_GZ\-_\`@//_
M`/%T>7\0?^?KPW_X#S__`!==110!R_E_$'_GZ\-_^`\__P`71Y?Q!_Y^O#?_
M`(#S_P#Q==110!R_E_$'_GZ\-_\`@//_`/%T>7\0?^?KPW_X#S__`!==110!
MR_E_$'_GZ\-_^`\__P`71Y?Q!_Y^O#?_`(#S_P#Q==110!R_E_$'_GZ\-_\`
M@//_`/%T>7\0?^?KPW_X#S__`!==110!R_E_$'_GZ\-_^`\__P`71Y?Q!_Y^
MO#?_`(#S_P#Q=:=WKB66H36\T6(H(%GDE&XX4^83P%/3RSWYS3(O$EG<W]M:
M6P:4S2/&Y(*^65#]01ZQL/UH`S_+^(/_`#]>&_\`P'G_`/BZ/+^(/_/UX;_\
M!Y__`(NM&'Q%;7FH06=DOG&5#(7)*A4&P@].<AP13$\1QQO*M]!]G$<QAW*S
M298()&Z+P`N3GV-`%'R_B#_S]>&__`>?_P"+H\OX@_\`/UX;_P#`>?\`^+JY
M=^+M*LF1)VF5FY*F%@5`ZDY'0>WKQFI8?%&EW#E(I96<$#:('W'EAP,9/*-^
M5`&=Y?Q!_P"?KPW_`.`\_P#\71Y?Q!_Y^O#?_@//_P#%UIZ=XCT_5;L6UH9'
M8Q>;N:,J,84CKSR'4_C6K0!R_E_$'_GZ\-_^`\__`,71Y?Q!_P"?KPW_`.`\
M_P#\77444`<OY?Q!_P"?KPW_`.`\_P#\71Y?Q!_Y^O#?_@//_P#%UU%%`'+^
M7\0?^?KPW_X#S_\`Q='E_$'_`)^O#?\`X#S_`/Q==110!R_E_$'_`)^O#?\`
MX#S_`/Q=2:7>^)H?$4.G:X^E217%I-/&UE%(K!HWB7G<QX(D_2NDK&NO^1VT
MO_L&WG_HRVH`V:***`,:U_Y';5/^P;9_^C+FIC<ZA<:I=6UM);11VX3F2)G+
M%@3V85#:_P#([:I_V#;/_P!&7-36/_(>U3Z0_P#H)H`D\O5_^?NR_P#`9_\`
MXY1Y>K_\_=E_X#/_`/'*OT4`94^GW]RZ//+I\C1_=+6C''(/]_U`/X#TJJGA
ML1R"1(-)1AT*V+#^';_?_NDCZ5OT4`8DNB331B.5=,95C\H`V;<)C&W[_3!/
MYFG7-E?GR'DDL',3;8R;9_DW#:<?O/0ULU!=?<C_`.NJ?S%`&.WAL.,-;Z2?
ME"<V)^Z%V@??_N\?2@>&RK;EATM3NW<6;#G(.?O^JC\A6_2=Z`.:FT.WTVTD
MN)(](@@@4R.19,`H!#$X#^J*?J!6E;0:C';1);7-@L"H!&$MFVA<<8_>=,5F
M>/8&O=!BT])3&][=Q0`#^++<Y]@`3^%101ZKX.A2,F35=(08^5?W]J/8?QH/
MS'OBHYK,JVAN^7J__/W9?^`S_P#QRCR]7_Y^[+_P&?\`^.5/97UMJ-JEU9SI
M/#(,JZ'(-6*LDH>7J_\`S]V7_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7
MJ_\`S]V7_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7_@,__P`<
MH\O5_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7_@,__P`<H\O5_P#G[LO_``&?
M_P".5?HH`H>7J_\`S]V7_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7J_\`
MS]V7_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7_@,__P`<H\O5
M_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7_@,__P`<H\O5_P#G[LO_``&?_P".
M5?HH`H>7J_\`S]V7_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7
M_@,__P`<H\O5_P#G[LO_``&?_P".5?HH`H>7J_\`S]V7_@,__P`<H\O5_P#G
M[LO_``&?_P".5?HH`QKC1[F[>1[AM/D:1!&^ZU?YE&<`_O.?O'\S38M"F@N%
MN(ETQ9E)(D%FVX$DD\[^^YO^^CZUMT4`8T.CW-M,DT']FQR(&"LEHPP#C/\`
M'[#\A43:3<27,D;C36W$RL6M&.YF!1B1O[KQ]*WJ@'_'^_\`UR7^9H`Q3X80
MKM-MI&,8_P"/$].!_?\`8?E3O^$<.X-Y6EDA@P)LVX()(/W^N6;\S6_10!BV
MNBW%E()+7^S8G"[0RVC`[<*,??Z811_P$5;\O5_^?NR_\!G_`/CE7Z*`*'EZ
MO_S]V7_@,_\`\<H\O5_^?NR_\!G_`/CE7Z*`*'EZO_S]V7_@,_\`\<H\O5_^
M?NR_\!G_`/CE7Z*`*'EZO_S]V7_@,_\`\<H\O5_^?NR_\!G_`/CE7Z*`*'EZ
MO_S]V7_@,_\`\<K.*WB^-M.^URPR?\2V\V^5$4Q^\MLYRQS705C77_([:7_V
M#;S_`-&6U`&S1110!S8DND^(=RD,>Z)].M?.)'W1ON<'/;FKFE-.VLZH;B..
M-_W/$<A<8VGN0/Y4EK_R.VJ?]@VS_P#1ES4UC_R'M4^D/_H)H`TZ***`"BBB
M@`J"Z^Y'_P!=4_F*GJ"Z^Y'_`-=4_F*`)B<5REWK>JVOB.[,4`N]/M$C6X6)
M#YB;LME1GYB`1G^5=3(X1220`HR2>U<_X=S_`&!<:JS)&][+)=;I.@4\+D^F
MT+4OL:TVHQ<FKE9=3L_$OBO3/L$ZSVUC#+<N1G&\_NU!!Z'EC75#G->6:1JT
M6JZW>:K%?II5Y.56VWY\J954`JV0`1G/N,C'OW>DZZMQ,;"_A^QZ@HR86;*R
M#^\C?Q+^HH7F)J,U>F[I?@07N@7%E=OJ?AZ5+:Y?YIK5^(+GZC^%O]H?C5O2
M-?@U.1[62-[2_A'[ZTFX=?<?WE]"*U`=PZ8K.U?0K36$0R[H;F$Y@NH3MDB/
MJ#_3H:+-;$7ON:5+7-V^N7>C7"6/B,(%=ML&I(,12^@<?P-^A[5T8.1D=*:=
MP:L+1113$%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!4`_X_W_ZY+_,U/4`_X_W_`.N2_P`S0!/1110`4444`%%%%`!1110`4444
M`%8UU_R.VE_]@V\_]&6U;-8UU_R.VE_]@V\_]&6U`&S1110!C6O_`".VJ?\`
M8-L__1ES4UC_`,A[5/I#_P"@FH;7_D=M4_[!MG_Z,N:FL?\`D/:I](?_`$$T
M`:=%%%`!1110`5!=?<C_`.NJ?S%3U!=?<C_ZZI_,4`9OBF=X=#GCA.V6[VVT
M9`R=SG;_`%)_"JWBAAI?@R>VME&]XEM(%]6;"#'YY_"I-4_TWQ1IECC*6RO>
M2>F0-B?JS'\*BUK_`$_Q/HNE_>6%GOI@.P0;4_\`'F_2H?4V>D8KYEG2?#5C
MIV@QZ2\4<\*;LB1`0VYB>_U_2LO5/!?[A4TN\:)4.Z.WG8LD9]4;[T9^AQ[5
MUHHJUM8PMKS+<X[2?$^H:5*NG>*;=X"3MBO>L;^FXC@'WX]P*Z])5D0.K!E(
MR"#D$4DT$=Q$T4R+)&XPR.,@CW%<7?\`A_5O#4YO?#=W,;/):6Q8>8%_W5)Y
M'L"#[GI1L5[TG_2_X'Y'93V\-Y`\%Q$DL4@VNCC(8>]<Z;34O"IWZ>LNHZ2#
MEK,G=-;C_IF3]Y?]D\^AI--\91&V674X/(B<X%W"3)`3Z$]4/LP%=)#/%<PK
M+!(LD;#*NAR#]"*3C<2EK;\"'3=3L]6M%NK&=9HFXR.H/<$=0?8U;K!U#P_(
M+QM4T2=;'4#_`*P$9BN?:1?_`&8<BBQ\56SS"QU5/[-U$,$-O*>').`4;HRD
M]Q^-*]MQV[&]15&XUO2K0D7.I6D)'423JO\`,UGOXW\.*VU-3CF;T@1I?_00
M:?,NX69O45S_`/PET4G_`!ZZ-K-R.S+9,@/XOBC^V]?FYM_"LH4]#<WD<?Z#
M<:7,@LSH**Y[S/&$QRMOH]J/1Y))2/R"BE_LOQ/-S-XDA@_V;:P7^;L:+]D%
MO,WBZA@N1N(R!GDC_)%+FN+E\':U-K"7DGB&Z<+A`XE"/Y9QN`"I@<\_@*U?
M^$4;_H8]<_\``I?_`(FDFWT'9=S?S]/SHS]/SK`_X11_^ACUW_P*7_XFC_A%
M'_Z&/7?_``*7_P")IW?8++N;^?I^=&?I^=8'_"*/_P!#'KO_`(%+_P#$T?\`
M"*/_`-#'KO\`X%+_`/$T7?8++N;^:175B0""5ZC/2L$^%&_Z&/7/_`I?_B:R
MM/\`!^NVE]+<?\)'<1&?F1E<2,Q'"Y#I@X'':E=]@LNYVE+7/_V;XI@YB\0V
MMS_LW-@!^J,/Y4";QA!R]EI%T/2*>2(_^/*13OY"MYG045SYUW6X>;GPK<[?
M6VNHI?T)!H_X2^VCYNM*U>U'=I+%V`_%<T<R"S.@HK!C\;^&Y'V'5H8F])@T
M7_H0%:-OK&F79Q;:A:S?]<YE;^1I\R"S+M0#_C_?_KDO\S1:7EO?6ZW%K*LL
M3$A74Y!P<']10/\`C_?_`*Y+_,TQ$]%%%`!1110`4444`%%%%`!1110`5C77
M_([:7_V#;S_T9;5LUC77_([:7_V#;S_T9;4`;-%%%`&-:_\`([:I_P!@VS_]
M&7-36/\`R'M4^D/_`*":AM?^1VU3_L&V?_HRYJ:Q_P"0]JGTA_\`030!IT44
M4`%%%%`!5>[)V)Q_RU3^=6*S=>O5T_29KQL8@`?'TZ4#2N[(HZ(3>:OJVI'&
M&F%K&>ORQCG'_`BU0>'C_:/BC7-5/S)$ZV,)/8(,OC_@3?I4UL?^$:\$B:4@
MO;VQEDW<;I#\Q_-C3O!%BUCX2LA+S-.IN)3W+.=W/X$#\*CL74=Y.WH;]%%%
M69A2$9[TM%`&#J.@2+<OJ.CR);7C_P"MC8?N;D>CKZ_[0Y^M9-A:6MU<RKID
ML^@:M'S-:``QM[[/NLONN*[,C)ZUG:KH=IJL:F3=#/%S#<1'$D1]0?Z=#2VV
M-+QFK5/OZHSF\0:AHXVZYIK&,$9O+(%X\>K+]Y?UJ#4M,TWQS&DBW2/;P;D4
MJH8,3C+#G/;%-L]3N_[1.A^($7=+@13K\J3@=CSPQ[K]:T)O".D33/<10O9W
M+'/GVDAB8'\./S%'NR6IG*%2E+>Y-9>&=%LHD6/2K$.B@&1;9`2?7I6FB)&H
M5%55'0`8K!-MXETPYM[R#5H1_P`L[E?*EQZ!UX/XBG)XMM8&$>K6ESI4AXS<
M)F,GVD&5_/%/E[$<_?0WL4`8J*&YAN8A+!(DL;#(9&!!_&I0<]J"PHI:*`$I
M:*2@!:*3-5;[5+'38O-O;J*W3L9'`S]/6@&[%NF[N<5@GQ'=7W&BZ/<72GI<
M3_N(OJ"PW'\!0-%UC41G5=9:%#UM]/7RQ^+G+']*=B.>^VI>O-=LK&\6SF?%
MQ(`8H\C,A)Q@<_SQ_.M!6R.:QD\':"D$L0TZ)A,NUV?+,??<3G/OFJWV36/#
MQ#6+OJMBO6VE;]]&/]AC]X>QY]Z!7DMT=)16?IFMV6K(QMI/WD?$L+C;)&?1
ME/(J^#FD6FGJ@Q12T4#(Y(8YEVR1JZGLRY%9&I^$=%U*UEB.FV4<CC`E6V7<
MON#ZUMT4FDQW:.2\*6A\-ZM>^'GE+Q.!=69(P"IX<#Z'''H<UTR_\?[_`/7)
M?YFLCQ5:3&TAU6S0M>:8_GQJ.LB='3\5S^(%:%C=PW[)>6[AX9[='1AW!)-3
M'30<M=2]1115DA1110`4444`%%%%`!1110`5C77_`".VE_\`8-O/_1EM6S6-
M=?\`([:7_P!@V\_]&6U`&S1110!C6O\`R.VJ?]@VS_\`1ES4UC_R'M4^D/\`
MZ":AM?\`D=M4_P"P;9_^C+FIK'_D/:I](?\`T$T`:=%%%`!1110`5@^)V6?[
M!IC8_P!.ND#?[B?.W\@/QK=)Q7-S-]O\7N^,IIT4<8YX\R1@Q_\`'57\Z3-*
M>]^W]?F5/'\IN;*PT.-L/JEVD9Q_<!!8_P`JZV)!'$J*H55&`!T`KBU8ZQ\4
M\`[HM'M3VX\QN/SPQ_[YKMAG'-);LS6PM%%%4`4444`%)2T4`4]2TVUU2S>U
MNDW1MSP<%3V(/8CUK+TW4KG3+M-(U=R[N<6EX>!<#^ZWHX_6M^JFI:=;:I9O
M:W:;XF_`@]B#V(]:374TC)6Y9;%OK37C612CJ&4C!!&0:P=.U*YTN[32-7<R
M&0XM+P\"<?W6]''ZUT`.:$[DS@XLPYO"6G>:T]@TVF3GK)9OY8/U7[I_*HR?
M$VEGD6VL1#N/W$W]5/Z5T-)CFJN9<BZ:&)!XMTUI5@O?-TVX/_+*]3R\_1ON
MG\#6RLBNH92"I&00<@TR>VANHVBN(DEC;JDBAE/X&N>N_!\4<T;Z+<SZ6^XE
MC#(3&!_US.0<_AZT:"]]>9T%S=P6<1EN98X8AU>1PJC\36.?%<5V2FC6%SJC
M=-\:[(1_VT;`_+--TSPCIT$<<M["UY=+UDNI#-@^V>!Z]*WU0*,#&.PQTHT'
M[S\C!%AXAU+F]U*/3HCUAL5W28]#(PX_`59L?#&E6$WGI;^=<]3<7#&60GUW
M-G'X5K`8I:+@H(3%%+12+"D(S2T4`9>J>'[/4W6<E[>[C_U=U`=DB?CW'L>*
MH+JVIZ#\FN0FYM1P-0MTZ#_IH@Y'U&1]*Z.FE<TR''JB.VNH+R!9[:5)8G&5
M=&!!_$5+6#<^&VMIWO="N!87#'+Q;<P3'_:3M]1@TMGXD$=PMCK-L=.NVX0N
MV8IC_L/T_`X-%@YK:2-ZBFALBE!S2+"N:T*+^Q=?O-&9L02*;BQ'HA.70?[K
M'\C735SGBBSG<KJ5DI:]TP+<1*.LBY(=/^!+G\<5,NXUV.BI:KV-Y#J%C#>6
M[;HIT#H?4$9JQ5""BBB@`HHHH`****`"BBB@`K&NO^1VTO\`[!MY_P"C+:MF
ML:Z_Y';2_P#L&WG_`*,MJ`-FBBB@#FPMV?B'<F`@0C3K7SLXQC?<X]^M7-*6
M==9U07,D;O\`NN8T*#&T]B3_`#I+7_D=M4_[!MG_`.C+FIK'_D/:I](?_030
M!IT444`%%%%`#'8*"20`!DDGI7,Z+*L>A2ZQ.=HO+IKMB>R;L+_XZHK0\4SO
M#H5Q'%Q-<XMXB.NYSM'\\_A61XXEBTGP6;*,[595@C`XX49/_CJD?C2ZEM\M
M)OO^A%\-X9+FSU'6YLB34;MFY'\*_P#URP_"NT%9?AG3_P"R_#=A9%=KQPKO
M'^T>6_4FM6B.Q%K:!1113`****`"BBB@`I*6B@"IJ.G6VIVCVMW'YD3CD=P>
MQ![$>M9&GZC<:1=QZ3JSF19#BTO6X$O^P_H_\_K70XJMJ%A;ZE:/:W48DB<<
M@_S'H?>DUV-(35N66Q9!S2USMAJ%QHMU'I6JR&6.0XL[UO\`EI_L/Z/[]_K7
M0@YH3N*47%BT444R`HHHH`****`"BBB@`HHHH`****`"H+RRMK^W:WNX$FB<
M<HXR#4]%`'.'3]6T#YM*E:_LAULKA_G0?],W/\F_.KFF^([/4Y!!#',EP"1+
M!*FUX<=V'IZ>OYUK$9KF]=TYM-FCU^Q5WGM6+7*@Y:>$_>'OC@@>U/<R:<=5
ML=)4(_X_V_ZY#^9IUM<175O'<0.'BE4,C#H0>AIH_P"/]O\`KDO\S2-3"T3.
MBZY=Z"W%O+F[L<]`I/SQC_=8YQZ-71UB>*;*>:QCU"R7=?::_P!H@`ZN!]]/
M^!+D?7%:>GWL&I6$%[;-NAG0.A]C4K30;[EFBBBJ$%%%%`!1110`4444`%8U
MU_R.VE_]@V\_]&6U;-8UU_R.VE_]@V\_]&6U`&S1110!C6O_`".VJ?\`8-L_
M_1ES4UC_`,A[5/I#_P"@FH;7_D=M4_[!MG_Z,N:FL?\`D/:I](?_`$$T`:=%
M%%`!112$XZ4`86J'[9XGTRQ'*VX>\D'T^5/U8G\*P/%;1ZMXQTO1VP8XV4NO
MNQW'_P`=3'_`ZW=%/VS6=7U,X"^:+6,G^[&/FQ_P(M^5<YX>_P")OXMNM7(R
MJ,'4GJ/,<*G_`)#C!_X%4]/4NK\48]O^'_,]"7I2TE+5$!1110`4444`%%%%
M`!1110`4F*6B@"K?V%OJ-I):W48DBD&"I_G[&L:PU"YT2ZCTO59#+!(=MI>M
M_'_L/Z-Z'O\`6NBJO?6-OJ-J]K=1B6&08932:-(SLN66Q8!S2USEG?W.@W4>
MF:K(TUM(=MG>N>OI'(?[WH>_UKH@<]J$[BG'E%HI.?2CGTID"T4G/I1SZ4`+
M12<^E(6(/2@!U%)FEH`****`"BBB@`I",C!Z4M%`'.:2W]A:Q)H<G%K<;IK!
MCT'=XOP/(]C[5MJ<W[_]<E_F:IZ_I;:I8;87$=U`PEMI?[D@Z?@>A]C4>A:F
MNJQ_:=GERB,1S1'K'("0RG\:9$='RFO7.:-_Q)->NM";Y;:XS=V/H`3^\C'T
M8Y`]&KI*Q/%-C/<:?'?6*YO].?[1;@=7Q]Y/HRY'Y5$NYHNQM4M5M.OH-3T^
M"^MFW13H'4_7L?>K-4(****`"BBB@`HHHH`*QKK_`)';2_\`L&WG_HRVK9K&
MNO\`D=M+_P"P;>?^C+:@#9HHHH`QK7_D=M4_[!MG_P"C+FIK'_D/:I](?_03
M4-K_`,CMJG_8-L__`$9<U-8_\A[5/I#_`.@F@#3HHHH`*IZI>IIVFW-XY^6"
M)GQZX'2KE8/BC-RMCI:Y_P!.ND5\?\\T^=OT4#\:3T1=./-))E&5)M%\!);K
M_P`?<\8C&>IFE//ZL3^%)X.M$CT,W:?=NKS,9/7RD(C3_P`=0'\:K^.KUQ)#
M;Q<M;PO<X'=V_=1?^/.3^%=':V2Z=H]C9)C;;B*,$=\8&:75(B_-*4F:5%)1
M5`+1244`+1244`+1244`+1244`+1110`4A&:6B@"KJ%A#J5E+:7"!HY5P01F
ML2R\/:W:6_D1>)9HXT9M@>WCD.W<<98C).*Z6BE9&D:DHJR,+^Q]?_Z&B3_P
M"BH_L?7_`/H:)/\`P"BK<SS3)IXK>-I9I$C1>2SL`!^)HLA^UEY?<O\`(QO[
M'U__`*&B3_P"BI/[(U_/_(T2?^`47^%$GB^P>0PZ;#<:I*#@BTC+(OU<X4#\
M:9CQ3J1R6M-'B/I_I$P_DH_6K]D^N@O;2[+[E_D)-IVM6\;2S>+&CC499FLX
M@!^E8&F:GJ/B*2YL[7Q'*7$;;<VL7S#IR0/EKI(O".G-(LVHO/JDRG(:\D+@
M?1?NC\JAN_"-K$PO-&QI]_&<I(I)1O\`99>FT^G;C'2J4:5FFV'MI]E]R_R%
MCE\3:8N)8+75HAWB;R)?R/RG\Q4\/BS3&E$-YYNG3'I'>QF//T)^4_@:=HVM
MB^DDL[R$VFI0#][;L>H_O(?XE/K6G+;0W$;13Q)+&W574$'\#6;BXZ#YXR^)
M?=I_P!Z2I(%9&#*PR"#G-.!S6$_A*SB<RZ7<7.ER'G_1G^0GW0Y4_D*;YGB;
M3?OQ6NK0C^*,^1+^1RI_,4K]PY(OX7]^G_`_$Z"BL.'Q9IID$-Z)M-F/1+V,
MQY^C?=/YUL)*D@5HV5E89#*<@T)W(E"4=T244@-+3)$(S7-7KKX?\2+?*F+.
M_P!L=V1TCDZ(_P!#C:?J*Z:J%[9P:@UQ:7*!XIH`K`^A)H)DKK0O*<T5A>'+
MZ91-H]\Y:\L"%WMUFC_@?\1P?<&MVACB[JYSFD'^Q/$-SHC<6UWNN['T&3^\
MC'T)W`>C&NCK%\46$]UIZ7=D,W^GO]HM_P#:(^\GT9<C\16AIE_!JFG07ULV
M8IT#KZCV/N.E2M-"GW+=%%%4(****`"BBB@`K&NO^1VTO_L&WG_HRVK9K&NO
M^1VTO_L&WG_HRVH`V:***`,:U_Y';5/^P;9_^C+FIK'_`)#VJ?2'_P!!-0VO
M_([:I_V#;/\`]&7-36/_`"'M4^D/_H)H`TZ***`$)Q6$A-]XRE?_`)9Z=:A!
MSP))#D_^.J/SK;=@H))``')/:N5T^]%CX5U'7V'[R[>6X0'J1]V,?D%_.D]6
MD:1?+"4OZ_JQG?\`(7\61'JD]^6!Z_NK9>/P,K?I7;77$<?_`%U3^8KEO"%C
MY6K7);D:=:Q60;UD/[R4_7<RUM>(M1_LW3A(D?G7#2*L$(ZROGA1_GIFB*<G
MH9)6BC"\7'4=4U>#2](=FEBC,LX#8$0)P"<D#)[#V/K6E!I'B98(U?Q,@8*`
M?]`5N?J6Y^M7-`TEM,LV:XD$U[<.9;J;'WW/8>PZ`>U:M;NI9**V7D%C"_LG
MQ)_T,\?_`(+E_P#BJ/[)\2?]#/'_`."Y?_BJWJ*GVC\ON06,'^R?$G_0SQ_^
M"Y?_`(JC^R?$G_0SQ_\`@N7_`.*K>HH]H_+[D%C`_LGQ)_T,\?\`X+E_^*K&
MUOP_XKGN(6BUA;H*."L0A\LYZXW?KUKN*2G&K).]E]R"QSZQ>+XE51/I%R`/
MO.DD9/Y$C]*<=1\30?+)H%O<'^]!?`?HRBM[%%3S]T@L81\1WL(_TKPWJ:'_
M`*8A)1^C4?\`"8Z;&,W=OJ%G_P!=[*0?R!K=Q1BCFCU7X_\`#AJ8T'B_P]/]
MS5K=?^NC;/\`T+%7X-5T^Z.+>^MIO^N<RM_(U-+;03KMGB24>CJ#6?/X8T*X
M'[S2+(^X@4'\P*/<?<-2:76]-@N&MYKV&.11DAWP!]3TJ@_BZRE<Q:7!<ZI(
M#@_98\H#[N<*!^-48_AYI$>K+=J`8%?>+9DW+GZD],]L5U,<21($C5551@*H
MP!52]FMM?P#4P=GBG4FRTEIH\1[(/M$H_$X4?K4D/A'3?-$U^T^IS#D/>R&0
M#Z+]T?E6Y2U/M)=-`L,CBCBC$<:*B*,!5&`!["G4M%0,*3%+10!EZSHD.K1H
M_F-;W<!W07,?WXS_`%![CO5;2=;F^U?V3K$:0:BHRC+Q'<J/XD/\UZBMPC-4
M=5TBUU>U\BY4@J=T<J'#QL.C*>QJU+[,MOR$7AS1CFN>T[5[K3;M-)UQ@9'.
M+6]`PEQ['^Z_MW[5T-3*+B,CEMH9XVCFC21&ZJZ@@_@:QW\)64;F73)[C2Y#
MS_HKX0GW0Y4_E6[14VN7&<H[,Y>\N/$^C1;V6WU6W1EW-$ACF(R,C;R#QZ8K
M<TW4;;4[)+NVD5T<=CT/<'T(JT5S6#J.C7-G=OJFB;5G;FXM2<1W/_Q+^A_.
MC8N\9JS5GW-\'-0C_C_?_KDO\S532-8MM5MVDAW))&VV6%QAXF_NL.U6E.;]
M^/\`EDO\S3,FG%V9D>([:6V>#7;)"UQ8Y\Q%ZS0G[Z^Y'4>X]ZV;2YBO+6.Y
M@</%*H=&'<&I2,USNF-_8.M/H[\6=V6FL2>BGJ\?_LP]B?2F9_#*_1G15SFE
M?\23Q'<Z,>+6]W7=GZ*<_O8Q^)W`>A-='6/XGT^>[TY;FR'^GV+BXMO]IEZK
M]&&1^-1+N:+L;%+532]0AU73+>_MSF.=`X!ZCU!]P>/PJW5""BBB@`HHHH`*
MQKK_`)';2_\`L&WG_HRVK9K&NO\`D=M+_P"P;>?^C+:@#9HHHH`YU()9/B%=
MRI*R)%IUKO4-C=F2YQD=ZN:9&T>M:HK2O*?W)W.%!^Z?0"F6O_([:I_V#;/_
M`-&7-36/_(>U3Z0_^@F@#3HHHH`QO%%R\&BS1PG]]=%;>/'7<YV_R)/X5GZX
MMO`-)T8?+:19GF'<10@$9]MVWZU;U/\`TSQ5IEEU2V1[R3ZCY$_5F/X5@:[(
M]]=:LT9PT\D.CVY'8L09?T)_[YJ;[LNHO=C#OK_7W&[X6Q:^&%U&[(C>\+WT
M[$X`W_-^`"X_*J^GQ2ZU<0Z_>HRJ)-MA$>`L98?.5_O$=\].PHO4&N:BF@VX
MQIUEM-ZR]&(^Y#_4^V*Z"X4+%$J@`"1``.W(K1+DC;J_Z_$AN[)Z6BBI`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"KJ&G
MVNIVCVMY")87'*G^8]#[UB&^O?#,\45\[7&D8"+>.-\L;?\`30C`V]@<'W-=
M+3)(DFC:.1%=&&&5AD$>]5&5M'L`J.LB!U(96&00>"*=7+E+GP@Y>!9+G1"<
MM$,L]G[KW*>W:NCM[F&[@2>WD66*0;D=3D$42C;5;`2TA&:6BI`R=0T1);Q=
M2LW:WOT7:'4X64=ED&#E?U'8U6T;5YKB^>TU&);?4(XP'C`PKC)^9.3E>?\`
M'%;Q&361JNCP:K<;79XIHD5X9X^'B;)Y!_F.]*W8UC)-<LOO[?\``-<'-9^M
M:6FJV8BW&.:)A+!(IP4D'0]#]#[$U2TW6;FWNQI6M*D=V?\`4S*,1W(]5]&]
M5_*MP?-S33,YPMHS-T#5&U/3]UPJQW<+F*YC48"2#KCD\=Q[&M.N=U=3H>L1
MZW'_`,>L^V&_'8#.$D_`G!]C[5T2L&&0<BFS.+>S.<L,Z#XE?2_NV6I;[BVS
MSMESF1!Z#'S`?7GM71BN>\:VMQ=Z(JV,4K7J3H]O)$"3"P_BX[8R/QI=%\4)
M<M#8:M!)IVI,H_=3KM68]S&3P?IUK-.SL:VNKG0T4459(4444`%8UU_R.VE_
M]@V\_P#1EM6S6-=?\CMI?_8-O/\`T9;4`;-%%%`&-:_\CMJG_8-L_P#T9<U-
M8_\`(>U3Z0_^@FH;7_D=M4_[!MG_`.C+FIK'_D/:I](?_030!ITA.*6J6K7R
M:;I=U>OT@B9\>I`X%`TKNR,:PNHUN-=UZ8_NX7,2'_8B'./JQ:N9GFN[2YT'
M3X8_-U*1);THPR//ER`S>R@N?^`UJZI''I7@_3=+N7"?:G4W3'J%'[R4_H1^
M-3^#!_;5_J/B6X@\N267[-;JPYCB0#CZDYS[BB*LDV.;O5;730Z#1=*BTC3D
MMD8R-DM+*WWI'/+,?J:LW7W(_P#KJG\ZF%0W7W(_^NJ?S%#=W=DD]%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`"$`\&N5U&WF\(F74]-7S=.9MUS8YQL).-\?IR>5Z5U=17-M%=P/!.@>-QAE
M/>JC+E>NP&1H?BS3=;B;9-'#,K;3"\@W'Z=S6WFLH^%]#:W-N^F6\B$Y^=-Q
MS]3S5;_A$+2#)TZ^O].)_A@N"4_[Y;(JFJ;>CL+4WJ@`S?M_UR7^9K'^Q>*+
M,_N-4L[]<?=NX#&W_?2'^E1C6]6M;LF_\/SG*`%K*19AU/.#@_I2Y'T:87-C
M4=,M=4M&MKN/>AY!!PRGL0>Q'K61::C=Z'<)I^LOYL$AVVU^1@-Z))Z-[]#]
M:FB\8:))((YKLV<I./+NXVA(/_`@!6BZV6JV;QL8;JWD7:P!#*PJ90E'5HUA
M45N66J)IX(KNWD@F0/%(I5U/0@CD5B^';B6RFGT"[<M+9@-!(W66`_=/N1]T
M_2H$FN?"K"*Y=[G1R<1W!^9[7V?U3T;MWJSX@MGFMX-9TXA[NQ_>Q[3Q+&?O
M)]".GOBDG?0SJP<;26J-T'-5=1TRRU:U:UOK=)XF_A8=#Z@]0?<4FGZG:ZE;
M0SVTJNLT8D49Y`]Q]>*N4`GU1S7E:WX;YMS+K.FK_P`LG/\`I,(_V3TD'L>?
M>M?2]9L-8MS-93K(%.'0\/&?1E/(/UJ]6-JGANVO[@7UM*]AJ*CY;N#AC[,.
MCCV-39K8JZ>YL4M<W'XAO-'=;?Q)`L2$[4U"$$P/_O=XS]>/>NACD61`Z,&5
MAE64Y!%--,35A]8UU_R.VE_]@V\_]&6U;-8UU_R.VE_]@V\_]&6U,1LT444`
M8UK_`,CMJG_8-L__`$9<U-8_\A[5/I#_`.@FH;7_`)';5/\`L&V?_HRYJ:Q_
MY#VJ?2'_`-!-`&G6#XF_TDV&ECG[;<KY@_Z9I\[?^@@?C6Z3BN(U[59I/%CV
MMBP^UPVODQ,>D)?YI)#_`+J!?Q(HY7+1&E/1\W8BUYX-8URXO)7$FG>'X&>1
M>TDW79[@;1GWXKI_"]DVG^&K&WDSYOE!Y<_WV^9OU)KC['3DC\):=IL>[.N:
M@'<-RQA!WDG_`(`@S_O5Z*!@8IR=Y66R,8?!?OJ+4%U]R/\`ZZI_,5/4%U]R
M/_KJG\Q2*)Z***`"BBB@`HHHH`****`"BBB@`HHHH`RO$`W6L"F$SAKA<Q9Q
MYG!./QK%Q+_T(\G_`'_A_P#BJW-;D\J.TDV,^VY5MJ#).`>![U6/B0C_`)@>
MK_\`@,/\::FH[JY2A*6QS274QU'R_P#A%E)\PI]E#Q;P,=?O9]\D8Q^9TOWO
M_0CR?]_X?_BJO#Q0WVED_L/5<!`<?9QNZGWZ<5+_`,)*W4:%J_\`X##_`.*I
MNK!_97XE>QF9.MHME=F&QTRR)6R:Y994R5VL`<D,.Q/0')'XU#:ZSH,JLDFE
M0^9&I)V])".H0=VR#\OH"<UTE[?7<-W910QQ;;N0Q_O,Y4A'<]/]T#\3573?
M$#7'V);F#YKVUCG4P(S["V/E8`':.>&/'!Z8YDS,.#4M/:^D1]%MWMV*"&2(
MA@N2%W,PR-F3G<.GI5R>?2XQ;.NC1@3PQ2;)1M.9)%0#/L6R?PK1M=<N[J&T
MF6WAQ/YHD7S#E-NX`YQTRH'K\WM4FF:J=2N[</;(A?3XKH,#DKYA.5^G`H`S
M)4MY]"_M"TT:RB\V!)86N9!M);!P>G/)[C)[BF1BQ^TMFSL)HA)!&41-LL;2
M$J0PW'IE3V_B':KY\3&STN6\U.TDC9+AHO*BVL1A=PYW8/RCJ#^7.);/Q!9:
MG?Q6\=K<&0%F#-&-J$%U))SQ]T\^X]:`+?\`86E?\^$/_?-']A:5_P`^$/\`
MWS5&V\5VUQ<06_V:X\V>%9D"J"-K*64=<YP#V[4Z\UJ^BN)4@L/D%HTT7F=7
M=2,I@'(X(ZCG/%`%S^PM*_Y\(?\`OFC0QMTJ-1T5Y%`]`'8`4:5JJ:FLF$VM
M&(VX)((=`P(R!ZX_"ET3_D%I_P!=)/\`T8U`%^BBB@`HHHH`2H`,W[?]<E_F
M:L5`/^/]_P#KDO\`,T`.EMX;A#'-$DJ'JKJ"/R-9$W@_0Y7:2*S^R2GGS+5V
MA(_[Y(%;E%4I2CLP.-UWPWK2VHCTS5[RYC+?/!<LK<?[W!(]LU1T?3?&7AU$
M2""WO;=D8BW,Q'E'(SC/`^F2.M>@4A&:J51RCRLJ$N6YYTDG]C2O<"YU+0Y)
M?FE6XM1+;L^<D_+D`'/8BM:Q\:3<+/#;7Z_\]=-F#M^,388?AFNM,:L"#R#U
M%86I^!]`U7+26*PR'_EI!\ASZ\<'\14)]Q<E-[7C^*+UAX@TS4FV6UVC2CK"
MWRR#ZJ<&M`-D]*\[U'X:W2C_`$/4&N43E8YG*LOT;!'_`(Z*AMKCQ+X>94GU
M">*)>-NHP&2+_OZA;'XXIM0Z/[Q^SJ=-?3_)GI,D23(T<B*Z,,,K#((]Q7//
MH-[HCM/X;F58B=SZ;.Q\EO\`</6,_I[57A\9W,=L)[K1WGBQS<:=*MPGUP,$
M#ZT1_$31KB5([59YCMW2#RRI09QT/7KVH5*4MD0II.QKZ3K]OJ<CVLD4EG?Q
M#][:3C#CW'9E]QQ45U_R.VE_]@V\_P#1EM4^I:+8:Y"AN8V62/YH9XF*21'U
M5AR*PM/&HV_CZTL-0OX+WR-+N6BD5=LNUI;?_6`<9^7@CKSQ6:;V93L=A111
M5",:U_Y';5/^P;9_^C+FIK'_`)#VJ?2'_P!!-5[9E'CC4E+`%M-L\#/)_>7-
M203Q6^LZK+-(L:*(<LYP!\I[T`7-2U"WTRQFO+I]D,*[F/?V`]STKB(H"?#M
MUK&-NH^(IA#'GK&CM@*#_N\_@/2G^)+P^(EF,#YL()%M[<CI<W+G;D>H3.?K
M]*U<6TWB/2M/A=#!IMJ9P`>"<;$_(;C5M<KMU*D[4O5V)+>%)O&<-O$/]'T:
MP"J!_"\AP/\`QQ/UKI:Y[PC_`*7%J&L$Y_M&\=HV]8D^1/T7/XUT591VN)Z:
M!4%U]R/_`*ZI_,5/4%U]R/\`ZZI_,50B>BBB@`HHHH`****`"BBB@`HHHH`*
M***`,S6Y%ACM97SM2Y5CM!)P`3T'6JB^+]*Y^2^_\`9O_B:MZW+'!%:S2L%C
MCN59F/8`$DU2_P"$X\,?]!>'\F_PHNEN)J3V*X\;:>;GR_LMT&W[2WV67[H&
M0<;<YYZ8_IFW_P`)?I6?N7W_`(`3?_$U2'C/PK]K\G[;"%7]Z)<'&\DY[9S_
M`(U:_P"$X\,_]!B'\F_PI<T2>2IU?X%N_NV2[LD6QAG^T.5B>1]I1MCL>-IQ
MPN/QJKI>MV02SCDMH-/^W6Z30!7&&S@;.@^;D8'?G'0U:O[F!;NQ#V+W+2N?
ML\@V\-L8G&2,?*I_/ZU7TG4M*5;58K5;#[7;I)`'VKO3C"@@]1N'R^_'>F61
M6MW;W$=E<1:-;@2B5`1MW1;=^?X?NDC!/JXXYJSI5_;7=Q`L-DD!DT^*X5AC
M(1B<)P.@Q5:WGTEX[*:'1V"3"5(F")\F-Y93\W&<-STRP]:M:5<Z;-<0BTLS
M"[6$4J-M`Q"Q.U.#VQTZ4`5(]9L9&ALY--4)YQC*X4JA\UXE(&.<E3]`:B.I
M>&+75#=")H[F,F(.(G"Y!D7`[<F.09]C5J"]TM+BQ2/3FC::XGCC<QJ!&ZLP
M?+9P"Q#$8Y/YU7O&\+7!DMW,,4ID(+K%AM^Z3H2N"2WFC'.?G'/-`%A=2T6T
M%K/%`%$T0EC<0G<JEE1>,9&3(`!V&>@HN]:TI=+FU-H$DC,"S!G55\P8!0<\
MYY&,]*1Y-"6"Q\PB6(P[HG*Y!0NF,C'=RF,#J..E3'4]&AT9_+"/9QVV\1)'
MPT>W.`#QR"./>@"O9^([4W3(+.2,3.C&3.=V]EC5C[$E<$9R/3&*TM$_Y!:?
M]=)/_1C50%W8M<B*33I8(PT$@E(3:Y9L19`8G[PXR.OM5_1/^06G_723_P!&
M-0!?HHHH`****`"H!_Q_O_UR7^9J>H!_Q_O_`-<E_F:`)Z***`"BBB@`HHHH
M`0@&DV`]>:=10!CW7A;2;F4SK;FUN#_RVM6,3_FO7\:P=5\#W$\PG$L.HLH.
M/M(,4N/^ND>,_P#`@:[:DH6CNM#3VDFK2U7F<-92>++4E(ED81R*OV>\99"P
M(Z"5.<8R<L.W7L=6V>67Q9I<EP")FTZ]\P%-NT^;;<?0>O.>M=&%`.:R+K_D
M=M+_`.P;>?\`HRVH,FE>ZT-FBBB@9SBV2W'Q!NKAG(-OIUJ0!WR]R.M4-4M+
M1+N_LYIKB(.898WD26<,0"""3G(]LULVO_([:I_V#;/_`-&7-;---IW0'#V%
MCH-K9VL#W-R?L\YFVI#.B@X(&`!VR.>O%+,--<7[VM^4N;T>7<N+.3@=<#"Y
M7@GZYSUK=/B>UBNG@N4:'$IC1L$ASN*^GJ!TSC(S4#>*=+MY))$#;&^>:38P
MYPH';DX(_(>M#;DVWU&];>1#H%_8:/IHL7N7:.-V\H):RX13SMY7L2<>V*T_
M^$CTO_GK-_X#2_\`Q-36.KVFH32Q6[,SPG;)E"-I[C/K5ZI2L#=S+_X2/2_^
M>LW_`(#2_P#Q-17'B'375`LDQQ(I/^C2],_[M;-9^IZF=,\MWA#1,3N?=RH"
MLY.,'.`I_2F(C_X2/2_^>LW_`(#2_P#Q-'_"1Z7_`,]9O_`:7_XFHY?$^G1$
M*?-9VD,00)@E@<$<\<'/Y4P>+=)*%O-DX3S,>4V=N,YZ4`3+XFTEBP6>0E3@
MXMY#@]?[OO2_\)'I?_/6;_P&E_\`B:BBUNS\N[FM(6/EA)IR1MX.5)]>%3/T
M`IL7BBR,$<DX>)G`(0*S$'@$'C@[LK]10!/_`,)'I?\`SUF_\!I?_B:/^$CT
MO_GK-_X#2_\`Q-+;:W%<V;7"1G"70MF&>A\P)G]0<5IT`9?_``D>E_\`/6;_
M`,!I?_B:/^$CTO\`YZS?^`TO_P`33[[538721R09B9"Y<-R,,J_=QZN/UJK+
MXLTR--X:5AL#\1G[NX#=SVY%`$__``D>E_\`/6;_`,!I?_B:1?$NDN@=)Y65
MAD$6\A!'_?-,'BC3"YC#R%Q)Y141-D-D#'YD#/2H3XBM+72+:\MK<_8F8Q*2
M=NT*<9QSQA6/X#UH`M?\)'I?_/6;_P`!I?\`XFC_`(2/2_\`GK-_X#2__$U!
M<>*+.WBFWJQGBC+F(*V,[=V-V/<9],U?74!)+:B*/?%<J6$@8<<9''<>_P!/
MP`,O4M8L;N*(07+))%*LBF2TE*G'8X`]:B_M^7_GYMO_``"GKI:R9]>CL[F:
M.[B\N.,X\Q26S\I;ICCY5)HL!BK=Q+.)A<1;Q(9!^XNL;CG)QG'>K3^(G1=S
MW=HJ]R;*<"K<GBW3(LEFEVK'YCGRS\HR%&1UZMC\#1/XBTB4&"0O(#,(2OE'
M'F=0N>G:E9#N9\^J_:98)9;B`O;L6C(M+D;205)XZ\$_G4-M<6UH(Q$;7]TB
MI'OL[ERBKT`W9QCVK8E\0".6T46QQ>1J\19\$Y!.#P<<[1]7%-D\5Z<-GE%Y
M`Q4DE2H"L<`Y(QR>U,1CPS6\`C$4\:"-650(;O&&))XSSR<\^WH*DM;V&SD2
M2"6W1HX%@7_1;DXC7H.?3/7K72Q7GF:A/:&,J8D1PV>&#9]O]FK#$A"5&X@<
M#.,T`<E#>Q0%/+GA`1WD`-M=$;F)8G!.,Y)/MGBJ5U;V-TCCSHHG=MQD2WN<
M@DN3UXY\V3_OH^V.DC\1VX8I=1M$_F%`$!<'YG7.0/6-S]![TQ?%NEDL2TH4
M;L-LR#MQNZ>F?\*`,-I;8K:Q2W<+^2GEINMK@%@&5P,]3@H"/I5AKRW?3!IC
MM:268C$8B>RN&&T#`'//%:A\1:5/<0*H>60,AB_=D8WG8""?J?PS3G\1Q0WD
M]O<0^5Y!^8[B>,GGI[Q]_P#EH*`,@WD7EK&LULB*\;[5LI\'R\%![`$`X'I[
MFM/3M9TZSL4@DN)'<%BS+:R@$EB>/E]ZL6WB&SN[^&U@W'SA)M9E*\IC(P1[
M_I5NPOH]1MVFB!"K(\?)Z[6(S^.,T`5?^$CTO_GK-_X#2_\`Q-'_``D>E_\`
M/6;_`,!I?_B:MZA=-8V,UTL8D\E"Y4MMR`,GG%4)/$UA;K+]I+1O#GS`$9@N
M"1UQSR#^5`$G_"1Z7_SUF_\``:7_`.)I/^$ETDN4$\NX`$C[/)D#_OGV-0CQ
M7I@;;(TD;;W3#(3RHR>1QT(_.GVVMV5Y>,ME$\ER\#-\R[,A&(`)/3YBPZ>M
M`$G_``D>E_\`/6;_`,!I?_B:B'B#3?MC/YDVTQ@9^S2]<G_9J.W\664D)FG5
MH8]^S."QS@GH!_=P3Z9J>#7H[N*]:V@>5[3!"9P7RH(Z].I'?I0`[_A(]+_Y
MZS?^`TO_`,31_P`)'I?_`#UF_P#`:7_XFM""7SH$E`P'4,.O<>^#574M1_LX
M0'RO,\Z0IU/RX5FSP#V4T`0_\)'I?_/6;_P&E_\`B:/^$CTO_GK-_P"`TO\`
M\359?%=D;PQ%6$>QG$G))VXR-N/]X_A4\?B/3Y4=E,OR2+&08SPQQQ]1D9]*
M`%7Q-I+@E9Y&P<'%O(<'_OFE_P"$CTO_`)ZS?^`TO_Q-01:]8_V;+>6$1>,,
M'<,#'PS$%N1Z@Y^E.C\3V)BC>;=&9$615"LWRDX'0<'(;CVH`E_X2/2_^>LW
M_@-+_P#$T?\`"1Z7_P`]9O\`P&E_^)I;/6HKRSL[E(R!=2"/&[.UMI)^N,$5
MIT`9?_"1Z7_SUF_\!I?_`(FC_A(]+_YZS?\`@-+_`/$T^ZU=;2_-L\+%5C1V
M<9.-S,H&,>J@<D=?:J4'BVQ=9GE5HUC9]I7+;E7JW3CM^=`%EO$NDHA=YY55
M1DDV\@`'_?-44U*UU#QMI_V9W;R]-N]VZ-DZR6WJ!GI5BY\2:2UD3<>88)HF
M+`Q'E<A2"/J<8Z]:C-PEUXQTN6/.TZ=>KR,'(EM@1^8H`WZ***`,:U_Y';5/
M^P;9_P#HRYK9K&M?^1VU3_L&V?\`Z,N:M6^NZ/=7[V%MJUE->(6#V\=PC2*5
MZ@J#D8[T`6?LEN228(R2<DE!R?7]337L+23_`%EK"^?[T8-/@N(+J,R6\T<R
M!F0M&P8;E)!&1W!!!]Q4M`$<<$,1)CB1">NU0,_YR?SJ2BFF1%=49U#/G:I/
M)QUQ0`ZHY(8IAB2-7'/#*#U&#^G%+)-%$,RR(@QGYF`_SU'YT^@"'[);DDF"
M,YY^X*3[%:XQ]FBQC&-@]Q_(G\ZGHH`C2"&/.R)%W<'"@9I'MX9/OQ(W!'*@
M\'K4M%`$*VMNH(6&,`MN("CDYSGZYJ:BB@".2&*4@R1HY`P"R@X_S@?E339V
MQ!!MXB",'*#GG/\`/FIJ*`(/L=MVMXNN?N#KQ_@/RIZP1)'Y:QHJ#HH4`?E4
ME%`$+VMO(27AC8GKN4'/&/Y<4JVL"NCK#&&0$(P094'KCTJ6B@`J)K:!V+/"
MC,>I*@D\8_D<5+10!`;.U88-O$1[H*#9VQ.3;Q$YSG8/\]S4]%`$4A@@C#2-
M'&B\`M@`?YXJ,6MG,@80P.K#((0$$'G^N?QJ'5K`ZC;QQ#`*2;PVXJRD`X*L
M.AR??C([U@_\(KJ\>X6^MF`NVYG167G$?.P';_`PQTPWX4`=1"UNY=H&C8AM
MKE"#\P[''<5&NH63L56\@)7J!("1\VW_`-"X^O%8NDZ'>V.IF66X<HY>654=
MO+9CC:!ELY&&R2.01Z5*WAR0:M)?0WAB5V<B,)G:&`)Q[^8H?\3ZT`:LL5G`
MGF2I!&H(^9@``<\<_4_F:=]BM?\`GVBZ8^X.E<U<^&]:NK989=50@A2V"Y`<
M/G(R3D$8X.0"!726,<T-G%'<,K2JH#,I)!/KSS^=`#A:6X;<((MW7.P9ZY_F
M<T]HD<$,BL&&"".HI]%`$(M+<2"001AP<AM@R#4H`'0`=^*6B@!KHLB%'4,K
M#!!&0149M+9LY@C.<Y^0<Y.3_(5-10!`;.U))-O$2<Y)0<YZTY+:&-]Z1(K'
MNJ@&I:*`(S!$V,QJ<'(RHX/K35L[9,[;>)<@`X0#('3^0_*IJ*`"FM&KLK,H
M)4Y4D=#[4ZB@"`6=J&W"WB#8QD(,X_R!^52&)"I4HN&.2,=:?10!!;V=O:1-
M%!$J(S%BH'&2<FG-;PN<M$C'&,E0>,Y_GS4M%`$2VT$:A4AC4!MP`0#!QC/U
MQ4M%%`$;0Q.26C1BPP25!R/2FK:6Z,66"-6.<D(!G/6IJ*`(+BTM[N!H)XE>
M-P5*D=CU^E9<Z+'XTTI$&%&FW@`]/WEM6W6-=?\`([:7_P!@V\_]&6U`&S11
M10!C6O\`R.VJ?]@VS_\`1ES63IT.OV,E_&EOJK%GN6MUE>S^R@M(S(05/F]Q
MU]3D5-K5AXNC\12:CX<;1O*GM(H)5U`R[@T;RL-NP=,2=_2JW_%T?^I3_P#)
MF@"YH&CZAX>L+VRGFBG@\H20SPH8\/LVL"&=CGY0Q;/)8GKUQ["QUV;2(9FA
MU>6TE$3R6ZZEBYE;8^YTE,@VH6,9V;E^Z>!G:;G_`!='_J4__)FC_BZ/_4I_
M^3-`$5A!KLNK2Q227CW%OY:2S_:_W"_Z.NY=F1EBQ!#!?4Y'0W#'KL\;W3Z;
M<"2.%EC@DND#LWEXX97^7+=#D=B2.T'_`!='_J4__)FC_BZ/_4I_^3-`%>QT
M?7T>VFG@O3)&UPD;->DF)'\MEW;IF)^ZZ_>;G';!%J/2M<GS#*VH0J\B"ZD^
MWD>=\X+-%AR8UVY&!M//`R,TW_BZ/_4I_P#DS1_Q='_J4_\`R9H`Z31H+FVT
MJ&"[:1I8RRYDD\QBH8[<L223MQR3GUJ]7&_\71_ZE/\`\F:/^+H_]2G_`.3-
M`'945QO_`!='_J4__)FC_BZ/_4I_^3-`'945QO\`Q='_`*E/_P`F:/\`BZ/_
M`%*?_DS0!V5%<;_Q='_J4_\`R9H_XNC_`-2G_P"3-`'945QO_%T?^I3_`/)F
MC_BZ/_4I_P#DS0!V-+7&_P#%T?\`J4__`"9H_P"+H_\`4I_^3-`'8TM<;_Q=
M'_J4_P#R9H_XNC_U*?\`Y,T`=E17&_\`%T?^I3_\F:/^+H_]2G_Y,T`=E17&
M_P#%T?\`J4__`"9H_P"+H_\`4I_^3-`'945QO_%T?^I3_P#)FC_BZ/\`U*?_
M`),T`=E17&_\71_ZE/\`\F:/^+H_]2G_`.3-`'945QO_`!='_J4__)FC_BZ/
M_4I_^3-`'945QO\`Q='_`*E/_P`F:/\`BZ/_`%*?_DS0!V5%<;_Q='_J4_\`
MR9H_XNC_`-2G_P"3-`'945QO_%T?^I3_`/)FC_BZ/_4I_P#DS0!V5%<;_P`7
M1_ZE/_R9H_XNC_U*?_DS0!V5%<;_`,71_P"I3_\`)FC_`(NC_P!2G_Y,T`=E
M17&_\71_ZE/_`,F:/^+H_P#4I_\`DS0!V5%<;_Q='_J4_P#R9H_XNC_U*?\`
MY,T`=E17&_\`%T?^I3_\F:/^+H_]2G_Y,T`=E17&_P#%T?\`J4__`"9H_P"+
MH_\`4I_^3-`'95C77_([:7_V#;S_`-&6U8W_`!='_J4__)FK.BV'BZ3Q%'J/
?B-M&\J"TE@B73S+N+2/$QW;QTQ'V]:`.IHHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
